Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Almora,1.1,Total number of pregnant women Registered for ANC,TOTAL,1040.0,1122.0,1048.0,980.0,1084.0,936.0,844.0,660.0,718.0,788.0,965.0,914.0,11099.0
Almora,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,566.0,605.0,563.0,638.0,659.0,536.0,460.0,386.0,419.0,503.0,608.0,541.0,6484.0
Almora,1.2,Number of Pregnant women registered under JSY,TOTAL,1040.0,1122.0,1048.0,980.0,1084.0,936.0,845.0,660.0,717.0,787.0,966.0,909.0,11094.0
Almora,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,627.0,615.0,730.0,712.0,739.0,699.0,675.0,617.0,621.0,515.0,566.0,582.0,7698.0
Almora,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,788.0,782.0,751.0,668.0,767.0,673.0,571.0,446.0,501.0,529.0,705.0,696.0,7877.0
Almora,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,671.0,912.0,814.0,795.0,734.0,806.0,698.0,557.0,549.0,539.0,629.0,769.0,8473.0
Almora,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,94.0,495.0,577.0,326.0,153.0,111.0,100.0,36.0,236.0,59.0,605.0,1620.0,4412.0
Almora,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,7.0,25.0,6.0,9.0,8.0,17.0,13.0,8.0,2.0,8.0,19.0,7.0,129.0
Almora,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,1.0,2.0,3.0,1.0,1.0,0.0,0.0,0.0,0.0,8.0
Almora,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,247.0,551.0,303.0,534.0,617.0,558.0,485.0,470.0,387.0,236.0,539.0,553.0,5480.0
Almora,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,3.0,11.0,3.0,14.0,4.0,7.0,6.0,50.0,2.0,9.0,4.0,115.0
Almora,1.8,Number of pregnancy test kits used at SC level,TOTAL,617.0,590.0,547.0,832.0,409.0,571.0,481.0,559.0,666.0,595.0,557.0,433.0,6857.0
Almora,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,78.0,103.0,104.0,114.0,112.0,150.0,111.0,104.0,113.0,83.0,116.0,109.0,1297.0
Almora,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,29.0,35.0,44.0,69.0,69.0,103.0,64.0,59.0,66.0,56.0,70.0,80.0,744.0
Almora,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,107.0,138.0,148.0,183.0,181.0,253.0,175.0,163.0,179.0,139.0,186.0,189.0,2041.0
Almora,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,81.0,105.0,114.0,128.0,124.0,174.0,111.0,107.0,114.0,103.0,137.0,106.0,1404.0
Almora,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,25.0,24.0,25.0,53.0,22.0,11.0,16.0,33.0,31.0,36.0,13.0,289.0
Almora,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,283.0,341.0,397.0,460.0,526.0,570.0,458.0,540.0,423.0,353.0,450.0,489.0,5290.0
Almora,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,222.0,252.0,245.0,339.0,385.0,458.0,325.0,429.0,289.0,290.0,369.0,380.0,3983.0
Almora,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,278.0,307.0,407.0,388.0,554.0,545.0,398.0,525.0,457.0,360.0,412.0,479.0,5110.0
Almora,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,131.0,207.0,199.0,272.0,332.0,364.0,291.0,455.0,365.0,289.0,374.0,499.0,3778.0
Almora,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,22.0,42.0,30.0,40.0,54.0,46.0,34.0,47.0,41.0,49.0,29.0,32.0,466.0
Almora,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,26.0,35.0,33.0,26.0,31.0,26.0,28.0,27.0,13.0,8.0,9.0,29.0,291.0
Almora,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Almora,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,26.0,35.0,33.0,26.0,31.0,26.0,28.0,27.0,13.0,8.0,9.0,29.0,291.0
Almora,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,16.0,26.0,22.0,37.0,44.0,40.0,23.0,34.0,32.0,36.0,21.0,26.0,357.0
Almora,4.1.1.a,Number of male live births,TOTAL,212.0,265.0,297.0,364.0,380.0,449.0,359.0,422.0,343.0,286.0,352.0,422.0,4151.0
Almora,4.1.1.b,Number of female live births,TOTAL,200.0,253.0,272.0,322.0,383.0,424.0,321.0,343.0,313.0,265.0,321.0,319.0,3736.0
Almora,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,412.0,518.0,569.0,686.0,763.0,873.0,680.0,765.0,656.0,551.0,673.0,741.0,7887.0
Almora,4.1.2,Number of still births,TOTAL,5.0,7.0,14.0,16.0,16.0,11.0,4.0,15.0,9.0,5.0,10.0,14.0,126.0
Almora,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,32.0,35.0,47.0,43.0,40.0,41.0,29.0,29.0,29.0,28.0,33.0,28.0,414.0
Almora,4.2.1,Number of Newborns weighed at birth,TOTAL,400.0,507.0,560.0,685.0,761.0,865.0,665.0,754.0,644.0,553.0,655.0,711.0,7760.0
Almora,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,35.0,38.0,41.0,49.0,77.0,68.0,40.0,87.0,60.0,52.0,44.0,87.0,678.0
Almora,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,394.0,502.0,553.0,684.0,752.0,865.0,656.0,750.0,645.0,554.0,663.0,717.0,7735.0
Almora,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Almora,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,26.0,35.0,33.0,26.0,31.0,21.0,28.0,27.0,13.0,8.0,10.0,28.0,286.0
Almora,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Almora,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,26.0,38.0,33.0,26.0,31.0,21.0,28.0,27.0,13.0,8.0,10.0,28.0,289.0
Almora,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,16.0,26.0,22.0,37.0,44.0,40.0,23.0,34.0,32.0,36.0,21.0,21.0,352.0
Almora,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,42.0,64.0,50.0,63.0,75.0,66.0,51.0,61.0,45.0,44.0,28.0,54.0,643.0
Almora,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Almora,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,42.0,61.0,51.0,63.0,75.0,66.0,51.0,61.0,45.0,44.0,31.0,54.0,644.0
Almora,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,8.0,25.0,2.0,4.0,17.0,9.0,21.0,6.0,4.0,3.0,4.0,4.0,107.0
Almora,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,340.0,343.0,435.0,497.0,649.0,642.0,599.0,609.0,492.0,458.0,577.0,577.0,6218.0
Almora,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,302.0,372.0,375.0,436.0,527.0,535.0,420.0,453.0,387.0,412.0,406.0,430.0,5055.0
Almora,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,28.0,25.0,28.0,25.0,43.0,27.0,18.0,22.0,15.0,34.0,47.0,28.0,340.0
Almora,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Almora,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,28.0,25.0,28.0,26.0,43.0,27.0,18.0,22.0,15.0,34.0,47.0,28.0,341.0
Almora,7.2,Number of MTPs conducted at Private Facilities,TOTAL,5.0,5.0,5.0,2.0,19.0,7.0,9.0,14.0,7.0,5.0,6.0,6.0,90.0
Almora,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,123.0,146.0,94.0,204.0,151.0,181.0,141.0,144.0,113.0,99.0,107.0,115.0,1618.0
Almora,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,196.0,264.0,255.0,256.0,288.0,313.0,221.0,289.0,203.0,208.0,245.0,236.0,2974.0
Almora,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,319.0,410.0,349.0,460.0,439.0,494.0,362.0,433.0,316.0,307.0,352.0,351.0,4592.0
Almora,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2.0,1.0,0.0,115.0,1.0,1.0,2.0,1.0,8.0,40.0,2.0,1.0,174.0
Almora,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,21.0,7.0,0.0,0.0,19.0,4.0,0.0,18.0,0.0,69.0
Almora,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,0.0,8.0,15.0,13.0,0.0,0.0,0.0,0.0,3.0,17.0,58.0
Almora,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Almora,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,2.0,0.0,144.0,23.0,14.0,2.0,20.0,12.0,40.0,23.0,18.0,301.0
Almora,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,9.0
Almora,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Almora,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,9.0
Almora,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,9.0,3.0,2.0,75.0,5.0,4.0,1.0,52.0,170.0,245.0,150.0,16.0,732.0
Almora,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,29.0,4.0,0.0,0.0,34.0,41.0,31.0,93.0,9.0,241.0
Almora,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,8.0,11.0,4.0,13.0,4.0,8.0,7.0,7.0,9.0,36.0,46.0,5.0,158.0
Almora,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Almora,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,17.0,14.0,6.0,117.0,13.0,12.0,8.0,93.0,220.0,312.0,289.0,30.0,1131.0
Almora,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,3.0,1.0,4.0,0.0,4.0,4.0,3.0,1.0,2.0,1.0,2.0,25.0
Almora,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Almora,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,3.0,1.0,4.0,0.0,4.0,4.0,3.0,1.0,2.0,1.0,2.0,25.0
Almora,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,325.0,514.0,552.0,1265.0,471.0,445.0,430.0,412.0,461.0,430.0,399.0,366.0,6070.0
Almora,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,41.0,57.0,64.0,125.0,65.0,59.0,65.0,59.0,42.0,38.0,38.0,43.0,696.0
Almora,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,23.0,26.0,39.0,75.0,37.0,21.0,18.0,18.0,22.0,39.0,16.0,12.0,346.0
Almora,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,10.0,70.0,42.0,64.0,81.0,67.0,91.0,39.0,20.0,24.0,17.0,23.0,548.0
Almora,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Almora,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,399.0,667.0,697.0,1529.0,654.0,592.0,604.0,528.0,545.0,531.0,470.0,444.0,7660.0
Almora,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,18.0,19.0,29.0,39.0,51.0,37.0,31.0,20.0,37.0,74.0,25.0,53.0,433.0
Almora,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.06,Number of IUCD removals,TOTAL,135.0,111.0,142.0,218.0,178.0,175.0,170.0,189.0,226.0,166.0,173.0,198.0,2081.0
Almora,9.07,Number of Oral Pills cycles distributed,TOTAL,2376.0,2992.0,3398.0,4774.0,3350.0,3072.0,2969.0,4197.0,3790.0,3889.0,2800.0,2817.0,40424.0
Almora,9.08,Number of Condom pieces distributed,TOTAL,28908.0,40633.0,41794.0,59400.0,43768.0,39552.0,41123.0,43538.0,39149.0,38061.0,33871.0,27648.0,477445.0
Almora,9.09,Number of Centchroman (weekly) pills given,TOTAL,22.0,3.0,11.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,42.0
Almora,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,227.0,267.0,377.0,591.0,321.0,392.0,324.0,270.0,227.0,214.0,227.0,197.0,3634.0
Almora,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0
Almora,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,5.0,0.0,6.0
Almora,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,9.12,Number of Institutions having NSV trained doctors,TOTAL,7.0,6.0,6.0,7.0,5.0,6.0,4.0,4.0,6.0,4.0,4.0,4.0,-1.0
Almora,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,563.0,620.0,725.0,617.0,821.0,1002.0,815.0,744.0,759.0,686.0,743.0,781.0,8876.0
Almora,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,5.0,7.0,4.0,6.0,5.0,3.0,5.0,4.0,6.0,4.0,52.0,9.0,110.0
Almora,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,13.0,8.0,3.0,4.0,5.0,3.0,5.0,5.0,6.0,4.0,46.0,7.0,109.0
Almora,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,37.0,13.0,11.0,6.0,4.0,2.0,7.0,6.0,5.0,6.0,66.0,5.0,168.0
Almora,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,726.0,763.0,672.0,616.0,633.0,799.0,844.0,928.0,743.0,784.0,689.0,658.0,8855.0
Almora,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,677.0,795.0,805.0,689.0,605.0,606.0,806.0,845.0,905.0,715.0,714.0,782.0,8944.0
Almora,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,738.0,733.0,787.0,812.0,691.0,616.0,661.0,789.0,820.0,872.0,725.0,768.0,9012.0
Almora,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,346.0,482.0,508.0,566.0,656.0,787.0,607.0,687.0,516.0,429.0,604.0,572.0,6760.0
Almora,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,770.0,757.0,680.0,621.0,638.0,796.0,849.0,936.0,745.0,790.0,742.0,668.0,8992.0
Almora,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,680.0,782.0,804.0,671.0,606.0,606.0,815.0,848.0,920.0,717.0,759.0,781.0,8989.0
Almora,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,763.0,743.0,797.0,804.0,694.0,616.0,664.0,790.0,821.0,880.0,790.0,778.0,9140.0
Almora,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,266.0,343.0,352.0,369.0,491.0,563.0,437.0,470.0,342.0,297.0,394.0,358.0,4682.0
Almora,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4.0,18.0,8.0,41.0,11.0,33.0,20.0,11.0,13.0,3.0,7.0,8.0,177.0
Almora,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,13.0,18.0,6.0,12.0,14.0,13.0,36.0,15.0,16.0,7.0,8.0,21.0,179.0
Almora,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,39.0,18.0,18.0,42.0,17.0,16.0,22.0,9.0,13.0,10.0,13.0,20.0,237.0
Almora,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,573.0,907.0,1009.0,973.0,893.0,775.0,803.0,770.0,753.0,691.0,601.0,634.0,9382.0
Almora,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,566.0,664.0,692.0,720.0,763.0,698.0,673.0,631.0,555.0,660.0,591.0,671.0,7884.0
Almora,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,43.0,0.0,51.0,39.0,34.0,0.0,37.0,35.0,24.0,37.0,43.0,343.0
Almora,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,300.0,426.0,459.0,484.0,451.0,406.0,408.0,381.0,399.0,359.0,292.0,318.0,4683.0
Almora,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,251.0,380.0,446.0,458.0,411.0,357.0,347.0,369.0,329.0,307.0,279.0,290.0,4224.0
Almora,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,551.0,806.0,905.0,942.0,862.0,763.0,755.0,750.0,728.0,666.0,571.0,608.0,8907.0
Almora,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,688.0,773.0,761.0,775.0,829.0,727.0,725.0,659.0,575.0,666.0,642.0,740.0,8560.0
Almora,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,688.0,771.0,757.0,774.0,830.0,726.0,721.0,657.0,576.0,666.0,638.0,733.0,8537.0
Almora,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,7.0,7.0,8.0,16.0,6.0,5.0,6.0,9.0,4.0,4.0,11.0,40.0,123.0
Almora,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,200.0,237.0,248.0,267.0,272.0,293.0,239.0,235.0,248.0,306.0,267.0,263.0,3075.0
Almora,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,197.0,213.0,239.0,237.0,238.0,239.0,236.0,241.0,193.0,288.0,233.0,231.0,2785.0
Almora,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,397.0,450.0,487.0,504.0,510.0,532.0,475.0,476.0,441.0,594.0,500.0,494.0,5860.0
Almora,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,728.0,891.0,1062.0,1049.0,963.0,1119.0,951.0,897.0,879.0,941.0,744.0,705.0,10929.0
Almora,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,730.0,984.0,1008.0,1122.0,1088.0,1081.0,1014.0,980.0,921.0,946.0,853.0,749.0,11476.0
Almora,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,653.0,734.0,910.0,1172.0,1060.0,1073.0,1066.0,908.0,780.0,926.0,805.0,761.0,10848.0
Almora,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,2.0,0.0,4.0,4.0,4.0,7.0,1.0,3.0,0.0,0.0,2.0,27.0
Almora,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,29.0,48.0,85.0,94.0,93.0,64.0,71.0,66.0,60.0,67.0,67.0,744.0
Almora,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1124.0,1201.0,1166.0,1246.0,1206.0,1238.0,1249.0,1291.0,1280.0,1379.0,1463.0,1371.0,15214.0
Almora,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1084.0,1144.0,1136.0,1207.0,1186.0,1201.0,1211.0,1228.0,1213.0,1253.0,1332.0,1325.0,14520.0
Almora,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1048.0,1110.0,1104.0,1169.0,1128.0,1162.0,1166.0,1206.0,1196.0,1224.0,1296.0,1299.0,14108.0
Almora,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Almora,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,550.0,693.0,788.0,805.0,686.0,532.0,764.0,721.0,674.0,651.0,514.0,507.0,7885.0
Almora,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,524.0,598.0,518.0,587.0,631.0,650.0,701.0,752.0,676.0,694.0,512.0,481.0,7324.0
Almora,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,616.0,599.0,706.0,670.0,722.0,700.0,612.0,739.0,563.0,574.0,531.0,501.0,7533.0
Almora,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,11.0,4.0,0.0,1.0,0.0,3.0,0.0,0.0,0.0,1.0,20.0
Almora,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,192.0,146.0,133.0,132.0,129.0,114.0,61.0,58.0,85.0,69.0,49.0,50.0,1218.0
Almora,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,1.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,7.0
Almora,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,4.0,8.0,29.0,8.0,8.0,6.0,9.0,5.0,11.0,14.0,14.0,9.0,125.0
Almora,13.1,Number of Patients operated for cataract,TOTAL,41.0,37.0,9.0,725.0,15.0,17.0,11.0,35.0,28.0,52.0,51.0,26.0,1047.0
Almora,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,32.0,26.0,0.0,24.0,15.0,16.0,8.0,27.0,15.0,17.0,32.0,21.0,233.0
Almora,13.3,Number of School children detected with Refractive errors,TOTAL,3.0,15.0,1.0,4.0,3.0,3.0,12.0,1.0,10.0,3.0,7.0,6.0,68.0
Almora,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Almora,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,4.0,4.0,4.0,5.0,4.0,4.0,5.0,4.0,4.0,4.0,5.0,-1.0
Almora,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,5.0,3.0,5.0,1.0,2.0,2.0,1.0,2.0,3.0,4.0,1.0,-1.0
Almora,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,726.0,749.0,761.0,756.0,768.0,746.0,745.0,752.0,839.0,824.0,800.0,840.0,-1.0
Almora,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,4.0,4.0,4.0,4.0,4.0,4.0,5.0,4.0,4.0,4.0,5.0,-1.0
Almora,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0
Almora,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,9.0,8.0,6.0,8.0,7.0,7.0,5.0,7.0,7.0,5.0,5.0,5.0,-1.0
Almora,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,5.0,-1.0
Almora,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Almora,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Almora,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Almora,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Almora,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,79.0,173.0,215.0,132.0,220.0,169.0,130.0,110.0,90.0,59.0,113.0,139.0,1629.0
Almora,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,494.0,358.0,769.0,469.0,555.0,679.0,435.0,320.0,683.0,326.0,579.0,594.0,6261.0
Almora,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,243.0,316.0,138.0,101.0,147.0,88.0,105.0,142.0,178.0,237.0,272.0,271.0,2238.0
Almora,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,573.0,495.0,1093.0,1023.0,1261.0,1167.0,782.0,653.0,643.0,759.0,1090.0,806.0,10345.0
Almora,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,322.0,489.0,353.0,233.0,367.0,257.0,235.0,252.0,268.0,296.0,385.0,410.0,3867.0
Almora,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1067.0,853.0,1862.0,1492.0,1816.0,1846.0,1217.0,973.0,1326.0,1085.0,1669.0,1400.0,16606.0
Almora,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,12.0,5.0,4.0,3.0,7.0,4.0,6.0,4.0,9.0,9.0,3.0,71.0
Almora,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,5.0,5.0,0.0,5.0,7.0,4.0,4.0,6.0,6.0,6.0,8.0,57.0
Almora,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,6.0,17.0,10.0,4.0,8.0,14.0,8.0,10.0,10.0,15.0,15.0,11.0,128.0
Almora,14.11,In-Patient Head Count at midnight,TOTAL,359.0,415.0,734.0,458.0,889.0,422.0,305.0,224.0,221.0,365.0,246.0,930.0,5568.0
Almora,14.12.1,OPD attendance (All),TOTAL,31348.0,42151.0,49658.0,46126.0,52624.0,54329.0,39372.0,35066.0,36811.0,36794.0,50905.0,42318.0,517502.0
Almora,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,99.0,86.0,80.0,78.0,95.0,46.0,59.0,85.0,70.0,62.0,90.0,85.0,935.0
Almora,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,2.0,2.0,0.0,0.0,0.0,17.0,21.0,48.0,29.0,12.0,131.0
Almora,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Almora,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,74.0,64.0,76.0,74.0,93.0,71.0,112.0,42.0,55.0,61.0,30.0,28.0,780.0
Almora,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Almora,14.14.a,Number of patients given AYUSH treatment,TOTAL,1701.0,1611.0,1837.0,1789.0,2033.0,1944.0,1698.0,1592.0,1411.0,1331.0,1526.0,1601.0,20074.0
Almora,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,891.0,631.0,445.0,1100.0,987.0,911.0,876.0,842.0,575.0,1059.0,898.0,996.0,10211.0
Almora,14.14.c,Number of Adolescents counselled,TOTAL,15.0,41.0,36.0,51.0,27.0,14.0,10.0,10.0,45.0,35.0,15.0,37.0,336.0
Almora,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Almora,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2402.0,2566.0,3002.0,2544.0,2694.0,2740.0,2347.0,1833.0,2353.0,1817.0,2506.0,2201.0,29005.0
Almora,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,35.0,18.0,20.0,19.0,30.0,29.0,34.0,28.0,17.0,30.0,31.0,11.0,302.0
Almora,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,166.0,214.0,218.0,204.0,195.0,178.0,188.0,230.0,216.0,181.0,196.0,166.0,2352.0
Almora,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,4.0,0.0,1.0,4.0,0.0,0.0,3.0,1.0,2.0,15.0
Almora,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,207.0,138.0,143.0,143.0,157.0,122.0,176.0,138.0,162.0,144.0,152.0,162.0,1844.0
Almora,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,2.0,1.0,4.0,0.0,12.0
Almora,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,521.0,560.0,538.0,491.0,585.0,516.0,444.0,446.0,592.0,372.0,524.0,425.0,6014.0
Almora,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Almora,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,894.0,912.0,899.0,838.0,937.0,816.0,808.0,814.0,970.0,697.0,872.0,753.0,10210.0
Almora,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,1.0,0.0,5.0,1.0,1.0,6.0,0.0,2.0,4.0,5.0,2.0,28.0
Almora,15.2,Number of Widal tests conducted,Number tested,488.0,564.0,631.0,595.0,967.0,902.0,640.0,372.0,396.0,236.0,376.0,443.0,6610.0
Almora,15.3.a,Number of VDRL tests conducted on males,Number tested,42.0,25.0,15.0,13.0,17.0,14.0,8.0,13.0,18.0,13.0,22.0,2.0,202.0
Almora,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,17.0,19.0,38.0,26.0,37.0,28.0,32.0,39.0,15.0,40.0,63.0,78.0,432.0
Almora,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,498.0,507.0,591.0,501.0,621.0,457.0,372.0,384.0,440.0,283.0,414.0,429.0,5497.0
Almora,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,557.0,551.0,644.0,540.0,675.0,499.0,412.0,436.0,473.0,336.0,499.0,509.0,6131.0
Almora,15.4.1,Number of blood smears examined for Malaria,TOTAL,316.0,248.0,516.0,549.0,919.0,943.0,749.0,521.0,515.0,366.0,402.0,356.0,6400.0
Almora,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,4.0,4.0,2.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,12.0
Almora,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,8970.0,6620.0,,,,,,,,,,,15590.0
Almora,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2350.0,1800.0,,,,,,,,,,,4150.0
Almora,16.1.1,Stock position of DPT vaccines,5. Total Stock,6620.0,4820.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11440.0
Almora,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,6140.0,2540.0,,,,,,,,,,,8680.0
Almora,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3600.0,1490.0,,,,,,,,,,,5090.0
Almora,16.1.1A,Stock Position of Pentavalent,5. Total Stock,2540.0,1050.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3590.0
Almora,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2630.0,990.0,,,,,,,,,,,3620.0
Almora,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5000.0,6400.0,,,,,,,,,,,11400.0
Almora,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,6640.0,2400.0,,,,,,,,,,,9040.0
Almora,16.1.2,Stock position of OPV vaccines,5. Total Stock,990.0,4990.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5980.0
Almora,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,7050.0,2250.0,,,,,,,,,,,9300.0
Almora,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,5500.0,,,,,,,,,,,5500.0
Almora,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4800.0,2200.0,,,,,,,,,,,7000.0
Almora,16.1.3,Stock position of TT vaccines,5. Total Stock,2250.0,5550.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7800.0
Almora,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Almora,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Almora,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Almora,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Almora,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4400.0,2530.0,,,,,,,,,,,6930.0
Almora,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1870.0,1060.0,,,,,,,,,,,2930.0
Almora,16.1.5,Stock position of BCG vaccines,5. Total Stock,2530.0,1470.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0
Almora,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5200.0,3600.0,,,,,,,,,,,8800.0
Almora,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1600.0,1300.0,,,,,,,,,,,2900.0
Almora,16.1.6,Stock position of Measles vaccines,5. Total Stock,3600.0,2300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5900.0
Almora,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Almora,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Almora,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Almora,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Almora,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,9750.0,7950.0,,,,,,,,,,,17700.0
Almora,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1800.0,380.0,,,,,,,,,,,2180.0
Almora,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,7950.0,7570.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15520.0
Almora,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,4942.0,2842.0,,,,,,,,,,,7784.0
Almora,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,2100.0,1300.0,,,,,,,,,,,3400.0
Almora,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2842.0,1542.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4384.0
Almora,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,30240.0,,,,,,,,,,,30240.0
Almora,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,126000.0,50400.0,,,,,,,,,,,176400.0
Almora,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,95760.0,30240.0,,,,,,,,,,,126000.0
Almora,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,30240.0,50400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,80640.0
Almora,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,3300.0,,,,,,,,,,,3300.0
Almora,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,8000.0,6000.0,,,,,,,,,,,14000.0
Almora,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,4700.0,3300.0,,,,,,,,,,,8000.0
Almora,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,3300.0,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9300.0
Almora,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,900.0,,,,,,,,,,,900.0
Almora,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,,,,,,,,,,,0.0
Almora,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Almora,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,600.0,,,,,,,,,,,600.0
Almora,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,300.0
Almora,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Almora,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Almora,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Almora,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Almora,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,600.0,450.0,,,,,,,,,,,1050.0
Almora,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,150.0,350.0,,,,,,,,,,,500.0
Almora,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,450.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,550.0
Almora,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,60.0,0.0,,,,,,,,,,,60.0
Almora,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.02,Stock Position of Gloves,4. Stock Distributed,60.0,0.0,,,,,,,,,,,60.0
Almora,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,6760.0,6440.0,,,,,,,,,,,13200.0
Almora,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,320.0,1140.0,,,,,,,,,,,1460.0
Almora,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,6440.0,5300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11740.0
Almora,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Almora,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Almora,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Almora,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Almora,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,7500.0,,,,,,,,,,,7500.0
Almora,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,6000.0,,,,,,,,,,,6000.0
Almora,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Almora,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Almora,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,13500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13500.0
Almora,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Almora,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,0.0,,,,,,,,,,,0.0
Almora,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Almora,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Almora,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Almora,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,,,,,,,,,,,0.0
Almora,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Almora,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Almora,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Almora,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,0.0,,,,,,,,,,,0.0
Almora,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,,,,,,,,,,,0.0
Almora,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Almora,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1249.0,1099.0,,,,,,,,,,,2348.0
Almora,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,150.0,6.0,,,,,,,,,,,156.0
Almora,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1099.0,1093.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2192.0
Almora,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,17517.0,16367.0,,,,,,,,,,,33884.0
Almora,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,,,,,,,,,,,0.0
Almora,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,1150.0,3550.0,,,,,,,,,,,4700.0
Almora,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,16367.0,12817.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29184.0
Almora,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Almora,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Almora,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Almora,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Almora,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Almora,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Almora,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Almora,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Almora,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Almora,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Almora,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Almora,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Almora,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Almora,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Almora,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Almora,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Almora,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Almora,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,1.0,,1.0,,,2.0
Almora,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Almora,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,1.0,,1.0,,,2.0
Almora,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,,,1.0,,,1.0,,,,,3.0
Almora,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Almora,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,,,1.0,,,1.0,,,,,3.0
Almora,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,,1.0,1.0,1.0,,,1.0,,3.0,,8.0
Almora,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Almora,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,,1.0,1.0,1.0,,,1.0,,3.0,,8.0
Almora,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,,,,,,,1.0,,2.0
Almora,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Almora,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,,,,,,,1.0,,2.0
Almora,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Almora,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Almora,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Almora,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,,,,,,1.0
Almora,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Almora,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,,,,,,1.0,,,2.0
Almora,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Almora,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Almora,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Almora,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,1.0,,,1.0,1.0,1.0,1.0,,,,6.0
Almora,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Almora,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,1.0,,,1.0,1.0,1.0,1.0,,,1.0,7.0
Almora,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,1.0,,,,,,,,2.0
Almora,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,1.0,,,1.0,,2.0
Almora,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,1.0,,,1.0,,,1.0,,4.0
Almora,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,1.0,1.0,,2.0,,,1.0,,,3.0,9.0
Almora,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,,,,,,2.0,,,3.0
Almora,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,1.0,1.0,,2.0,,,1.0,2.0,,3.0,12.0
Almora,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,3.0,,,,1.0,,1.0,,,1.0,,8.0
Almora,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,4.0,2.0,4.0,1.0,1.0,3.0,1.0,1.0,3.0,7.0,2.0,31.0
Almora,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,4.0,7.0,2.0,4.0,1.0,2.0,3.0,2.0,1.0,3.0,8.0,2.0,39.0
Almora,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Almora,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Almora,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Almora,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,3.0,,,,2.0,,,1.0,,,,6.0
Almora,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,2.0,,,1.0,,,,,,,4.0
Almora,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,3.0,2.0,,,3.0,,,1.0,,,,10.0
Almora,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,1.0,1.0,1.0,,,,,,1.0,,,4.0
Almora,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Almora,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,1.0,1.0,1.0,,,,,,1.0,,,4.0
Almora,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Almora,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,3.0,3.0,1.0,1.0,,,2.0,2.0,3.0,3.0,1.0,20.0
Almora,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,1.0,2.0,3.0,3.0,1.0,3.0,3.0,2.0,2.0,4.0,,25.0
Almora,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,4.0,5.0,4.0,4.0,2.0,3.0,5.0,4.0,5.0,7.0,1.0,46.0
Almora,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,1.0,1.0,2.0
Almora,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Almora,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,1.0,1.0,2.0
Almora,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Almora,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Almora,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Almora,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Almora,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Almora,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Almora,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Almora,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Almora,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Almora,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,1.0,,,1.0,2.0
Almora,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Almora,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,1.0,,,1.0,2.0
Almora,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Almora,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Almora,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,,,,,,1.0
Almora,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Almora,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Almora,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Almora,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Almora,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,2.0,2.0,1.0,1.0,1.0,2.0,1.0,,,1.0,1.0,12.0
Almora,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,2.0,,,,,,,,,,3.0
Almora,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,3.0,4.0,1.0,2.0,1.0,2.0,1.0,,,1.0,1.0,16.0
Almora,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,1.0,,1.0,,,,1.0,,1.0,1.0,1.0,7.0
Almora,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,1.0,,,,,,,,,,2.0
Almora,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,2.0,1.0,1.0,,,,1.0,,1.0,1.0,1.0,9.0
Almora,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Almora,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Almora,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Almora,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Almora,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Almora,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,1.0,,,,1.0,1.0,2.0,3.0,1.0,1.0,,11.0
Almora,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,1.0,1.0,1.0,1.0,2.0,,1.0,2.0,1.0,,,12.0
Almora,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,2.0,1.0,2.0,1.0,3.0,1.0,3.0,5.0,2.0,1.0,,24.0
Almora,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Almora,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,1.0,2.0,,,3.0,1.0,2.0,1.0,1.0,2.0,13.0
Almora,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,4.0,2.0,5.0,2.0,6.0,4.0,3.0,3.0,1.0,9.0,5.0,3.0,47.0
Almora,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,4.0,3.0,6.0,4.0,6.0,4.0,6.0,4.0,3.0,10.0,6.0,5.0,61.0
Almora,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,,,1.0,,,,,,2.0
Almora,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,,7.0,4.0,5.0,12.0,5.0,9.0,7.0,12.0,5.0,3.0,70.0
Almora,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,12.0,6.0,31.0,37.0,19.0,33.0,24.0,28.0,25.0,35.0,37.0,31.0,318.0
Almora,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,13.0,6.0,38.0,42.0,24.0,45.0,30.0,37.0,32.0,47.0,42.0,34.0,390.0
Bageshwar,1.1,Total number of pregnant women Registered for ANC,TOTAL,395.0,317.0,342.0,401.0,411.0,349.0,327.0,313.0,286.0,337.0,401.0,323.0,4202.0
Bageshwar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,320.0,260.0,260.0,330.0,338.0,284.0,235.0,253.0,225.0,275.0,317.0,261.0,3358.0
Bageshwar,1.2,Number of Pregnant women registered under JSY,TOTAL,395.0,317.0,342.0,401.0,411.0,349.0,327.0,313.0,286.0,337.0,401.0,323.0,4202.0
Bageshwar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,339.0,297.0,356.0,328.0,369.0,299.0,279.0,272.0,308.0,305.0,309.0,286.0,3747.0
Bageshwar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,377.0,307.0,324.0,375.0,391.0,333.0,304.0,296.0,269.0,314.0,377.0,310.0,3977.0
Bageshwar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,354.0,361.0,312.0,337.0,371.0,376.0,324.0,304.0,289.0,293.0,340.0,331.0,3992.0
Bageshwar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,0.0,0.0,0.0,0.0,0.0,144.0,118.0,114.0,2.0,0.0,0.0,0.0,378.0
Bageshwar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,0.0,2.0,0.0,10.0,8.0,5.0,11.0,10.0,0.0,0.0,0.0,1.0,47.0
Bageshwar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,70.0,51.0,69.0,85.0,74.0,80.0,84.0,69.0,116.0,83.0,104.0,76.0,961.0
Bageshwar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,13.0,7.0,18.0,29.0,39.0,13.0,31.0,23.0,23.0,46.0,27.0,22.0,291.0
Bageshwar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,83.0,58.0,87.0,114.0,113.0,93.0,115.0,92.0,139.0,129.0,131.0,98.0,1252.0
Bageshwar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,74.0,41.0,76.0,86.0,81.0,68.0,83.0,62.0,96.0,89.0,77.0,72.0,905.0
Bageshwar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,37.0,11.0,9.0,39.0,27.0,21.0,21.0,24.0,2.0,23.0,30.0,12.0,256.0
Bageshwar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,130.0,141.0,158.0,209.0,242.0,207.0,201.0,135.0,169.0,206.0,233.0,150.0,2181.0
Bageshwar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,36.0,101.0,61.0,107.0,129.0,132.0,164.0,106.0,152.0,163.0,187.0,114.0,1452.0
Bageshwar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,130.0,141.0,158.0,209.0,242.0,207.0,201.0,135.0,169.0,206.0,233.0,150.0,2181.0
Bageshwar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,108.0,133.0,130.0,176.0,218.0,175.0,196.0,110.0,145.0,197.0,218.0,121.0,1927.0
Bageshwar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Bageshwar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Bageshwar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Bageshwar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Bageshwar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,1.0,2.0,1.0,0.0,3.0,2.0,0.0,0.0,4.0,2.0,0.0,15.0
Bageshwar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bageshwar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,1.0,2.0,1.0,0.0,3.0,2.0,0.0,0.0,4.0,2.0,0.0,15.0
Bageshwar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Bageshwar,4.1.1.a,Number of male live births,TOTAL,105.0,114.0,131.0,169.0,188.0,158.0,166.0,107.0,156.0,181.0,203.0,124.0,1802.0
Bageshwar,4.1.1.b,Number of female live births,TOTAL,107.0,84.0,113.0,156.0,162.0,140.0,148.0,118.0,148.0,151.0,160.0,124.0,1611.0
Bageshwar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,212.0,198.0,244.0,325.0,350.0,298.0,314.0,225.0,304.0,332.0,363.0,248.0,3413.0
Bageshwar,4.1.2,Number of still births,TOTAL,1.0,1.0,1.0,0.0,5.0,2.0,2.0,2.0,4.0,3.0,1.0,0.0,22.0
Bageshwar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,37.0,33.0,35.0,10.0,22.0,5.0,2.0,19.0,53.0,19.0,11.0,25.0,271.0
Bageshwar,4.2.1,Number of Newborns weighed at birth,TOTAL,205.0,193.0,235.0,317.0,331.0,292.0,305.0,217.0,299.0,326.0,346.0,237.0,3303.0
Bageshwar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,7.0,12.0,6.0,5.0,1.0,2.0,4.0,6.0,2.0,9.0,14.0,13.0,81.0
Bageshwar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,209.0,196.0,240.0,322.0,348.0,296.0,310.0,223.0,303.0,332.0,356.0,240.0,3375.0
Bageshwar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,1.0,2.0,1.0,0.0,3.0,2.0,0.0,0.0,4.0,2.0,,15.0
Bageshwar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bageshwar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,1.0,2.0,1.0,0.0,3.0,2.0,0.0,0.0,4.0,2.0,0.0,15.0
Bageshwar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Bageshwar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,1.0,2.0,1.0,0.0,3.0,2.0,0.0,0.0,4.0,2.0,0.0,15.0
Bageshwar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,1.0,2.0,1.0,0.0,3.0,2.0,0.0,0.0,4.0,2.0,0.0,15.0
Bageshwar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,100.0,81.0,239.0,227.0,242.0,265.0,286.0,188.0,202.0,279.0,287.0,182.0,2578.0
Bageshwar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,64.0,59.0,146.0,159.0,227.0,153.0,160.0,136.0,116.0,195.0,191.0,66.0,1672.0
Bageshwar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,36.0,33.0,35.0,9.0,20.0,4.0,2.0,19.0,53.0,19.0,9.0,8.0,247.0
Bageshwar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,0.0,0.0,1.0,2.0,1.0,0.0,0.0,0.0,0.0,2.0,17.0,24.0
Bageshwar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,37.0,33.0,35.0,10.0,22.0,5.0,2.0,19.0,53.0,19.0,11.0,25.0,271.0
Bageshwar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,21.0,31.0,23.0,18.0,18.0,22.0,10.0,21.0,18.0,19.0,23.0,24.0,248.0
Bageshwar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,85.0,113.0,88.0,90.0,90.0,89.0,108.0,102.0,81.0,72.0,70.0,69.0,1057.0
Bageshwar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,106.0,144.0,111.0,108.0,108.0,111.0,118.0,123.0,99.0,91.0,93.0,93.0,1305.0
Bageshwar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,8.0,1.0,0.0,10.0
Bageshwar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,8.0,0.0,2.0,0.0,0.0,36.0,24.0,17.0,0.0,87.0
Bageshwar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,2.0,2.0,4.0,0.0,2.0,2.0,2.0,1.0,11.0,18.0,1.0,46.0
Bageshwar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bageshwar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,2.0,2.0,12.0,0.0,4.0,2.0,2.0,38.0,43.0,36.0,1.0,143.0
Bageshwar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bageshwar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,69.0,38.0,16.0,0.0,123.0
Bageshwar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,44.0,0.0,4.0,1.0,0.0,211.0,52.0,77.0,4.0,393.0
Bageshwar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,1.0,2.0,3.0,26.0,3.0,0.0,1.0,15.0,32.0,6.0,38.0,6.0,133.0
Bageshwar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bageshwar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,1.0,2.0,3.0,70.0,3.0,4.0,2.0,15.0,312.0,96.0,131.0,10.0,649.0
Bageshwar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bageshwar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Bageshwar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bageshwar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Bageshwar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bageshwar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,,1.0
Bageshwar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bageshwar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bageshwar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bageshwar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,138.0,148.0,176.0,331.0,208.0,180.0,184.0,168.0,375.0,221.0,194.0,180.0,2503.0
Bageshwar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,4.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Bageshwar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0,0.0,35.0,0.0,53.0
Bageshwar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,21.0,13.0,22.0,37.0,23.0,,0.0,0.0,30.0,42.0,38.0,,226.0
Bageshwar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bageshwar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,159.0,161.0,198.0,372.0,233.0,180.0,184.0,168.0,423.0,263.0,267.0,180.0,2788.0
Bageshwar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,4.0,0.0,0.0,37.0,23.0,2.0,0.0,0.0,18.0,42.0,73.0,0.0,199.0
Bageshwar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bageshwar,9.06,Number of IUCD removals,TOTAL,29.0,35.0,36.0,86.0,65.0,57.0,51.0,38.0,36.0,55.0,54.0,46.0,588.0
Bageshwar,9.07,Number of Oral Pills cycles distributed,TOTAL,529.0,562.0,408.0,825.0,623.0,719.0,577.0,605.0,508.0,537.0,472.0,463.0,6828.0
Bageshwar,9.08,Number of Condom pieces distributed,TOTAL,7618.0,7618.0,8563.0,11674.0,8124.0,7164.0,6798.0,6090.0,6420.0,7144.0,7050.0,7100.0,91363.0
Bageshwar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,33.0,36.0,46.0,43.0,40.0,49.0,50.0,51.0,45.0,63.0,58.0,48.0,562.0
Bageshwar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bageshwar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,9.12,Number of Institutions having NSV trained doctors,TOTAL,14.0,13.0,14.0,13.0,13.0,13.0,13.0,13.0,13.0,13.0,13.0,13.0,-1.0
Bageshwar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,308.0,253.0,285.0,265.0,350.0,310.0,294.0,297.0,299.0,256.0,310.0,400.0,3627.0
Bageshwar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Bageshwar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,381.0,292.0,276.0,312.0,290.0,350.0,344.0,446.0,399.0,315.0,324.0,275.0,4004.0
Bageshwar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,374.0,354.0,364.0,272.0,353.0,297.0,323.0,358.0,451.0,318.0,301.0,307.0,4072.0
Bageshwar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,393.0,349.0,383.0,345.0,304.0,332.0,315.0,362.0,389.0,445.0,332.0,291.0,4240.0
Bageshwar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,88.0,59.0,85.0,183.0,118.0,107.0,78.0,137.0,130.0,82.0,95.0,76.0,1238.0
Bageshwar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,381.0,292.0,276.0,312.0,290.0,350.0,344.0,446.0,399.0,315.0,324.0,275.0,4004.0
Bageshwar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,374.0,354.0,364.0,272.0,353.0,297.0,323.0,358.0,451.0,318.0,301.0,307.0,4072.0
Bageshwar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,393.0,349.0,383.0,345.0,304.0,332.0,315.0,362.0,389.0,445.0,332.0,291.0,4240.0
Bageshwar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,106.0,65.0,97.0,108.0,18.0,12.0,14.0,63.0,51.0,12.0,25.0,9.0,580.0
Bageshwar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Bageshwar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,335.0,303.0,406.0,396.0,394.0,376.0,309.0,397.0,322.0,323.0,332.0,320.0,4213.0
Bageshwar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,407.0,356.0,390.0,360.0,384.0,350.0,316.0,327.0,260.0,244.0,427.0,352.0,4173.0
Bageshwar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,186.0,156.0,215.0,208.0,209.0,198.0,168.0,218.0,168.0,168.0,165.0,158.0,2217.0
Bageshwar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,149.0,147.0,191.0,188.0,185.0,178.0,141.0,179.0,154.0,155.0,167.0,162.0,1996.0
Bageshwar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,335.0,303.0,406.0,396.0,394.0,376.0,309.0,397.0,322.0,323.0,332.0,320.0,4213.0
Bageshwar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,407.0,365.0,390.0,407.0,385.0,393.0,323.0,335.0,301.0,255.0,431.0,358.0,4350.0
Bageshwar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,407.0,365.0,390.0,407.0,385.0,393.0,323.0,335.0,301.0,255.0,431.0,358.0,4350.0
Bageshwar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,63.0,36.0,82.0,88.0,94.0,88.0,54.0,69.0,89.0,68.0,61.0,67.0,859.0
Bageshwar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,58.0,32.0,61.0,80.0,77.0,83.0,50.0,69.0,85.0,71.0,59.0,73.0,798.0
Bageshwar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,121.0,68.0,143.0,168.0,171.0,171.0,104.0,138.0,174.0,139.0,120.0,140.0,1657.0
Bageshwar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,456.0,411.0,463.0,456.0,479.0,443.0,384.0,418.0,317.0,288.0,408.0,319.0,4842.0
Bageshwar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,447.0,428.0,481.0,451.0,505.0,435.0,393.0,426.0,439.0,370.0,403.0,386.0,5164.0
Bageshwar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,369.0,355.0,390.0,346.0,410.0,369.0,322.0,329.0,322.0,301.0,288.0,344.0,4145.0
Bageshwar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,43.0,39.0,44.0,30.0,46.0,60.0,53.0,58.0,52.0,55.0,59.0,38.0,577.0
Bageshwar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,294.0,299.0,336.0,287.0,387.0,313.0,305.0,309.0,295.0,307.0,314.0,301.0,3747.0
Bageshwar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,264.0,265.0,291.0,268.0,360.0,305.0,293.0,297.0,287.0,295.0,308.0,293.0,3526.0
Bageshwar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,263.0,261.0,288.0,268.0,356.0,303.0,277.0,297.0,287.0,295.0,308.0,293.0,3496.0
Bageshwar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,318.0,232.0,335.0,439.0,452.0,397.0,121.0,109.0,53.0,43.0,36.0,18.0,2553.0
Bageshwar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,63.0,45.0,76.0,333.0,168.0,168.0,45.0,17.0,0.0,0.0,0.0,0.0,915.0
Bageshwar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,77.0,77.0,36.0,156.0,43.0,151.0,80.0,53.0,0.0,0.0,0.0,0.0,673.0
Bageshwar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,13.1,Number of Patients operated for cataract,TOTAL,8.0,24.0,14.0,22.0,21.0,22.0,66.0,46.0,19.0,40.0,91.0,83.0,456.0
Bageshwar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,8.0,24.0,14.0,22.0,21.0,22.0,66.0,46.0,19.0,40.0,91.0,83.0,456.0
Bageshwar,13.3,Number of School children detected with Refractive errors,TOTAL,6.0,8.0,87.0,28.0,28.0,31.0,34.0,46.0,38.0,40.0,35.0,17.0,398.0
Bageshwar,13.4,Number of children provided free glasses,TOTAL,6.0,0.0,0.0,28.0,9.0,7.0,34.0,34.0,38.0,40.0,35.0,17.0,248.0
Bageshwar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Bageshwar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,11.0,11.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,-1.0
Bageshwar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,232.0,236.0,233.0,240.0,234.0,239.0,247.0,256.0,234.0,246.0,228.0,201.0,-1.0
Bageshwar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Bageshwar,14.05,Number of RKS meetings held during the month,TOTAL,2.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,2.0,11.0
Bageshwar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,14.0,14.0,14.0,13.0,13.0,13.0,13.0,13.0,13.0,13.0,13.0,13.0,-1.0
Bageshwar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,4.0,2.0,8.0,0.0,8.0,3.0,2.0,0.0,0.0,1.0,2.0,0.0,30.0
Bageshwar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Bageshwar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,3.0,3.0,3.0,3.0,4.0,4.0,1.0,4.0,4.0,4.0,1.0,-1.0
Bageshwar,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Bageshwar,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Bageshwar,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Bageshwar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,50.0,17.0,80.0,74.0,64.0,226.0,165.0,15.0,63.0,82.0,95.0,5.0,936.0
Bageshwar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,188.0,362.0,294.0,239.0,264.0,98.0,233.0,250.0,226.0,228.0,200.0,231.0,2813.0
Bageshwar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,55.0,33.0,52.0,89.0,81.0,461.0,91.0,35.0,42.0,67.0,93.0,6.0,1105.0
Bageshwar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,441.0,565.0,714.0,472.0,604.0,128.0,404.0,487.0,465.0,499.0,647.0,430.0,5856.0
Bageshwar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,105.0,50.0,132.0,163.0,145.0,687.0,256.0,50.0,105.0,149.0,188.0,11.0,2041.0
Bageshwar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,629.0,927.0,1008.0,711.0,868.0,226.0,637.0,737.0,691.0,727.0,847.0,661.0,8669.0
Bageshwar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,5.0,3.0,5.0,2.0,3.0,6.0,3.0,13.0,9.0,11.0,5.0,72.0
Bageshwar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,2.0,1.0,2.0,1.0,1.0,1.0,3.0,9.0,8.0,8.0,3.0,42.0
Bageshwar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,10.0,7.0,4.0,7.0,3.0,4.0,7.0,6.0,22.0,17.0,19.0,8.0,114.0
Bageshwar,14.11,In-Patient Head Count at midnight,TOTAL,1198.0,2621.0,2172.0,2560.0,2476.0,2148.0,1812.0,1205.0,1292.0,1167.0,1172.0,1711.0,21534.0
Bageshwar,14.12.1,OPD attendance (All),TOTAL,18001.0,20872.0,21487.0,21402.0,26850.0,29293.0,20696.0,19896.0,21670.0,22335.0,20264.0,19506.0,262272.0
Bageshwar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,5.0,22.0,12.0,3.0,11.0,7.0,5.0,6.0,5.0,0.0,2.0,78.0
Bageshwar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Bageshwar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,13.0,37.0,34.0,38.0,31.0,23.0,32.0,35.0,24.0,26.0,0.0,32.0,325.0
Bageshwar,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Bageshwar,14.14.a,Number of patients given AYUSH treatment,TOTAL,656.0,510.0,718.0,699.0,696.0,656.0,624.0,243.0,707.0,753.0,676.0,757.0,7695.0
Bageshwar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,44.0,62.0,80.0,79.0,63.0,90.0,57.0,0.0,70.0,61.0,45.0,50.0,701.0
Bageshwar,14.14.c,Number of Adolescents counselled,TOTAL,8.0,0.0,12.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32.0
Bageshwar,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Bageshwar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,672.0,682.0,616.0,436.0,729.0,726.0,576.0,538.0,570.0,482.0,553.0,638.0,7218.0
Bageshwar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,12.0,15.0,4.0,7.0,2.0,10.0,3.0,0.0,10.0,0.0,10.0,1.0,74.0
Bageshwar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,29.0,42.0,35.0,30.0,28.0,24.0,10.0,20.0,17.0,22.0,26.0,17.0,300.0
Bageshwar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Bageshwar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,72.0,77.0,81.0,61.0,66.0,87.0,49.0,54.0,73.0,82.0,56.0,51.0,809.0
Bageshwar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Bageshwar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,115.0,93.0,128.0,109.0,109.0,107.0,94.0,122.0,85.0,98.0,104.0,86.0,1250.0
Bageshwar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,216.0,212.0,244.0,200.0,203.0,218.0,153.0,196.0,175.0,202.0,186.0,154.0,2359.0
Bageshwar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,4.0
Bageshwar,15.2,Number of Widal tests conducted,Number tested,83.0,89.0,102.0,0.0,173.0,228.0,146.0,49.0,50.0,63.0,75.0,83.0,1141.0
Bageshwar,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,108.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,110.0
Bageshwar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,4.0,2.0,3.0,0.0,2.0,3.0,1.0,2.0,4.0,1.0,2.0,2.0,26.0
Bageshwar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,112.0,95.0,102.0,146.0,109.0,99.0,59.0,85.0,83.0,74.0,87.0,82.0,1133.0
Bageshwar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,116.0,97.0,105.0,254.0,111.0,102.0,62.0,87.0,87.0,75.0,89.0,84.0,1269.0
Bageshwar,15.4.1,Number of blood smears examined for Malaria,TOTAL,351.0,460.0,563.0,529.0,804.0,540.0,630.0,470.0,322.0,214.0,257.0,256.0,5396.0
Bageshwar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bageshwar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,5000.0,2000.0,360.0,200.0,420.0,190.0,0.0,230.0,230.0,0.0,0.0,500.0,9130.0
Bageshwar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,3000.0,0.0,500.0,500.0,0.0,1500.0,200.0,0.0,1500.0,1000.0,0.0,8200.0
Bageshwar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3000.0,4640.0,160.0,280.0,730.0,190.0,1270.0,200.0,230.0,1500.0,500.0,500.0,13200.0
Bageshwar,16.1.1,Stock position of DPT vaccines,5. Total Stock,2000.0,360.0,200.0,420.0,190.0,0.0,230.0,230.0,0.0,0.0,500.0,0.0,4130.0
Bageshwar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1165.0,205.0,505.0,550.0,0.0,1950.0,1390.0,3340.0,2840.0,1000.0,0.0,2000.0,14945.0
Bageshwar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,3000.0,3000.0,0.0,4000.0,0.0,5000.0,500.0,0.0,0.0,2500.0,0.0,18000.0
Bageshwar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,960.0,2700.0,2955.0,550.0,2050.0,560.0,3050.0,1000.0,1840.0,1000.0,500.0,1500.0,18665.0
Bageshwar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,205.0,505.0,550.0,0.0,1950.0,1390.0,3340.0,2840.0,1000.0,0.0,2000.0,500.0,14280.0
Bageshwar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,4820.0,820.0,1000.0,0.0,0.0,4744.0,1444.0,1884.0,4884.0,884.0,384.0,514.0,21378.0
Bageshwar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,2000.0,3000.0,3000.0,8000.0,0.0,4000.0,6000.0,0.0,0.0,2000.0,0.0,28000.0
Bageshwar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4000.0,1820.0,4000.0,3000.0,3256.0,3300.0,3560.0,3000.0,4000.0,500.0,1870.0,514.0,32820.0
Bageshwar,16.1.2,Stock position of OPV vaccines,5. Total Stock,820.0,1000.0,0.0,0.0,4744.0,1444.0,1884.0,4884.0,884.0,384.0,514.0,0.0,16558.0
Bageshwar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4480.0,1670.0,860.0,500.0,1500.0,2730.0,1030.0,3240.0,5240.0,4000.0,2000.0,2500.0,29750.0
Bageshwar,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,2000.0,2000.0,3000.0,4000.0,0.0,5000.0,3000.0,0.0,1000.0,2000.0,0.0,22000.0
Bageshwar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2810.0,2810.0,2360.0,2000.0,2770.0,1700.0,2790.0,1000.0,1240.0,3000.0,1500.0,2500.0,26480.0
Bageshwar,16.1.3,Stock position of TT vaccines,5. Total Stock,1670.0,860.0,500.0,1500.0,2730.0,1030.0,3240.0,5240.0,4000.0,2000.0,2500.0,0.0,25270.0
Bageshwar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2930.0,1500.0,350.0,750.0,1250.0,3710.0,3140.0,4040.0,5540.0,5000.0,1500.0,2000.0,31710.0
Bageshwar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,1000.0,2000.0,3000.0,4000.0,0.0,3000.0,2000.0,0.0,0.0,1000.0,0.0,16000.0
Bageshwar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1430.0,2150.0,1600.0,2500.0,1540.0,570.0,2100.0,500.0,540.0,3500.0,500.0,1000.0,17930.0
Bageshwar,16.1.5,Stock position of BCG vaccines,5. Total Stock,1500.0,350.0,750.0,1250.0,3710.0,3140.0,4040.0,5540.0,5000.0,1500.0,2000.0,1000.0,29780.0
Bageshwar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,615.0,0.0,220.0,0.0,0.0,370.0,0.0,0.0,1500.0,1500.0,500.0,500.0,5205.0
Bageshwar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,1000.0,1000.0,1500.0,1500.0,0.0,1500.0,2000.0,0.0,250.0,750.0,0.0,9500.0
Bageshwar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,615.0,780.0,1220.0,1500.0,1130.0,370.0,1500.0,500.0,0.0,1250.0,750.0,500.0,10115.0
Bageshwar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,220.0,0.0,0.0,370.0,0.0,0.0,1500.0,1500.0,500.0,500.0,0.0,4590.0
Bageshwar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3100.0,1680.0,390.0,90.0,600.0,435.0,103.0,423.0,1623.0,1000.0,200.0,500.0,10144.0
Bageshwar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,900.0,600.0,0.0,1500.0,1200.0,0.0,0.0,600.0,0.0,4800.0
Bageshwar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1420.0,1290.0,300.0,390.0,765.0,332.0,1180.0,0.0,623.0,800.0,300.0,500.0,7900.0
Bageshwar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1680.0,390.0,90.0,600.0,435.0,103.0,423.0,1623.0,1000.0,200.0,500.0,0.0,7044.0
Bageshwar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Bageshwar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Bageshwar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Bageshwar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Bageshwar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bageshwar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bageshwar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bageshwar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Bageshwar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,0.0,0.0,0.0,0.0,0.0,14000.0,13600.0,13600.0,41200.0
Bageshwar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,10800.0,18000.0,0.0,0.0,14400.0,0.0,0.0,0.0,43200.0
Bageshwar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,10800.0,18000.0,0.0,0.0,400.0,400.0,0.0,0.0,29600.0
Bageshwar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14000.0,13600.0,13600.0,13600.0,54800.0
Bageshwar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,0.0,0.0,1500.0,1500.0,1500.0,1400.0,1300.0,1300.0,8500.0
Bageshwar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Bageshwar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bageshwar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,0.0,500.0,0.0,0.0,100.0,100.0,0.0,0.0,700.0
Bageshwar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,1500.0,1500.0,1500.0,1400.0,1300.0,1300.0,1300.0,9800.0
Bageshwar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Bageshwar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bageshwar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bageshwar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Bageshwar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bageshwar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bageshwar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Bageshwar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bageshwar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bageshwar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Bageshwar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bageshwar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bageshwar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Bageshwar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bageshwar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bageshwar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Bageshwar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bageshwar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bageshwar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Bageshwar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bageshwar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bageshwar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Bageshwar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bageshwar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bageshwar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bageshwar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Bageshwar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Bageshwar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,1.0,,,,,,1.0
Bageshwar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Bageshwar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Bageshwar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,,,,,,,,1.0,,,2.0
Bageshwar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,1.0,,1.0,,,,2.0,,,1.0,7.0
Bageshwar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,3.0,1.0,4.0,,1.0,2.0,3.0,2.0,1.0,2.0,,21.0
Bageshwar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,4.0,2.0,4.0,1.0,1.0,2.0,3.0,4.0,1.0,2.0,1.0,28.0
Bageshwar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,1.0,,2.0,,,,3.0
Bageshwar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,1.0,,2.0,,,,3.0
Bageshwar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,,2.0,1.0,,1.0,,,,,1.0,6.0
Bageshwar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,1.0,,1.0,,,,1.0,3.0
Bageshwar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,,2.0,1.0,1.0,1.0,1.0,,,,2.0,9.0
Bageshwar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Bageshwar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,1.0,,,1.0,,,,,,1.0,1.0,7.0
Bageshwar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,1.0,,,1.0,,,,,,1.0,1.0,7.0
Bageshwar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Bageshwar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,1.0,1.0
Bageshwar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Bageshwar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Bageshwar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,,,,,,,,,,,,1.0
Bageshwar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Bageshwar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Bageshwar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Chamoli,1.1,Total number of pregnant women Registered for ANC,TOTAL,647.0,650.0,606.0,688.0,711.0,651.0,560.0,459.0,492.0,496.0,734.0,639.0,7333.0
Chamoli,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,398.0,362.0,371.0,464.0,439.0,445.0,368.0,305.0,327.0,335.0,458.0,425.0,4697.0
Chamoli,1.2,Number of Pregnant women registered under JSY,TOTAL,638.0,627.0,591.0,676.0,702.0,644.0,552.0,458.0,477.0,502.0,703.0,633.0,7203.0
Chamoli,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,494.0,442.0,490.0,512.0,490.0,543.0,515.0,442.0,457.0,381.0,434.0,421.0,5621.0
Chamoli,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,600.0,584.0,562.0,632.0,666.0,610.0,525.0,411.0,458.0,463.0,677.0,567.0,6755.0
Chamoli,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,603.0,641.0,652.0,590.0,673.0,711.0,605.0,480.0,452.0,510.0,489.0,716.0,7122.0
Chamoli,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,70.0,67.0,47.0,22.0,39.0,21.0,30.0,48.0,0.0,0.0,0.0,6.0,350.0
Chamoli,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,15.0,6.0,17.0,20.0,10.0,32.0,6.0,11.0,6.0,7.0,6.0,5.0,141.0
Chamoli,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,44.0,46.0,43.0,35.0,45.0,48.0,20.0,14.0,12.0,14.0,19.0,15.0,355.0
Chamoli,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,2.0,3.0,3.0,4.0,0.0,0.0,0.0,6.0,2.0,5.0,2.0,27.0
Chamoli,1.8,Number of pregnancy test kits used at SC level,TOTAL,70.0,118.0,80.0,27.0,86.0,60.0,15.0,36.0,74.0,64.0,60.0,15.0,705.0
Chamoli,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,64.0,79.0,82.0,112.0,132.0,144.0,108.0,111.0,92.0,120.0,113.0,93.0,1250.0
Chamoli,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,35.0,26.0,37.0,44.0,43.0,51.0,47.0,55.0,46.0,37.0,45.0,31.0,497.0
Chamoli,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,99.0,105.0,119.0,156.0,175.0,195.0,155.0,166.0,138.0,157.0,158.0,124.0,1747.0
Chamoli,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,43.0,46.0,55.0,61.0,100.0,112.0,98.0,116.0,83.0,94.0,82.0,76.0,966.0
Chamoli,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,2.0,1.0,1.0,0.0,0.0,9.0
Chamoli,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,225.0,241.0,283.0,321.0,307.0,419.0,307.0,332.0,276.0,308.0,309.0,320.0,3648.0
Chamoli,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,155.0,158.0,194.0,178.0,210.0,304.0,264.0,234.0,154.0,202.0,226.0,212.0,2491.0
Chamoli,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,248.0,225.0,294.0,312.0,312.0,417.0,327.0,333.0,261.0,321.0,292.0,307.0,3649.0
Chamoli,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,157.0,144.0,191.0,212.0,219.0,272.0,216.0,209.0,172.0,204.0,219.0,200.0,2415.0
Chamoli,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Chamoli,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Chamoli,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Chamoli,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Chamoli,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,7.0,4.0,12.0,2.0,6.0,15.0,9.0,8.0,9.0,10.0,2.0,10.0,94.0
Chamoli,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Chamoli,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamoli,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,7.0,4.0,12.0,2.0,6.0,15.0,9.0,8.0,9.0,10.0,2.0,10.0,94.0
Chamoli,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Chamoli,4.1.1.a,Number of male live births,TOTAL,190.0,167.0,203.0,264.0,238.0,321.0,237.0,273.0,214.0,218.0,239.0,216.0,2780.0
Chamoli,4.1.1.b,Number of female live births,TOTAL,154.0,173.0,196.0,212.0,239.0,309.0,224.0,225.0,196.0,244.0,227.0,226.0,2625.0
Chamoli,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,344.0,340.0,399.0,476.0,477.0,630.0,461.0,498.0,410.0,462.0,466.0,442.0,5405.0
Chamoli,4.1.2,Number of still births,TOTAL,4.0,4.0,6.0,5.0,2.0,10.0,6.0,5.0,7.0,12.0,5.0,3.0,69.0
Chamoli,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,12.0,22.0,8.0,23.0,18.0,13.0,6.0,14.0,36.0,26.0,6.0,6.0,190.0
Chamoli,4.2.1,Number of Newborns weighed at birth,TOTAL,339.0,339.0,399.0,470.0,469.0,625.0,448.0,484.0,411.0,453.0,456.0,438.0,5331.0
Chamoli,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,7.0,18.0,27.0,42.0,26.0,39.0,27.0,21.0,27.0,26.0,22.0,12.0,294.0
Chamoli,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,329.0,340.0,385.0,473.0,475.0,623.0,452.0,492.0,406.0,454.0,455.0,436.0,5320.0
Chamoli,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,7.0,4.0,12.0,2.0,6.0,15.0,9.0,8.0,9.0,10.0,2.0,10.0,94.0
Chamoli,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Chamoli,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamoli,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,7.0,4.0,12.0,2.0,6.0,15.0,9.0,8.0,9.0,10.0,2.0,10.0,94.0
Chamoli,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Chamoli,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,7.0,4.0,12.0,2.0,6.0,15.0,9.0,8.0,9.0,10.0,2.0,10.0,94.0
Chamoli,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,7.0,4.0,12.0,2.0,6.0,15.0,9.0,8.0,9.0,10.0,2.0,10.0,94.0
Chamoli,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,227.0,190.0,295.0,320.0,330.0,430.0,334.0,357.0,310.0,324.0,316.0,246.0,3679.0
Chamoli,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,202.0,150.0,265.0,270.0,326.0,396.0,314.0,322.0,269.0,270.0,295.0,184.0,3263.0
Chamoli,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,9.0,17.0,6.0,21.0,11.0,12.0,6.0,10.0,32.0,24.0,11.0,10.0,169.0
Chamoli,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,9.0,17.0,6.0,21.0,11.0,12.0,6.0,10.0,32.0,24.0,11.0,10.0,169.0
Chamoli,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,12.0,9.0,7.0,12.0,15.0,8.0,17.0,8.0,10.0,13.0,7.0,0.0,118.0
Chamoli,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,77.0,68.0,62.0,53.0,55.0,74.0,78.0,70.0,60.0,81.0,61.0,10.0,749.0
Chamoli,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,89.0,77.0,69.0,65.0,70.0,82.0,95.0,78.0,70.0,94.0,68.0,10.0,867.0
Chamoli,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,4.0,12.0,7.0,1.0,0.0,12.0,14.0,6.0,0.0,0.0,56.0
Chamoli,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,1.0,5.0,1.0,1.0,1.0,7.0,11.0,1.0,1.0,0.0,30.0
Chamoli,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,,4.0,1.0,5.0,3.0,0.0,0.0,0.0,0.0,,,13.0
Chamoli,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamoli,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,9.0,18.0,13.0,5.0,1.0,19.0,25.0,7.0,1.0,0.0,99.0
Chamoli,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chamoli,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,8.0,6.0,3.0,26.0,19.0,12.0,6.0,95.0,136.0,167.0,19.0,1.0,498.0
Chamoli,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,66.0,23.0,39.0,63.0,63.0,21.0,52.0,103.0,338.0,62.0,12.0,19.0,861.0
Chamoli,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,14.0,9.0,4.0,14.0,8.0,5.0,0.0,32.0,10.0,50.0,,,146.0
Chamoli,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamoli,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,88.0,38.0,46.0,103.0,90.0,38.0,58.0,230.0,484.0,279.0,31.0,20.0,1505.0
Chamoli,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chamoli,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,,,,,,,,,,,,0.0
Chamoli,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamoli,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chamoli,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chamoli,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,,,,,,,,,,,,0.0
Chamoli,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamoli,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chamoli,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chamoli,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,151.0,180.0,190.0,625.0,192.0,371.0,342.0,275.0,251.0,216.0,217.0,227.0,3237.0
Chamoli,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,19.0,13.0,27.0,80.0,20.0,27.0,33.0,29.0,41.0,19.0,15.0,25.0,348.0
Chamoli,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,44.0,53.0,59.0,206.0,54.0,76.0,53.0,66.0,63.0,43.0,26.0,27.0,770.0
Chamoli,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,18.0,18.0,18.0,73.0,,17.0,25.0,4.0,18.0,38.0,1.0,21.0,251.0
Chamoli,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamoli,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,232.0,264.0,294.0,984.0,266.0,491.0,453.0,374.0,373.0,316.0,259.0,300.0,4606.0
Chamoli,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,12.0,9.0,11.0,7.0,6.0,8.0,19.0,4.0,11.0,20.0,0.0,10.0,117.0
Chamoli,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Chamoli,9.06,Number of IUCD removals,TOTAL,116.0,96.0,116.0,137.0,100.0,135.0,137.0,110.0,121.0,124.0,94.0,136.0,1422.0
Chamoli,9.07,Number of Oral Pills cycles distributed,TOTAL,532.0,327.0,182.0,641.0,177.0,186.0,172.0,130.0,142.0,1271.0,2132.0,2362.0,8254.0
Chamoli,9.08,Number of Condom pieces distributed,TOTAL,8626.0,10348.0,8020.0,7853.0,2000.0,1800.0,1960.0,1450.0,1550.0,10639.0,16665.0,18845.0,89756.0
Chamoli,9.09,Number of Centchroman (weekly) pills given,TOTAL,3.0,0.0,0.0,5.0,0.0,0.0,3.0,0.0,0.0,0.0,1.0,20.0,32.0
Chamoli,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,11.0,39.0,20.0,98.0,11.0,9.0,4.0,3.0,0.0,105.0,139.0,195.0,634.0
Chamoli,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chamoli,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,6.0,6.0,4.0,4.0,4.0,4.0,5.0,5.0,5.0,5.0,7.0,-1.0
Chamoli,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,529.0,409.0,497.0,473.0,674.0,769.0,670.0,559.0,610.0,503.0,726.0,510.0,6929.0
Chamoli,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,9.0
Chamoli,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,557.0,558.0,516.0,346.0,607.0,639.0,716.0,640.0,431.0,717.0,639.0,634.0,7000.0
Chamoli,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,595.0,619.0,596.0,393.0,460.0,575.0,657.0,695.0,512.0,609.0,698.0,644.0,7053.0
Chamoli,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,583.0,607.0,607.0,463.0,545.0,508.0,570.0,612.0,539.0,708.0,597.0,700.0,7039.0
Chamoli,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,391.0,357.0,469.0,401.0,498.0,568.0,472.0,470.0,370.0,400.0,534.0,441.0,5371.0
Chamoli,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,561.0,558.0,515.0,340.0,608.0,622.0,712.0,643.0,471.0,706.0,636.0,615.0,6987.0
Chamoli,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,588.0,607.0,587.0,397.0,465.0,560.0,658.0,684.0,576.0,596.0,703.0,643.0,7064.0
Chamoli,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,574.0,594.0,601.0,475.0,542.0,498.0,564.0,624.0,597.0,691.0,626.0,700.0,7086.0
Chamoli,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,99.0,188.0,193.0,191.0,194.0,262.0,220.0,279.0,206.0,261.0,294.0,301.0,2688.0
Chamoli,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Chamoli,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,470.0,604.0,703.0,614.0,651.0,584.0,671.0,495.0,557.0,510.0,576.0,504.0,6939.0
Chamoli,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,470.0,528.0,598.0,505.0,561.0,444.0,552.0,359.0,488.0,555.0,724.0,664.0,6448.0
Chamoli,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,231.0,308.0,335.0,283.0,336.0,302.0,345.0,246.0,281.0,258.0,307.0,233.0,3465.0
Chamoli,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,215.0,277.0,347.0,295.0,293.0,241.0,284.0,219.0,243.0,215.0,269.0,253.0,3151.0
Chamoli,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,446.0,585.0,682.0,578.0,629.0,543.0,629.0,465.0,524.0,473.0,576.0,486.0,6616.0
Chamoli,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,517.0,552.0,581.0,410.0,598.0,469.0,551.0,356.0,516.0,563.0,744.0,652.0,6509.0
Chamoli,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,517.0,552.0,581.0,450.0,598.0,469.0,551.0,356.0,516.0,563.0,744.0,647.0,6544.0
Chamoli,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,80.0,102.0,88.0,79.0,80.0,67.0,82.0,68.0,85.0,110.0,87.0,93.0,1021.0
Chamoli,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,66.0,77.0,82.0,64.0,60.0,62.0,74.0,58.0,93.0,75.0,83.0,100.0,894.0
Chamoli,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,146.0,179.0,170.0,143.0,140.0,129.0,156.0,126.0,178.0,185.0,170.0,193.0,1915.0
Chamoli,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,541.0,609.0,639.0,329.0,571.0,523.0,521.0,408.0,577.0,693.0,704.0,560.0,6675.0
Chamoli,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,582.0,613.0,653.0,634.0,605.0,600.0,603.0,569.0,630.0,557.0,676.0,606.0,7328.0
Chamoli,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,505.0,522.0,571.0,526.0,564.0,503.0,486.0,494.0,490.0,518.0,627.0,495.0,6301.0
Chamoli,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chamoli,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,497.0,487.0,495.0,512.0,520.0,513.0,527.0,474.0,498.0,513.0,531.0,520.0,6087.0
Chamoli,10.4.2,Number of Immunisation sessions held during the month,TOTAL,457.0,479.0,473.0,492.0,500.0,495.0,516.0,446.0,478.0,499.0,526.0,504.0,5865.0
Chamoli,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,440.0,453.0,445.0,455.0,471.0,469.0,484.0,426.0,457.0,474.0,482.0,480.0,5536.0
Chamoli,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,46.0,49.0
Chamoli,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,16.0,23.0,37.0,46.0,60.0,39.0,18.0,10.0,11.0,0.0,13.0,10.0,283.0
Chamoli,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,13.1,Number of Patients operated for cataract,TOTAL,92.0,0.0,0.0,2.0,0.0,0.0,83.0,133.0,2.0,13.0,108.0,26.0,459.0
Chamoli,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,92.0,0.0,0.0,2.0,0.0,0.0,83.0,133.0,2.0,13.0,108.0,26.0,459.0
Chamoli,13.3,Number of School children detected with Refractive errors,TOTAL,3.0,5.0,32.0,16.0,26.0,31.0,23.0,17.0,11.0,32.0,31.0,10.0,237.0
Chamoli,13.4,Number of children provided free glasses,TOTAL,3.0,3.0,0.0,0.0,18.0,32.0,16.0,7.0,9.0,15.0,8.0,8.0,119.0
Chamoli,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,3.0,2.0,3.0,3.0,3.0,2.0,2.0,2.0,2.0,3.0,-1.0
Chamoli,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,3.0,3.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,3.0,-1.0
Chamoli,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,272.0,296.0,292.0,300.0,301.0,287.0,305.0,278.0,284.0,287.0,288.0,298.0,-1.0
Chamoli,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,5.0,5.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,5.0,-1.0
Chamoli,14.05,Number of RKS meetings held during the month,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,3.0,2.0,25.0
Chamoli,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,9.0,10.0,10.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,9.0,-1.0
Chamoli,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1.0,3.0,0.0,0.0,0.0,1.0,1.0,1.0,2.0,2.0,0.0,0.0,11.0
Chamoli,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,4.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,-1.0
Chamoli,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,2.0,1.0,1.0,2.0,3.0,3.0,3.0,3.0,3.0,-1.0
Chamoli,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Chamoli,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Chamoli,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Chamoli,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,30.0,31.0,41.0,42.0,31.0,39.0,30.0,31.0,25.0,27.0,34.0,32.0,393.0
Chamoli,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,196.0,734.0,305.0,224.0,224.0,357.0,192.0,114.0,150.0,84.0,489.0,122.0,3191.0
Chamoli,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,28.0,29.0,40.0,38.0,45.0,52.0,18.0,27.0,23.0,18.0,25.0,22.0,365.0
Chamoli,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,397.0,966.0,639.0,444.0,503.0,825.0,539.0,254.0,383.0,338.0,802.0,345.0,6435.0
Chamoli,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,58.0,60.0,81.0,80.0,76.0,91.0,48.0,58.0,48.0,45.0,59.0,54.0,758.0
Chamoli,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,593.0,1700.0,944.0,668.0,727.0,1182.0,731.0,368.0,533.0,422.0,1291.0,467.0,9626.0
Chamoli,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chamoli,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Chamoli,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,0.0,0.0,1.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Chamoli,14.11,In-Patient Head Count at midnight,TOTAL,24.0,31.0,26.0,58.0,15.0,45.0,73.0,20.0,38.0,24.0,30.0,34.0,418.0
Chamoli,14.12.1,OPD attendance (All),TOTAL,20236.0,22854.0,24325.0,22487.0,25225.0,23007.0,20313.0,17080.0,19329.0,19242.0,20552.0,19620.0,254270.0
Chamoli,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,55.0,50.0,78.0,19.0,45.0,54.0,53.0,54.0,54.0,47.0,37.0,50.0,596.0
Chamoli,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,19.0,26.0,29.0,8.0,15.0,20.0,35.0,18.0,133.0,13.0,5.0,20.0,341.0
Chamoli,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Chamoli,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,47.0,31.0,32.0,28.0,34.0,24.0,65.0,59.0,35.0,52.0,103.0,54.0,564.0
Chamoli,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Chamoli,14.14.a,Number of patients given AYUSH treatment,TOTAL,1546.0,1796.0,1980.0,1869.0,1912.0,1764.0,1606.0,1782.0,1971.0,2093.0,1570.0,1840.0,21729.0
Chamoli,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,152.0,146.0,423.0,307.0,405.0,307.0,214.0,203.0,296.0,351.0,276.0,289.0,3369.0
Chamoli,14.14.c,Number of Adolescents counselled,TOTAL,4.0,5.0,0.0,0.0,2.0,0.0,0.0,2.0,2.0,0.0,0.0,2.0,17.0
Chamoli,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Chamoli,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,946.0,828.0,1092.0,1188.0,1144.0,1162.0,668.0,607.0,926.0,708.0,850.0,783.0,10902.0
Chamoli,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,39.0,44.0,57.0,62.0,49.0,59.0,35.0,7.0,18.0,43.0,18.0,22.0,453.0
Chamoli,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,168.0,74.0,147.0,108.0,75.0,46.0,99.0,77.0,78.0,84.0,77.0,40.0,1073.0
Chamoli,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Chamoli,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,167.0,97.0,172.0,149.0,149.0,39.0,147.0,215.0,397.0,227.0,108.0,23.0,1890.0
Chamoli,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chamoli,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,227.0,159.0,326.0,258.0,239.0,199.0,122.0,171.0,243.0,158.0,180.0,142.0,2424.0
Chamoli,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,55.0,0.0,0.0,65.0
Chamoli,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,562.0,330.0,645.0,515.0,463.0,284.0,368.0,463.0,718.0,469.0,365.0,205.0,5387.0
Chamoli,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,1.0,1.0,1.0,1.0,10.0,0.0,0.0,55.0,0.0,0.0,69.0
Chamoli,15.2,Number of Widal tests conducted,Number tested,150.0,205.0,279.0,361.0,387.0,331.0,169.0,98.0,169.0,108.0,80.0,170.0,2507.0
Chamoli,15.3.a,Number of VDRL tests conducted on males,Number tested,2.0,9.0,40.0,13.0,13.0,0.0,9.0,6.0,0.0,2.0,4.0,0.0,98.0
Chamoli,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,56.0,50.0,37.0,42.0,41.0,14.0,20.0,16.0,11.0,3.0,16.0,0.0,306.0
Chamoli,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,119.0,119.0,235.0,206.0,134.0,128.0,106.0,29.0,132.0,151.0,120.0,70.0,1549.0
Chamoli,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,177.0,178.0,312.0,261.0,188.0,142.0,135.0,51.0,143.0,156.0,140.0,70.0,1953.0
Chamoli,15.4.1,Number of blood smears examined for Malaria,TOTAL,413.0,112.0,441.0,411.0,260.0,452.0,354.0,199.0,312.0,412.0,53.0,262.0,3681.0
Chamoli,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Chamoli,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,67.0,0.0,0.0,0.0,62.0,0.0,0.0,0.0,0.0,0.0,129.0
Chamoli,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1850.0,1500.0,550.0,0.0,1000.0,0.0,250.0,,,,,,5150.0
Chamoli,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1000.0,1000.0,0.0,2000.0,0.0,3000.0,0.0,,,,,,7000.0
Chamoli,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1350.0,1950.0,550.0,1000.0,1000.0,2750.0,250.0,,,,,,8850.0
Chamoli,16.1.1,Stock position of DPT vaccines,5. Total Stock,1500.0,550.0,0.0,1000.0,0.0,250.0,0.0,0.0,0.0,0.0,0.0,0.0,3300.0
Chamoli,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1550.0,1950.0,2650.0,350.0,1250.0,180.0,1160.0,,,,,,9090.0
Chamoli,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,3000.0,3000.0,0.0,3000.0,0.0,5000.0,0.0,,,,,,14000.0
Chamoli,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2600.0,2300.0,2300.0,2100.0,1070.0,4020.0,1160.0,,,,,,15550.0
Chamoli,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1950.0,2650.0,350.0,1250.0,180.0,1160.0,0.0,0.0,0.0,0.0,0.0,0.0,7540.0
Chamoli,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,400.0,1100.0,8400.0,2000.0,4600.0,2300.0,3380.0,,,,,,22180.0
Chamoli,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5000.0,10000.0,0.0,8000.0,0.0,8000.0,0.0,,,,,,31000.0
Chamoli,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4300.0,2700.0,6400.0,5400.0,2300.0,6920.0,2700.0,,,,,,30720.0
Chamoli,16.1.2,Stock position of OPV vaccines,5. Total Stock,1100.0,8400.0,2000.0,4600.0,2300.0,3380.0,680.0,0.0,0.0,0.0,0.0,0.0,22460.0
Chamoli,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2350.0,4400.0,5000.0,1250.0,3200.0,1800.0,4200.0,,,,,,22200.0
Chamoli,16.1.3,Stock position of TT vaccines,2. Stocks Received,5000.0,5000.0,0.0,6000.0,0.0,6000.0,0.0,,,,,,22000.0
Chamoli,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2950.0,4400.0,3750.0,4050.0,1400.0,3600.0,3500.0,,,,,,23650.0
Chamoli,16.1.3,Stock position of TT vaccines,5. Total Stock,4400.0,5000.0,1250.0,3200.0,1800.0,4200.0,700.0,0.0,0.0,0.0,0.0,0.0,20550.0
Chamoli,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1200.0,1400.0,3250.0,1600.0,2900.0,1900.0,2050.0,,,,,,14300.0
Chamoli,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,3000.0,0.0,3000.0,0.0,2000.0,0.0,,,,,,10000.0
Chamoli,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1800.0,1150.0,1650.0,1700.0,1000.0,1850.0,1850.0,,,,,,11000.0
Chamoli,16.1.5,Stock position of BCG vaccines,5. Total Stock,1400.0,3250.0,1600.0,2900.0,1900.0,2050.0,200.0,0.0,0.0,0.0,0.0,0.0,13300.0
Chamoli,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,350.0,1775.0,3125.0,1000.0,2025.0,1025.0,1625.0,,,,,,10925.0
Chamoli,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,3000.0,0.0,3000.0,0.0,3000.0,0.0,,,,,,12000.0
Chamoli,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1575.0,1650.0,2125.0,1975.0,1000.0,2400.0,1450.0,,,,,,12175.0
Chamoli,16.1.6,Stock position of Measles vaccines,5. Total Stock,1775.0,3125.0,1000.0,2025.0,1025.0,1625.0,175.0,0.0,0.0,0.0,0.0,0.0,10750.0
Chamoli,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1700.0,1250.0,700.0,500.0,300.0,300.0,1300.0,,,,,,6050.0
Chamoli,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,1500.0,0.0,,,,,,1500.0
Chamoli,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,450.0,550.0,200.0,200.0,0.0,500.0,300.0,,,,,,2200.0
Chamoli,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1250.0,700.0,500.0,300.0,300.0,1300.0,1000.0,0.0,0.0,0.0,0.0,0.0,5350.0
Chamoli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Chamoli,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Chamoli,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Chamoli,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamoli,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,500.0,4028.0,3304.0,2300.0,1900.0,1300.0,700.0,,,,,,14032.0
Chamoli,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,2000.0
Chamoli,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,472.0,724.0,1004.0,400.0,600.0,600.0,600.0,,,,,,4400.0
Chamoli,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2028.0,3304.0,2300.0,1900.0,1300.0,700.0,100.0,0.0,0.0,0.0,0.0,0.0,11632.0
Chamoli,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,2400.0,24600.0,14200.0,10000.0,7000.0,4700.0,48400.0,,,,,,111300.0
Chamoli,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,39000.0,0.0,0.0,0.0,0.0,50400.0,0.0,,,,,,89400.0
Chamoli,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,16800.0,10400.0,4200.0,3000.0,2300.0,6700.0,25200.0,,,,,,68600.0
Chamoli,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,24600.0,14200.0,10000.0,7000.0,4700.0,48400.0,23200.0,0.0,0.0,0.0,0.0,0.0,132100.0
Chamoli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200.0,2050.0,1800.0,1350.0,1050.0,800.0,4400.0,,,,,,11650.0
Chamoli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,0.0,0.0,0.0,0.0,4000.0,0.0,,,,,,6400.0
Chamoli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Chamoli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,550.0,250.0,450.0,300.0,250.0,400.0,800.0,,,,,,3000.0
Chamoli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2050.0,1800.0,1350.0,1050.0,800.0,4400.0,3600.0,0.0,0.0,0.0,0.0,0.0,15050.0
Chamoli,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,1.0,,1.0,,2.0
Chamoli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,,,1.0
Chamoli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chamoli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,,,,,,,,1.0
Chamoli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Chamoli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chamoli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Chamoli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Chamoli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chamoli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Chamoli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,,,1.0
Chamoli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chamoli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,1.0,,,,,,,1.0
Chamoli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Chamoli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Chamoli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,,,,1.0,,,,,,2.0
Chamoli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,,,,,,,,,1.0,2.0
Chamoli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chamoli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,,,,,,,,1.0,2.0
Chamoli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,1.0,,1.0
Chamoli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Chamoli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,1.0,,,1.0,,2.0
Chamoli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chamoli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chamoli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Chamoli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,1.0,1.0,1.0,,,1.0,,1.0,,2.0,9.0
Chamoli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
Chamoli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,1.0,1.0,1.0,1.0,,,1.0,,1.0,1.0,2.0,10.0
Chamoli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Chamoli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Chamoli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Chamoli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,1.0,,,,,,,1.0,1.0,,,5.0
Chamoli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,,1.0,,,,,,,2.0
Chamoli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,1.0,1.0,,,1.0,,,1.0,1.0,,,7.0
Chamoli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Chamoli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,,2.0,,,,,1.0,,2.0,,6.0
Chamoli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,1.0,2.0,6.0,1.0,1.0,5.0,3.0,3.0,3.0,4.0,1.0,32.0
Chamoli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,1.0,2.0,8.0,1.0,1.0,5.0,4.0,4.0,3.0,6.0,1.0,39.0
Chamoli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Chamoli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Chamoli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,,,,,,,,,1.0
Chamoli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,1.0,,,,,,,,,2.0
Chamoli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,,1.0,,1.0,,,,,3.0
Chamoli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,1.0,1.0,1.0,,,,,1.0,1.0,6.0
Chamoli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,,,3.0,1.0,2.0,,1.0,,,1.0,1.0,11.0
Chamoli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Chamoli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Chamoli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Chamoli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,1.0,2.0,,2.0,1.0,1.0,1.0,,1.0,1.0,11.0
Chamoli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,1.0,4.0,1.0,2.0,1.0,2.0,2.0,,3.0,2.0,1.0,22.0
Chamoli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,2.0,5.0,3.0,2.0,3.0,3.0,3.0,1.0,3.0,3.0,2.0,33.0
Chamoli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,,2.0,,,,,,3.0
Chamoli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,,,1.0,,,,,,1.0,,,4.0
Chamoli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,,,1.0,1.0,,2.0,,,1.0,,,7.0
Chamoli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Chamoli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Chamoli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,1.0,,,,,,,,,,,,1.0
Chamoli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Chamoli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Chamoli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Chamoli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Chamoli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Chamoli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Chamoli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Chamoli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Chamoli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Chamoli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Chamoli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Chamoli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Chamoli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,1.0,1.0,,,1.0,,,,4.0
Chamoli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Chamoli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,1.0,1.0,,,1.0,,,,4.0
Chamoli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,2.0,,,,,,2.0
Chamoli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,,2.0,4.0,3.0,4.0,6.0,1.0,4.0,3.0,2.0,3.0,35.0
Chamoli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,1.0,1.0,1.0,,3.0,1.0,1.0,1.0,3.0,1.0,14.0
Chamoli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,,3.0,5.0,4.0,4.0,11.0,2.0,5.0,4.0,5.0,4.0,51.0
Chamoli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Chamoli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,,,,1.0,,,1.0,1.0,,,1.0,5.0
Chamoli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Chamoli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,,,1.0,1.0,,,1.0,1.0,,,1.0,6.0
Chamoli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Chamoli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Chamoli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,,,,,,,,,1.0
Chamoli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Chamoli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,1.0,1.0,,1.0,,,,,,,3.0
Chamoli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,5.0,,1.0,,1.0,,2.0,,1.0,,11.0
Chamoli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,6.0,1.0,1.0,1.0,1.0,,2.0,,1.0,,14.0
Chamoli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Chamoli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,2.0,3.0,5.0,4.0,5.0,3.0,8.0,3.0,2.0,4.0,3.0,43.0
Chamoli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,11.0,12.0,25.0,13.0,14.0,25.0,21.0,20.0,19.0,17.0,24.0,22.0,223.0
Chamoli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,12.0,14.0,28.0,18.0,18.0,30.0,24.0,28.0,22.0,19.0,29.0,25.0,267.0
Chamoli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,2.0,,,,1.0,1.0,,,,,4.0
Chamoli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,2.0,2.0,,5.0,4.0,,4.0,7.0,6.0,2.0,1.0,33.0
Chamoli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,5.0,11.0,21.0,16.0,15.0,11.0,14.0,12.0,26.0,24.0,21.0,23.0,199.0
Chamoli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,13.0,25.0,16.0,20.0,15.0,15.0,17.0,33.0,30.0,23.0,24.0,236.0
Champawat,1.1,Total number of pregnant women Registered for ANC,TOTAL,446.0,439.0,383.0,458.0,428.0,459.0,333.0,315.0,358.0,374.0,409.0,376.0,4778.0
Champawat,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,223.0,234.0,227.0,252.0,244.0,231.0,196.0,155.0,190.0,232.0,235.0,216.0,2635.0
Champawat,1.2,Number of Pregnant women registered under JSY,TOTAL,446.0,439.0,383.0,458.0,428.0,459.0,333.0,315.0,358.0,374.0,409.0,376.0,4778.0
Champawat,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,293.0,315.0,293.0,350.0,340.0,360.0,362.0,333.0,311.0,316.0,331.0,294.0,3898.0
Champawat,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,432.0,418.0,350.0,432.0,392.0,430.0,309.0,296.0,338.0,354.0,394.0,347.0,4492.0
Champawat,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,352.0,408.0,390.0,372.0,407.0,421.0,411.0,288.0,313.0,325.0,339.0,387.0,4413.0
Champawat,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,64.0,115.0,101.0,104.0,48.0,29.0,24.0,23.0,259.0,97.0,55.0,52.0,971.0
Champawat,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,13.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,24.0
Champawat,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Champawat,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,225.0,151.0,202.0,163.0,152.0,186.0,131.0,105.0,78.0,68.0,115.0,120.0,1696.0
Champawat,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,3.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,1.0,9.0
Champawat,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,29.0,22.0,20.0,17.0,13.0,12.0,10.0,15.0,26.0,164.0
Champawat,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,41.0,45.0,41.0,42.0,47.0,44.0,51.0,47.0,41.0,55.0,51.0,38.0,543.0
Champawat,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,24.0,16.0,29.0,22.0,14.0,20.0,17.0,23.0,24.0,23.0,37.0,24.0,273.0
Champawat,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,65.0,61.0,70.0,64.0,61.0,64.0,68.0,70.0,65.0,78.0,88.0,62.0,816.0
Champawat,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,60.0,56.0,57.0,58.0,55.0,58.0,56.0,58.0,59.0,56.0,71.0,58.0,702.0
Champawat,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,3.0,7.0,26.0,24.0,17.0,15.0,19.0,8.0,22.0,19.0,12.0,33.0,205.0
Champawat,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,180.0,155.0,135.0,216.0,201.0,181.0,196.0,191.0,188.0,172.0,168.0,167.0,2150.0
Champawat,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,159.0,115.0,90.0,122.0,114.0,113.0,121.0,112.0,101.0,102.0,75.0,106.0,1330.0
Champawat,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,130.0,131.0,47.0,127.0,92.0,87.0,92.0,374.0,269.0,195.0,115.0,278.0,1937.0
Champawat,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,97.0,94.0,74.0,127.0,113.0,79.0,109.0,265.0,231.0,174.0,120.0,206.0,1689.0
Champawat,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Champawat,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Champawat,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Champawat,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Champawat,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champawat,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Champawat,4.1.1.a,Number of male live births,TOTAL,107.0,110.0,96.0,144.0,135.0,125.0,146.0,127.0,128.0,130.0,123.0,118.0,1489.0
Champawat,4.1.1.b,Number of female live births,TOTAL,136.0,104.0,102.0,135.0,125.0,116.0,112.0,127.0,120.0,115.0,128.0,108.0,1428.0
Champawat,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,243.0,214.0,198.0,279.0,260.0,241.0,258.0,254.0,248.0,245.0,251.0,226.0,2917.0
Champawat,4.1.2,Number of still births,TOTAL,4.0,3.0,8.0,6.0,4.0,4.0,6.0,8.0,4.0,7.0,6.0,4.0,64.0
Champawat,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,10.0,18.0,8.0,9.0,15.0,8.0,5.0,1.0,3.0,1.0,6.0,3.0,87.0
Champawat,4.2.1,Number of Newborns weighed at birth,TOTAL,225.0,192.0,187.0,260.0,244.0,227.0,241.0,231.0,230.0,232.0,235.0,218.0,2722.0
Champawat,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,14.0,8.0,8.0,21.0,15.0,11.0,14.0,9.0,5.0,10.0,4.0,8.0,127.0
Champawat,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,246.0,212.0,198.0,277.0,256.0,233.0,255.0,247.0,243.0,239.0,246.0,222.0,2874.0
Champawat,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champawat,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Champawat,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,16.0,26.0,21.0,66.0,48.0,72.0,50.0,58.0,40.0,30.0,0.0,43.0,470.0
Champawat,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,222.0,173.0,197.0,277.0,263.0,227.0,266.0,239.0,250.0,214.0,236.0,228.0,2792.0
Champawat,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,176.0,136.0,135.0,171.0,156.0,201.0,200.0,205.0,224.0,172.0,189.0,185.0,2150.0
Champawat,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,3.0
Champawat,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,8.0,16.0,5.0,7.0,10.0,4.0,3.0,0.0,0.0,1.0,2.0,2.0,58.0
Champawat,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,8.0,16.0,5.0,7.0,10.0,4.0,3.0,0.0,0.0,1.0,2.0,2.0,58.0
Champawat,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,7.0,12.0,10.0,9.0,10.0,12.0,14.0,11.0,10.0,10.0,18.0,7.0,130.0
Champawat,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,26.0,46.0,33.0,54.0,50.0,41.0,41.0,55.0,50.0,56.0,52.0,63.0,567.0
Champawat,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,33.0,58.0,43.0,63.0,60.0,53.0,55.0,66.0,60.0,66.0,70.0,70.0,697.0
Champawat,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Champawat,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champawat,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Champawat,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Champawat,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,0.0,0.0,31.0,0.0,0.0,0.0,0.0,66.0,34.0,42.0,0.0,173.0
Champawat,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,16.0,4.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,68.0,47.0,24.0,174.0
Champawat,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,46.0,89.0,44.0,43.0,231.0
Champawat,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champawat,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,16.0,4.0,0.0,46.0,0.0,0.0,0.0,9.0,112.0,191.0,133.0,67.0,578.0
Champawat,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Champawat,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0
Champawat,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Champawat,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champawat,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,1.0,0.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26.0
Champawat,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Champawat,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champawat,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Champawat,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,8.0,23.0,34.0,48.0,45.0,52.0,41.0,40.0,54.0,50.0,29.0,12.0,436.0
Champawat,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,4.0
Champawat,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,35.0,24.0,17.0,27.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,128.0
Champawat,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,18.0,15.0,9.0,16.0,11.0,6.0,3.0,7.0,9.0,10.0,6.0,12.0,122.0
Champawat,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champawat,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,61.0,62.0,60.0,93.0,60.0,61.0,47.0,50.0,68.0,63.0,38.0,27.0,690.0
Champawat,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,56.0,39.0,13.0,31.0,19.0,19.0,15.0,14.0,22.0,15.0,15.0,18.0,276.0
Champawat,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Champawat,9.06,Number of IUCD removals,TOTAL,10.0,7.0,11.0,18.0,16.0,12.0,11.0,13.0,11.0,31.0,8.0,20.0,168.0
Champawat,9.07,Number of Oral Pills cycles distributed,TOTAL,0.0,0.0,349.0,851.0,677.0,683.0,428.0,509.0,552.0,559.0,517.0,265.0,5390.0
Champawat,9.08,Number of Condom pieces distributed,TOTAL,7104.0,4890.0,8712.0,16834.0,9784.0,10761.0,8566.0,8377.0,9606.0,8615.0,7175.0,5301.0,105725.0
Champawat,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,4.0,17.0,0.0,30.0
Champawat,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Champawat,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Champawat,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,374.0,350.0,268.0,317.0,372.0,365.0,324.0,319.0,392.0,321.0,338.0,373.0,4113.0
Champawat,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,7.0,8.0,0.0,0.0,0.0,0.0,15.0
Champawat,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,3.0,8.0,0.0,0.0,0.0,0.0,13.0
Champawat,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4.0,0.0,0.0,0.0,0.0,1.0,7.0,3.0,0.0,0.0,0.0,0.0,15.0
Champawat,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,367.0,392.0,309.0,264.0,291.0,402.0,308.0,302.0,383.0,355.0,322.0,358.0,4053.0
Champawat,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,343.0,347.0,360.0,323.0,288.0,308.0,360.0,310.0,356.0,359.0,346.0,351.0,4051.0
Champawat,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,379.0,332.0,321.0,349.0,348.0,299.0,286.0,323.0,370.0,345.0,349.0,377.0,4078.0
Champawat,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,51.0,45.0,28.0,30.0,37.0,49.0,73.0,58.0,65.0,66.0,69.0,82.0,653.0
Champawat,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,362.0,392.0,310.0,264.0,291.0,402.0,322.0,310.0,383.0,355.0,322.0,358.0,4071.0
Champawat,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,349.0,347.0,360.0,323.0,288.0,308.0,364.0,318.0,356.0,359.0,346.0,351.0,4069.0
Champawat,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,374.0,332.0,321.0,349.0,349.0,300.0,297.0,326.0,370.0,345.0,349.0,377.0,4089.0
Champawat,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,24.0,21.0,21.0,29.0,21.0,30.0,146.0
Champawat,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,4.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,6.0
Champawat,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1.0,5.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,7.0
Champawat,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,5.0,6.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
Champawat,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,314.0,352.0,357.0,340.0,329.0,389.0,341.0,307.0,344.0,360.0,299.0,321.0,4053.0
Champawat,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,253.0,290.0,279.0,316.0,286.0,315.0,241.0,201.0,269.0,270.0,318.0,334.0,3372.0
Champawat,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,179.0,177.0,187.0,202.0,176.0,209.0,191.0,155.0,170.0,175.0,145.0,163.0,2129.0
Champawat,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,135.0,172.0,170.0,138.0,155.0,176.0,149.0,151.0,168.0,187.0,154.0,158.0,1913.0
Champawat,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,314.0,349.0,357.0,340.0,331.0,385.0,340.0,306.0,338.0,362.0,299.0,321.0,4042.0
Champawat,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,305.0,329.0,334.0,349.0,361.0,317.0,301.0,223.0,312.0,299.0,388.0,355.0,3873.0
Champawat,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,305.0,329.0,334.0,349.0,361.0,317.0,301.0,223.0,312.0,299.0,388.0,355.0,3873.0
Champawat,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,10.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0
Champawat,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,5.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,7.0
Champawat,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,15.0,9.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,25.0
Champawat,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,332.0,288.0,338.0,319.0,331.0,378.0,329.0,281.0,343.0,404.0,372.0,359.0,4074.0
Champawat,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,278.0,286.0,291.0,328.0,323.0,291.0,341.0,294.0,310.0,341.0,309.0,329.0,3721.0
Champawat,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,251.0,277.0,258.0,284.0,282.0,267.0,327.0,219.0,287.0,280.0,286.0,262.0,3280.0
Champawat,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,30.0,15.0,35.0,43.0,128.0
Champawat,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,573.0,568.0,566.0,581.0,561.0,584.0,580.0,558.0,573.0,545.0,547.0,574.0,6810.0
Champawat,10.4.2,Number of Immunisation sessions held during the month,TOTAL,535.0,515.0,533.0,565.0,545.0,567.0,565.0,517.0,563.0,530.0,536.0,556.0,6527.0
Champawat,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,435.0,433.0,430.0,436.0,458.0,497.0,477.0,437.0,489.0,452.0,465.0,464.0,5473.0
Champawat,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1270.0,1290.0,2560.0
Champawat,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,110.0,584.0,694.0
Champawat,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,141.0,149.0
Champawat,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Champawat,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,76.0,70.0,91.0,124.0,105.0,61.0,52.0,47.0,27.0,31.0,31.0,68.0,783.0
Champawat,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Champawat,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,1.0,4.0,1.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,11.0
Champawat,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,49.0,0.0,100.0,0.0,0.0,18.0,167.0
Champawat,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,49.0,0.0,100.0,0.0,0.0,18.0,167.0
Champawat,13.3,Number of School children detected with Refractive errors,TOTAL,3.0,3.0,0.0,0.0,2.0,11.0,8.0,15.0,5.0,0.0,8.0,0.0,55.0
Champawat,13.4,Number of children provided free glasses,TOTAL,3.0,0.0,0.0,0.0,0.0,1.0,8.0,12.0,4.0,0.0,8.0,0.0,36.0
Champawat,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Champawat,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Champawat,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,242.0,243.0,259.0,258.0,260.0,259.0,257.0,250.0,261.0,251.0,255.0,260.0,-1.0
Champawat,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,2.0,3.0,3.0,-1.0
Champawat,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,4.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Champawat,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,3.0,-1.0
Champawat,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,8.0,4.0,4.0,4.0,6.0,6.0,6.0,6.0,5.0,5.0,5.0,6.0,-1.0
Champawat,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Champawat,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Champawat,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Champawat,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,20.0,81.0,31.0,89.0,73.0,67.0,32.0,32.0,39.0,26.0,36.0,40.0,566.0
Champawat,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,138.0,286.0,90.0,206.0,137.0,306.0,136.0,101.0,191.0,93.0,90.0,145.0,1919.0
Champawat,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,30.0,68.0,27.0,63.0,50.0,44.0,17.0,14.0,43.0,18.0,19.0,20.0,413.0
Champawat,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,411.0,453.0,140.0,384.0,387.0,193.0,343.0,283.0,334.0,325.0,286.0,409.0,3948.0
Champawat,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,50.0,149.0,58.0,152.0,123.0,111.0,49.0,46.0,82.0,44.0,55.0,60.0,979.0
Champawat,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,549.0,739.0,230.0,590.0,524.0,499.0,479.0,384.0,525.0,418.0,376.0,554.0,5867.0
Champawat,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,1.0,1.0,1.0,1.0,5.0,5.0,3.0,5.0,0.0,0.0,0.0,23.0
Champawat,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,2.0,0.0,1.0,2.0,1.0,3.0,0.0,0.0,1.0,10.0
Champawat,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,1.0,1.0,1.0,3.0,1.0,6.0,7.0,4.0,8.0,0.0,0.0,1.0,33.0
Champawat,14.11,In-Patient Head Count at midnight,TOTAL,149.0,287.0,108.0,504.0,447.0,406.0,329.0,234.0,332.0,205.0,237.0,268.0,3506.0
Champawat,14.12.1,OPD attendance (All),TOTAL,14338.0,16074.0,16607.0,19146.0,19146.0,22104.0,16210.0,13864.0,16509.0,12150.0,16366.0,15868.0,198382.0
Champawat,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Champawat,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Champawat,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,68.0,156.0,0.0,181.0,118.0,124.0,158.0,150.0,164.0,55.0,86.0,69.0,1329.0
Champawat,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Champawat,14.14.a,Number of patients given AYUSH treatment,TOTAL,1098.0,1210.0,1211.0,946.0,1223.0,1205.0,690.0,837.0,1068.0,892.0,1137.0,1141.0,12658.0
Champawat,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,23.0,33.0,35.0,22.0,1.0,43.0,29.0,57.0,15.0,54.0,99.0,358.0,769.0
Champawat,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,16.0
Champawat,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Champawat,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,630.0,366.0,637.0,587.0,521.0,568.0,262.0,309.0,224.0,348.0,167.0,892.0,5511.0
Champawat,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,2.0,3.0,3.0,3.0,2.0,4.0,3.0,0.0,0.0,1.0,0.0,2.0,23.0
Champawat,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,87.0,101.0,50.0,60.0,54.0,89.0,50.0,48.0,60.0,23.0,107.0,60.0,789.0
Champawat,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,3.0
Champawat,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,72.0,100.0,82.0,84.0,77.0,93.0,69.0,24.0,93.0,98.0,81.0,79.0,952.0
Champawat,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,5.0
Champawat,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,224.0,199.0,149.0,184.0,194.0,144.0,113.0,137.0,126.0,83.0,215.0,179.0,1947.0
Champawat,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,383.0,400.0,281.0,328.0,325.0,326.0,232.0,209.0,279.0,204.0,403.0,318.0,3688.0
Champawat,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0,1.0,8.0
Champawat,15.2,Number of Widal tests conducted,Number tested,95.0,77.0,153.0,193.0,154.0,332.0,247.0,134.0,98.0,29.0,159.0,223.0,1894.0
Champawat,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0
Champawat,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,4.0
Champawat,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,103.0,110.0,77.0,103.0,103.0,75.0,57.0,68.0,58.0,41.0,102.0,88.0,985.0
Champawat,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,103.0,110.0,77.0,103.0,103.0,75.0,57.0,68.0,65.0,41.0,102.0,88.0,992.0
Champawat,15.4.1,Number of blood smears examined for Malaria,TOTAL,215.0,107.0,134.0,149.0,182.0,363.0,175.0,66.0,44.0,71.0,100.0,68.0,1674.0
Champawat,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,0.0,0.0,2.0,2.0,3.0,2.0,0.0,0.0,1.0,0.0,0.0,11.0
Champawat,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3750.0,3500.0,4250.0,,,3000.0,,1000.0,250.0,,,,15750.0
Champawat,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,3000.0,0.0,,,0.0,,0.0,3000.0,,,,6000.0
Champawat,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,,0.0
Champawat,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,250.0,2250.0,1000.0,,,1250.0,,750.0,200.0,,,,5700.0
Champawat,16.1.1,Stock position of DPT vaccines,5. Total Stock,3500.0,4250.0,3250.0,0.0,0.0,1750.0,0.0,250.0,3050.0,0.0,0.0,0.0,16050.0
Champawat,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,730.0,250.0,200.0,,,1200.0,,1000.0,250.0,,,,3630.0
Champawat,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,2000.0,0.0,,,0.0,,0.0,4000.0,,,,6000.0
Champawat,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,,0.0
Champawat,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,480.0,2050.0,200.0,,,1100.0,,750.0,700.0,,,,5280.0
Champawat,16.1.1A,Stock Position of Pentavalent,5. Total Stock,250.0,200.0,0.0,0.0,0.0,100.0,0.0,250.0,3550.0,0.0,0.0,0.0,4350.0
Champawat,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,9100.0,7000.0,7000.0,,,6500.0,,3000.0,1000.0,,,,33600.0
Champawat,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,5000.0,0.0,,,0.0,,0.0,3500.0,,,,8500.0
Champawat,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,,0.0
Champawat,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2100.0,5000.0,1500.0,,,4500.0,,2000.0,1000.0,,,,16100.0
Champawat,16.1.2,Stock position of OPV vaccines,5. Total Stock,7000.0,7000.0,5500.0,0.0,0.0,2000.0,0.0,1000.0,3500.0,0.0,0.0,0.0,26000.0
Champawat,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4250.0,3250.0,3000.0,,,3250.0,,3500.0,1750.0,,,,19000.0
Champawat,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,2500.0,0.0,,,0.0,,0.0,4000.0,,,,6500.0
Champawat,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,,0.0
Champawat,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1000.0,2750.0,750.0,,,2250.0,,1750.0,500.0,,,,9000.0
Champawat,16.1.3,Stock position of TT vaccines,5. Total Stock,3250.0,3000.0,2250.0,0.0,0.0,1000.0,0.0,1750.0,5250.0,0.0,0.0,0.0,16500.0
Champawat,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,,,,0.0,,,,,0.0
Champawat,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,0.0,,,,,0.0
Champawat,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,0.0,,,,,0.0
Champawat,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,,,,0.0,,,,,0.0
Champawat,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4000.0,4000.0,4250.0,,,4000.0,,4000.0,3000.0,,,,23250.0
Champawat,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,2000.0,0.0,,,0.0,,0.0,3000.0,,,,5000.0
Champawat,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,,0.0
Champawat,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,0.0,1750.0,750.0,,,1250.0,,1000.0,750.0,,,,5500.0
Champawat,16.1.5,Stock position of BCG vaccines,5. Total Stock,4000.0,4250.0,3500.0,0.0,0.0,2750.0,0.0,3000.0,5250.0,0.0,0.0,0.0,22750.0
Champawat,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1750.0,1500.0,1750.0,,,2250.0,,2000.0,1125.0,,,,10375.0
Champawat,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,1500.0,0.0,,,0.0,,0.0,2000.0,,,,3500.0
Champawat,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,,0.0
Champawat,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,250.0,1250.0,625.0,,,1125.0,,875.0,500.0,,,,4625.0
Champawat,16.1.6,Stock position of Measles vaccines,5. Total Stock,1500.0,1750.0,1125.0,0.0,0.0,1125.0,0.0,1125.0,2625.0,0.0,0.0,0.0,9250.0
Champawat,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,,,,0.0,0.0,,,,0.0
Champawat,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,0.0,0.0,,,,0.0
Champawat,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,0.0,0.0,,,,0.0
Champawat,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,,,,,0.0,0.0,,,,0.0
Champawat,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3500.0,3500.0,5300.0,,,4400.0,,3900.0,3900.0,,,,24500.0
Champawat,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,2100.0,0.0,,,0.0,,0.0,0.0,,,,2100.0
Champawat,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,,0.0
Champawat,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,300.0,300.0,,,500.0,,0.0,300.0,,,,1400.0
Champawat,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3500.0,5300.0,5000.0,0.0,0.0,3900.0,0.0,3900.0,3600.0,0.0,0.0,0.0,25200.0
Champawat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Champawat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Champawat,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Champawat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Champawat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Champawat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Champawat,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Champawat,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Champawat,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Champawat,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Champawat,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Champawat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Champawat,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Champawat,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Champawat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Champawat,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Champawat,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Champawat,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Champawat,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Champawat,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champawat,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1500.0,1500.0,1500.0,,,400.0,,400.0,400.0,,,,5700.0
Champawat,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,,0.0
Champawat,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,,0.0
Champawat,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,700.0,,,0.0,,0.0,200.0,,,,900.0
Champawat,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1500.0,1500.0,800.0,0.0,0.0,400.0,0.0,400.0,200.0,0.0,0.0,0.0,4800.0
Champawat,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,,,17000.0,,32000.0,28100.0,,,,77100.0
Champawat,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,7200.0,,,0.0,,0.0,0.0,,,,7200.0
Champawat,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,,0.0
Champawat,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,4500.0,,,300.0,,3900.0,5400.0,,,,14100.0
Champawat,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,2700.0,0.0,0.0,16700.0,0.0,28100.0,22700.0,0.0,0.0,0.0,70200.0
Champawat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,400.0,400.0,400.0,,,2500.0,,4500.0,4500.0,,,,12700.0
Champawat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,4000.0,,,0.0,,0.0,0.0,,,,4000.0
Champawat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,,,0.0
Champawat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,1000.0,,,0.0,,0.0,500.0,,,,1500.0
Champawat,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,400.0,400.0,3400.0,0.0,0.0,2500.0,0.0,4500.0,4000.0,0.0,0.0,0.0,15200.0
Champawat,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,1.0,1.0,,,,,2.0
Champawat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Champawat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Champawat,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Champawat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,3.0,,,1.0,4.0
Champawat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Champawat,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,3.0,,,1.0,4.0
Champawat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,,,1.0
Champawat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Champawat,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,1.0,,,1.0
Champawat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,1.0,,,,1.0,1.0,1.0,1.0,,5.0
Champawat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Champawat,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,1.0,,,,1.0,1.0,1.0,1.0,,5.0
Champawat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,1.0,1.0,,1.0,,3.0
Champawat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Champawat,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,1.0,1.0,,1.0,,3.0
Champawat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Champawat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Champawat,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Champawat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Champawat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Champawat,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,,,,,,,,,,,1.0
Champawat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Champawat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Champawat,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Champawat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,,1.0,1.0,,1.0,1.0,,2.0,1.0,8.0
Champawat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,,,,,,,1.0,,2.0
Champawat,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,1.0,1.0,1.0,1.0,,1.0,1.0,,3.0,1.0,10.0
Champawat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Champawat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Champawat,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Champawat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Champawat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Champawat,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,1.0,1.0,,2.0
Champawat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,1.0,,1.0,2.0,2.0,,,,,,7.0
Champawat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,,5.0,8.0,11.0,10.0,11.0,8.0,8.0,1.0,7.0,6.0,77.0
Champawat,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,1.0,6.0,8.0,12.0,12.0,13.0,8.0,8.0,1.0,7.0,6.0,84.0
Champawat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Champawat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Champawat,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,1.0,,,,,,,,,1.0
Champawat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Champawat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,3.0,,,2.0,,,,,,,6.0
Champawat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,1.0,,,1.0,1.0,,,2.0,1.0,,7.0
Champawat,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,2.0,4.0,1.0,,3.0,1.0,,,2.0,1.0,,14.0
Champawat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Champawat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Champawat,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,1.0,,,,,,,,1.0
Champawat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,2.0,3.0,1.0,1.0,1.0,4.0,3.0,3.0,2.0,2.0,2.0,25.0
Champawat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,2.0,6.0,2.0,2.0,3.0,,3.0,5.0,1.0,2.0,2.0,29.0
Champawat,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,4.0,9.0,3.0,3.0,4.0,4.0,6.0,8.0,3.0,4.0,4.0,54.0
Champawat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,1.0,1.0,,,2.0
Champawat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,2.0,1.0,,,,3.0
Champawat,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,2.0,2.0,1.0,,,5.0
Champawat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Champawat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Champawat,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Champawat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Champawat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Champawat,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Champawat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Champawat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Champawat,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Champawat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Champawat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Champawat,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Champawat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Champawat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Champawat,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Champawat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,,1.0,,,,,,,2.0
Champawat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Champawat,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,,1.0,,,,,,,2.0
Champawat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,2.0,2.0,2.0,1.0,1.0,1.0,4.0,1.0,4.0,3.0,,23.0
Champawat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,3.0,,1.0,,,,2.0,1.0,1.0,,9.0
Champawat,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,3.0,5.0,2.0,2.0,1.0,1.0,4.0,3.0,5.0,4.0,,32.0
Champawat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,,1.0,,,2.0,2.0,,,1.0,1.0,1.0,9.0
Champawat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Champawat,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,,1.0,,,3.0,2.0,,,1.0,1.0,1.0,10.0
Champawat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Champawat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Champawat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Champawat,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,,,,,,,,,1.0
Champawat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Champawat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,,4.0,,2.0,,2.0,2.0,3.0,,,,16.0
Champawat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,3.0,3.0,3.0,2.0,3.0,,2.0,3.0,6.0,6.0,,33.0
Champawat,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,5.0,3.0,7.0,3.0,4.0,3.0,2.0,4.0,6.0,6.0,6.0,,49.0
Champawat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Champawat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,4.0,8.0,6.0,3.0,5.0,5.0,3.0,4.0,7.0,2.0,47.0
Champawat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,8.0,15.0,20.0,16.0,12.0,13.0,14.0,15.0,17.0,31.0,18.0,17.0,196.0
Champawat,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,8.0,15.0,24.0,24.0,18.0,16.0,19.0,20.0,20.0,35.0,25.0,20.0,244.0
Champawat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,2.0,,,,1.0,1.0,,1.0,,,5.0
Champawat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,2.0,6.0,2.0,3.0,5.0,7.0,9.0,6.0,3.0,3.0,11.0,57.0
Champawat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,8.0,9.0,13.0,7.0,8.0,16.0,13.0,13.0,17.0,13.0,14.0,13.0,144.0
Champawat,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,8.0,11.0,21.0,9.0,11.0,21.0,21.0,23.0,23.0,17.0,17.0,24.0,206.0
Dehradun,1.1,Total number of pregnant women Registered for ANC,TOTAL,3085.0,3326.0,2708.0,3366.0,3139.0,3063.0,3103.0,2513.0,3157.0,3582.0,3687.0,4016.0,38745.0
Dehradun,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2303.0,2695.0,1893.0,2601.0,2406.0,2247.0,2155.0,1880.0,2217.0,2599.0,2642.0,3094.0,28732.0
Dehradun,1.2,Number of Pregnant women registered under JSY,TOTAL,3085.0,3326.0,2708.0,3366.0,3139.0,3063.0,3103.0,2513.0,3157.0,3583.0,3687.0,3956.0,38686.0
Dehradun,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3067.0,3681.0,3660.0,3863.0,3721.0,3626.0,3415.0,3018.0,3855.0,3450.0,3541.0,3684.0,42581.0
Dehradun,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2641.0,2992.0,2312.0,2940.0,2767.0,2662.0,2648.0,2120.0,2604.0,2734.0,2909.0,3368.0,32697.0
Dehradun,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2693.0,3380.0,2818.0,2988.0,3074.0,3190.0,3119.0,2805.0,2892.0,2917.0,2933.0,3928.0,36737.0
Dehradun,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,573.0,653.0,415.0,694.0,553.0,719.0,454.0,592.0,1071.0,580.0,729.0,721.0,7754.0
Dehradun,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,136.0,174.0,224.0,367.0,376.0,375.0,334.0,204.0,239.0,235.0,180.0,174.0,3018.0
Dehradun,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,2.0,3.0,5.0,2.0,2.0,1.0,2.0,4.0,7.0,6.0,1.0,36.0
Dehradun,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3136.0,3370.0,2972.0,3573.0,3120.0,3055.0,3546.0,3104.0,3162.0,3819.0,3223.0,3404.0,39484.0
Dehradun,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,117.0,116.0,119.0,163.0,71.0,48.0,129.0,65.0,113.0,159.0,178.0,147.0,1425.0
Dehradun,1.8,Number of pregnancy test kits used at SC level,TOTAL,185.0,210.0,152.0,128.0,35.0,47.0,33.0,34.0,29.0,10.0,25.0,42.0,930.0
Dehradun,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,18.0,5.0,11.0,14.0,7.0,18.0,14.0,10.0,26.0,31.0,19.0,18.0,191.0
Dehradun,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,69.0,108.0,94.0,109.0,93.0,104.0,102.0,107.0,71.0,74.0,69.0,75.0,1075.0
Dehradun,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,87.0,113.0,105.0,123.0,100.0,122.0,116.0,117.0,97.0,105.0,88.0,93.0,1266.0
Dehradun,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,79.0,98.0,117.0,123.0,96.0,102.0,120.0,112.0,78.0,91.0,72.0,81.0,1169.0
Dehradun,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,4.0,3.0,0.0,8.0,3.0,9.0,3.0,1.0,0.0,5.0,2.0,1.0,39.0
Dehradun,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1306.0,1465.0,1209.0,1638.0,1628.0,1554.0,1732.0,1583.0,1652.0,1714.0,1537.0,1500.0,18518.0
Dehradun,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,489.0,483.0,460.0,478.0,493.0,586.0,516.0,467.0,520.0,488.0,309.0,742.0,6031.0
Dehradun,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1279.0,1402.0,1150.0,1590.0,1599.0,1485.0,1710.0,1546.0,1664.0,1682.0,1567.0,1459.0,18133.0
Dehradun,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,577.0,710.0,496.0,1651.0,591.0,707.0,1859.0,813.0,1118.0,875.0,1251.0,1394.0,12042.0
Dehradun,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,412.0,432.0,472.0,448.0,432.0,414.0,429.0,423.0,412.0,455.0,470.0,443.0,5242.0
Dehradun,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Dehradun,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Dehradun,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Dehradun,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,7.0,5.0,0.0,3.0,1.0,5.0,2.0,6.0,7.0,0.0,0.0,0.0,36.0
Dehradun,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,268.0,287.0,244.0,336.0,297.0,245.0,364.0,327.0,371.0,392.0,356.0,382.0,3869.0
Dehradun,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dehradun,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,275.0,292.0,244.0,339.0,298.0,250.0,366.0,333.0,378.0,392.0,356.0,382.0,3905.0
Dehradun,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,125.0,136.0,146.0,135.0,128.0,102.0,112.0,130.0,125.0,126.0,145.0,132.0,1542.0
Dehradun,4.1.1.a,Number of male live births,TOTAL,918.0,1020.0,941.0,1134.0,1128.0,1046.0,1166.0,1083.0,1115.0,1202.0,1056.0,1034.0,12843.0
Dehradun,4.1.1.b,Number of female live births,TOTAL,867.0,975.0,818.0,1066.0,1017.0,1033.0,1090.0,1039.0,1030.0,1066.0,1019.0,966.0,11986.0
Dehradun,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1785.0,1995.0,1759.0,2200.0,2145.0,2079.0,2256.0,2122.0,2145.0,2268.0,2075.0,2000.0,24829.0
Dehradun,4.1.2,Number of still births,TOTAL,32.0,39.0,41.0,31.0,31.0,28.0,53.0,24.0,37.0,37.0,35.0,39.0,427.0
Dehradun,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,178.0,258.0,166.0,207.0,194.0,184.0,141.0,116.0,375.0,210.0,222.0,188.0,2439.0
Dehradun,4.2.1,Number of Newborns weighed at birth,TOTAL,1776.0,1991.0,1739.0,2186.0,2141.0,2072.0,2240.0,2104.0,2132.0,2263.0,2068.0,1998.0,24710.0
Dehradun,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,242.0,278.0,243.0,311.0,311.0,191.0,328.0,327.0,362.0,360.0,328.0,310.0,3591.0
Dehradun,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1756.0,1902.0,1687.0,2158.0,2125.0,2037.0,2184.0,2098.0,2112.0,2097.0,1916.0,1823.0,23895.0
Dehradun,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,3.0
Dehradun,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,3.0,3.0,7.0,4.0,0.0,0.0,7.0,2.0,6.0,0.0,6.0,5.0,43.0
Dehradun,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,268.0,287.0,244.0,336.0,297.0,245.0,494.0,327.0,371.0,392.0,358.0,382.0,4001.0
Dehradun,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dehradun,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,271.0,290.0,251.0,340.0,298.0,245.0,501.0,330.0,378.0,392.0,364.0,387.0,4047.0
Dehradun,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,125.0,136.0,146.0,135.0,128.0,102.0,112.0,130.0,125.0,126.0,145.0,132.0,1542.0
Dehradun,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,393.0,423.0,358.0,471.0,425.0,347.0,606.0,457.0,496.0,518.0,503.0,514.0,5511.0
Dehradun,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,2.0,3.0,5.0,2.0,2.0,1.0,2.0,4.0,7.0,6.0,1.0,36.0
Dehradun,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,393.0,423.0,373.0,449.0,393.0,325.0,606.0,457.0,478.0,518.0,503.0,514.0,5432.0
Dehradun,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,239.0,271.0,235.0,248.0,233.0,170.0,283.0,214.0,190.0,245.0,256.0,246.0,2830.0
Dehradun,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1735.0,2008.0,1723.0,2140.0,2093.0,2031.0,1892.0,1762.0,2087.0,2211.0,2047.0,1934.0,23663.0
Dehradun,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1677.0,2014.0,1774.0,1781.0,1851.0,2108.0,1935.0,1839.0,2383.0,2192.0,1824.0,1773.0,23151.0
Dehradun,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,5.0
Dehradun,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,149.0,161.0,84.0,126.0,125.0,117.0,90.0,89.0,132.0,163.0,157.0,144.0,1537.0
Dehradun,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,149.0,161.0,84.0,126.0,125.0,117.0,90.0,89.0,132.0,163.0,157.0,144.0,1537.0
Dehradun,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,41.0,88.0,30.0,68.0,125.0,513.0,106.0,102.0,99.0,94.0,106.0,136.0,1508.0
Dehradun,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,687.0,1049.0,710.0,886.0,948.0,889.0,735.0,830.0,1069.0,1217.0,1101.0,1152.0,11273.0
Dehradun,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,728.0,1137.0,740.0,954.0,1073.0,1402.0,841.0,932.0,1168.0,1311.0,1207.0,1288.0,12781.0
Dehradun,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,0.0,2.0,1.0,1.0,13.0
Dehradun,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,6.0,2.0,2.0,3.0,0.0,6.0,0.0,2.0,11.0,16.0,3.0,10.0,61.0
Dehradun,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,4.0,8.0,3.0,19.0,10.0,2.0,4.0,1.0,2.0,1.0,4.0,5.0,63.0
Dehradun,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dehradun,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,12.0,11.0,6.0,23.0,11.0,9.0,5.0,4.0,13.0,19.0,8.0,16.0,137.0
Dehradun,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dehradun,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,17.0,9.0,9.0,22.0,9.0,11.0,8.0,44.0,99.0,27.0,17.0,14.0,286.0
Dehradun,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,4.0,8.0,14.0,27.0,0.0,3.0,6.0,41.0,278.0,111.0,87.0,146.0,725.0
Dehradun,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,59.0,53.0,53.0,62.0,25.0,28.0,38.0,33.0,57.0,118.0,55.0,21.0,602.0
Dehradun,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dehradun,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,80.0,70.0,76.0,111.0,34.0,42.0,52.0,118.0,434.0,256.0,159.0,181.0,1613.0
Dehradun,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dehradun,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dehradun,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,9.0,6.0,1.0,9.0,2.0,8.0,1.0,9.0,5.0,51.0
Dehradun,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dehradun,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,2.0,0.0,9.0,6.0,1.0,9.0,2.0,8.0,1.0,9.0,5.0,52.0
Dehradun,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dehradun,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,42.0,36.0,31.0,56.0,41.0,37.0,54.0,29.0,50.0,43.0,38.0,49.0,506.0
Dehradun,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dehradun,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,42.0,36.0,31.0,56.0,41.0,37.0,54.0,29.0,50.0,43.0,38.0,49.0,506.0
Dehradun,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,29.0,47.0,55.0,53.0,74.0,74.0,69.0,71.0,76.0,82.0,93.0,46.0,769.0
Dehradun,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,431.0,395.0,426.0,627.0,474.0,469.0,408.0,373.0,405.0,410.0,373.0,409.0,5200.0
Dehradun,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,71.0,74.0,65.0,111.0,68.0,77.0,75.0,80.0,99.0,95.0,91.0,72.0,978.0
Dehradun,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,31.0,77.0,50.0,72.0,64.0,71.0,66.0,51.0,51.0,88.0,68.0,60.0,749.0
Dehradun,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,152.0,193.0,163.0,213.0,157.0,123.0,589.0,137.0,145.0,132.0,136.0,153.0,2293.0
Dehradun,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dehradun,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,685.0,739.0,704.0,1023.0,763.0,740.0,1138.0,641.0,700.0,725.0,668.0,694.0,9220.0
Dehradun,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,99.0,112.0,133.0,77.0,50.0,63.0,524.0,92.0,60.0,132.0,83.0,65.0,1490.0
Dehradun,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dehradun,9.06,Number of IUCD removals,TOTAL,173.0,225.0,195.0,182.0,174.0,221.0,194.0,173.0,196.0,267.0,185.0,194.0,2379.0
Dehradun,9.07,Number of Oral Pills cycles distributed,TOTAL,4683.0,4568.0,4327.0,7899.0,5491.0,4810.0,3637.0,4546.0,5042.0,5125.0,4941.0,4667.0,59736.0
Dehradun,9.08,Number of Condom pieces distributed,TOTAL,77011.0,68905.0,57604.0,101238.0,76074.0,60568.0,44062.0,56839.0,57287.0,51802.0,42589.0,58384.0,752363.0
Dehradun,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,274.0,318.0,263.0,292.0,219.0,180.0,181.0,245.0,255.0,384.0,222.0,390.0,3223.0
Dehradun,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,13.0
Dehradun,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,3.0,7.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,1.0,26.0
Dehradun,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,5.0
Dehradun,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,7.0,6.0,7.0,8.0,8.0,7.0,8.0,7.0,7.0,7.0,6.0,-1.0
Dehradun,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2203.0,2602.0,2099.0,2931.0,2656.0,2857.0,3027.0,2686.0,2904.0,2771.0,2683.0,2543.0,31962.0
Dehradun,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,33.0,9.0,31.0,38.0,2.0,5.0,117.0,18.0,8.0,59.0,20.0,8.0,348.0
Dehradun,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,136.0,56.0,45.0,62.0,27.0,18.0,91.0,48.0,39.0,56.0,29.0,13.0,620.0
Dehradun,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,322.0,186.0,113.0,98.0,58.0,43.0,93.0,48.0,52.0,80.0,39.0,15.0,1147.0
Dehradun,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2333.0,2693.0,2280.0,2812.0,2506.0,2677.0,3232.0,2467.0,3164.0,2913.0,2781.0,2844.0,32702.0
Dehradun,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2462.0,2842.0,2475.0,2746.0,2661.0,2557.0,2761.0,2801.0,3017.0,3164.0,2798.0,2839.0,33123.0
Dehradun,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2383.0,2803.0,2538.0,2774.0,2524.0,2714.0,2691.0,2609.0,3180.0,3042.0,2938.0,2942.0,33138.0
Dehradun,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1724.0,1781.0,1448.0,1784.0,1965.0,2104.0,1907.0,2178.0,2258.0,2094.0,1990.0,2019.0,23252.0
Dehradun,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2418.0,2539.0,2277.0,2656.0,2494.0,2671.0,3078.0,2498.0,3165.0,2957.0,2645.0,2822.0,32220.0
Dehradun,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2571.0,2706.0,2468.0,2693.0,2663.0,2626.0,2576.0,2841.0,3027.0,3064.0,2797.0,2804.0,32836.0
Dehradun,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2663.0,2744.0,2571.0,2686.0,2484.0,2751.0,2540.0,2562.0,3346.0,3065.0,2981.0,2943.0,33336.0
Dehradun,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,769.0,869.0,837.0,1089.0,956.0,1155.0,944.0,1416.0,1378.0,1311.0,1357.0,1261.0,13342.0
Dehradun,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,42.0,33.0,54.0,20.0,23.0,33.0,45.0,73.0,18.0,86.0,19.0,2.0,448.0
Dehradun,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,179.0,101.0,83.0,48.0,36.0,36.0,45.0,38.0,51.0,114.0,19.0,10.0,760.0
Dehradun,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,664.0,601.0,504.0,411.0,365.0,368.0,442.0,298.0,42.0,49.0,37.0,10.0,3791.0
Dehradun,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2336.0,2787.0,2744.0,3220.0,2953.0,2880.0,3072.0,2780.0,3139.0,2824.0,2714.0,2576.0,34025.0
Dehradun,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1989.0,2413.0,1924.0,2370.0,1980.0,1973.0,2813.0,2120.0,3284.0,2633.0,2720.0,2740.0,28959.0
Dehradun,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,47.0,47.0
Dehradun,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,913.0,1138.0,1118.0,1367.0,1125.0,1274.0,1387.0,1053.0,1188.0,1106.0,1130.0,1050.0,13849.0
Dehradun,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,892.0,1057.0,1067.0,1257.0,1048.0,1202.0,1269.0,1030.0,1018.0,1052.0,1080.0,1075.0,13047.0
Dehradun,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1805.0,2195.0,2185.0,2624.0,2173.0,2476.0,2656.0,2083.0,2206.0,2158.0,2210.0,2125.0,26896.0
Dehradun,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2643.0,2962.0,2422.0,2825.0,2493.0,2417.0,3340.0,2433.0,2811.0,2601.0,2674.0,2725.0,32346.0
Dehradun,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2635.0,2833.0,2421.0,2774.0,2482.0,2420.0,3140.0,2437.0,2833.0,2585.0,2676.0,2731.0,31967.0
Dehradun,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42.0,42.0
Dehradun,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,619.0,841.0,621.0,730.0,685.0,618.0,1001.0,641.0,800.0,786.0,926.0,1078.0,9346.0
Dehradun,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,567.0,766.0,562.0,692.0,622.0,631.0,987.0,581.0,724.0,783.0,896.0,858.0,8669.0
Dehradun,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1186.0,1607.0,1183.0,1422.0,1307.0,1249.0,1988.0,1222.0,1524.0,1569.0,1822.0,1936.0,18015.0
Dehradun,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1323.0,1492.0,3651.0,1535.0,1543.0,1792.0,1791.0,1424.0,1581.0,1833.0,1388.0,1413.0,20766.0
Dehradun,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,981.0,1208.0,1178.0,1239.0,1100.0,1127.0,1287.0,1052.0,1254.0,1339.0,946.0,1115.0,13826.0
Dehradun,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,805.0,960.0,966.0,998.0,909.0,836.0,913.0,804.0,911.0,925.0,740.0,881.0,10648.0
Dehradun,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,3.0,3.0,3.0,12.0,8.0,6.0,4.0,7.0,3.0,2.0,3.0,57.0
Dehradun,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,10.0,47.0,40.0,15.0,36.0,21.0,38.0,20.0,14.0,241.0
Dehradun,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1048.0,1174.0,1023.0,1096.0,1052.0,1120.0,1283.0,1240.0,1325.0,1309.0,1284.0,1307.0,14261.0
Dehradun,10.4.2,Number of Immunisation sessions held during the month,TOTAL,981.0,1110.0,948.0,1051.0,1010.0,1069.0,1248.0,1141.0,1282.0,1234.0,1212.0,1248.0,13534.0
Dehradun,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,964.0,1069.0,927.0,1025.0,991.0,1044.0,1208.0,1088.0,1226.0,1182.0,1158.0,1193.0,13075.0
Dehradun,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,164.0,818.0,1218.0,1523.0,1313.0,764.0,814.0,578.0,305.0,281.0,264.0,130.0,8172.0
Dehradun,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,7.0,180.0,335.0,435.0,404.0,75.0,88.0,83.0,64.0,48.0,28.0,51.0,1798.0
Dehradun,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,11.0,82.0,110.0,132.0,69.0,9.0,37.0,6.0,8.0,9.0,9.0,2.0,484.0
Dehradun,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,11.0,8.0,16.0,7.0,4.0,6.0,0.0,4.0,7.0,4.0,4.0,7.0,78.0
Dehradun,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1377.0,2353.0,2121.0,2648.0,2358.0,1652.0,2185.0,2228.0,1973.0,1883.0,2100.0,2298.0,25176.0
Dehradun,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,1.0,9.0,6.0,20.0,29.0,44.0,44.0,31.0,31.0,23.0,20.0,258.0
Dehradun,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,2172.0,1992.0,2080.0,3309.0,3204.0,1830.0,2590.0,2614.0,2456.0,2507.0,3369.0,2868.0,30991.0
Dehradun,13.1,Number of Patients operated for cataract,TOTAL,1363.0,1239.0,1025.0,1067.0,155.0,144.0,195.0,237.0,326.0,295.0,288.0,328.0,6662.0
Dehradun,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,1361.0,1236.0,1002.0,1059.0,153.0,143.0,194.0,232.0,301.0,262.0,263.0,317.0,6523.0
Dehradun,13.3,Number of School children detected with Refractive errors,TOTAL,52.0,12.0,11.0,83.0,82.0,17.0,54.0,16.0,16.0,60.0,28.0,21.0,452.0
Dehradun,13.4,Number of children provided free glasses,TOTAL,42.0,0.0,0.0,11.0,16.0,7.0,17.0,6.0,12.0,14.0,2.0,2.0,129.0
Dehradun,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,6.0,7.0,7.0,7.0,7.0,7.0,7.0,8.0,6.0,7.0,-1.0
Dehradun,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,6.0,-1.0
Dehradun,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,510.0,588.0,485.0,522.0,522.0,546.0,496.0,456.0,477.0,508.0,450.0,472.0,-1.0
Dehradun,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,12.0,13.0,11.0,13.0,13.0,12.0,10.0,10.0,12.0,11.0,13.0,11.0,-1.0
Dehradun,14.05,Number of RKS meetings held during the month,TOTAL,3.0,2.0,3.0,3.0,1.0,1.0,0.0,0.0,5.0,3.0,3.0,3.0,27.0
Dehradun,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,19.0,16.0,22.0,25.0,23.0,17.0,16.0,12.0,14.0,13.0,15.0,13.0,-1.0
Dehradun,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,682.0,763.0,476.0,812.0,691.0,839.0,3566.0,780.0,806.0,779.0,1106.0,542.0,11842.0
Dehradun,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,2.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,3.0,2.0,2.0,-1.0
Dehradun,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,14.0,14.0,11.0,27.0,16.0,12.0,12.0,11.0,11.0,13.0,10.0,11.0,-1.0
Dehradun,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Dehradun,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Dehradun,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Dehradun,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1061.0,1277.0,1122.0,1415.0,1202.0,1071.0,1511.0,673.0,1183.0,1221.0,997.0,845.0,13578.0
Dehradun,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1076.0,1369.0,1321.0,1273.0,1298.0,1554.0,1397.0,1765.0,1319.0,1307.0,1237.0,1691.0,16607.0
Dehradun,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,863.0,1141.0,846.0,1191.0,1087.0,963.0,1215.0,659.0,1015.0,1018.0,901.0,741.0,11640.0
Dehradun,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2495.0,3437.0,2805.0,3228.0,3258.0,3062.0,3640.0,3604.0,3375.0,3304.0,3151.0,3367.0,38726.0
Dehradun,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1924.0,2418.0,1968.0,2606.0,2289.0,2034.0,2726.0,1332.0,2198.0,2239.0,1898.0,1586.0,25218.0
Dehradun,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3571.0,4806.0,4126.0,4501.0,4556.0,4616.0,5037.0,5369.0,4694.0,4611.0,4388.0,5058.0,55333.0
Dehradun,14.10.2.a,Number of death cases of Inpatient males,TOTAL,56.0,49.0,49.0,63.0,68.0,52.0,54.0,55.0,85.0,62.0,54.0,42.0,689.0
Dehradun,14.10.2.b,Number of death cases of Inpatient females,TOTAL,26.0,47.0,32.0,35.0,32.0,19.0,30.0,29.0,35.0,30.0,32.0,27.0,374.0
Dehradun,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,82.0,96.0,81.0,98.0,100.0,71.0,84.0,84.0,120.0,92.0,86.0,69.0,1063.0
Dehradun,14.11,In-Patient Head Count at midnight,TOTAL,7846.0,8853.0,8008.0,5329.0,4785.0,4739.0,4909.0,4553.0,4746.0,4742.0,4269.0,2090.0,64869.0
Dehradun,14.12.1,OPD attendance (All),TOTAL,155607.0,192595.0,158504.0,186499.0,191799.0,189429.0,195273.0,155887.0,185244.0,173802.0,177112.0,141181.0,2102932.0
Dehradun,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,672.0,798.0,685.0,905.0,801.0,549.0,727.0,905.0,735.0,851.0,738.0,740.0,9106.0
Dehradun,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,28.0,7.0,0.0,25.0,14.0,22.0,23.0,6.0,4.0,1.0,63.0,29.0,222.0
Dehradun,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Dehradun,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,428.0,636.0,622.0,755.0,698.0,518.0,751.0,629.0,591.0,647.0,446.0,713.0,7434.0
Dehradun,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Dehradun,14.14.a,Number of patients given AYUSH treatment,TOTAL,6282.0,5653.0,5702.0,6656.0,7322.0,6311.0,5378.0,5645.0,5936.0,16534.0,6634.0,7508.0,85561.0
Dehradun,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2358.0,2552.0,2447.0,2858.0,3249.0,3239.0,3236.0,2319.0,2853.0,2573.0,3056.0,2708.0,33448.0
Dehradun,14.14.c,Number of Adolescents counselled,TOTAL,73.0,225.0,167.0,255.0,305.0,367.0,235.0,310.0,413.0,314.0,331.0,352.0,3347.0
Dehradun,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Dehradun,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8388.0,10708.0,8848.0,12203.0,12071.0,12999.0,13250.0,10407.0,11833.0,11443.0,11740.0,11097.0,134987.0
Dehradun,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,153.0,191.0,204.0,271.0,176.0,276.0,215.0,246.0,316.0,246.0,254.0,261.0,2809.0
Dehradun,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,754.0,373.0,437.0,974.0,375.0,230.0,378.0,700.0,596.0,795.0,729.0,1158.0,7499.0
Dehradun,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,10.0,1.0,2.0,16.0,2.0,2.0,0.0,5.0,0.0,14.0,10.0,15.0,77.0
Dehradun,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,530.0,340.0,412.0,760.0,497.0,289.0,401.0,557.0,445.0,663.0,704.0,546.0,6144.0
Dehradun,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,7.0,0.0,1.0,3.0,3.0,0.0,3.0,1.0,0.0,10.0,3.0,6.0,37.0
Dehradun,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2346.0,2523.0,1915.0,2628.0,2184.0,1654.0,1905.0,1935.0,1885.0,1972.0,2095.0,1779.0,24821.0
Dehradun,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,5.0,2.0,2.0,0.0,0.0,1.0,1.0,1.0,2.0,5.0,0.0,20.0
Dehradun,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3630.0,3236.0,2764.0,4362.0,3056.0,2173.0,2684.0,3192.0,2926.0,3430.0,3528.0,3483.0,38464.0
Dehradun,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,18.0,6.0,5.0,21.0,5.0,2.0,4.0,7.0,1.0,26.0,18.0,21.0,134.0
Dehradun,15.2,Number of Widal tests conducted,Number tested,1370.0,1783.0,1434.0,1658.0,2152.0,3792.0,3734.0,1719.0,1649.0,1090.0,1190.0,1428.0,22999.0
Dehradun,15.3.a,Number of VDRL tests conducted on males,Number tested,806.0,642.0,594.0,772.0,593.0,482.0,833.0,554.0,548.0,490.0,445.0,395.0,7154.0
Dehradun,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,254.0,143.0,47.0,249.0,169.0,126.0,189.0,106.0,175.0,225.0,139.0,211.0,2033.0
Dehradun,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1948.0,2195.0,1610.0,2088.0,2079.0,1985.0,1722.0,1812.0,2268.0,2183.0,2245.0,2402.0,24537.0
Dehradun,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,3008.0,2980.0,2251.0,3109.0,2841.0,2593.0,2744.0,2472.0,2991.0,2898.0,2829.0,3008.0,33724.0
Dehradun,15.4.1,Number of blood smears examined for Malaria,TOTAL,2034.0,1778.0,1818.0,2565.0,3397.0,4330.0,4535.0,2340.0,1741.0,1394.0,1631.0,1981.0,29544.0
Dehradun,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,4.0,1.0,24.0,45.0,77.0,86.0,36.0,13.0,5.0,8.0,3.0,2.0,304.0
Dehradun,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,1.0,1.0,6.0,29.0,2.0,2.0,0.0,0.0,0.0,0.0,41.0
Dehradun,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,11010.0,6220.0,2960.0,190.0,0.0,4550.0,140.0,10650.0,5420.0,5070.0,2410.0,1220.0,49840.0
Dehradun,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,0.0,2000.0,10000.0,0.0,17000.0,0.0,5000.0,3000.0,3000.0,3000.0,43000.0
Dehradun,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4790.0,3260.0,2770.0,2190.0,5450.0,4410.0,6490.0,5230.0,5350.0,5650.0,4190.0,4220.0,54000.0
Dehradun,16.1.1,Stock position of DPT vaccines,5. Total Stock,6220.0,2960.0,190.0,0.0,4550.0,140.0,10650.0,5420.0,5070.0,2420.0,1220.0,0.0,38840.0
Dehradun,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,14650.0,6190.0,4520.0,880.0,1020.0,20.0,3140.0,1110.0,470.0,540.0,2500.0,4160.0,39200.0
Dehradun,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,7000.0,0.0,8000.0,5000.0,8000.0,6500.0,2500.0,8000.0,10000.0,7700.0,3900.0,66600.0
Dehradun,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,8460.0,8670.0,3640.0,7860.0,6000.0,4880.0,8530.0,3140.0,7930.0,8040.0,6040.0,7790.0,80980.0
Dehradun,16.1.1A,Stock Position of Pentavalent,5. Total Stock,6190.0,4520.0,880.0,1020.0,20.0,3140.0,1110.0,470.0,540.0,2500.0,4160.0,270.0,24820.0
Dehradun,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,8740.0,0.0,1600.0,3120.0,12700.0,9940.0,6760.0,20820.0,6600.0,5320.0,0.0,0.0,75600.0
Dehradun,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,15000.0,15000.0,20000.0,10000.0,10000.0,30000.0,0.0,15000.0,8000.0,15000.0,10000.0,148000.0
Dehradun,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,8740.0,13400.0,13480.0,10420.0,12760.0,13180.0,15940.0,14220.0,16280.0,13320.0,15000.0,9600.0,156340.0
Dehradun,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,1600.0,3120.0,12700.0,9940.0,6760.0,20820.0,6600.0,5320.0,0.0,0.0,400.0,67260.0
Dehradun,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,9510.0,13160.0,5060.0,8340.0,1980.0,8330.0,9910.0,20010.0,14430.0,14120.0,6940.0,5210.0,117000.0
Dehradun,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,0.0,10000.0,5000.0,15000.0,8000.0,20000.0,0.0,10000.0,0.0,5000.0,5000.0,88000.0
Dehradun,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6350.0,8100.0,6720.0,11360.0,8650.0,6420.0,9900.0,5580.0,10310.0,7180.0,6730.0,9000.0,96300.0
Dehradun,16.1.3,Stock position of TT vaccines,5. Total Stock,13160.0,5060.0,8340.0,1980.0,8330.0,9910.0,20010.0,14430.0,14120.0,6940.0,5210.0,1210.0,108700.0
Dehradun,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,0.0,,,,0.0,0.0,,,,,0.0
Dehradun,16.1.4,Stock position of DT vaccines,2. Stocks Received,,0.0,0.0,,,,0.0,0.0,,,,,0.0
Dehradun,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,0.0,0.0,,,,0.0,0.0,,,,,0.0
Dehradun,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,0.0,0.0,,,,0.0,0.0,,,,,0.0
Dehradun,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3480.0,5330.0,6550.0,3990.0,200.0,2550.0,3520.0,6860.0,2940.0,2470.0,2260.0,1400.0,41550.0
Dehradun,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,4000.0,0.0,0.0,5000.0,5000.0,10000.0,0.0,6000.0,3000.0,3000.0,5000.0,46000.0
Dehradun,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2950.0,2780.0,2560.0,3790.0,2650.0,4030.0,6660.0,3920.0,6470.0,3210.0,3860.0,4880.0,47760.0
Dehradun,16.1.5,Stock position of BCG vaccines,5. Total Stock,5530.0,6550.0,3990.0,200.0,2550.0,3520.0,6860.0,2940.0,2470.0,2260.0,1400.0,1520.0,39790.0
Dehradun,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3470.0,2940.0,2790.0,3365.0,145.0,4385.0,2680.0,7590.0,2030.0,2590.0,2040.0,1595.0,35620.0
Dehradun,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,5000.0,5000.0,2000.0,10000.0,0.0,13000.0,0.0,8000.0,5000.0,5000.0,5000.0,63000.0
Dehradun,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5530.0,5150.0,4425.0,5220.0,5760.0,1705.0,8090.0,5560.0,7440.0,5550.0,5445.0,6315.0,66190.0
Dehradun,16.1.6,Stock position of Measles vaccines,5. Total Stock,2940.0,2790.0,3365.0,145.0,4385.0,2680.0,7590.0,2030.0,2590.0,2040.0,1595.0,280.0,32430.0
Dehradun,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,0.0,,,,,,,,,,0.0
Dehradun,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,0.0,,,,,,,,,,0.0
Dehradun,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,0.0,,,,,,,,,,0.0
Dehradun,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,0.0,,,,,,,,,,0.0
Dehradun,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,8910.0,5010.0,3820.0,1870.0,360.0,2160.0,1800.0,620.0,160.0,1490.0,1670.0,1210.0,29080.0
Dehradun,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,3000.0,1800.0,3600.0,3100.0,3100.0,3000.0,1500.0,2000.0,21100.0
Dehradun,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,3900.0,1190.0,1950.0,1510.0,1200.0,2160.0,4780.0,3560.0,1770.0,2820.0,1960.0,2760.0,29560.0
Dehradun,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5010.0,3820.0,1870.0,360.0,2160.0,1800.0,620.0,160.0,1490.0,1670.0,1210.0,450.0,20620.0
Dehradun,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,300.0,300.0,300.0,300.0,1050.0,1050.0,1050.0,1550.0,1200.0,600.0,600.0,600.0,8900.0
Dehradun,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,3000.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,3000.0,9000.0
Dehradun,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,2250.0,0.0,0.0,2500.0,350.0,600.0,0.0,0.0,950.0,6650.0
Dehradun,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,300.0,300.0,300.0,1050.0,1050.0,1050.0,1550.0,1200.0,600.0,600.0,600.0,2650.0,11250.0
Dehradun,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,30240.0,30240.0,30240.0,30240.0,10080.0,10080.0,10080.0,32380.0,10080.0,10080.0,10080.0,10080.0,223900.0
Dehradun,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,201600.0,0.0,0.0,135000.0,0.0,0.0,0.0,0.0,291084.0,627684.0
Dehradun,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,221760.0,0.0,0.0,112700.0,22300.0,0.0,0.0,0.0,293580.0,650340.0
Dehradun,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,30240.0,30240.0,30240.0,10080.0,10080.0,10080.0,32380.0,10080.0,10080.0,10080.0,10080.0,7584.0,201244.0
Dehradun,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,6900.0,6900.0,6900.0,6900.0,3000.0,3000.0,3000.0,3000.0,39600.0
Dehradun,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,24000.0,0.0,0.0,15000.0,0.0,0.0,0.0,0.0,25200.0,64200.0
Dehradun,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,17100.0,0.0,6900.0,15000.0,3900.0,0.0,0.0,0.0,28200.0,71100.0
Dehradun,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,6900.0,6900.0,0.0,6900.0,3000.0,3000.0,3000.0,3000.0,0.0,32700.0
Dehradun,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1311.0,1311.0,1311.0,1311.0,1311.0,1311.0,1311.0,4211.0,3811.0,3811.0,3811.0,3811.0,28632.0
Dehradun,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,10000.0
Dehradun,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,7100.0,400.0,0.0,0.0,0.0,3811.0,11311.0
Dehradun,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1311.0,1311.0,1311.0,1311.0,1311.0,1311.0,4211.0,3811.0,3811.0,3811.0,3811.0,0.0,27321.0
Dehradun,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1000.0,400.0,200.0,200.0,200.0,12500.0
Dehradun,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,1000.0,2000.0
Dehradun,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,1500.0,600.0,200.0,0.0,0.0,200.0,2500.0
Dehradun,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1500.0,1500.0,1500.0,1500.0,1500.0,1500.0,1000.0,400.0,200.0,200.0,200.0,1000.0,12000.0
Dehradun,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,50.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Dehradun,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,50.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Dehradun,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,9950.0,8550.0,7850.0,6450.0,5725.0,5225.0,3825.0,3175.0,2750.0,2400.0,1275.0,975.0,58150.0
Dehradun,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.02,Stock Position of Gloves,4. Stock Distributed,1400.0,700.0,1400.0,725.0,500.0,1400.0,650.0,425.0,350.0,1125.0,300.0,300.0,9275.0
Dehradun,16.3.02,Stock Position of Gloves,5. Total Stock,8550.0,7850.0,6450.0,5725.0,5225.0,3825.0,3175.0,2750.0,2400.0,1275.0,975.0,675.0,48875.0
Dehradun,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,,0.0
Dehradun,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,6350.0,3500.0,2800.0,1550.0,3250.0,1250.0,250.0,100.0,100.0,0.0,0.0,0.0,19150.0
Dehradun,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,2600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2600.0
Dehradun,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,2850.0,700.0,1250.0,900.0,2000.0,1000.0,150.0,0.0,100.0,0.0,0.0,0.0,8950.0
Dehradun,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,3500.0,2800.0,1550.0,3250.0,1250.0,250.0,100.0,100.0,0.0,0.0,0.0,0.0,12800.0
Dehradun,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,90.0,85.0,73.0,61.0,39.0,39.0,50.0,36.0,29.0,28.0,19.0,19.0,568.0
Dehradun,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Dehradun,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,5.0,12.0,12.0,22.0,0.0,39.0,14.0,7.0,1.0,9.0,0.0,3.0,124.0
Dehradun,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,85.0,73.0,61.0,39.0,39.0,50.0,36.0,29.0,28.0,19.0,19.0,16.0,494.0
Dehradun,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,4716946.0,0.0,0.0,0.0,0.0,0.0,4716946.0
Dehradun,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,5163756.0,0.0,0.0,0.0,0.0,0.0,0.0,5163756.0
Dehradun,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,446810.0,4716946.0,0.0,0.0,0.0,0.0,0.0,5163756.0
Dehradun,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,4716946.0,0.0,0.0,0.0,0.0,0.0,0.0,4716946.0
Dehradun,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,5590.0,1640.0,640.0,900.0,0.0,4300.0,2800.0,4400.0,2900.0,1950.0,650.0,0.0,25770.0
Dehradun,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,1000.0,0.0,6000.0,0.0,5000.0,0.0,0.0,0.0,0.0,5000.0,17000.0
Dehradun,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,3950.0,1000.0,740.0,900.0,1700.0,1500.0,3400.0,1500.0,950.0,1300.0,650.0,500.0,18090.0
Dehradun,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,1640.0,640.0,900.0,0.0,4300.0,2800.0,4400.0,2900.0,1950.0,650.0,0.0,4500.0,24680.0
Dehradun,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,600.0,200.0,175.0,50.0,25.0,15.0,15.0,15.0,15.0,15.0,0.0,0.0,1125.0
Dehradun,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,400.0,25.0,125.0,25.0,10.0,0.0,0.0,0.0,0.0,15.0,0.0,0.0,600.0
Dehradun,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,200.0,175.0,50.0,25.0,15.0,15.0,15.0,15.0,15.0,0.0,0.0,0.0,525.0
Dehradun,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,34580.0,29030.0,24930.0,12430.0,9355.0,7105.0,4525.0,18575.0,17475.0,15200.0,12350.0,10750.0,196305.0
Dehradun,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,17000.0,0.0,0.0,0.0,0.0,16200.0,33200.0
Dehradun,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,5550.0,4100.0,12500.0,3075.0,2250.0,2580.0,2950.0,1100.0,2275.0,2850.0,1600.0,5500.0,46330.0
Dehradun,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,29030.0,24930.0,12430.0,9355.0,7105.0,4525.0,18575.0,17475.0,15200.0,12350.0,10750.0,21450.0,183175.0
Dehradun,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1100.0,3400.0,700.0,600.0,0.0,260.0,0.0,0.0,0.0,1400.0,100.0,100.0,7660.0
Dehradun,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6000.0,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,8000.0,0.0,0.0,10000.0,28000.0
Dehradun,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3700.0,2700.0,100.0,600.0,3740.0,260.0,0.0,0.0,6600.0,1300.0,0.0,5700.0,24700.0
Dehradun,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3400.0,700.0,600.0,0.0,260.0,0.0,0.0,0.0,1400.0,100.0,100.0,4400.0,10960.0
Dehradun,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,23400.0,3000.0,2000.0,35300.0,14300.0,8200.0,10000.0,8800.0,47500.0,12100.0,9100.0,173700.0
Dehradun,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,43200.0,0.0,0.0,62400.0,0.0,0.0,72000.0,0.0,72000.0,0.0,0.0,91600.0,341200.0
Dehradun,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,19800.0,20400.0,1000.0,29100.0,21000.0,6100.0,70200.0,1200.0,33300.0,35400.0,3000.0,64300.0,304800.0
Dehradun,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,23400.0,3000.0,2000.0,35300.0,14300.0,8200.0,10000.0,8800.0,47500.0,12100.0,9100.0,36400.0,210100.0
Dehradun,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,900.0,300.0,0.0,0.0,2200.0,1300.0,1200.0,0.0,0.0,4200.0,3200.0,3000.0,16300.0
Dehradun,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,0.0,0.0,4000.0,0.0,0.0,2000.0,0.0,6000.0,0.0,0.0,2000.0,16400.0
Dehradun,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dehradun,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3000.0,300.0,0.0,1800.0,900.0,100.0,3200.0,0.0,1800.0,1000.0,200.0,3200.0,15500.0
Dehradun,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,300.0,0.0,0.0,2200.0,1300.0,1200.0,0.0,0.0,4200.0,3200.0,3000.0,1800.0,17200.0
Dehradun,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Dehradun,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,2.0,,1.0,,,,,1.0,1.0,6.0
Dehradun,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Dehradun,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,2.0,,1.0,,,1.0,,1.0,1.0,7.0
Dehradun,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,6.0,3.0,,2.0,3.0,2.0,3.0,4.0,3.0,2.0,1.0,6.0,35.0
Dehradun,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,,,,1.0,,,,,,,2.0
Dehradun,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,6.0,4.0,,2.0,3.0,3.0,3.0,4.0,3.0,2.0,1.0,6.0,37.0
Dehradun,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,3.0,,3.0,6.0,4.0,3.0,3.0,6.0,8.0,1.0,3.0,42.0
Dehradun,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
Dehradun,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,3.0,,3.0,6.0,4.0,3.0,3.0,6.0,9.0,1.0,3.0,43.0
Dehradun,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,,,1.0,,1.0,1.0,2.0,,1.0,1.0,8.0
Dehradun,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dehradun,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,,,1.0,,1.0,1.0,2.0,,1.0,1.0,8.0
Dehradun,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dehradun,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dehradun,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Dehradun,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dehradun,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dehradun,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Dehradun,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dehradun,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dehradun,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Dehradun,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dehradun,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dehradun,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dehradun,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Dehradun,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,1.0,,,,,,1.0
Dehradun,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,1.0,,,,,,1.0
Dehradun,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Dehradun,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Dehradun,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,,,,,,1.0
Dehradun,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,1.0,8.0,,,,,,,,9.0
Dehradun,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,5.0,1.0,,,,,,,,6.0
Dehradun,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,6.0,9.0,,,,,,,,15.0
Dehradun,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,5.0,3.0,,,,,,1.0,,10.0
Dehradun,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,5.0,6.0,,,,,1.0,2.0,1.0,16.0
Dehradun,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,2.0,10.0,9.0,,,,,1.0,3.0,1.0,26.0
Dehradun,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Dehradun,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Dehradun,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Dehradun,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,2.0,,,,,,,,2.0
Dehradun,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Dehradun,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,1.0,2.0,,,,,,,,3.0
Dehradun,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,2.0,1.0,,,,,,,,3.0
Dehradun,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Dehradun,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,2.0,1.0,,,,,,,,3.0
Dehradun,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,1.0,1.0,,,,,,,,2.0
Dehradun,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,,2.0,1.0,,,,,,1.0,,5.0
Dehradun,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,1.0,,3.0,2.0,,,,,,1.0,,7.0
Dehradun,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Dehradun,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,11.0,5.0,,,,,,,,16.0
Dehradun,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,10.0,6.0,,,,,,,,16.0
Dehradun,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,21.0,12.0,,,,,,,,33.0
Dehradun,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Dehradun,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dehradun,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Dehradun,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Dehradun,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dehradun,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Dehradun,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,1.0,,,,,,,2.0
Dehradun,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dehradun,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,1.0,,,,,,,2.0
Dehradun,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Dehradun,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dehradun,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Dehradun,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Dehradun,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dehradun,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Dehradun,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Dehradun,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Dehradun,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,1.0,,,,,,,1.0
Dehradun,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,6.0,3.0,,,,,1.0,2.0,,12.0
Dehradun,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,1.0,2.0,,,,,,,,,3.0
Dehradun,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,1.0,8.0,3.0,,,,,1.0,2.0,,15.0
Dehradun,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Dehradun,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,3.0,2.0,,,,,,,,5.0
Dehradun,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Dehradun,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,3.0,3.0,,,,,,,,6.0
Dehradun,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Dehradun,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Dehradun,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Dehradun,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,7.0,16.0,,,,,,,,23.0
Dehradun,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,6.0,3.0,,,,,,,,9.0
Dehradun,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,13.0,19.0,,,,,,,,32.0
Dehradun,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Dehradun,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,4.0,3.0,,,,,,,,7.0
Dehradun,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,2.0,5.0,,,,,,,,7.0
Dehradun,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,7.0,8.0,,,,,,,,15.0
Dehradun,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Dehradun,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,2.0,3.0,,5.0
Dehradun,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,2.0,1.0,,3.0
Dehradun,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,4.0,4.0,,8.0
Garhwal,1.1,Total number of pregnant women Registered for ANC,TOTAL,1274.0,1301.0,1043.0,1235.0,1351.0,950.0,805.0,850.0,972.0,766.0,1295.0,904.0,12746.0
Garhwal,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,575.0,571.0,516.0,584.0,687.0,516.0,432.0,452.0,498.0,405.0,632.0,472.0,6340.0
Garhwal,1.2,Number of Pregnant women registered under JSY,TOTAL,1270.0,1301.0,1043.0,1235.0,1348.0,950.0,802.0,847.0,982.0,773.0,1299.0,896.0,12746.0
Garhwal,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,894.0,867.0,873.0,828.0,936.0,952.0,957.0,869.0,913.0,841.0,927.0,874.0,10731.0
Garhwal,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,920.0,872.0,878.0,814.0,992.0,724.0,643.0,554.0,577.0,574.0,842.0,673.0,9063.0
Garhwal,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,856.0,941.0,854.0,920.0,843.0,909.0,776.0,677.0,592.0,597.0,733.0,789.0,9487.0
Garhwal,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,768.0,936.0,853.0,797.0,831.0,585.0,712.0,451.0,823.0,589.0,715.0,713.0,8773.0
Garhwal,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,20.0,39.0,24.0,17.0,22.0,10.0,14.0,21.0,19.0,34.0,26.0,111.0,357.0
Garhwal,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,3.0,3.0,0.0,3.0,2.0,1.0,2.0,0.0,6.0,0.0,1.0,21.0
Garhwal,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,581.0,590.0,647.0,731.0,708.0,657.0,581.0,493.0,539.0,589.0,634.0,616.0,7366.0
Garhwal,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,17.0,35.0,25.0,68.0,10.0,70.0,2.0,26.0,36.0,39.0,5.0,5.0,338.0
Garhwal,1.8,Number of pregnancy test kits used at SC level,TOTAL,329.0,336.0,306.0,302.0,324.0,218.0,179.0,169.0,141.0,156.0,165.0,155.0,2780.0
Garhwal,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,67.0,46.0,52.0,81.0,86.0,96.0,76.0,66.0,60.0,43.0,56.0,47.0,776.0
Garhwal,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,55.0,67.0,35.0,80.0,80.0,95.0,92.0,66.0,55.0,84.0,77.0,58.0,844.0
Garhwal,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,122.0,113.0,87.0,161.0,166.0,191.0,168.0,132.0,115.0,127.0,133.0,105.0,1620.0
Garhwal,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,99.0,94.0,80.0,123.0,140.0,142.0,130.0,110.0,85.0,94.0,99.0,93.0,1289.0
Garhwal,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,4.0,8.0,6.0,51.0,23.0,15.0,15.0,10.0,72.0,30.0,6.0,9.0,249.0
Garhwal,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,525.0,516.0,616.0,784.0,877.0,878.0,765.0,650.0,712.0,730.0,633.0,581.0,8267.0
Garhwal,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,383.0,393.0,420.0,554.0,599.0,693.0,620.0,424.0,486.0,401.0,464.0,486.0,5923.0
Garhwal,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,540.0,296.0,585.0,768.0,826.0,761.0,809.0,627.0,333.0,702.0,616.0,590.0,7453.0
Garhwal,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,83.0,297.0,186.0,214.0,319.0,249.0,176.0,276.0,1009.0,187.0,226.0,414.0,3636.0
Garhwal,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,23.0,31.0,30.0,44.0,39.0,33.0,34.0,13.0,45.0,41.0,41.0,33.0,407.0
Garhwal,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Garhwal,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Garhwal,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Garhwal,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,,,,,,,0.0,0.0,0.0
Garhwal,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,103.0,62.0,108.0,127.0,132.0,96.0,66.0,62.0,82.0,50.0,57.0,93.0,1038.0
Garhwal,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwal,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,103.0,62.0,108.0,127.0,132.0,96.0,66.0,62.0,82.0,50.0,57.0,93.0,1038.0
Garhwal,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Garhwal,4.1.1.a,Number of male live births,TOTAL,341.0,361.0,401.0,499.0,577.0,581.0,472.0,410.0,478.0,504.0,422.0,381.0,5427.0
Garhwal,4.1.1.b,Number of female live births,TOTAL,326.0,295.0,330.0,495.0,509.0,523.0,479.0,373.0,398.0,400.0,371.0,341.0,4840.0
Garhwal,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,667.0,656.0,731.0,994.0,1086.0,1104.0,951.0,783.0,876.0,904.0,793.0,722.0,10267.0
Garhwal,4.1.2,Number of still births,TOTAL,23.0,14.0,17.0,15.0,9.0,21.0,15.0,28.0,15.0,12.0,17.0,13.0,199.0
Garhwal,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,74.0,90.0,75.0,85.0,80.0,65.0,40.0,49.0,40.0,43.0,56.0,59.0,756.0
Garhwal,4.2.1,Number of Newborns weighed at birth,TOTAL,656.0,648.0,721.0,972.0,1064.0,1098.0,942.0,770.0,860.0,887.0,767.0,701.0,10086.0
Garhwal,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,54.0,52.0,52.0,61.0,94.0,98.0,59.0,38.0,55.0,49.0,53.0,60.0,725.0
Garhwal,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,644.0,635.0,674.0,950.0,964.0,1014.0,870.0,744.0,846.0,832.0,723.0,609.0,9505.0
Garhwal,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,,0.0,,0.0,,,,,,0.0,0.0,0.0
Garhwal,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,127.0,89.0,145.0,150.0,140.0,99.0,66.0,75.0,98.0,38.0,53.0,93.0,1173.0
Garhwal,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwal,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,127.0,89.0,145.0,150.0,140.0,99.0,66.0,75.0,98.0,38.0,53.0,93.0,1173.0
Garhwal,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Garhwal,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,127.0,89.0,145.0,38.0,140.0,99.0,66.0,75.0,98.0,0.0,29.0,93.0,999.0
Garhwal,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,3.0,5.0,2.0,3.0,0.0,1.0,1.0,1.0,6.0,1.0,1.0,25.0
Garhwal,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,127.0,49.0,93.0,17.0,140.0,85.0,66.0,75.0,7.0,0.0,29.0,93.0,781.0
Garhwal,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,59.0,71.0,122.0,125.0,112.0,74.0,45.0,52.0,47.0,38.0,53.0,30.0,828.0
Garhwal,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,516.0,627.0,707.0,840.0,862.0,835.0,718.0,654.0,728.0,753.0,634.0,554.0,8428.0
Garhwal,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,438.0,426.0,381.0,350.0,506.0,505.0,365.0,497.0,526.0,263.0,302.0,262.0,4821.0
Garhwal,6.3,PNC maternal complications attended,TOTAL,1.0,7.0,14.0,4.0,6.0,35.0,3.0,12.0,31.0,10.0,4.0,4.0,131.0
Garhwal,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,67.0,73.0,65.0,73.0,52.0,53.0,32.0,27.0,11.0,37.0,17.0,47.0,554.0
Garhwal,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,6.0,11.0,0.0,0.0,3.0,0.0,22.0
Garhwal,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,67.0,73.0,65.0,73.0,52.0,55.0,38.0,38.0,11.0,37.0,20.0,47.0,576.0
Garhwal,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,28.0,17.0,23.0,19.0,28.0,18.0,39.0,21.0,21.0,29.0,83.0,23.0,349.0
Garhwal,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,165.0,147.0,173.0,169.0,205.0,181.0,189.0,201.0,175.0,199.0,154.0,182.0,2140.0
Garhwal,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,193.0,164.0,196.0,188.0,233.0,199.0,228.0,222.0,196.0,228.0,237.0,205.0,2489.0
Garhwal,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,1.0,2.0,5.0,2.0,0.0,3.0,1.0,7.0,1.0,0.0,22.0
Garhwal,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,2.0,0.0,,,,,,,3.0,0.0,0.0,5.0
Garhwal,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,4.0,9.0
Garhwal,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwal,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,2.0,2.0,4.0,6.0,3.0,0.0,3.0,1.0,10.0,1.0,4.0,36.0
Garhwal,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Garhwal,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,9.0,5.0,6.0,33.0,20.0,30.0,8.0,59.0,123.0,231.0,97.0,45.0,666.0
Garhwal,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,3.0,0.0,15.0,3.0,11.0,14.0,38.0,112.0,91.0,27.0,18.0,332.0
Garhwal,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,21.0,23.0,20.0,16.0,2.0,27.0,9.0,17.0,13.0,17.0,8.0,25.0,198.0
Garhwal,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwal,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,30.0,31.0,26.0,64.0,25.0,68.0,31.0,114.0,248.0,339.0,132.0,88.0,1196.0
Garhwal,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Garhwal,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,,,,,,,,0.0,0.0,0.0
Garhwal,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,4.0,12.0,12.0,2.0,1.0,0.0,1.0,3.0,0.0,3.0,39.0
Garhwal,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwal,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,1.0,4.0,12.0,12.0,2.0,1.0,0.0,1.0,3.0,0.0,3.0,39.0
Garhwal,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Garhwal,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,,,,0.0,,,,0.0,0.0,0.0
Garhwal,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,13.0,20.0,19.0,20.0,9.0,5.0,4.0,20.0,17.0,18.0,27.0,172.0
Garhwal,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwal,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,13.0,20.0,19.0,20.0,9.0,5.0,4.0,20.0,17.0,18.0,27.0,172.0
Garhwal,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Garhwal,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,260.0,233.0,263.0,280.0,310.0,268.0,267.0,290.0,250.0,251.0,228.0,215.0,3115.0
Garhwal,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,7.0,4.0,4.0,6.0,7.0,7.0,3.0,2.0,5.0,18.0,9.0,12.0,84.0
Garhwal,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,,,,,,,1.0,0.0,0.0,1.0
Garhwal,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,62.0,69.0,113.0,116.0,94.0,103.0,94.0,77.0,91.0,45.0,52.0,55.0,971.0
Garhwal,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Garhwal,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,329.0,306.0,380.0,402.0,411.0,378.0,364.0,369.0,346.0,315.0,289.0,282.0,4171.0
Garhwal,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,30.0,44.0,39.0,62.0,33.0,39.0,24.0,21.0,39.0,12.0,28.0,25.0,396.0
Garhwal,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Garhwal,9.06,Number of IUCD removals,TOTAL,77.0,125.0,126.0,237.0,119.0,118.0,151.0,151.0,120.0,126.0,127.0,170.0,1647.0
Garhwal,9.07,Number of Oral Pills cycles distributed,TOTAL,1816.0,1451.0,2340.0,4112.0,2612.0,2703.0,2260.0,2191.0,2246.0,2071.0,1444.0,1667.0,26913.0
Garhwal,9.08,Number of Condom pieces distributed,TOTAL,24445.0,20250.0,26890.0,34100.0,34796.0,32200.0,32973.0,34353.0,32739.0,28353.0,27606.0,29045.0,357750.0
Garhwal,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,2.0,5.0,7.0,6.0,3.0,4.0,30.0
Garhwal,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,3.0
Garhwal,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,7.0,1.0,0.0,2.0,1.0,1.0,1.0,2.0,3.0,5.0,7.0,6.0,36.0
Garhwal,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,1.0,2.0,1.0,1.0,1.0,0.0,1.0,0.0,2.0,0.0,10.0
Garhwal,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,8.0,9.0,8.0,8.0,10.0,8.0,6.0,4.0,7.0,9.0,7.0,-1.0
Garhwal,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,875.0,781.0,718.0,931.0,1007.0,1176.0,1179.0,858.0,994.0,939.0,949.0,842.0,11249.0
Garhwal,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,1.0,0.0,28.0,2.0,1.0,7.0,0.0,1.0,0.0,3.0,4.0,47.0
Garhwal,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,10.0,5.0,3.0,47.0,2.0,6.0,0.0,6.0,2.0,4.0,5.0,5.0,95.0
Garhwal,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,52.0,32.0,7.0,36.0,5.0,4.0,10.0,31.0,18.0,25.0,12.0,7.0,239.0
Garhwal,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,804.0,858.0,769.0,702.0,721.0,833.0,1045.0,968.0,890.0,748.0,838.0,825.0,10001.0
Garhwal,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,804.0,848.0,834.0,773.0,713.0,698.0,849.0,1010.0,1025.0,812.0,862.0,828.0,10056.0
Garhwal,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,781.0,767.0,867.0,827.0,760.0,718.0,696.0,779.0,975.0,850.0,920.0,892.0,9832.0
Garhwal,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,618.0,550.0,582.0,784.0,897.0,797.0,781.0,527.0,735.0,537.0,678.0,595.0,8081.0
Garhwal,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,834.0,831.0,766.0,720.0,722.0,799.0,1052.0,971.0,872.0,733.0,885.0,833.0,10018.0
Garhwal,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,826.0,845.0,835.0,782.0,706.0,665.0,846.0,1017.0,1013.0,755.0,868.0,822.0,9980.0
Garhwal,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,828.0,775.0,867.0,835.0,756.0,678.0,704.0,802.0,982.0,841.0,937.0,893.0,9898.0
Garhwal,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,490.0,458.0,487.0,523.0,763.0,661.0,651.0,487.0,672.0,663.0,586.0,518.0,6959.0
Garhwal,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,5.0,27.0,0.0,1.0,2.0,0.0,1.0,3.0,2.0,1.0,5.0,10.0,57.0
Garhwal,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,17.0,28.0,2.0,5.0,0.0,3.0,2.0,7.0,5.0,2.0,4.0,18.0,93.0
Garhwal,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,67.0,50.0,6.0,8.0,1.0,0.0,3.0,2.0,9.0,2.0,6.0,15.0,169.0
Garhwal,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,754.0,912.0,1022.0,1040.0,928.0,870.0,907.0,831.0,820.0,722.0,814.0,678.0,10298.0
Garhwal,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,778.0,749.0,795.0,909.0,782.0,763.0,671.0,621.0,676.0,637.0,874.0,781.0,9036.0
Garhwal,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,400.0,459.0,486.0,543.0,466.0,455.0,483.0,519.0,429.0,420.0,429.0,379.0,5468.0
Garhwal,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,337.0,399.0,450.0,446.0,432.0,401.0,425.0,425.0,354.0,332.0,380.0,321.0,4702.0
Garhwal,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,737.0,858.0,936.0,989.0,898.0,856.0,908.0,944.0,783.0,752.0,809.0,700.0,10170.0
Garhwal,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,854.0,749.0,852.0,935.0,826.0,803.0,711.0,655.0,699.0,653.0,960.0,833.0,9530.0
Garhwal,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,855.0,740.0,849.0,934.0,815.0,780.0,711.0,655.0,704.0,651.0,975.0,832.0,9501.0
Garhwal,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,238.0,269.0,257.0,297.0,277.0,276.0,220.0,218.0,236.0,190.0,323.0,274.0,3075.0
Garhwal,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,227.0,211.0,249.0,261.0,236.0,209.0,213.0,191.0,187.0,182.0,269.0,228.0,2663.0
Garhwal,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,465.0,480.0,506.0,558.0,513.0,485.0,433.0,409.0,423.0,372.0,592.0,502.0,5738.0
Garhwal,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,691.0,663.0,864.0,762.0,743.0,699.0,706.0,632.0,752.0,839.0,720.0,744.0,8815.0
Garhwal,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,561.0,597.0,692.0,648.0,650.0,660.0,623.0,694.0,569.0,658.0,660.0,661.0,7673.0
Garhwal,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,578.0,588.0,739.0,680.0,624.0,616.0,611.0,598.0,570.0,643.0,598.0,563.0,7408.0
Garhwal,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,2.0,0.0,5.0,3.0,0.0,0.0,1.0,0.0,0.0,11.0
Garhwal,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,2.0,61.0,66.0,78.0,94.0,103.0,60.0,77.0,75.0,64.0,680.0
Garhwal,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1161.0,1147.0,1165.0,1162.0,1202.0,1228.0,1192.0,1159.0,1190.0,1393.0,1435.0,1336.0,14770.0
Garhwal,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1038.0,1035.0,1044.0,1030.0,1045.0,1044.0,1046.0,1053.0,1044.0,1250.0,1310.0,1210.0,13149.0
Garhwal,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,969.0,961.0,972.0,963.0,978.0,981.0,996.0,980.0,965.0,1068.0,1120.0,1032.0,11985.0
Garhwal,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,643.0,843.0,906.0,946.0,801.0,763.0,700.0,390.0,376.0,318.0,324.0,842.0,7852.0
Garhwal,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,633.0,738.0,953.0,941.0,763.0,777.0,611.0,311.0,303.0,264.0,423.0,675.0,7392.0
Garhwal,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,348.0,567.0,664.0,693.0,590.0,542.0,523.0,186.0,231.0,221.0,260.0,463.0,5288.0
Garhwal,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,6.0,12.0,2.0,5.0,0.0,2.0,0.0,0.0,1.0,28.0
Garhwal,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,78.0,121.0,154.0,168.0,189.0,98.0,66.0,73.0,62.0,63.0,80.0,67.0,1219.0
Garhwal,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,6.0,5.0,3.0,0.0,0.0,0.0,0.0,0.0,2.0,16.0
Garhwal,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,17.0,8.0,16.0,15.0,18.0,16.0,22.0,24.0,13.0,26.0,17.0,16.0,208.0
Garhwal,13.1,Number of Patients operated for cataract,TOTAL,171.0,105.0,81.0,73.0,72.0,25.0,74.0,124.0,180.0,231.0,249.0,267.0,1652.0
Garhwal,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,171.0,105.0,81.0,65.0,63.0,98.0,74.0,124.0,180.0,231.0,249.0,267.0,1708.0
Garhwal,13.3,Number of School children detected with Refractive errors,TOTAL,123.0,108.0,161.0,115.0,143.0,469.0,389.0,144.0,149.0,123.0,130.0,354.0,2408.0
Garhwal,13.4,Number of children provided free glasses,TOTAL,8.0,3.0,24.0,19.0,14.0,117.0,91.0,60.0,61.0,53.0,17.0,146.0,613.0
Garhwal,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,5.0,5.0,4.0,4.0,4.0,4.0,4.0,5.0,4.0,6.0,6.0,-1.0
Garhwal,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,6.0,6.0,5.0,6.0,6.0,6.0,6.0,6.0,6.0,7.0,6.0,-1.0
Garhwal,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,537.0,544.0,519.0,502.0,508.0,502.0,507.0,518.0,504.0,512.0,513.0,507.0,-1.0
Garhwal,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,6.0,6.0,6.0,5.0,5.0,5.0,5.0,6.0,6.0,7.0,6.0,-1.0
Garhwal,14.05,Number of RKS meetings held during the month,TOTAL,14.0,14.0,12.0,12.0,13.0,11.0,10.0,10.0,10.0,9.0,11.0,10.0,136.0
Garhwal,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,14.0,16.0,16.0,14.0,15.0,15.0,15.0,15.0,15.0,14.0,16.0,13.0,-1.0
Garhwal,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,14.0,19.0,18.0,17.0,12.0,16.0,18.0,12.0,48.0,8.0,6.0,10.0,198.0
Garhwal,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,5.0,4.0,5.0,5.0,-1.0
Garhwal,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,3.0,3.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,0.0,-1.0
Garhwal,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Garhwal,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Garhwal,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Garhwal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,648.0,837.0,897.0,839.0,944.0,801.0,582.0,638.0,705.0,671.0,614.0,827.0,9003.0
Garhwal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1103.0,1309.0,1416.0,1114.0,1281.0,1461.0,1266.0,903.0,911.0,1106.0,1000.0,909.0,13779.0
Garhwal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,592.0,751.0,840.0,965.0,865.0,685.0,527.0,627.0,614.0,525.0,528.0,710.0,8229.0
Garhwal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1207.0,1731.0,1755.0,1508.0,1533.0,1835.0,1468.0,994.0,1104.0,1241.0,1128.0,959.0,16463.0
Garhwal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1240.0,1588.0,1737.0,1804.0,1809.0,1486.0,1109.0,1265.0,1319.0,1196.0,1142.0,1537.0,17232.0
Garhwal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2310.0,3040.0,3171.0,2622.0,2814.0,3296.0,2734.0,1897.0,2015.0,2347.0,2128.0,1868.0,30242.0
Garhwal,14.10.2.a,Number of death cases of Inpatient males,TOTAL,34.0,41.0,44.0,31.0,54.0,45.0,40.0,41.0,53.0,55.0,45.0,40.0,523.0
Garhwal,14.10.2.b,Number of death cases of Inpatient females,TOTAL,12.0,18.0,21.0,13.0,18.0,24.0,16.0,12.0,25.0,16.0,18.0,19.0,212.0
Garhwal,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,46.0,59.0,65.0,44.0,72.0,69.0,56.0,53.0,78.0,71.0,63.0,59.0,735.0
Garhwal,14.11,In-Patient Head Count at midnight,TOTAL,5130.0,6809.0,7118.0,5300.0,7184.0,6372.0,4166.0,2525.0,4102.0,4535.0,4789.0,4001.0,62031.0
Garhwal,14.12.1,OPD attendance (All),TOTAL,63632.0,69294.0,71608.0,71772.0,83134.0,82588.0,70777.0,58440.0,68937.0,62528.0,66736.0,65989.0,835435.0
Garhwal,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1296.0,1232.0,341.0,396.0,740.0,246.0,284.0,168.0,448.0,332.0,128.0,246.0,5857.0
Garhwal,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,16.0,17.0,37.0,27.0,37.0,16.0,0.0,2.0,1.0,0.0,0.0,3.0,156.0
Garhwal,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Garhwal,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1032.0,933.0,1126.0,1174.0,643.0,404.0,970.0,847.0,885.0,805.0,143.0,645.0,9607.0
Garhwal,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Garhwal,14.14.a,Number of patients given AYUSH treatment,TOTAL,7671.0,6791.0,7095.0,9060.0,7683.0,7182.0,9393.0,8103.0,9080.0,8510.0,9213.0,9409.0,99190.0
Garhwal,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1488.0,2111.0,620.0,870.0,2584.0,2726.0,2270.0,1658.0,2048.0,2349.0,2281.0,2454.0,23459.0
Garhwal,14.14.c,Number of Adolescents counselled,TOTAL,230.0,175.0,303.0,363.0,429.0,577.0,323.0,1136.0,1312.0,1450.0,1311.0,400.0,8009.0
Garhwal,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Garhwal,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4064.0,2668.0,2819.0,3060.0,3587.0,3278.0,2112.0,1746.0,1978.0,3458.0,2233.0,2107.0,33110.0
Garhwal,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,112.0,55.0,58.0,90.0,59.0,53.0,12.0,9.0,12.0,10.0,33.0,15.0,518.0
Garhwal,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,592.0,563.0,531.0,513.0,523.0,496.0,560.0,422.0,489.0,408.0,389.0,464.0,5950.0
Garhwal,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,4.0,5.0,1.0,2.0,3.0,1.0,2.0,5.0,2.0,2.0,5.0,36.0
Garhwal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,918.0,815.0,930.0,1025.0,957.0,1071.0,853.0,963.0,269.0,930.0,525.0,1290.0,10546.0
Garhwal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,2.0,2.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,9.0
Garhwal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,699.0,698.0,733.0,750.0,709.0,506.0,451.0,391.0,1411.0,492.0,575.0,619.0,8034.0
Garhwal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,27.0,30.0
Garhwal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2209.0,2076.0,2194.0,2288.0,2189.0,2073.0,1864.0,1776.0,2169.0,1830.0,1489.0,2373.0,24530.0
Garhwal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6.0,6.0,8.0,2.0,3.0,3.0,2.0,2.0,6.0,3.0,2.0,32.0,75.0
Garhwal,15.2,Number of Widal tests conducted,Number tested,567.0,726.0,763.0,712.0,1271.0,1873.0,1289.0,586.0,528.0,371.0,452.0,510.0,9648.0
Garhwal,15.3.a,Number of VDRL tests conducted on males,Number tested,12.0,8.0,18.0,16.0,21.0,21.0,19.0,17.0,9.0,15.0,15.0,10.0,181.0
Garhwal,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,508.0,487.0,580.0,614.0,641.0,675.0,540.0,695.0,96.0,672.0,494.0,809.0,6811.0
Garhwal,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,503.0,562.0,608.0,672.0,571.0,441.0,470.0,354.0,1112.0,425.0,765.0,581.0,7064.0
Garhwal,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1023.0,1057.0,1206.0,1302.0,1233.0,1137.0,1029.0,1066.0,1217.0,1112.0,1274.0,1400.0,14056.0
Garhwal,15.4.1,Number of blood smears examined for Malaria,TOTAL,822.0,852.0,991.0,1126.0,1574.0,1948.0,1618.0,895.0,777.0,677.0,1047.0,807.0,13134.0
Garhwal,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,3.0,10.0,11.0,19.0,50.0,16.0,3.0,0.0,0.0,139.0,5.0,257.0
Garhwal,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,17.0,6.0,1.0,0.0,0.0,0.0,0.0,24.0
Garhwal,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,5910.0,3850.0,5070.0,4390.0,3000.0,2570.0,5080.0,2340.0,6490.0,4600.0,4100.0,7630.0,55030.0
Garhwal,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,3000.0,2000.0,3000.0,1000.0,4000.0,,6000.0,,2000.0,6000.0,,27000.0
Garhwal,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2060.0,1780.0,2480.0,4390.0,1430.0,1490.0,2740.0,1850.0,1890.0,2500.0,2470.0,2560.0,27640.0
Garhwal,16.1.1,Stock position of DPT vaccines,5. Total Stock,3850.0,5070.0,4590.0,3000.0,2570.0,5080.0,2340.0,6490.0,4600.0,4100.0,7630.0,5070.0,54390.0
Garhwal,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,11250.0,8430.0,7640.0,5190.0,6340.0,7840.0,9470.0,6350.0,4910.0,2460.0,6450.0,9490.0,85820.0
Garhwal,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,2000.0,1000.0,6000.0,3000.0,4000.0,,2000.0,,7000.0,6000.0,,31000.0
Garhwal,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2820.0,2790.0,3450.0,4850.0,1500.0,2370.0,3120.0,3440.0,2450.0,3010.0,2960.0,3070.0,35830.0
Garhwal,16.1.1A,Stock Position of Pentavalent,5. Total Stock,8430.0,7640.0,5190.0,6340.0,7840.0,9470.0,6350.0,4910.0,2460.0,6450.0,9490.0,6420.0,80990.0
Garhwal,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,20400.0,14700.0,16540.0,11500.0,18200.0,22260.0,26120.0,18440.0,20940.0,14480.0,11300.0,8460.0,203340.0
Garhwal,16.1.2,Stock position of OPV vaccines,2. Stocks Received,26500.0,10000.0,32600.0,16000.0,8000.0,10000.0,,37000.0,,119800.0,84000.0,,343900.0
Garhwal,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,32200.0,8160.0,37640.0,9300.0,3940.0,6140.0,7680.0,10200.0,6460.0,122980.0,86840.0,4700.0,336240.0
Garhwal,16.1.2,Stock position of OPV vaccines,5. Total Stock,14700.0,16540.0,11500.0,18200.0,22260.0,26120.0,18440.0,45240.0,14480.0,11300.0,8460.0,3760.0,211000.0
Garhwal,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,10120.0,6620.0,7970.0,5870.0,8110.0,10740.0,9630.0,4510.0,10110.0,7920.0,9270.0,10320.0,101190.0
Garhwal,16.1.3,Stock position of TT vaccines,2. Stocks Received,,5000.0,2000.0,8000.0,5000.0,3000.0,,10000.0,,5000.0,5000.0,,43000.0
Garhwal,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.1.3,Stock position of TT vaccines,4. Stock Distributed,3500.0,3650.0,4100.0,5760.0,2370.0,4110.0,5120.0,4400.0,2190.0,3650.0,3950.0,4290.0,47090.0
Garhwal,16.1.3,Stock position of TT vaccines,5. Total Stock,6620.0,7970.0,5870.0,8110.0,10740.0,9630.0,4510.0,10110.0,7920.0,9270.0,10320.0,6030.0,97100.0
Garhwal,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Garhwal,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Garhwal,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Garhwal,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4950.0,3140.0,6730.0,5320.0,6020.0,5070.0,5260.0,2850.0,6020.0,4910.0,5050.0,6250.0,61570.0
Garhwal,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,5000.0,0.0,3000.0,0.0,2000.0,,5000.0,,2000.0,3000.0,,20000.0
Garhwal,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1810.0,1410.0,1410.0,2300.0,950.0,1810.0,2410.0,1830.0,1110.0,1860.0,1800.0,2080.0,20780.0
Garhwal,16.1.5,Stock position of BCG vaccines,5. Total Stock,3140.0,6730.0,5320.0,6020.0,5070.0,5260.0,2850.0,6020.0,4910.0,5050.0,6250.0,4170.0,60790.0
Garhwal,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5020.0,3065.0,4910.0,4860.0,4945.0,6065.0,5565.0,2860.0,5510.0,4165.0,3780.0,6820.0,57565.0
Garhwal,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,4000.0,2000.0,4000.0,2500.0,2000.0,,5000.0,,2000.0,5000.0,,26500.0
Garhwal,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1955.0,2155.0,2050.0,3915.0,1380.0,2500.0,2705.0,2350.0,1345.0,2385.0,1960.0,1940.0,26640.0
Garhwal,16.1.6,Stock position of Measles vaccines,5. Total Stock,3065.0,4910.0,4860.0,4945.0,6065.0,5565.0,2860.0,5510.0,4165.0,3780.0,6820.0,4880.0,57425.0
Garhwal,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Garhwal,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Garhwal,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Garhwal,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3280.0,1870.0,2090.0,1740.0,1340.0,940.0,2570.0,2090.0,5770.0,5520.0,4690.0,3960.0,35860.0
Garhwal,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,900.0,,,0.0,2100.0,,4500.0,,0.0,,,7500.0
Garhwal,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1410.0,680.0,350.0,400.0,400.0,470.0,480.0,820.0,250.0,830.0,730.0,490.0,7310.0
Garhwal,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1870.0,2090.0,1740.0,1340.0,940.0,2570.0,2090.0,5770.0,5520.0,4690.0,3960.0,3470.0,36050.0
Garhwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,9722.0,9415.0,10869.0,10462.0,10018.0,9599.0,9177.0,8807.0,8381.0,8005.0,7660.0,7340.0,109455.0
Garhwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,1800.0,,,,,,,,,,,1800.0
Garhwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,307.0,346.0,407.0,444.0,419.0,422.0,370.0,426.0,376.0,345.0,320.0,327.0,4509.0
Garhwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,9415.0,10869.0,10462.0,10018.0,9599.0,9177.0,8807.0,8381.0,8005.0,7660.0,7340.0,7013.0,106746.0
Garhwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,56509.0,46244.0,277845.0,250319.0,215027.0,182176.0,151144.0,121767.0,97175.0,72299.0,54250.0,121309.0,1646064.0
Garhwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,252000.0,,,0.0,,,,,,86400.0,,338400.0
Garhwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Garhwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,10265.0,20399.0,24586.0,35292.0,32851.0,31032.0,29377.0,24592.0,24906.0,18049.0,19341.0,21795.0,292485.0
Garhwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,46244.0,277845.0,253259.0,215027.0,182176.0,151144.0,121767.0,97175.0,72269.0,54250.0,121309.0,99514.0,1691979.0
Garhwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3741.0,2780.0,13732.0,12155.0,9913.0,7741.0,5523.0,3516.0,1812.0,946.0,428.0,22740.0,85027.0
Garhwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,12000.0,,,0.0,,,,,,22900.0,,34900.0
Garhwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,,,,,,,0.0
Garhwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,961.0,1048.0,1577.0,2242.0,2162.0,2218.0,2007.0,1704.0,866.0,518.0,588.0,1085.0,16976.0
Garhwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2780.0,13732.0,12155.0,9913.0,7751.0,5523.0,3516.0,1812.0,946.0,428.0,22740.0,21655.0,102951.0
Garhwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Garhwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Garhwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Garhwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,700.0,700.0,600.0,500.0,300.0,300.0,3300.0,3300.0,3300.0,2400.0,2000.0,2000.0,19400.0
Garhwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,0.0,,0.0,3000.0,,,,,,,3000.0
Garhwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,0.0,,0.0,,,,,,,,0.0
Garhwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,100.0,100.0,200.0,,,,,900.0,400.0,,,1700.0
Garhwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,700.0,600.0,500.0,300.0,300.0,3300.0,3300.0,3300.0,2400.0,2000.0,2000.0,2000.0,20700.0
Garhwal,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,490.0,,,,,,,,,,,490.0
Garhwal,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Garhwal,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,140.0,,,,,,,,,,,140.0
Garhwal,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,350.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,350.0
Garhwal,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,660.0,,390.0,150.0,50.0,50.0,50.0,50.0,50.0,50.0,50.0,150.0,1700.0
Garhwal,16.3.02,Stock Position of Gloves,2. Stocks Received,,,0.0,,0.0,0.0,,,,,,3200.0,3200.0
Garhwal,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,0.0,,0.0,0.0,,,,,,,0.0
Garhwal,16.3.02,Stock Position of Gloves,4. Stock Distributed,170.0,,240.0,100.0,0.0,,,,,,,,510.0
Garhwal,16.3.02,Stock Position of Gloves,5. Total Stock,490.0,0.0,150.0,50.0,50.0,50.0,50.0,50.0,50.0,50.0,50.0,3350.0,4390.0
Garhwal,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,0.0,0.0
Garhwal,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,21.0,21.0
Garhwal,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Garhwal,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0,21.0
Garhwal,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,15200.0,12450.0,10800.0,10100.0,9800.0,6600.0,4200.0,1900.0,71050.0
Garhwal,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,20000.0,0.0,0.0,,,,,,,20000.0
Garhwal,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,0.0,0.0,,,,,,,0.0
Garhwal,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,4800.0,2750.0,1650.0,700.0,800.0,3200.0,2400.0,2100.0,700.0,19100.0
Garhwal,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,15200.0,12450.0,10800.0,10100.0,9300.0,6600.0,4200.0,2100.0,1200.0,71950.0
Garhwal,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Garhwal,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Garhwal,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Garhwal,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Garhwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,14.0,9.0,30.0,8.0,7.0,7.0,16.0,14.0,10.0,7.0,7.0,7.0,136.0
Garhwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,,0.0,10.0,,,,,,,10.0
Garhwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,0.0,,0.0,0.0,,,,,,,0.0
Garhwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,5.0,1.0,0.0,1.0,,1.0,2.0,4.0,3.0,,,,17.0
Garhwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,9.0,8.0,30.0,7.0,7.0,16.0,14.0,10.0,7.0,7.0,7.0,7.0,129.0
Garhwal,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,1503440.0,1503440.0,682440.0,,,,3689320.0
Garhwal,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,3063840.0,,,,,,,3063840.0
Garhwal,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,1560400.0,,821000.0,682440.0,,,,3063840.0
Garhwal,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,1503440.0,1503440.0,682440.0,0.0,0.0,0.0,0.0,3689320.0
Garhwal,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,889436.0,889436.0,362736.0,,,,2141608.0
Garhwal,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,1809236.0,,,,,,,1809236.0
Garhwal,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,919800.0,,526700.0,362736.0,,,,1809236.0
Garhwal,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,889436.0,889436.0,362736.0,0.0,0.0,0.0,0.0,2141608.0
Garhwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,8277.0,6177.0,4157.0,2087.0,637.0,250.0,13000.0,11700.0,10170.0,7570.0,9331.0,7381.0,80737.0
Garhwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,0.0,,,18000.0,,,,4000.0,,,22000.0
Garhwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,0.0,,,,,,,,,,0.0
Garhwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,2100.0,1970.0,2070.0,1450.0,350.0,250.0,1300.0,1530.0,2600.0,2239.0,1495.0,1340.0,18694.0
Garhwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,6177.0,4207.0,2087.0,637.0,287.0,18000.0,11700.0,10170.0,7570.0,9331.0,7836.0,6041.0,84043.0
Garhwal,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,3000.0,440.0,390.0,330.0,169.0,159.0,144.0,100.0,75.0,40.0,20.0,500.0,5367.0
Garhwal,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,500.0,,0.0,,0.0,,,,,,,,500.0
Garhwal,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,0.0,,0.0,,,,,,,,0.0
Garhwal,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,3060.0,50.0,60.0,161.0,10.0,15.0,44.0,25.0,55.0,20.0,15.0,475.0,3990.0
Garhwal,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,440.0,390.0,330.0,169.0,159.0,144.0,100.0,75.0,20.0,20.0,5.0,25.0,1877.0
Garhwal,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,16000.0,11370.0,4520.0,345.0,23245.0,22220.0,11720.0,11720.0,11720.0,8520.0,18435.0,25150.0,164965.0
Garhwal,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,0.0,64320.0,0.0,,,,,11340.0,,,75660.0
Garhwal,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,0.0,,0.0,,,,,,,,0.0
Garhwal,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,6730.0,6850.0,4175.0,41100.0,1025.0,10500.0,,,3200.0,1425.0,1165.0,1500.0,77670.0
Garhwal,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,9270.0,4520.0,345.0,23565.0,22220.0,11720.0,11720.0,11720.0,8520.0,18435.0,17270.0,23650.0,162955.0
Garhwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,10600.0,9600.0,8200.0,7200.0,5800.0,5600.0,5000.0,3800.0,2600.0,2200.0,200.0,4200.0,65000.0
Garhwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,0.0,,0.0,,,,,4000.0,,4000.0
Garhwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1000.0,1400.0,1000.0,1400.0,200.0,600.0,1200.0,1200.0,400.0,2000.0,,200.0,10600.0
Garhwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,9600.0,8200.0,7200.0,5800.0,5600.0,5000.0,3800.0,2600.0,2200.0,200.0,4200.0,4000.0,58400.0
Garhwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,62700.0,56400.0,45600.0,39900.0,28900.0,25500.0,92500.0,86200.0,80800.0,79000.0,70000.0,66700.0,734200.0
Garhwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,0.0,,72000.0,,,,,,,72000.0
Garhwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,6300.0,10800.0,5700.0,11000.0,3400.0,5000.0,6300.0,5400.0,1800.0,9000.0,3300.0,7500.0,75500.0
Garhwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,56400.0,45600.0,39900.0,28900.0,25500.0,92500.0,86200.0,80800.0,79000.0,70000.0,66700.0,59200.0,730700.0
Garhwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,8000.0,6800.0,6000.0,5600.0,4400.0,4200.0,4000.0,3200.0,2400.0,2200.0,2000.0,1800.0,50600.0
Garhwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,0.0,,0.0,,,,,,,0.0
Garhwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Garhwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1200.0,800.0,400.0,1200.0,200.0,200.0,800.0,800.0,200.0,200.0,200.0,200.0,6400.0
Garhwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6800.0,6000.0,5600.0,4400.0,4200.0,4000.0,3200.0,2400.0,2200.0,2000.0,1800.0,1600.0,44200.0
Garhwal,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,1.0,,1.0,,,2.0
Garhwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,1.0,1.0,2.0
Garhwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Garhwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,1.0,1.0,2.0
Garhwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,,1.0,2.0
Garhwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Garhwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,,,,,,,1.0,2.0
Garhwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Garhwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Garhwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Garhwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,1.0,1.0,,1.0,,1.0,,,,,5.0
Garhwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Garhwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,1.0,1.0,,1.0,,2.0,,,,,6.0
Garhwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,,,1.0,,1.0,,1.0,1.0,5.0
Garhwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,1.0,,,,,,1.0
Garhwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,,,2.0,,1.0,,1.0,1.0,6.0
Garhwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Garhwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Garhwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Garhwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Garhwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,1.0,,,,,,1.0
Garhwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,1.0,,1.0,,,,2.0
Garhwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Garhwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Garhwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Garhwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,3.0,1.0,,,3.0,,,,3.0,,,10.0
Garhwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,1.0,1.0,2.0
Garhwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,3.0,1.0,,,3.0,,,,3.0,1.0,1.0,12.0
Garhwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Garhwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Garhwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,,,,,,1.0
Garhwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,1.0,1.0,1.0,,,,3.0
Garhwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,3.0,,,1.0,,,,,5.0
Garhwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,,3.0,,1.0,2.0,1.0,,,,8.0
Garhwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,1.0,1.0,4.0,1.0,,,,,,,8.0
Garhwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,3.0,4.0,3.0,3.0,6.0,7.0,5.0,4.0,7.0,14.0,9.0,4.0,69.0
Garhwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,4.0,4.0,4.0,4.0,10.0,8.0,5.0,4.0,7.0,14.0,9.0,4.0,77.0
Garhwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Garhwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Garhwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Garhwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Garhwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,1.0,,,,1.0,,,2.0
Garhwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,1.0,1.0,,,,1.0,,,3.0
Garhwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Garhwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Garhwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Garhwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,,2.0,3.0,,2.0,2.0,3.0,2.0,1.0,1.0,2.0,20.0
Garhwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,4.0,8.0,3.0,3.0,3.0,5.0,2.0,3.0,4.0,3.0,1.0,40.0
Garhwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,4.0,10.0,6.0,3.0,5.0,7.0,5.0,5.0,5.0,4.0,3.0,60.0
Garhwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,1.0,1.0,,1.0,,3.0
Garhwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,,,1.0,1.0,1.0,,1.0,,1.0,,6.0
Garhwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,,,1.0,1.0,1.0,1.0,2.0,,2.0,,9.0
Garhwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Garhwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Garhwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Garhwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Garhwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Garhwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Garhwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Garhwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Garhwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Garhwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Garhwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Garhwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Garhwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Garhwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Garhwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Garhwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,,14.0
Garhwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Garhwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,,14.0
Garhwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,,1.0,,,,,,,,2.0
Garhwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,3.0,2.0,2.0,2.0,3.0,1.0,,1.0,1.0,1.0,16.0
Garhwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,3.0,,,1.0,,2.0,2.0,2.0,3.0,3.0,,16.0
Garhwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,4.0,3.0,2.0,4.0,2.0,5.0,3.0,2.0,4.0,4.0,1.0,34.0
Garhwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Garhwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,1.0,2.0,2.0,,1.0,1.0,,,2.0,1.0,,11.0
Garhwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,1.0,,,1.0,,,2.0
Garhwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,1.0,3.0,2.0,,1.0,2.0,,,3.0,1.0,,14.0
Garhwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,,2.0,1.0,,,,,,4.0
Garhwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Garhwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,,2.0,1.0,,,,,,4.0
Garhwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,,,1.0,2.0,1.0,1.0,1.0,,1.0,1.0,1.0,10.0
Garhwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,1.0,1.0,1.0,2.0,4.0,2.0,3.0,3.0,1.0,1.0,19.0
Garhwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,,1.0,2.0,3.0,3.0,5.0,3.0,3.0,4.0,2.0,2.0,29.0
Garhwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Garhwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,2.0,2.0,2.0,1.0,5.0,2.0,3.0,1.0,18.0
Garhwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,3.0,2.0,4.0,10.0,10.0,4.0,8.0,24.0,28.0,18.0,2.0,114.0
Garhwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,3.0,2.0,4.0,12.0,12.0,6.0,9.0,29.0,30.0,21.0,3.0,132.0
Garhwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Garhwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,2.0,3.0,10.0,6.0,4.0,9.0,2.0,2.0,1.0,2.0,3.0,47.0
Garhwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,15.0,24.0,19.0,19.0,20.0,20.0,24.0,14.0,11.0,26.0,16.0,11.0,219.0
Garhwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,18.0,26.0,22.0,29.0,26.0,24.0,34.0,16.0,13.0,27.0,18.0,14.0,267.0
Hardwar,1.1,Total number of pregnant women Registered for ANC,TOTAL,5476.0,4509.0,3692.0,4077.0,4716.0,4845.0,3791.0,3050.0,4289.0,3820.0,4328.0,4342.0,50935.0
Hardwar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2964.0,2510.0,2139.0,2408.0,2653.0,2675.0,2099.0,1828.0,2592.0,2578.0,2862.0,2789.0,30097.0
Hardwar,1.2,Number of Pregnant women registered under JSY,TOTAL,5476.0,4509.0,3692.0,4077.0,4709.0,4845.0,3791.0,3050.0,4289.0,3820.0,4328.0,4342.0,50928.0
Hardwar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2940.0,2859.0,2632.0,2914.0,3023.0,3335.0,2901.0,2683.0,3214.0,2811.0,2856.0,2890.0,35058.0
Hardwar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4740.0,3847.0,3290.0,3462.0,3708.0,3923.0,2902.0,2517.0,3423.0,3192.0,3676.0,3691.0,42371.0
Hardwar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4166.0,4541.0,3796.0,3541.0,3471.0,3846.0,3724.0,2901.0,3292.0,3126.0,3325.0,3638.0,43367.0
Hardwar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1939.0,998.0,823.0,634.0,808.0,849.0,507.0,514.0,652.0,571.0,592.0,624.0,9511.0
Hardwar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,159.0,203.0,218.0,251.0,259.0,221.0,256.0,212.0,215.0,266.0,217.0,212.0,2689.0
Hardwar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,9.0,6.0,11.0,9.0,4.0,4.0,2.0,4.0,1.0,13.0,4.0,1.0,68.0
Hardwar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2040.0,1796.0,1672.0,1864.0,2165.0,2295.0,2258.0,1816.0,2279.0,2506.0,2342.0,2454.0,25487.0
Hardwar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,107.0,144.0,142.0,148.0,117.0,106.0,82.0,26.0,99.0,107.0,131.0,99.0,1308.0
Hardwar,1.8,Number of pregnancy test kits used at SC level,TOTAL,589.0,571.0,486.0,967.0,518.0,532.0,433.0,456.0,474.0,270.0,354.0,333.0,5983.0
Hardwar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,85.0,86.0,87.0,82.0,84.0,121.0,107.0,133.0,143.0,146.0,152.0,114.0,1340.0
Hardwar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,467.0,610.0,649.0,662.0,663.0,637.0,589.0,490.0,548.0,577.0,448.0,453.0,6793.0
Hardwar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,552.0,696.0,736.0,744.0,747.0,758.0,696.0,623.0,691.0,723.0,600.0,567.0,8133.0
Hardwar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,327.0,408.0,388.0,482.0,418.0,412.0,393.0,384.0,479.0,472.0,351.0,338.0,4852.0
Hardwar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,10.0,7.0,9.0,15.0,23.0,16.0,21.0,2.0,33.0,53.0,11.0,142.0,342.0
Hardwar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,806.0,925.0,995.0,1175.0,1188.0,1044.0,1176.0,939.0,1055.0,1091.0,986.0,924.0,12304.0
Hardwar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,75.0,53.0,65.0,107.0,130.0,81.0,136.0,113.0,72.0,103.0,54.0,105.0,1094.0
Hardwar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,831.0,908.0,964.0,1180.0,1152.0,1056.0,1136.0,927.0,1082.0,1042.0,1015.0,920.0,12213.0
Hardwar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,640.0,701.0,874.0,926.0,890.0,843.0,1007.0,792.0,1279.0,969.0,887.0,1491.0,11299.0
Hardwar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,463.0,816.0,935.0,767.0,759.0,485.0,361.0,854.0,890.0,913.0,838.0,645.0,8726.0
Hardwar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Hardwar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Hardwar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Hardwar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,37.0,44.0,49.0,61.0,42.0,15.0,26.0,15.0,47.0,63.0,61.0,83.0,543.0
Hardwar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hardwar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,37.0,44.0,49.0,61.0,42.0,15.0,26.0,15.0,47.0,63.0,61.0,83.0,543.0
Hardwar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,106.0,126.0,103.0,103.0,87.0,155.0,85.0,187.0,10.0,29.0,89.0,115.0,1195.0
Hardwar,4.1.1.a,Number of male live births,TOTAL,947.0,1300.0,1427.0,1430.0,1412.0,1268.0,1156.0,1283.0,1355.0,1432.0,1300.0,1100.0,15410.0
Hardwar,4.1.1.b,Number of female live births,TOTAL,868.0,1111.0,1177.0,1238.0,1268.0,1010.0,1054.0,1118.0,1261.0,1267.0,1108.0,1018.0,13498.0
Hardwar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1815.0,2411.0,2604.0,2668.0,2680.0,2278.0,2210.0,2401.0,2616.0,2699.0,2408.0,2118.0,28908.0
Hardwar,4.1.2,Number of still births,TOTAL,21.0,38.0,32.0,28.0,27.0,21.0,27.0,30.0,34.0,35.0,24.0,30.0,347.0
Hardwar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,83.0,106.0,107.0,91.0,76.0,90.0,60.0,49.0,60.0,42.0,78.0,60.0,902.0
Hardwar,4.2.1,Number of Newborns weighed at birth,TOTAL,1733.0,2236.0,2433.0,2499.0,2597.0,2136.0,2092.0,1925.0,2495.0,2607.0,2293.0,2022.0,27068.0
Hardwar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,129.0,136.0,147.0,196.0,174.0,167.0,181.0,141.0,146.0,147.0,196.0,125.0,1885.0
Hardwar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1528.0,2058.0,2268.0,2339.0,2413.0,1987.0,1883.0,2065.0,2428.0,2411.0,2102.0,1799.0,25281.0
Hardwar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Hardwar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,75.0,77.0,61.0,75.0,66.0,26.0,38.0,26.0,55.0,69.0,66.0,83.0,717.0
Hardwar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hardwar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,75.0,77.0,61.0,75.0,66.0,26.0,38.0,26.0,55.0,69.0,66.0,83.0,717.0
Hardwar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Hardwar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,75.0,77.0,61.0,75.0,66.0,26.0,38.0,26.0,55.0,69.0,66.0,82.0,716.0
Hardwar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,9.0,6.0,11.0,9.0,4.0,4.0,2.0,1.0,1.0,13.0,4.0,1.0,65.0
Hardwar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,74.0,77.0,61.0,75.0,65.0,26.0,38.0,26.0,54.0,66.0,65.0,82.0,709.0
Hardwar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,55.0,66.0,61.0,60.0,66.0,30.0,38.0,23.0,35.0,37.0,50.0,48.0,569.0
Hardwar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1673.0,2045.0,2261.0,2276.0,2311.0,1901.0,2047.0,2275.0,2591.0,2484.0,2098.0,1809.0,25771.0
Hardwar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1305.0,1102.0,1119.0,1287.0,1218.0,1290.0,1225.0,1074.0,1464.0,1375.0,1247.0,1378.0,15084.0
Hardwar,6.3,PNC maternal complications attended,TOTAL,29.0,53.0,82.0,133.0,20.0,22.0,90.0,81.0,7.0,119.0,3.0,87.0,726.0
Hardwar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,72.0,67.0,60.0,54.0,33.0,43.0,29.0,20.0,23.0,11.0,31.0,24.0,467.0
Hardwar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,72.0,67.0,60.0,54.0,33.0,43.0,29.0,20.0,23.0,11.0,31.0,24.0,467.0
Hardwar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,140.0,123.0,151.0,157.0,69.0,127.0,117.0,141.0,183.0,116.0,85.0,261.0,1670.0
Hardwar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,586.0,336.0,334.0,370.0,491.0,425.0,413.0,273.0,464.0,387.0,539.0,559.0,5177.0
Hardwar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,726.0,459.0,485.0,527.0,560.0,552.0,530.0,414.0,647.0,503.0,624.0,820.0,6847.0
Hardwar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,10.0
Hardwar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0,8.0
Hardwar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,3.0,8.0
Hardwar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,4.0,3.0,0.0,5.0,3.0,2.0,0.0,2.0,5.0,24.0
Hardwar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hardwar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,9.0,3.0,0.0,5.0,3.0,2.0,1.0,4.0,13.0,40.0
Hardwar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,1.0,7.0,1.0,2.0,3.0,1.0,3.0,,18.0
Hardwar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,18.0,0.0,2.0,0.0,0.0,8.0,10.0,42.0,99.0,179.0
Hardwar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,138.0,0.0,0.0,35.0,180.0,101.0,79.0,20.0,129.0,682.0
Hardwar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,12.0,16.0,13.0,40.0,4.0,10.0,4.0,18.0,44.0,67.0,21.0,97.0,346.0
Hardwar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hardwar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,12.0,16.0,13.0,196.0,4.0,12.0,39.0,198.0,153.0,156.0,83.0,325.0,1207.0
Hardwar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,30.0,12.0,33.0,3.0,6.0,5.0,3.0,16.0,,108.0
Hardwar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Hardwar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Hardwar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hardwar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Hardwar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Hardwar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,,7.0
Hardwar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,19.0,24.0,5.0,7.0,6.0,1.0,1.0,0.0,3.0,8.0,4.0,3.0,81.0
Hardwar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hardwar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,19.0,24.0,5.0,7.0,6.0,1.0,1.0,0.0,3.0,15.0,4.0,3.0,88.0
Hardwar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Hardwar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,384.0,419.0,436.0,550.0,458.0,503.0,436.0,415.0,406.0,319.0,380.0,374.0,5080.0
Hardwar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,129.0,47.0,46.0,48.0,176.0,174.0,176.0,166.0,165.0,200.0,237.0,237.0,1801.0
Hardwar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,47.0,67.0,54.0,116.0,99.0,79.0,98.0,69.0,105.0,96.0,71.0,106.0,1007.0
Hardwar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,163.0,206.0,151.0,192.0,158.0,118.0,121.0,104.0,134.0,145.0,162.0,153.0,1807.0
Hardwar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hardwar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,723.0,739.0,687.0,906.0,891.0,874.0,831.0,754.0,810.0,760.0,850.0,870.0,9695.0
Hardwar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,210.0,277.0,215.0,307.0,285.0,184.0,221.0,174.0,208.0,215.0,243.0,238.0,2777.0
Hardwar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Hardwar,9.06,Number of IUCD removals,TOTAL,134.0,177.0,146.0,214.0,645.0,285.0,204.0,187.0,217.0,202.0,211.0,227.0,2849.0
Hardwar,9.07,Number of Oral Pills cycles distributed,TOTAL,3680.0,2604.0,3671.0,5884.0,4907.0,5331.0,5265.0,5042.0,4598.0,3890.0,3934.0,4606.0,53412.0
Hardwar,9.08,Number of Condom pieces distributed,TOTAL,47332.0,32491.0,48381.0,74193.0,67859.0,76585.0,74726.0,63808.0,73143.0,43818.0,53853.0,62099.0,718288.0
Hardwar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,536.0,380.0,461.0,1100.0,873.0,1110.0,1025.0,711.0,799.0,536.0,574.0,961.0,9066.0
Hardwar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Hardwar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,4.0,5.0,4.0,4.0,3.0,3.0,2.0,3.0,4.0,3.0,4.0,-1.0
Hardwar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3537.0,3133.0,3021.0,3512.0,3584.0,3876.0,3653.0,2760.0,3633.0,3030.0,3017.0,2904.0,39660.0
Hardwar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,416.0,248.0,157.0,120.0,29.0,23.0,18.0,19.0,106.0,27.0,6.0,6.0,1175.0
Hardwar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,760.0,594.0,461.0,342.0,128.0,104.0,52.0,45.0,147.0,56.0,28.0,13.0,2730.0
Hardwar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1529.0,1120.0,759.0,618.0,268.0,210.0,117.0,81.0,151.0,80.0,47.0,14.0,4994.0
Hardwar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,4246.0,3502.0,2988.0,3242.0,3118.0,3841.0,3601.0,3100.0,3979.0,3246.0,3343.0,3475.0,41681.0
Hardwar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3239.0,3920.0,3377.0,3209.0,2842.0,3312.0,3371.0,2955.0,3769.0,3308.0,3376.0,3170.0,39848.0
Hardwar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2467.0,2924.0,3450.0,3521.0,2905.0,3263.0,3151.0,2846.0,3676.0,3370.0,3401.0,3218.0,38192.0
Hardwar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1392.0,1291.0,1508.0,1768.0,1950.0,1975.0,1914.0,1572.0,1819.0,1667.0,1515.0,1580.0,19951.0
Hardwar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4732.0,3951.0,3307.0,3506.0,3326.0,4061.0,3665.0,3877.0,4192.0,3494.0,3542.0,3469.0,45122.0
Hardwar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3821.0,4506.0,3924.0,3635.0,3038.0,3433.0,3421.0,2996.0,3836.0,3359.0,3402.0,3178.0,42549.0
Hardwar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3779.0,4013.0,4192.0,4185.0,3224.0,3462.0,3247.0,2901.0,3745.0,3477.0,3430.0,3230.0,42885.0
Hardwar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,565.0,513.0,911.0,1058.0,983.0,836.0,932.0,609.0,860.0,805.0,614.0,697.0,9383.0
Hardwar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,35.0,12.0,7.0,34.0,0.0,18.0,0.0,104.0,25.0,24.0,0.0,0.0,259.0
Hardwar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,576.0,378.0,128.0,133.0,30.0,43.0,11.0,56.0,48.0,42.0,6.0,0.0,1451.0
Hardwar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1408.0,1078.0,390.0,234.0,122.0,81.0,15.0,50.0,47.0,49.0,16.0,4.0,3494.0
Hardwar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4302.0,4324.0,3744.0,4196.0,3493.0,4018.0,3590.0,2959.0,3615.0,3035.0,2825.0,2655.0,42756.0
Hardwar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4559.0,3988.0,3124.0,3362.0,2778.0,3218.0,2948.0,2480.0,3572.0,3103.0,3165.0,2925.0,39222.0
Hardwar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2244.0,2297.0,1955.0,2195.0,1902.0,2153.0,1937.0,1597.0,1963.0,1633.0,1489.0,1390.0,22755.0
Hardwar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2055.0,1998.0,1750.0,1983.0,1590.0,1855.0,1671.0,1362.0,1652.0,1398.0,1336.0,1270.0,19920.0
Hardwar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4299.0,4295.0,3705.0,4178.0,3492.0,4008.0,3608.0,2959.0,3615.0,3031.0,2825.0,2660.0,42675.0
Hardwar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4768.0,3981.0,3161.0,3358.0,2851.0,3211.0,2917.0,2446.0,3565.0,3134.0,3137.0,2912.0,39441.0
Hardwar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4767.0,3951.0,3154.0,3356.0,2832.0,3201.0,2926.0,2440.0,3563.0,3136.0,3131.0,2918.0,39375.0
Hardwar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1262.0,969.0,668.0,907.0,883.0,929.0,783.0,663.0,955.0,837.0,866.0,778.0,10500.0
Hardwar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1156.0,912.0,674.0,929.0,741.0,806.0,740.0,606.0,850.0,762.0,807.0,742.0,9725.0
Hardwar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2418.0,1881.0,1342.0,1836.0,1624.0,1735.0,1523.0,1269.0,1805.0,1599.0,1673.0,1520.0,20225.0
Hardwar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1539.0,1381.0,1176.0,1077.0,1406.0,1775.0,1855.0,1455.0,1732.0,1610.0,1530.0,1479.0,18015.0
Hardwar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1463.0,1334.0,1229.0,1249.0,1414.0,1874.0,1839.0,1735.0,1593.0,1517.0,1547.0,1425.0,18219.0
Hardwar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1255.0,1226.0,1031.0,1104.0,1390.0,1702.0,1758.0,1502.0,1532.0,1354.0,1293.0,1252.0,16399.0
Hardwar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,0.0,8.0,0.0,0.0,0.0,0.0,10.0
Hardwar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,712.0,940.0,1066.0,963.0,1687.0,1581.0,1595.0,1082.0,1284.0,1265.0,1094.0,1231.0,14500.0
Hardwar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1970.0,1920.0,1793.0,1756.0,1899.0,2289.0,2153.0,1995.0,2203.0,2132.0,2030.0,2044.0,24184.0
Hardwar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1799.0,1784.0,1496.0,1618.0,1790.0,2190.0,1978.0,1678.0,2061.0,1954.0,1799.0,1818.0,21965.0
Hardwar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1611.0,1638.0,1373.0,1539.0,1611.0,1911.0,1779.0,1495.0,1888.0,1678.0,1608.0,1595.0,19726.0
Hardwar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4439.0,5025.0,4023.0,4585.0,3845.0,4224.0,3038.0,598.0,837.0,2898.0,3074.0,2644.0,39230.0
Hardwar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,841.0,721.0,700.0,887.0,692.0,970.0,904.0,256.0,335.0,675.0,1031.0,931.0,8943.0
Hardwar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,258.0,156.0,229.0,146.0,324.0,357.0,295.0,96.0,228.0,266.0,241.0,386.0,2982.0
Hardwar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,1.0,1.0,1.0,1.0,0.0,1.0,2.0,0.0,1.0,0.0,0.0,9.0
Hardwar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1012.0,511.0,741.0,654.0,654.0,565.0,580.0,657.0,552.0,378.0,600.0,719.0,7623.0
Hardwar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,0.0,2.0,1.0,10.0,12.0,6.0,0.0,0.0,0.0,4.0,4.0,40.0
Hardwar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,54.0,26.0,36.0,30.0,57.0,32.0,27.0,50.0,28.0,28.0,11.0,22.0,401.0
Hardwar,13.1,Number of Patients operated for cataract,TOTAL,811.0,460.0,242.0,433.0,327.0,536.0,497.0,726.0,678.0,832.0,972.0,973.0,7487.0
Hardwar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,811.0,460.0,242.0,433.0,327.0,536.0,497.0,726.0,678.0,832.0,972.0,973.0,7487.0
Hardwar,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,337.0,3.0,90.0,82.0,150.0,132.0,304.0,167.0,55.0,38.0,51.0,1409.0
Hardwar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,14.0,120.0,84.0,53.0,102.0,94.0,56.0,38.0,561.0
Hardwar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,4.0,5.0,4.0,4.0,4.0,5.0,5.0,5.0,5.0,5.0,4.0,-1.0
Hardwar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,6.0,5.0,5.0,4.0,5.0,6.0,4.0,5.0,5.0,4.0,6.0,-1.0
Hardwar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1076.0,1078.0,1000.0,1098.0,858.0,875.0,789.0,662.0,838.0,853.0,813.0,658.0,-1.0
Hardwar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,5.0,6.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Hardwar,14.05,Number of RKS meetings held during the month,TOTAL,2.0,2.0,1.0,4.0,3.0,5.0,3.0,2.0,5.0,6.0,5.0,3.0,41.0
Hardwar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,6.0,7.0,6.0,5.0,6.0,7.0,5.0,6.0,6.0,5.0,7.0,-1.0
Hardwar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,17.0,22.0,18.0,17.0,12.0,6.0,8.0,10.0,14.0,5.0,11.0,16.0,156.0
Hardwar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,3.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Hardwar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,7.0,7.0,7.0,7.0,6.0,7.0,7.0,7.0,7.0,7.0,7.0,5.0,-1.0
Hardwar,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Hardwar,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Hardwar,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Hardwar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,306.0,331.0,376.0,426.0,447.0,441.0,385.0,318.0,435.0,397.0,384.0,360.0,4606.0
Hardwar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,380.0,600.0,427.0,490.0,506.0,562.0,474.0,485.0,313.0,382.0,397.0,362.0,5378.0
Hardwar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,294.0,309.0,327.0,387.0,414.0,393.0,380.0,280.0,375.0,376.0,350.0,348.0,4233.0
Hardwar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1409.0,1499.0,1635.0,2012.0,1971.0,1558.0,1655.0,1296.0,1256.0,1744.0,1425.0,1378.0,18838.0
Hardwar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,600.0,640.0,703.0,813.0,861.0,834.0,765.0,598.0,810.0,773.0,734.0,708.0,8839.0
Hardwar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1789.0,2099.0,2062.0,2502.0,2477.0,2120.0,2129.0,1781.0,1569.0,2126.0,1822.0,1740.0,24216.0
Hardwar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,12.0,21.0,13.0,23.0,24.0,20.0,28.0,18.0,14.0,26.0,19.0,20.0,238.0
Hardwar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,5.0,2.0,1.0,7.0,6.0,6.0,3.0,6.0,4.0,5.0,3.0,52.0
Hardwar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,16.0,26.0,15.0,24.0,31.0,26.0,34.0,21.0,20.0,30.0,24.0,23.0,290.0
Hardwar,14.11,In-Patient Head Count at midnight,TOTAL,1535.0,1826.0,1866.0,2163.0,2240.0,1689.0,1729.0,1461.0,1472.0,1719.0,1718.0,1533.0,20951.0
Hardwar,14.12.1,OPD attendance (All),TOTAL,96798.0,77500.0,80754.0,82925.0,90414.0,111736.0,92406.0,78545.0,86497.0,84834.0,89784.0,94004.0,1066197.0
Hardwar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,127.0,119.0,132.0,130.0,102.0,160.0,166.0,67.0,113.0,90.0,128.0,134.0,1468.0
Hardwar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,10.0
Hardwar,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Hardwar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,116.0,126.0,115.0,104.0,85.0,91.0,90.0,190.0,172.0,64.0,90.0,200.0,1443.0
Hardwar,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Hardwar,14.14.a,Number of patients given AYUSH treatment,TOTAL,3904.0,5134.0,4535.0,6140.0,8379.0,9056.0,6922.0,5317.0,5160.0,6550.0,6505.0,6363.0,73965.0
Hardwar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,956.0,742.0,820.0,1593.0,1721.0,1699.0,885.0,871.0,1248.0,958.0,868.0,809.0,13170.0
Hardwar,14.14.c,Number of Adolescents counselled,TOTAL,43.0,211.0,182.0,246.0,436.0,651.0,500.0,859.0,584.0,1941.0,674.0,3555.0,9882.0
Hardwar,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Hardwar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5087.0,5478.0,5163.0,6435.0,7419.0,7551.0,5840.0,5052.0,5377.0,5042.0,5730.0,6153.0,70327.0
Hardwar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,242.0,339.0,313.0,299.0,282.0,370.0,186.0,222.0,242.0,244.0,258.0,256.0,3253.0
Hardwar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,581.0,471.0,308.0,368.0,256.0,374.0,376.0,402.0,375.0,325.0,285.0,345.0,4466.0
Hardwar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,15.0,7.0,5.0,7.0,2.0,6.0,5.0,5.0,5.0,3.0,5.0,2.0,67.0
Hardwar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,275.0,255.0,195.0,181.0,151.0,294.0,224.0,173.0,240.0,198.0,247.0,249.0,2682.0
Hardwar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,1.0,0.0,4.0,1.0,0.0,0.0,0.0,4.0,1.0,1.0,2.0,18.0
Hardwar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2108.0,1981.0,1700.0,1983.0,2049.0,1501.0,1595.0,1845.0,1877.0,1656.0,2215.0,2223.0,22733.0
Hardwar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3.0,1.0,3.0,0.0,0.0,2.0,2.0,0.0,1.0,0.0,0.0,1.0,13.0
Hardwar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2964.0,2707.0,2203.0,2532.0,2456.0,2169.0,2195.0,2420.0,2492.0,2179.0,2747.0,2817.0,29881.0
Hardwar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,22.0,9.0,8.0,11.0,3.0,8.0,7.0,5.0,10.0,4.0,6.0,5.0,98.0
Hardwar,15.2,Number of Widal tests conducted,Number tested,1078.0,676.0,851.0,748.0,839.0,2314.0,1904.0,1100.0,560.0,509.0,872.0,1090.0,12541.0
Hardwar,15.3.a,Number of VDRL tests conducted on males,Number tested,101.0,17.0,108.0,96.0,83.0,138.0,134.0,255.0,312.0,229.0,121.0,128.0,1722.0
Hardwar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,73.0,15.0,28.0,30.0,21.0,66.0,70.0,54.0,97.0,117.0,121.0,132.0,824.0
Hardwar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1791.0,1526.0,1645.0,1926.0,1508.0,1819.0,1491.0,1599.0,1543.0,1716.0,2087.0,2027.0,20678.0
Hardwar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1965.0,1558.0,1781.0,2052.0,1612.0,2023.0,1695.0,1908.0,1952.0,2062.0,2329.0,2287.0,23224.0
Hardwar,15.4.1,Number of blood smears examined for Malaria,TOTAL,867.0,851.0,1155.0,1179.0,1565.0,3036.0,2561.0,1409.0,664.0,535.0,745.0,918.0,15485.0
Hardwar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,11.0,128.0,54.0,63.0,183.0,46.0,7.0,1.0,0.0,1.0,0.0,495.0
Hardwar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,0.0,18.0,10.0,5.0,14.0,1.0,1.0,0.0,0.0,1.0,132.0,184.0
Hardwar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0.0,1500.0,2000.0,4000.0,7000.0,3000.0,4500.0,7000.0,7000.0,,2000.0,,38000.0
Hardwar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,8000.0,8000.0,8000.0,2000.0,6000.0,6000.0,4000.0,5000.0,,10000.0,,67000.0
Hardwar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,8500.0,7500.0,6000.0,5000.0,6000.0,5000.0,3500.0,4000.0,7500.0,,5500.0,,58500.0
Hardwar,16.1.1,Stock position of DPT vaccines,5. Total Stock,1500.0,2000.0,4000.0,7000.0,3000.0,4000.0,7000.0,7000.0,4500.0,0.0,6500.0,0.0,46500.0
Hardwar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,20000.0,13000.0,5500.0,0.0,4000.0,1500.0,9000.0,400.0,500.0,,5500.0,,59400.0
Hardwar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,8000.0,0.0,15000.0,7500.0,15000.0,5000.0,2500.0,12000.0,,15000.0,,80000.0
Hardwar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,12500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,12500.0
Hardwar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,15500.0,5500.0,11000.0,10000.0,13500.0,13600.0,2400.0,12000.0,,5500.0,,89000.0
Hardwar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,7500.0,5500.0,0.0,4000.0,1500.0,3000.0,400.0,500.0,500.0,0.0,15000.0,0.0,37900.0
Hardwar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,26500.0,5000.0,19500.0,14500.0,0.0,21500.0,20000.0,29300.0,,,19300.0,,155600.0
Hardwar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,30000.0,15000.0,0.0,40000.0,20000.0,30000.0,20000.0,,,20000.0,,175000.0
Hardwar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0
Hardwar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,21500.0,15500.0,20000.0,14500.0,18500.0,35000.0,20700.0,17500.0,,,6500.0,,169700.0
Hardwar,16.1.2,Stock position of OPV vaccines,5. Total Stock,5000.0,19500.0,14500.0,0.0,21500.0,6500.0,29300.0,31800.0,0.0,0.0,32800.0,0.0,160900.0
Hardwar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,9000.0,1000.0,9000.0,19000.0,34000.0,27000.0,16000.0,21000.0,19000.0,,22000.0,,177000.0
Hardwar,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,20000.0,20000.0,20000.0,0.0,0.0,15000.0,10000.0,10000.0,,10000.0,,115000.0
Hardwar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,18000.0,12000.0,10000.0,5000.0,7000.0,18500.0,10000.0,12000.0,10000.0,,7500.0,,110000.0
Hardwar,16.1.3,Stock position of TT vaccines,5. Total Stock,1000.0,9000.0,19000.0,34000.0,27000.0,8500.0,21000.0,19000.0,19000.0,0.0,24500.0,0.0,182000.0
Hardwar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,8550.0,8500.0,10000.0,7000.0,8500.0,9000.0,8500.0,10500.0,18500.0,,11000.0,,100050.0
Hardwar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,6000.0,6000.0,8000.0,8000.0,8000.0,8000.0,8000.0,,6000.0,,78000.0
Hardwar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,10050.0,8500.0,9000.0,4500.0,7500.0,13500.0,6000.0,0.0,16000.0,,7000.0,,82050.0
Hardwar,16.1.5,Stock position of BCG vaccines,5. Total Stock,8500.0,10000.0,7000.0,8500.0,9000.0,3500.0,10500.0,18500.0,10500.0,0.0,10000.0,0.0,96000.0
Hardwar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,0.0,2750.0,2250.0,5250.0,5250.0,500.0,2500.0,11250.0,,6000.0,,35750.0
Hardwar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,12750.0,10000.0,10000.0,10000.0,10000.0,10000.0,10000.0,5000.0,,8000.0,,95750.0
Hardwar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,10000.0,10000.0,10500.0,7500.0,10000.0,13750.0,8000.0,1250.0,8750.0,,5250.0,,85000.0
Hardwar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,2750.0,2250.0,4750.0,5250.0,1500.0,2500.0,11250.0,7500.0,0.0,8750.0,0.0,46500.0
Hardwar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1800.0,1200.0,5700.0,21300.0,18300.0,16500.0,14100.0,14100.0,13500.0,,10200.0,,116700.0
Hardwar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,8100.0,7800.0,9000.0,0.0,0.0,0.0,0.0,0.0,,0.0,,24900.0
Hardwar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,600.0,3600.0,1200.0,12000.0,1800.0,2400.0,0.0,600.0,3300.0,,600.0,,26100.0
Hardwar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1200.0,5700.0,12300.0,18300.0,16500.0,14100.0,14100.0,13500.0,10200.0,0.0,9600.0,0.0,115500.0
Hardwar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,1800.0,1800.0,1800.0,,1800.0,,7200.0
Hardwar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,0.0,1800.0,0.0,0.0,0.0,,0.0,,1800.0
Hardwar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,1800.0,1800.0,1800.0,1800.0,0.0,1800.0,0.0,9000.0
Hardwar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,34000.0,0.0,1600.0,0.0,0.0,,0.0,0.0,35600.0
Hardwar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,252000.0,144232.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,396232.0
Hardwar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,252000.0,110232.0,34000.0,0.0,0.0,0.0,0.0,,0.0,0.0,396232.0
Hardwar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,34000.0,0.0,0.0,1600.0,0.0,0.0,0.0,0.0,0.0,35600.0
Hardwar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,6000.0,0.0,2000.0,2000.0,2000.0,,0.0,0.0,12000.0
Hardwar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,9000.0,6000.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,15000.0
Hardwar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,9000.0,0.0,6000.0,0.0,0.0,0.0,0.0,,0.0,0.0,15000.0
Hardwar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,6000.0,0.0,0.0,2000.0,2000.0,2000.0,0.0,0.0,0.0,12000.0
Hardwar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,450.0,0.0,1000.0,1000.0,1000.0,,1000.0,,4450.0
Hardwar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,2600.0,3000.0,0.0,0.0,0.0,0.0,0.0,,0.0,,5600.0
Hardwar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,2600.0,2550.0,450.0,0.0,0.0,0.0,0.0,,0.0,,5600.0
Hardwar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,450.0,0.0,0.0,1000.0,1000.0,1000.0,0.0,1000.0,0.0,4450.0
Hardwar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,500.0,500.0,500.0,,500.0,,2000.0
Hardwar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,,0.0,,10000.0
Hardwar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,8000.0,0.0,,0.0,,0.0,,8000.0
Hardwar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,2000.0,500.0,500.0,500.0,0.0,500.0,0.0,4000.0
Hardwar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Hardwar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Hardwar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Hardwar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Hardwar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Hardwar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hardwar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3000.0,0.0,0.0,13000.0,0.0,2000.0,0.0,0.0,7400.0,,4200.0,,29600.0
Hardwar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,4000.0,0.0,8000.0,2000.0,2000.0,8000.0,6000.0,,800.0,,30800.0
Hardwar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3000.0,0.0,4000.0,13000.0,6000.0,4000.0,2000.0,600.0,4200.0,,3800.0,,40600.0
Hardwar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,7400.0,9200.0,0.0,1200.0,0.0,19800.0
Hardwar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,600.0,6000.0,27700.0,11800.0,10000.0,18600.0,54000.0,68400.0,,28800.0,,225900.0
Hardwar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,18000.0,50400.0,54000.0,72000.0,56000.0,54000.0,54000.0,36000.0,54000.0,,36000.0,,484400.0
Hardwar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,17400.0,45000.0,32300.0,87900.0,57800.0,56800.0,18600.0,21600.0,57600.0,,22000.0,,417000.0
Hardwar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,600.0,6000.0,27700.0,11800.0,10000.0,7200.0,54000.0,68400.0,64800.0,0.0,42800.0,0.0,293300.0
Hardwar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,400.0,200.0,200.0,5600.0,1200.0,1200.0,2100.0,3600.0,5900.0,,8400.0,,28800.0
Hardwar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,0.0,4000.0,4000.0,4000.0,4000.0,4000.0,3600.0,0.0,,4000.0,,30000.0
Hardwar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Hardwar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2600.0,0.0,2600.0,8400.0,4000.0,5200.0,2500.0,1300.0,4200.0,,300.0,,31100.0
Hardwar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,200.0,200.0,1600.0,1200.0,1200.0,0.0,3600.0,5900.0,1700.0,0.0,12100.0,0.0,27700.0
Hardwar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,,2.0,,1.0,,2.0,,2.0,1.0,9.0
Hardwar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,1.0,2.0
Hardwar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hardwar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,1.0,,,,,1.0,2.0
Hardwar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,1.0,1.0,,,,2.0,,1.0,1.0,,7.0
Hardwar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hardwar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,1.0,1.0,,,,2.0,,1.0,1.0,,7.0
Hardwar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,1.0,,,,,3.0,1.0,,,,,7.0
Hardwar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
Hardwar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,1.0,,,,,3.0,1.0,,1.0,,,8.0
Hardwar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,1.0,,1.0,4.0,,4.0,4.0,6.0,8.0,3.0,31.0
Hardwar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,,,1.0,,2.0
Hardwar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,2.0,,1.0,4.0,,4.0,4.0,6.0,9.0,3.0,33.0
Hardwar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,2.0,1.0,,2.0,,5.0
Hardwar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,1.0,,1.0,1.0,3.0
Hardwar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,2.0,2.0,,3.0,1.0,8.0
Hardwar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,1.0,1.0,,,,,,,,,,,2.0
Hardwar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hardwar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,1.0,,,,,,,,,,,2.0
Hardwar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,,,1.0,,,2.0
Hardwar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,1.0,1.0,,,2.0
Hardwar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,,,,,1.0,2.0,,,4.0
Hardwar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hardwar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hardwar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Hardwar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,,4.0,2.0,4.0,2.0,3.0,3.0,4.0,11.0,2.0,36.0
Hardwar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,,1.0,1.0,,1.0,2.0,2.0,2.0,1.0,1.0,12.0
Hardwar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,1.0,,5.0,3.0,4.0,3.0,5.0,5.0,6.0,12.0,3.0,48.0
Hardwar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Hardwar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Hardwar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Hardwar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,2.0,,,3.0,4.0,1.0,3.0,3.0,1.0,1.0,,19.0
Hardwar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,1.0,,,1.0,1.0,1.0,,,,,,6.0
Hardwar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,3.0,,,4.0,5.0,2.0,3.0,3.0,1.0,1.0,,25.0
Hardwar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,2.0,,,1.0,,,,1.0,1.0,1.0,,7.0
Hardwar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,1.0,,1.0,,,2.0,3.0,2.0,3.0,1.0,4.0,18.0
Hardwar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,3.0,,1.0,1.0,,2.0,3.0,3.0,4.0,2.0,4.0,25.0
Hardwar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Hardwar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Hardwar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Hardwar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Hardwar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,,1.0,3.0,,,,,,,5.0
Hardwar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,2.0,,,,,,,,,,,2.0
Hardwar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,3.0,,,1.0,4.0,,,,,,,8.0
Hardwar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Hardwar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Hardwar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Hardwar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,3.0,2.0,2.0,11.0,3.0,5.0,2.0,4.0,6.0,6.0,3.0,50.0
Hardwar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,6.0,2.0,1.0,4.0,10.0,5.0,5.0,7.0,6.0,4.0,5.0,56.0
Hardwar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,9.0,4.0,3.0,15.0,13.0,10.0,7.0,11.0,12.0,10.0,8.0,106.0
Hardwar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Hardwar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,1.0,,3.0,1.0,2.0,7.0
Hardwar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,,,,1.0,1.0,1.0,,4.0
Hardwar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,,,,,,2.0,1.0,4.0,2.0,2.0,12.0
Hardwar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Hardwar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Hardwar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,1.0,,1.0
Hardwar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Hardwar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Hardwar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Hardwar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Hardwar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Hardwar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,,,,,,,,1.0
Hardwar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,1.0,,1.0,,,,,,,,,3.0
Hardwar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Hardwar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,1.0,,1.0,,,,,,,,,3.0
Hardwar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Hardwar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Hardwar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Hardwar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,1.0,3.0,2.0,2.0,,,,,9.0
Hardwar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Hardwar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,1.0,3.0,2.0,2.0,,,,,9.0
Hardwar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,1.0,,,,1.0,,,,2.0
Hardwar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,2.0,1.0,7.0,8.0,8.0,5.0,6.0,10.0,6.0,4.0,4.0,65.0
Hardwar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,2.0,2.0,,3.0,3.0,3.0,,3.0,16.0
Hardwar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,2.0,1.0,7.0,11.0,10.0,5.0,9.0,14.0,9.0,4.0,7.0,83.0
Hardwar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,4.0,2.0,1.0,,4.0,,2.0,3.0,2.0,4.0,3.0,26.0
Hardwar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Hardwar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,4.0,2.0,1.0,,4.0,,3.0,3.0,2.0,4.0,3.0,27.0
Hardwar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Hardwar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Hardwar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Hardwar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,,,,,,,,1.0
Hardwar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,1.0,,,,,1.0,,,,3.0
Hardwar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,1.0,1.0,2.0,,6.0,2.0,3.0,,2.0,1.0,19.0
Hardwar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,2.0,,3.0,4.0,2.0,,1.0,3.0,,4.0,2.0,21.0
Hardwar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,3.0,1.0,5.0,6.0,2.0,6.0,3.0,7.0,,6.0,3.0,43.0
Hardwar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,,,1.0,,,,,,,2.0
Hardwar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,2.0,2.0,2.0,1.0,,4.0,5.0,8.0,4.0,6.0,4.0,38.0
Hardwar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,3.0,3.0,12.0,6.0,7.0,14.0,8.0,17.0,17.0,16.0,10.0,15.0,128.0
Hardwar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,5.0,15.0,8.0,8.0,15.0,12.0,22.0,25.0,20.0,16.0,19.0,168.0
Hardwar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,2.0,1.0,,3.0,3.0,1.0,,,,,10.0
Hardwar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,11.0,14.0,14.0,17.0,10.0,21.0,25.0,30.0,29.0,29.0,23.0,11.0,234.0
Hardwar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,27.0,33.0,17.0,31.0,29.0,54.0,47.0,57.0,50.0,76.0,59.0,42.0,522.0
Hardwar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,38.0,47.0,33.0,49.0,39.0,78.0,75.0,88.0,79.0,105.0,82.0,53.0,766.0
Nainital,1.1,Total number of pregnant women Registered for ANC,TOTAL,1766.0,1674.0,1487.0,1748.0,1585.0,1506.0,1426.0,1244.0,1570.0,1601.0,1864.0,1540.0,19011.0
Nainital,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1196.0,1074.0,915.0,1074.0,954.0,957.0,939.0,736.0,985.0,1098.0,1205.0,1044.0,12177.0
Nainital,1.2,Number of Pregnant women registered under JSY,TOTAL,1744.0,1673.0,1482.0,1731.0,1573.0,1478.0,1394.0,1244.0,1564.0,1594.0,1859.0,1451.0,18787.0
Nainital,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1250.0,1369.0,1273.0,1350.0,1334.0,1316.0,1317.0,1173.0,1275.0,1290.0,1332.0,1306.0,15585.0
Nainital,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1582.0,1519.0,1304.0,1568.0,1435.0,1326.0,1283.0,1129.0,1397.0,1433.0,1630.0,1365.0,16971.0
Nainital,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1425.0,1688.0,1465.0,1457.0,1589.0,1501.0,1413.0,1270.0,1295.0,1491.0,1639.0,1611.0,17844.0
Nainital,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,155.0,429.0,387.0,396.0,314.0,376.0,375.0,166.0,342.0,399.0,387.0,495.0,4221.0
Nainital,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,59.0,62.0,52.0,70.0,123.0,63.0,78.0,36.0,45.0,43.0,31.0,33.0,695.0
Nainital,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Nainital,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,200.0,611.0,484.0,543.0,175.0,195.0,292.0,267.0,254.0,302.0,252.0,267.0,3842.0
Nainital,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,12.0,88.0,27.0,4.0,7.0,11.0,7.0,7.0,13.0,0.0,8.0,9.0,193.0
Nainital,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,4.0,1.0,0.0,0.0,7.0
Nainital,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,120.0,98.0,136.0,124.0,114.0,126.0,112.0,142.0,147.0,128.0,151.0,107.0,1505.0
Nainital,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,73.0,65.0,64.0,75.0,67.0,97.0,66.0,80.0,58.0,57.0,75.0,41.0,818.0
Nainital,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,193.0,163.0,200.0,199.0,181.0,223.0,178.0,222.0,205.0,185.0,226.0,148.0,2323.0
Nainital,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,155.0,123.0,160.0,150.0,131.0,182.0,141.0,194.0,184.0,147.0,173.0,114.0,1854.0
Nainital,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,1.0,6.0,1.0,0.0,2.0,13.0
Nainital,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,951.0,927.0,965.0,1163.0,1276.0,1236.0,1163.0,1024.0,1063.0,1089.0,1025.0,930.0,12812.0
Nainital,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,596.0,516.0,586.0,676.0,773.0,725.0,671.0,697.0,719.0,682.0,616.0,573.0,7830.0
Nainital,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,833.0,717.0,774.0,888.0,735.0,829.0,235.0,1133.0,1422.0,1069.0,1019.0,1081.0,10735.0
Nainital,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,391.0,465.0,466.0,609.0,401.0,477.0,173.0,966.0,702.0,931.0,700.0,662.0,6943.0
Nainital,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,102.0,128.0,116.0,175.0,137.0,128.0,169.0,134.0,210.0,149.0,127.0,142.0,1717.0
Nainital,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Nainital,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Nainital,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Nainital,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Nainital,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Nainital,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,261.0,254.0,250.0,347.0,338.0,331.0,333.0,290.0,292.0,300.0,274.0,264.0,3534.0
Nainital,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nainital,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,263.0,254.0,250.0,347.0,338.0,331.0,333.0,290.0,292.0,300.0,274.0,264.0,3536.0
Nainital,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,5.0,6.0,2.0,3.0,3.0,4.0,3.0,15.0,56.0,111.0,102.0,102.0,412.0
Nainital,4.1.1.a,Number of male live births,TOTAL,633.0,656.0,678.0,772.0,804.0,780.0,782.0,742.0,774.0,744.0,736.0,639.0,8740.0
Nainital,4.1.1.b,Number of female live births,TOTAL,598.0,570.0,585.0,763.0,796.0,793.0,727.0,637.0,694.0,666.0,629.0,566.0,8024.0
Nainital,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1231.0,1226.0,1263.0,1535.0,1600.0,1573.0,1509.0,1379.0,1468.0,1410.0,1365.0,1205.0,16764.0
Nainital,4.1.2,Number of still births,TOTAL,21.0,15.0,25.0,22.0,27.0,26.0,23.0,13.0,22.0,30.0,26.0,20.0,270.0
Nainital,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,151.0,183.0,148.0,193.0,158.0,157.0,121.0,67.0,208.0,186.0,138.0,99.0,1809.0
Nainital,4.2.1,Number of Newborns weighed at birth,TOTAL,1201.0,1216.0,1263.0,1528.0,1563.0,1522.0,1476.0,1345.0,1436.0,1405.0,1360.0,1204.0,16519.0
Nainital,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,124.0,122.0,125.0,33.0,39.0,80.0,29.0,25.0,28.0,36.0,155.0,93.0,889.0
Nainital,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1214.0,1143.0,1217.0,1529.0,1581.0,1545.0,1486.0,1367.0,1432.0,1320.0,1353.0,1191.0,16378.0
Nainital,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,32.0,,,,,,,,,,32.0
Nainital,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,94.0,102.0,115.0,140.0,123.0,104.0,91.0,75.0,71.0,76.0,55.0,71.0,1117.0
Nainital,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nainital,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,94.0,102.0,147.0,140.0,123.0,104.0,91.0,75.0,71.0,76.0,55.0,71.0,1149.0
Nainital,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Nainital,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,78.0,78.0,89.0,107.0,92.0,84.0,83.0,51.0,53.0,121.0,116.0,75.0,1027.0
Nainital,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,21.0,20.0,19.0,32.0,26.0,22.0,10.0,13.0,58.0,14.0,15.0,12.0,262.0
Nainital,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,74.0,68.0,94.0,114.0,100.0,95.0,73.0,63.0,65.0,76.0,117.0,63.0,1002.0
Nainital,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,36.0,42.0,47.0,35.0,29.0,21.0,21.0,31.0,16.0,26.0,25.0,19.0,348.0
Nainital,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1063.0,1004.0,1062.0,1306.0,1423.0,1443.0,1307.0,1157.0,1262.0,1178.0,1246.0,1043.0,14494.0
Nainital,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,856.0,902.0,789.0,1064.0,1088.0,1008.0,1025.0,815.0,969.0,926.0,1041.0,910.0,11393.0
Nainital,6.3,PNC maternal complications attended,TOTAL,12.0,13.0,14.0,18.0,16.0,14.0,9.0,7.0,7.0,6.0,5.0,5.0,126.0
Nainital,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,35.0,67.0,53.0,125.0,72.0,59.0,63.0,64.0,112.0,119.0,108.0,89.0,966.0
Nainital,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Nainital,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,35.0,67.0,53.0,125.0,72.0,59.0,63.0,64.0,112.0,119.0,108.0,93.0,970.0
Nainital,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,0.0,,0.0
Nainital,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1.0,54.0,0.0,1.0,0.0,2.0,49.0,47.0,47.0,28.0,18.0,19.0,266.0
Nainital,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,390.0,401.0,334.0,370.0,445.0,409.0,490.0,468.0,449.0,361.0,335.0,414.0,4866.0
Nainital,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,391.0,455.0,334.0,371.0,445.0,411.0,539.0,515.0,496.0,389.0,353.0,433.0,5132.0
Nainital,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,1.0,11.0,6.0,,5.0,0.0,1.0,5.0,9.0,4.0,42.0
Nainital,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,7.0,1.0,4.0,11.0,0.0,7.0,0.0,2.0,9.0,6.0,2.0,1.0,50.0
Nainital,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,0.0,1.0,2.0,4.0,4.0,1.0,2.0,3.0,4.0,2.0,2.0,28.0
Nainital,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nainital,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,10.0,1.0,6.0,24.0,10.0,11.0,6.0,4.0,13.0,15.0,13.0,7.0,120.0
Nainital,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nainital,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Nainital,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nainital,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nainital,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,9.0,2.0,9.0,51.0,21.0,11.0,42.0,25.0,40.0,135.0,89.0,9.0,443.0
Nainital,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,22.0,12.0,14.0,47.0,23.0,15.0,12.0,24.0,94.0,69.0,43.0,18.0,393.0
Nainital,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,22.0,20.0,16.0,33.0,15.0,9.0,9.0,10.0,21.0,23.0,38.0,17.0,233.0
Nainital,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nainital,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,53.0,34.0,39.0,131.0,59.0,35.0,63.0,59.0,155.0,227.0,170.0,44.0,1069.0
Nainital,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nainital,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Nainital,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,42.0,35.0,44.0,75.0,69.0,52.0,45.0,12.0,47.0,68.0,56.0,51.0,596.0
Nainital,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nainital,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,42.0,35.0,44.0,75.0,69.0,52.0,45.0,12.0,47.0,68.0,56.0,51.0,596.0
Nainital,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nainital,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1215.0,247.0,252.0,777.0,358.0,383.0,291.0,291.0,298.0,294.0,236.0,234.0,4876.0
Nainital,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,26.0,2.0,2.0,15.0,162.0,54.0,57.0,160.0,26.0,35.0,31.0,32.0,602.0
Nainital,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,266.0,300.0,255.0,311.0,324.0,385.0,269.0,283.0,310.0,288.0,373.0,221.0,3585.0
Nainital,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nainital,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1507.0,549.0,509.0,1103.0,844.0,822.0,617.0,734.0,634.0,617.0,640.0,487.0,9063.0
Nainital,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,199.0,214.0,256.0,263.0,72.0,82.0,31.0,60.0,40.0,56.0,44.0,2.0,1319.0
Nainital,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Nainital,9.06,Number of IUCD removals,TOTAL,88.0,127.0,112.0,190.0,137.0,156.0,187.0,132.0,163.0,144.0,123.0,160.0,1719.0
Nainital,9.07,Number of Oral Pills cycles distributed,TOTAL,730.0,1023.0,3027.0,5526.0,3103.0,4290.0,2708.0,2570.0,2055.0,3932.0,3035.0,6220.0,38219.0
Nainital,9.08,Number of Condom pieces distributed,TOTAL,17817.0,17461.0,33674.0,53613.0,34634.0,37822.0,33629.0,29157.0,30628.0,44003.0,39942.0,46077.0,418457.0
Nainital,9.09,Number of Centchroman (weekly) pills given,TOTAL,77.0,35.0,146.0,18.0,35.0,35.0,31.0,4.0,2.0,0.0,14.0,16.0,413.0
Nainital,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,413.0,458.0,338.0,410.0,276.0,257.0,259.0,531.0,524.0,579.0,588.0,599.0,5232.0
Nainital,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,5.0,0.0,2.0,1.0,0.0,3.0,0.0,2.0,1.0,0.0,1.0,0.0,15.0
Nainital,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,7.0,9.0,2.0,14.0,3.0,5.0,2.0,5.0,4.0,4.0,4.0,0.0,59.0
Nainital,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,2.0,0.0,1.0,0.0,1.0,0.0,6.0
Nainital,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,3.0,0.0,0.0,7.0
Nainital,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,4.0,4.0,4.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,6.0,-1.0
Nainital,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1298.0,1213.0,1142.0,1391.0,1448.0,1580.0,1494.0,1240.0,1388.0,1352.0,1405.0,1381.0,16332.0
Nainital,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2.0,1.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,56.0
Nainital,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,47.0,22.0,7.0,6.0,5.0,0.0,4.0,0.0,2.0,1.0,3.0,56.0,153.0
Nainital,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,135.0,57.0,43.0,17.0,12.0,3.0,2.0,0.0,3.0,6.0,1.0,66.0,345.0
Nainital,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1389.0,1295.0,1112.0,1307.0,1228.0,1526.0,1452.0,1450.0,1609.0,1415.0,1453.0,1470.0,16706.0
Nainital,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1313.0,1340.0,1225.0,1297.0,1247.0,1264.0,1446.0,1342.0,1552.0,1527.0,1535.0,1393.0,16481.0
Nainital,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1207.0,1237.0,1314.0,1321.0,1231.0,1304.0,1279.0,1336.0,1500.0,1514.0,1615.0,1539.0,16397.0
Nainital,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,866.0,906.0,874.0,1051.0,1122.0,1138.0,946.0,878.0,965.0,1045.0,1094.0,918.0,11803.0
Nainital,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1341.0,1304.0,1105.0,1315.0,1236.0,1530.0,1466.0,1449.0,1607.0,1398.0,1453.0,1432.0,16636.0
Nainital,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1702.0,1348.0,1224.0,1292.0,1244.0,1263.0,1425.0,1342.0,1557.0,1506.0,1538.0,1341.0,16782.0
Nainital,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1276.0,1268.0,1324.0,1334.0,1191.0,1305.0,1286.0,1328.0,1504.0,1472.0,2618.0,1482.0,17388.0
Nainital,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,600.0,653.0,549.0,696.0,689.0,602.0,570.0,623.0,532.0,650.0,583.0,555.0,7302.0
Nainital,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,8.0,124.0,66.0,108.0,79.0,69.0,92.0,159.0,94.0,99.0,84.0,80.0,1062.0
Nainital,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,64.0,140.0,95.0,110.0,78.0,77.0,82.0,132.0,107.0,95.0,110.0,90.0,1180.0
Nainital,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,169.0,170.0,108.0,132.0,101.0,77.0,80.0,152.0,94.0,98.0,121.0,112.0,1414.0
Nainital,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1267.0,1352.0,1206.0,1607.0,1351.0,1365.0,1334.0,1245.0,1459.0,1249.0,1373.0,1375.0,16183.0
Nainital,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1177.0,1258.0,1069.0,1256.0,1196.0,1166.0,1191.0,1019.0,1320.0,1130.0,1227.0,1288.0,14297.0
Nainital,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Nainital,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,669.0,666.0,629.0,838.0,676.0,709.0,661.0,628.0,770.0,640.0,681.0,680.0,8247.0
Nainital,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,583.0,633.0,576.0,766.0,659.0,606.0,639.0,591.0,686.0,605.0,672.0,657.0,7673.0
Nainital,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1252.0,1299.0,1205.0,1604.0,1335.0,1315.0,1300.0,1219.0,1456.0,1245.0,1353.0,1337.0,15920.0
Nainital,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1293.0,1378.0,1142.0,1375.0,1256.0,1205.0,1266.0,1022.0,1359.0,1212.0,1301.0,1307.0,15116.0
Nainital,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1299.0,1374.0,1144.0,1376.0,1251.0,1205.0,1277.0,1022.0,1356.0,1201.0,1300.0,1307.0,15112.0
Nainital,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,505.0,512.0,464.0,623.0,533.0,453.0,340.0,321.0,373.0,293.0,370.0,350.0,5137.0
Nainital,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,449.0,531.0,424.0,552.0,472.0,415.0,340.0,307.0,333.0,295.0,311.0,304.0,4733.0
Nainital,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,954.0,1043.0,888.0,1175.0,1005.0,868.0,680.0,628.0,706.0,588.0,681.0,654.0,9870.0
Nainital,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1080.0,1084.0,1117.0,1030.0,1059.0,1164.0,1012.0,786.0,1098.0,1298.0,1096.0,998.0,12822.0
Nainital,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,894.0,898.0,1001.0,1045.0,962.0,1075.0,983.0,949.0,1002.0,1470.0,1106.0,833.0,12218.0
Nainital,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,616.0,616.0,670.0,781.0,664.0,877.0,691.0,666.0,661.0,1068.0,760.0,640.0,8710.0
Nainital,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0
Nainital,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,998.0,955.0,991.0,1051.0,1024.0,1025.0,999.0,992.0,1044.0,1126.0,1118.0,1140.0,12463.0
Nainital,10.4.2,Number of Immunisation sessions held during the month,TOTAL,946.0,907.0,896.0,966.0,912.0,968.0,945.0,926.0,1014.0,1063.0,1060.0,1070.0,11673.0
Nainital,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,832.0,779.0,800.0,877.0,835.0,872.0,838.0,843.0,903.0,962.0,948.0,915.0,10404.0
Nainital,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1305.0,1344.0,1173.0,1686.0,1536.0,1829.0,1569.0,1541.0,1717.0,2729.0,1715.0,1599.0,19743.0
Nainital,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1695.0,1939.0,1978.0,1973.0,1729.0,2220.0,1769.0,1652.0,1651.0,2271.0,1918.0,2761.0,23556.0
Nainital,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1033.0,1510.0,1408.0,2022.0,2268.0,1762.0,1347.0,1451.0,1311.0,1737.0,1712.0,1541.0,19102.0
Nainital,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Nainital,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Nainital,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,11.0,17.0,6.0,3.0,8.0,11.0,10.0,1.0,6.0,4.0,9.0,2.0,88.0
Nainital,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,448.0,561.0,569.0,689.0,645.0,635.0,188.0,368.0,326.0,298.0,465.0,373.0,5565.0
Nainital,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,5.0,10.0,2.0,4.0,8.0,7.0,1.0,0.0,11.0,5.0,10.0,5.0,68.0
Nainital,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,260.0,280.0,208.0,237.0,256.0,247.0,31.0,253.0,220.0,196.0,276.0,143.0,2607.0
Nainital,13.1,Number of Patients operated for cataract,TOTAL,289.0,19.0,24.0,13.0,10.0,10.0,21.0,21.0,0.0,47.0,13.0,533.0,1000.0
Nainital,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,281.0,27.0,24.0,13.0,10.0,10.0,21.0,21.0,0.0,33.0,13.0,527.0,980.0
Nainital,13.3,Number of School children detected with Refractive errors,TOTAL,5.0,0.0,10.0,18.0,25.0,34.0,53.0,73.0,37.0,43.0,30.0,23.0,351.0
Nainital,13.4,Number of children provided free glasses,TOTAL,3.0,0.0,2.0,5.0,10.0,48.0,29.0,23.0,12.0,28.0,4.0,4.0,168.0
Nainital,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
Nainital,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,,,1.0,1.0,,,,,,,,-1.0
Nainital,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,591.0,563.0,569.0,566.0,531.0,501.0,463.0,490.0,523.0,524.0,491.0,528.0,-1.0
Nainital,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,-1.0
Nainital,14.05,Number of RKS meetings held during the month,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,3.0,3.0,3.0,3.0,28.0
Nainital,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,7.0,6.0,6.0,6.0,6.0,6.0,6.0,7.0,6.0,6.0,6.0,-1.0
Nainital,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,2.0,3.0,1.0,1.0,2.0,3.0,1.0,2.0,1.0,1.0,1.0,1.0,19.0
Nainital,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Nainital,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Nainital,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Nainital,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Nainital,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Nainital,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,393.0,519.0,498.0,436.0,362.0,394.0,284.0,284.0,258.0,218.0,282.0,319.0,4247.0
Nainital,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1048.0,1181.0,1003.0,976.0,686.0,1067.0,1072.0,959.0,638.0,659.0,824.0,932.0,11045.0
Nainital,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,410.0,499.0,479.0,461.0,412.0,414.0,319.0,283.0,273.0,261.0,244.0,307.0,4362.0
Nainital,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2328.0,2564.0,2348.0,2297.0,2403.0,2584.0,2077.0,1750.0,1976.0,2000.0,2224.0,2289.0,26840.0
Nainital,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,803.0,1018.0,977.0,897.0,774.0,808.0,603.0,567.0,531.0,479.0,526.0,626.0,8609.0
Nainital,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3376.0,3745.0,3351.0,3273.0,3089.0,3651.0,3149.0,2709.0,2614.0,2659.0,3048.0,3221.0,37885.0
Nainital,14.10.2.a,Number of death cases of Inpatient males,TOTAL,11.0,9.0,3.0,4.0,5.0,8.0,3.0,4.0,4.0,5.0,4.0,10.0,70.0
Nainital,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,5.0,2.0,4.0,5.0,2.0,0.0,0.0,3.0,3.0,2.0,6.0,39.0
Nainital,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,18.0,14.0,5.0,8.0,10.0,10.0,3.0,4.0,7.0,8.0,6.0,16.0,109.0
Nainital,14.11,In-Patient Head Count at midnight,TOTAL,3668.0,4260.0,7197.0,2893.0,2315.0,4264.0,3813.0,3421.0,1601.0,1550.0,1332.0,7348.0,43662.0
Nainital,14.12.1,OPD attendance (All),TOTAL,99339.0,103359.0,105392.0,109432.0,100147.0,125917.0,104072.0,90161.0,90583.0,84686.0,94616.0,81323.0,1189027.0
Nainital,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,492.0,404.0,353.0,413.0,514.0,848.0,471.0,434.0,701.0,689.0,812.0,732.0,6863.0
Nainital,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,30.0,126.0,20.0,32.0,27.0,0.0,0.0,1.0,1.0,1.0,1.0,9.0,248.0
Nainital,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Nainital,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,614.0,553.0,1050.0,725.0,419.0,667.0,658.0,673.0,610.0,586.0,488.0,621.0,7664.0
Nainital,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Nainital,14.14.a,Number of patients given AYUSH treatment,TOTAL,4426.0,3566.0,2862.0,2601.0,3878.0,3975.0,4669.0,2400.0,2633.0,3345.0,2495.0,3465.0,40315.0
Nainital,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1482.0,1531.0,3325.0,3028.0,1541.0,3076.0,2219.0,2099.0,1359.0,1399.0,976.0,3139.0,25174.0
Nainital,14.14.c,Number of Adolescents counselled,TOTAL,1626.0,1760.0,324.0,160.0,386.0,366.0,308.0,265.0,258.0,211.0,165.0,308.0,6137.0
Nainital,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Nainital,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3923.0,2230.0,2603.0,2812.0,1487.0,2872.0,2133.0,3053.0,1545.0,1460.0,1588.0,3945.0,29651.0
Nainital,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,78.0,91.0,177.0,74.0,38.0,119.0,61.0,132.0,42.0,35.0,20.0,164.0,1031.0
Nainital,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,281.0,135.0,171.0,133.0,36.0,129.0,138.0,145.0,38.0,115.0,34.0,201.0,1556.0
Nainital,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,2.0,0.0,0.0,0.0,2.0,3.0,0.0,0.0,0.0,1.0,8.0
Nainital,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,182.0,130.0,172.0,296.0,67.0,131.0,117.0,125.0,120.0,157.0,102.0,243.0,1842.0
Nainital,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,3.0,1.0,2.0,0.0,11.0
Nainital,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,850.0,529.0,548.0,408.0,421.0,544.0,479.0,432.0,387.0,422.0,368.0,564.0,5952.0
Nainital,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Nainital,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1313.0,794.0,891.0,837.0,524.0,804.0,734.0,702.0,545.0,694.0,504.0,1008.0,9350.0
Nainital,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,1.0,3.0,0.0,1.0,1.0,3.0,4.0,3.0,1.0,2.0,1.0,21.0
Nainital,15.2,Number of Widal tests conducted,Number tested,406.0,299.0,133.0,92.0,296.0,445.0,856.0,747.0,74.0,74.0,104.0,474.0,4000.0
Nainital,15.3.a,Number of VDRL tests conducted on males,Number tested,44.0,43.0,41.0,45.0,0.0,50.0,45.0,45.0,0.0,0.0,0.0,44.0,357.0
Nainital,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,98.0,89.0,128.0,94.0,0.0,108.0,96.0,94.0,15.0,0.0,0.0,56.0,778.0
Nainital,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,562.0,99.0,62.0,69.0,5.0,129.0,126.0,114.0,45.0,80.0,61.0,624.0,1976.0
Nainital,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,704.0,231.0,231.0,208.0,5.0,287.0,267.0,253.0,60.0,80.0,61.0,724.0,3111.0
Nainital,15.4.1,Number of blood smears examined for Malaria,TOTAL,340.0,247.0,465.0,387.0,463.0,782.0,554.0,483.0,58.0,154.0,206.0,268.0,4407.0
Nainital,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,5.0,10.0,20.0,16.0,18.0,25.0,19.0,1.0,1.0,0.0,0.0,118.0
Nainital,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,6.0,3.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,11.0
Nainital,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4560.0,5590.0,750.0,1100.0,4180.0,,,,,,,,16180.0
Nainital,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1030.0,2000.0,3000.0,6500.0,,,,5000.0,,,,,17530.0
Nainital,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,6840.0,2650.0,3420.0,3350.0,,,,,,,,16260.0
Nainital,16.1.1,Stock position of DPT vaccines,5. Total Stock,5590.0,750.0,1100.0,4180.0,830.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,17450.0
Nainital,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3620.0,3825.0,4450.0,400.0,5550.0,,,,,,,,17845.0
Nainital,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,205.0,8000.0,,11000.0,,,,3500.0,,,,,22705.0
Nainital,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,7375.0,4050.0,5850.0,3900.0,,,,,,,,21175.0
Nainital,16.1.1A,Stock Position of Pentavalent,5. Total Stock,3825.0,4450.0,400.0,5550.0,1650.0,0.0,0.0,3500.0,0.0,0.0,0.0,0.0,19375.0
Nainital,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,8900.0,8500.0,2900.0,3500.0,11000.0,,,,,,,,34800.0
Nainital,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,4000.0,9000.0,17000.0,,,,10000.0,,,,,40000.0
Nainital,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,400.0,9600.0,8400.0,9500.0,9460.0,,,,,,,,37360.0
Nainital,16.1.2,Stock position of OPV vaccines,5. Total Stock,8500.0,2900.0,3500.0,11000.0,1540.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,37440.0
Nainital,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,7480.0,7690.0,4000.0,6900.0,11500.0,,,,,,,,37570.0
Nainital,16.1.3,Stock position of TT vaccines,2. Stocks Received,210.0,5000.0,8000.0,12000.0,,,,15650.0,,,,,40860.0
Nainital,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,8690.0,5100.0,7400.0,3500.0,,,,,,,,24690.0
Nainital,16.1.3,Stock position of TT vaccines,5. Total Stock,7690.0,4000.0,6900.0,11500.0,8000.0,0.0,0.0,15650.0,0.0,0.0,0.0,0.0,53740.0
Nainital,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Nainital,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,6350.0,6520.0,8750.0,10750.0,7950.0,,,,,,,,40320.0
Nainital,16.1.5,Stock position of BCG vaccines,2. Stocks Received,170.0,5000.0,5000.0,0.0,,,,5000.0,,,,,15170.0
Nainital,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,2770.0,3000.0,2800.0,1300.0,,,,,,,,9870.0
Nainital,16.1.5,Stock position of BCG vaccines,5. Total Stock,6520.0,8750.0,10750.0,7950.0,6650.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,45620.0
Nainital,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2325.0,2985.0,1150.0,800.0,2630.0,,,,,,,,9890.0
Nainital,16.1.6,Stock position of Measles vaccines,2. Stocks Received,660.0,2500.0,3000.0,5000.0,,,,5000.0,,,,,16160.0
Nainital,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,4335.0,3350.0,3170.0,2225.0,,,,,,,,13080.0
Nainital,16.1.6,Stock position of Measles vaccines,5. Total Stock,2985.0,1150.0,800.0,2630.0,405.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,12970.0
Nainital,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Nainital,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,6720.0,6372.0,4370.0,3770.0,3470.0,,,,,,,,24702.0
Nainital,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,3000.0,,,,,3000.0
Nainital,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,348.0,2002.0,600.0,300.0,250.0,,,,,,,,3500.0
Nainital,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,6372.0,4370.0,3770.0,3470.0,3220.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,24202.0
Nainital,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1500.0,,3000.0,1000.0,700.0,,,700.0,,,,,6900.0
Nainital,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,3000.0,,,,,,,,,,,3000.0
Nainital,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,1500.0,,2000.0,300.0,0.0,,,0.0,,,,,3800.0
Nainital,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,3000.0,1000.0,700.0,700.0,0.0,0.0,700.0,0.0,0.0,0.0,0.0,6100.0
Nainital,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,85680.0,20160.0,252000.0,120960.0,65520.0,,,15120.0,,,,,559440.0
Nainital,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,252000.0,,,,,,,,,,,252000.0
Nainital,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,65520.0,,131040.0,55440.0,0.0,,,15120.0,,,,,267120.0
Nainital,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,20160.0,272160.0,120960.0,65520.0,65520.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,544320.0
Nainital,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,24000.0,10800.0,2400.0,,,0.0,,,,,37200.0
Nainital,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,24000.0,,,,,,,,,,,24000.0
Nainital,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,13200.0,8400.0,0.0,,,0.0,,,,,21600.0
Nainital,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,24000.0,10800.0,2400.0,2400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,39600.0
Nainital,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3000.0,3000.0,0.0,,,,,0.0,,,,,6000.0
Nainital,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nainital,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,3000.0,0.0,,,,,0.0,,,,,3000.0
Nainital,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
Nainital,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Nainital,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Nainital,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,0.0,,,,,0.0
Nainital,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Nainital,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Nainital,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Nainital,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Nainital,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Nainital,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Nainital,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Nainital,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Nainital,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Nainital,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Nainital,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Nainital,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Nainital,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Nainital,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nainital,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1800.0,3514.0,6600.0,4400.0,8800.0,,,,,,,,25114.0
Nainital,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,1714.0,4000.0,,6000.0,,,,0.0,,,,,11714.0
Nainital,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,914.0,2200.0,1600.0,2600.0,,,,,,,,7314.0
Nainital,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3514.0,6600.0,4400.0,8800.0,6200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29514.0
Nainital,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,55600.0,19561.0,21400.0,3500.0,64900.0,,,,,,,,164961.0
Nainital,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,1839.0,,72000.0,,,,0.0,,,,,73839.0
Nainital,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,36039.0,,17900.0,10600.0,21000.0,,,,,,,,85539.0
Nainital,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,19561.0,21400.0,3500.0,64900.0,43900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,153261.0
Nainital,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5500.0,3197.0,4200.0,3400.0,8600.0,,,,,,,,24897.0
Nainital,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,1003.0,,6000.0,,,,0.0,,,,,7003.0
Nainital,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Nainital,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2303.0,,800.0,800.0,1500.0,,,,,,,,5403.0
Nainital,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3197.0,4200.0,3400.0,8600.0,7100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26497.0
Nainital,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Nainital,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,,,,,,,,,1.0
Nainital,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nainital,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,,,,,,,,,1.0
Nainital,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Nainital,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nainital,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Nainital,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,1.0,,,1.0,1.0,,,,3.0
Nainital,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nainital,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,1.0,,,1.0,1.0,,,,3.0
Nainital,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,1.0,2.0,1.0,1.0,1.0,,,2.0,8.0
Nainital,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nainital,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,1.0,2.0,1.0,1.0,1.0,,,2.0,8.0
Nainital,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nainital,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nainital,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Nainital,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nainital,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nainital,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Nainital,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,1.0,,,1.0
Nainital,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Nainital,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,,,,,,1.0,,,2.0
Nainital,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nainital,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nainital,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Nainital,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,,,1.0,2.0,1.0,,1.0,1.0,,7.0
Nainital,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,1.0,1.0,,,2.0,4.0
Nainital,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,1.0,,,1.0,2.0,2.0,1.0,1.0,1.0,2.0,11.0
Nainital,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Nainital,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Nainital,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Nainital,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,1.0,,,,,2.0,,1.0,,,4.0
Nainital,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,1.0,,,1.0,,,,,2.0
Nainital,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,,1.0,,,3.0,,1.0,,,6.0
Nainital,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,,,,,1.0,,,,,2.0
Nainital,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,,,1.0,1.0,,1.0,2.0,1.0,,3.0,10.0
Nainital,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,2.0,,,1.0,1.0,,2.0,2.0,1.0,,3.0,12.0
Nainital,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Nainital,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,3.0,,,,,3.0
Nainital,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,3.0,,,,,3.0
Nainital,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Nainital,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Nainital,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,2.0,2.0,,,,1.0,,,1.0,2.0,,8.0
Nainital,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,3.0,2.0,,,,1.0,,,2.0,2.0,,10.0
Nainital,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Nainital,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Nainital,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Nainital,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Nainital,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,2.0,3.0,2.0,3.0,1.0,1.0,1.0,3.0,2.0,1.0,2.0,21.0
Nainital,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,1.0,3.0,2.0,1.0,1.0,1.0,3.0,,3.0,1.0,17.0
Nainital,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,2.0,4.0,5.0,5.0,2.0,2.0,2.0,6.0,3.0,4.0,3.0,39.0
Nainital,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,,,,,1.0,,,2.0
Nainital,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Nainital,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,1.0,,,,,1.0,,,2.0
Nainital,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Nainital,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Nainital,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Nainital,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Nainital,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Nainital,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Nainital,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Nainital,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Nainital,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Nainital,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,1.0,1.0,1.0,1.0,1.0,1.0,6.0
Nainital,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Nainital,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,1.0,1.0,1.0,1.0,1.0,1.0,6.0
Nainital,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Nainital,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Nainital,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Nainital,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Nainital,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Nainital,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Nainital,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Nainital,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,2.0,,5.0,3.0,1.0,1.0,1.0,2.0,1.0,1.0,17.0
Nainital,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Nainital,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,2.0,,5.0,3.0,1.0,1.0,1.0,3.0,2.0,1.0,19.0
Nainital,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,1.0,1.0,,2.0,,,,,,2.0,7.0
Nainital,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Nainital,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,1.0,1.0,,2.0,,,,,,2.0,7.0
Nainital,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Nainital,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Nainital,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,1.0,,1.0
Nainital,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Nainital,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,1.0,,,,,2.0,1.0,2.0,,1.0,8.0
Nainital,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,3.0,2.0,1.0,12.0,6.0,3.0,3.0,2.0,11.0,,43.0
Nainital,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,4.0,2.0,1.0,12.0,7.0,5.0,4.0,4.0,11.0,1.0,52.0
Nainital,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Nainital,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,1.0,2.0,,,2.0,3.0,1.0,,1.0,,1.0,12.0
Nainital,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,4.0,,2.0,1.0,8.0,8.0,,3.0,10.0,7.0,5.0,9.0,57.0
Nainital,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,1.0,4.0,1.0,8.0,10.0,3.0,4.0,10.0,8.0,5.0,10.0,69.0
Nainital,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,2.0,,,,2.0
Nainital,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,1.0,1.0,,,1.0,2.0,,1.0,1.0,3.0,,11.0
Nainital,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,1.0,5.0,3.0,,3.0,7.0,1.0,4.0,3.0,2.0,2.0,32.0
Nainital,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,2.0,2.0,6.0,3.0,,4.0,9.0,1.0,7.0,4.0,5.0,2.0,45.0
Pithoragarh,1.1,Total number of pregnant women Registered for ANC,TOTAL,799.0,761.0,670.0,681.0,671.0,663.0,546.0,630.0,592.0,598.0,731.0,730.0,8072.0
Pithoragarh,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,486.0,492.0,444.0,470.0,432.0,410.0,315.0,390.0,342.0,303.0,497.0,423.0,5004.0
Pithoragarh,1.2,Number of Pregnant women registered under JSY,TOTAL,799.0,761.0,670.0,681.0,671.0,663.0,546.0,630.0,592.0,598.0,730.0,730.0,8071.0
Pithoragarh,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,692.0,639.0,772.0,667.0,639.0,621.0,654.0,605.0,556.0,578.0,584.0,658.0,7665.0
Pithoragarh,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,740.0,698.0,616.0,607.0,594.0,595.0,485.0,538.0,538.0,514.0,635.0,659.0,7219.0
Pithoragarh,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,683.0,794.0,722.0,644.0,656.0,684.0,650.0,565.0,593.0,666.0,619.0,703.0,7979.0
Pithoragarh,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,629.0,612.0,465.0,451.0,411.0,578.0,529.0,423.0,510.0,313.0,347.0,227.0,5495.0
Pithoragarh,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,7.0
Pithoragarh,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,37.0,56.0,48.0,42.0,35.0,37.0,12.0,31.0,63.0,61.0,78.0,26.0,526.0
Pithoragarh,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,8.0,8.0,14.0,2.0,10.0,4.0,2.0,2.0,14.0,8.0,14.0,19.0,105.0
Pithoragarh,1.8,Number of pregnancy test kits used at SC level,TOTAL,2.0,1.0,47.0,41.0,56.0,52.0,44.0,38.0,50.0,38.0,55.0,44.0,468.0
Pithoragarh,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,126.0,96.0,121.0,116.0,133.0,136.0,125.0,113.0,119.0,129.0,145.0,110.0,1469.0
Pithoragarh,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,3.0,14.0,6.0,14.0,6.0,24.0,16.0,22.0,13.0,16.0,13.0,3.0,150.0
Pithoragarh,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,129.0,110.0,127.0,130.0,139.0,160.0,141.0,135.0,132.0,145.0,158.0,113.0,1619.0
Pithoragarh,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,125.0,105.0,125.0,141.0,140.0,157.0,139.0,128.0,126.0,139.0,156.0,113.0,1594.0
Pithoragarh,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,2.0,1.0,2.0,2.0,1.0,0.0,0.0,3.0,0.0,10.0,0.0,21.0
Pithoragarh,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,333.0,365.0,375.0,490.0,457.0,567.0,529.0,498.0,437.0,417.0,500.0,507.0,5475.0
Pithoragarh,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,271.0,186.0,279.0,355.0,330.0,420.0,405.0,376.0,327.0,324.0,393.0,419.0,4085.0
Pithoragarh,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,331.0,267.0,359.0,477.0,417.0,547.0,518.0,484.0,427.0,410.0,496.0,492.0,5225.0
Pithoragarh,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,147.0,199.0,186.0,266.0,218.0,240.0,217.0,306.0,241.0,174.0,305.0,271.0,2770.0
Pithoragarh,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,23.0,18.0,18.0,26.0,44.0,63.0,12.0,30.0,14.0,34.0,12.0,39.0,333.0
Pithoragarh,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Pithoragarh,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Pithoragarh,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Pithoragarh,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,3.0
Pithoragarh,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,34.0,47.0,47.0,59.0,53.0,52.0,57.0,61.0,39.0,45.0,50.0,18.0,562.0
Pithoragarh,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pithoragarh,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,34.0,47.0,47.0,59.0,53.0,52.0,57.0,61.0,41.0,45.0,51.0,18.0,565.0
Pithoragarh,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,3.0,7.0,4.0,4.0,10.0,10.0,8.0,2.0,3.0,7.0,9.0,15.0,82.0
Pithoragarh,4.1.1.a,Number of male live births,TOTAL,267.0,241.0,281.0,316.0,344.0,394.0,345.0,364.0,322.0,319.0,346.0,343.0,3882.0
Pithoragarh,4.1.1.b,Number of female live births,TOTAL,223.0,245.0,236.0,324.0,284.0,389.0,326.0,301.0,271.0,271.0,318.0,309.0,3497.0
Pithoragarh,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,490.0,486.0,517.0,640.0,628.0,783.0,671.0,665.0,593.0,590.0,664.0,652.0,7379.0
Pithoragarh,4.1.2,Number of still births,TOTAL,8.0,8.0,4.0,7.0,12.0,12.0,12.0,8.0,3.0,8.0,7.0,8.0,97.0
Pithoragarh,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,24.0,38.0,26.0,29.0,24.0,18.0,10.0,13.0,21.0,17.0,8.0,17.0,245.0
Pithoragarh,4.2.1,Number of Newborns weighed at birth,TOTAL,488.0,484.0,512.0,641.0,627.0,780.0,670.0,665.0,571.0,552.0,644.0,663.0,7297.0
Pithoragarh,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,41.0,49.0,28.0,54.0,35.0,22.0,33.0,36.0,21.0,46.0,29.0,36.0,430.0
Pithoragarh,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,488.0,484.0,519.0,640.0,627.0,780.0,670.0,665.0,571.0,552.0,663.0,663.0,7322.0
Pithoragarh,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Pithoragarh,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,34.0,45.0,47.0,,53.0,52.0,57.0,61.0,39.0,45.0,50.0,18.0,501.0
Pithoragarh,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pithoragarh,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,34.0,45.0,47.0,0.0,53.0,52.0,57.0,61.0,39.0,45.0,50.0,18.0,501.0
Pithoragarh,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Pithoragarh,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,34.0,45.0,47.0,0.0,53.0,52.0,57.0,61.0,41.0,45.0,51.0,18.0,504.0
Pithoragarh,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,34.0,45.0,47.0,0.0,53.0,52.0,57.0,61.0,41.0,45.0,66.0,18.0,519.0
Pithoragarh,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,41.0,41.0,43.0,,34.0,40.0,54.0,40.0,14.0,8.0,14.0,12.0,341.0
Pithoragarh,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,495.0,485.0,450.0,540.0,482.0,592.0,562.0,546.0,522.0,455.0,578.0,560.0,6267.0
Pithoragarh,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,298.0,297.0,243.0,308.0,266.0,314.0,298.0,310.0,309.0,264.0,334.0,319.0,3560.0
Pithoragarh,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5.0,9.0,22.0,29.0,20.0,14.0,10.0,9.0,17.0,8.0,8.0,17.0,168.0
Pithoragarh,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Pithoragarh,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,5.0,9.0,22.0,29.0,20.0,14.0,10.0,9.0,17.0,8.0,8.0,19.0,170.0
Pithoragarh,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,36.0,44.0,26.0,25.0,14.0,32.0,29.0,21.0,30.0,24.0,33.0,48.0,362.0
Pithoragarh,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,98.0,136.0,131.0,137.0,145.0,125.0,155.0,149.0,177.0,142.0,185.0,222.0,1802.0
Pithoragarh,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,134.0,180.0,157.0,162.0,159.0,157.0,184.0,170.0,207.0,166.0,218.0,270.0,2164.0
Pithoragarh,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,3.0,0.0,0.0,0.0,0.0,4.0,0.0,1.0,0.0,0.0,0.0,2.0,10.0
Pithoragarh,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Pithoragarh,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,1.0,2.0,6.0
Pithoragarh,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pithoragarh,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,6.0,0.0,0.0,0.0,0.0,4.0,0.0,1.0,0.0,0.0,1.0,4.0,16.0
Pithoragarh,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Pithoragarh,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,30.0,15.0,3.0,43.0,5.0,2.0,3.0,7.0,362.0,173.0,182.0,32.0,857.0
Pithoragarh,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,,1.0,0.0,0.0,83.0,213.0,49.0,139.0,0.0,485.0
Pithoragarh,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,6.0,4.0,0.0,1.0,3.0,0.0,0.0,,,7.0,0.0,7.0,28.0
Pithoragarh,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pithoragarh,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,36.0,19.0,3.0,44.0,9.0,2.0,3.0,90.0,575.0,229.0,321.0,39.0,1370.0
Pithoragarh,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Pithoragarh,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Pithoragarh,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,,,20.0,0.0,0.0,0.0,34.0,0.0,0.0,0.0,54.0
Pithoragarh,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,8.0,1.0,2.0,0.0,1.0,3.0,4.0,1.0,0.0,0.0,4.0,24.0
Pithoragarh,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pithoragarh,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,8.0,1.0,18.0,20.0,1.0,3.0,4.0,35.0,0.0,0.0,4.0,94.0
Pithoragarh,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Pithoragarh,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Pithoragarh,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,11.0,5.0,12.0,8.0,9.0,9.0,7.0,10.0,10.0,7.0,3.0,93.0
Pithoragarh,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pithoragarh,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,11.0,5.0,12.0,8.0,9.0,9.0,7.0,10.0,10.0,7.0,3.0,93.0
Pithoragarh,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Pithoragarh,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,407.0,461.0,445.0,939.0,406.0,497.0,471.0,432.0,436.0,388.0,428.0,572.0,5882.0
Pithoragarh,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,3.0,14.0,9.0,23.0,13.0,12.0,11.0,11.0,15.0,11.0,10.0,11.0,143.0
Pithoragarh,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,11.0,21.0,19.0,18.0,21.0,13.0,12.0,34.0,29.0,32.0,26.0,29.0,265.0
Pithoragarh,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,122.0,95.0,106.0,151.0,139.0,147.0,175.0,195.0,157.0,122.0,197.0,195.0,1801.0
Pithoragarh,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pithoragarh,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,543.0,591.0,579.0,1131.0,579.0,669.0,669.0,672.0,637.0,553.0,661.0,807.0,8091.0
Pithoragarh,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,130.0,112.0,129.0,161.0,154.0,164.0,179.0,198.0,159.0,126.0,201.0,200.0,1913.0
Pithoragarh,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Pithoragarh,9.06,Number of IUCD removals,TOTAL,89.0,99.0,138.0,117.0,115.0,89.0,91.0,94.0,108.0,101.0,110.0,100.0,1251.0
Pithoragarh,9.07,Number of Oral Pills cycles distributed,TOTAL,1877.0,2142.0,2449.0,3317.0,2611.0,2424.0,2431.0,2340.0,1681.0,1733.0,2299.0,2293.0,27597.0
Pithoragarh,9.08,Number of Condom pieces distributed,TOTAL,17935.0,22784.0,18984.0,31149.0,22024.0,24961.0,27199.0,26264.0,20419.0,16424.0,20540.0,19052.0,267735.0
Pithoragarh,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,180.0,0.0,4.0,21.0,205.0
Pithoragarh,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,107.0,94.0,248.0,138.0,74.0,14.0,42.0,42.0,32.0,40.0,26.0,15.0,872.0
Pithoragarh,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Pithoragarh,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Pithoragarh,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,4.0,5.0,5.0,5.0,5.0,5.0,5.0,4.0,5.0,5.0,5.0,-1.0
Pithoragarh,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,511.0,514.0,624.0,607.0,712.0,720.0,731.0,827.0,624.0,610.0,722.0,725.0,7927.0
Pithoragarh,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,641.0,631.0,561.0,544.0,574.0,698.0,705.0,746.0,692.0,660.0,553.0,702.0,7707.0
Pithoragarh,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,593.0,636.0,621.0,565.0,543.0,560.0,670.0,686.0,748.0,689.0,655.0,579.0,7545.0
Pithoragarh,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,759.0,588.0,629.0,623.0,581.0,542.0,576.0,630.0,724.0,743.0,690.0,656.0,7741.0
Pithoragarh,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,446.0,409.0,521.0,544.0,540.0,688.0,650.0,660.0,532.0,481.0,602.0,574.0,6647.0
Pithoragarh,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,639.0,628.0,562.0,544.0,575.0,701.0,705.0,746.0,701.0,650.0,554.0,699.0,7704.0
Pithoragarh,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,586.0,640.0,621.0,565.0,543.0,563.0,670.0,681.0,748.0,689.0,660.0,588.0,7554.0
Pithoragarh,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,758.0,587.0,632.0,622.0,581.0,542.0,576.0,630.0,725.0,743.0,689.0,647.0,7732.0
Pithoragarh,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,348.0,384.0,436.0,474.0,462.0,617.0,596.0,547.0,446.0,446.0,650.0,475.0,5881.0
Pithoragarh,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,71.0,82.0,68.0,59.0,69.0,84.0,89.0,84.0,75.0,87.0,80.0,93.0,941.0
Pithoragarh,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,74.0,71.0,86.0,64.0,76.0,70.0,88.0,71.0,86.0,71.0,83.0,98.0,938.0
Pithoragarh,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,65.0,74.0,71.0,88.0,80.0,80.0,83.0,72.0,109.0,81.0,71.0,63.0,937.0
Pithoragarh,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,533.0,726.0,763.0,720.0,695.0,661.0,615.0,699.0,695.0,553.0,539.0,705.0,7904.0
Pithoragarh,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,631.0,676.0,630.0,643.0,689.0,742.0,608.0,559.0,630.0,651.0,592.0,668.0,7719.0
Pithoragarh,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,0.0,0.0,8.0
Pithoragarh,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,317.0,366.0,388.0,368.0,353.0,393.0,343.0,382.0,391.0,341.0,297.0,378.0,4317.0
Pithoragarh,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,276.0,316.0,318.0,325.0,335.0,264.0,271.0,331.0,313.0,272.0,262.0,318.0,3601.0
Pithoragarh,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,593.0,682.0,706.0,693.0,688.0,657.0,614.0,713.0,704.0,613.0,559.0,696.0,7918.0
Pithoragarh,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,629.0,676.0,630.0,642.0,692.0,745.0,606.0,558.0,628.0,623.0,589.0,668.0,7686.0
Pithoragarh,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,629.0,676.0,630.0,642.0,692.0,745.0,606.0,558.0,628.0,653.0,589.0,668.0,7716.0
Pithoragarh,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,197.0,238.0,213.0,218.0,230.0,230.0,202.0,192.0,222.0,224.0,209.0,242.0,2617.0
Pithoragarh,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,159.0,148.0,256.0,176.0,199.0,199.0,183.0,171.0,183.0,175.0,166.0,199.0,2214.0
Pithoragarh,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,356.0,386.0,469.0,394.0,429.0,429.0,385.0,363.0,405.0,399.0,375.0,441.0,4831.0
Pithoragarh,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,482.0,537.0,553.0,587.0,677.0,629.0,538.0,545.0,647.0,658.0,621.0,684.0,7158.0
Pithoragarh,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,487.0,581.0,512.0,579.0,618.0,622.0,551.0,604.0,582.0,571.0,581.0,697.0,6985.0
Pithoragarh,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,378.0,421.0,437.0,437.0,448.0,448.0,433.0,433.0,441.0,382.0,396.0,474.0,5128.0
Pithoragarh,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,764.0,794.0,777.0,783.0,796.0,796.0,802.0,797.0,786.0,797.0,798.0,797.0,9487.0
Pithoragarh,10.4.2,Number of Immunisation sessions held during the month,TOTAL,670.0,693.0,682.0,692.0,693.0,706.0,701.0,693.0,696.0,714.0,712.0,692.0,8344.0
Pithoragarh,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,615.0,643.0,647.0,650.0,649.0,642.0,639.0,645.0,649.0,655.0,658.0,648.0,7740.0
Pithoragarh,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,0.0,0.0,0.0,339.0,535.0,500.0,605.0,608.0,529.0,480.0,616.0,4212.0
Pithoragarh,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,37.0,242.0,153.0,150.0,170.0,206.0,192.0,230.0,1380.0
Pithoragarh,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,124.0,145.0,136.0,157.0,190.0,201.0,178.0,226.0,1357.0
Pithoragarh,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,13.1,Number of Patients operated for cataract,TOTAL,912.0,1417.0,2001.0,2114.0,90.0,0.0,47.0,48.0,66.0,123.0,132.0,94.0,7044.0
Pithoragarh,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,55.0,91.0,105.0,85.0,90.0,0.0,45.0,48.0,66.0,123.0,132.0,1.0,841.0
Pithoragarh,13.3,Number of School children detected with Refractive errors,TOTAL,22.0,28.0,28.0,23.0,28.0,0.0,28.0,34.0,14.0,24.0,26.0,22.0,277.0
Pithoragarh,13.4,Number of children provided free glasses,TOTAL,6.0,5.0,8.0,1.0,8.0,0.0,0.0,3.0,5.0,1.0,2.0,1.0,40.0
Pithoragarh,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Pithoragarh,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Pithoragarh,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,2.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Pithoragarh,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,3.0,4.0,5.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,-1.0
Pithoragarh,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,394.0,427.0,422.0,445.0,422.0,434.0,424.0,430.0,437.0,438.0,435.0,423.0,-1.0
Pithoragarh,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,2.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Pithoragarh,14.05,Number of RKS meetings held during the month,TOTAL,3.0,2.0,2.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,24.0
Pithoragarh,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,6.0,6.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
Pithoragarh,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,1.0,-1.0
Pithoragarh,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Pithoragarh,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Pithoragarh,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Pithoragarh,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Pithoragarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,146.0,188.0,177.0,172.0,188.0,122.0,154.0,172.0,150.0,162.0,230.0,159.0,2020.0
Pithoragarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,650.0,745.0,815.0,609.0,642.0,255.0,517.0,446.0,603.0,558.0,578.0,619.0,7037.0
Pithoragarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,101.0,173.0,102.0,140.0,157.0,133.0,155.0,218.0,115.0,129.0,111.0,156.0,1690.0
Pithoragarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1410.0,1519.0,1261.0,1456.0,1475.0,942.0,1411.0,1135.0,1487.0,1390.0,1625.0,1385.0,16496.0
Pithoragarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,247.0,361.0,279.0,312.0,345.0,255.0,309.0,390.0,265.0,291.0,341.0,315.0,3710.0
Pithoragarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2060.0,2264.0,2076.0,2065.0,2117.0,1197.0,1928.0,1581.0,2090.0,1948.0,2203.0,2004.0,23533.0
Pithoragarh,14.10.2.a,Number of death cases of Inpatient males,TOTAL,16.0,10.0,13.0,16.0,12.0,4.0,15.0,14.0,20.0,13.0,12.0,13.0,158.0
Pithoragarh,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,3.0,10.0,9.0,2.0,0.0,14.0,13.0,7.0,3.0,6.0,7.0,80.0
Pithoragarh,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,22.0,13.0,23.0,25.0,14.0,4.0,29.0,27.0,27.0,16.0,18.0,20.0,238.0
Pithoragarh,14.11,In-Patient Head Count at midnight,TOTAL,5505.0,4645.0,4833.0,4678.0,5522.0,2294.0,5474.0,4813.0,4406.0,4468.0,4590.0,4162.0,55390.0
Pithoragarh,14.12.1,OPD attendance (All),TOTAL,30030.0,39310.0,41876.0,38209.0,43583.0,34079.0,39192.0,32662.0,34787.0,33056.0,35700.0,39284.0,441768.0
Pithoragarh,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,48.0,51.0,62.0,72.0,81.0,52.0,104.0,94.0,66.0,78.0,69.0,33.0,810.0
Pithoragarh,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,,,,,,,,,,,0.0
Pithoragarh,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Pithoragarh,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,172.0,182.0,178.0,192.0,211.0,164.0,241.0,182.0,165.0,145.0,170.0,133.0,2135.0
Pithoragarh,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Pithoragarh,14.14.a,Number of patients given AYUSH treatment,TOTAL,4901.0,4443.0,4032.0,4493.0,3952.0,2330.0,3330.0,3362.0,3667.0,3156.0,4231.0,4362.0,46259.0
Pithoragarh,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,355.0,593.0,278.0,312.0,333.0,207.0,299.0,221.0,164.0,223.0,267.0,289.0,3541.0
Pithoragarh,14.14.c,Number of Adolescents counselled,TOTAL,316.0,372.0,306.0,377.0,400.0,148.0,270.0,227.0,318.0,402.0,399.0,384.0,3919.0
Pithoragarh,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Pithoragarh,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,780.0,916.0,979.0,692.0,846.0,578.0,779.0,764.0,690.0,733.0,860.0,997.0,9614.0
Pithoragarh,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,14.0,8.0,15.0,13.0,15.0,8.0,14.0,10.0,13.0,70.0,9.0,23.0,212.0
Pithoragarh,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,152.0,207.0,264.0,171.0,203.0,20.0,116.0,62.0,143.0,176.0,146.0,172.0,1832.0
Pithoragarh,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,1.0,3.0,3.0,4.0,1.0,3.0,1.0,1.0,3.0,0.0,2.0,24.0
Pithoragarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,120.0,125.0,276.0,101.0,113.0,54.0,66.0,101.0,174.0,112.0,246.0,159.0,1647.0
Pithoragarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,4.0,2.0,1.0,1.0,1.0,0.0,1.0,3.0,0.0,0.0,14.0
Pithoragarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,202.0,218.0,174.0,274.0,302.0,238.0,187.0,197.0,237.0,276.0,257.0,246.0,2808.0
Pithoragarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Pithoragarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,474.0,550.0,714.0,546.0,618.0,312.0,369.0,360.0,554.0,564.0,649.0,577.0,6287.0
Pithoragarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,2.0,7.0,5.0,6.0,2.0,4.0,1.0,2.0,6.0,0.0,2.0,39.0
Pithoragarh,15.2,Number of Widal tests conducted,Number tested,257.0,264.0,171.0,269.0,269.0,159.0,10.0,110.0,53.0,55.0,97.0,211.0,1925.0
Pithoragarh,15.3.a,Number of VDRL tests conducted on males,Number tested,6.0,7.0,3.0,5.0,4.0,5.0,5.0,2.0,6.0,4.0,4.0,6.0,57.0
Pithoragarh,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,25.0,43.0,48.0,54.0,60.0,38.0,22.0,39.0,68.0,57.0,60.0,80.0,594.0
Pithoragarh,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,156.0,182.0,150.0,211.0,211.0,191.0,136.0,155.0,155.0,216.0,207.0,160.0,2130.0
Pithoragarh,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,187.0,232.0,201.0,270.0,275.0,234.0,163.0,196.0,229.0,277.0,271.0,246.0,2781.0
Pithoragarh,15.4.1,Number of blood smears examined for Malaria,TOTAL,587.0,277.0,300.0,245.0,288.0,199.0,223.0,201.0,156.0,175.0,164.0,224.0,3039.0
Pithoragarh,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1430.0,3060.0,4360.0,2690.0,5590.0,3190.0,1490.0,2720.0,,,,,24530.0
Pithoragarh,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2500.0,3000.0,,5000.0,,,3000.0,2500.0,,,,,16000.0
Pithoragarh,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,870.0,1700.0,1670.0,2100.0,2400.0,1700.0,1770.0,1780.0,,,,,13990.0
Pithoragarh,16.1.1,Stock position of DPT vaccines,5. Total Stock,3060.0,4360.0,2690.0,5590.0,3190.0,1490.0,2720.0,3440.0,0.0,0.0,0.0,0.0,26540.0
Pithoragarh,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,2770.0,3720.0,6510.0,3930.0,2020.0,2570.0,520.0,3420.0,,,,,25460.0
Pithoragarh,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,3000.0,5000.0,,,3700.0,,4500.0,2000.0,,,,,18200.0
Pithoragarh,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2050.0,2210.0,2580.0,1910.0,3150.0,2050.0,1600.0,2200.0,,,,,17750.0
Pithoragarh,16.1.1A,Stock Position of Pentavalent,5. Total Stock,3720.0,6510.0,3930.0,2020.0,2570.0,520.0,3420.0,3220.0,0.0,0.0,0.0,0.0,25910.0
Pithoragarh,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,4400.0,5800.0,5200.0,1000.0,4820.0,4320.0,820.0,3740.0,,,,,30100.0
Pithoragarh,16.1.2,Stock position of OPV vaccines,2. Stocks Received,4500.0,5000.0,,7000.0,6000.0,,7000.0,8000.0,,,,,37500.0
Pithoragarh,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,3100.0,5600.0,4200.0,3180.0,6500.0,3500.0,4080.0,4840.0,,,,,35000.0
Pithoragarh,16.1.2,Stock position of OPV vaccines,5. Total Stock,5800.0,5200.0,1000.0,4820.0,4320.0,820.0,3740.0,6900.0,0.0,0.0,0.0,0.0,32600.0
Pithoragarh,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4120.0,6820.0,8220.0,5160.0,10610.0,7530.0,4930.0,4780.0,,,,,52170.0
Pithoragarh,16.1.3,Stock position of TT vaccines,2. Stocks Received,5000.0,4000.0,,8000.0,,,2000.0,4000.0,,,,,23000.0
Pithoragarh,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2300.0,2600.0,3060.0,2550.0,3080.0,2600.0,2150.0,2700.0,,,,,21040.0
Pithoragarh,16.1.3,Stock position of TT vaccines,5. Total Stock,6820.0,8220.0,5160.0,10610.0,7530.0,4930.0,4780.0,6080.0,0.0,0.0,0.0,0.0,54130.0
Pithoragarh,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Pithoragarh,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Pithoragarh,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Pithoragarh,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1020.0,1750.0,3530.0,2310.0,1880.0,1340.0,270.0,1200.0,,,,,13300.0
Pithoragarh,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1500.0,3000.0,,500.0,700.0,,2000.0,2000.0,,,,,9700.0
Pithoragarh,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,770.0,1220.0,1220.0,930.0,1240.0,1070.0,1070.0,1300.0,,,,,8820.0
Pithoragarh,16.1.5,Stock position of BCG vaccines,5. Total Stock,1750.0,3530.0,2310.0,1880.0,1340.0,270.0,1200.0,1900.0,0.0,0.0,0.0,0.0,14180.0
Pithoragarh,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2150.0,3425.0,4025.0,2475.0,3710.0,1735.0,310.0,2610.0,,,,,20440.0
Pithoragarh,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2500.0,2000.0,,2500.0,350.0,,3250.0,2750.0,,,,,13350.0
Pithoragarh,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1225.0,1400.0,1550.0,1265.0,2325.0,1425.0,950.0,1950.0,,,,,12090.0
Pithoragarh,16.1.6,Stock position of Measles vaccines,5. Total Stock,3425.0,4025.0,2475.0,3710.0,1735.0,310.0,2610.0,3410.0,0.0,0.0,0.0,0.0,21700.0
Pithoragarh,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Pithoragarh,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Pithoragarh,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Pithoragarh,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,920.0,1560.0,4260.0,3860.0,5010.0,4310.0,3840.0,3190.0,,,,,26950.0
Pithoragarh,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1500.0,3000.0,,1800.0,,,,,,,,,6300.0
Pithoragarh,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,860.0,300.0,400.0,650.0,700.0,470.0,650.0,400.0,,,,,4430.0
Pithoragarh,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1560.0,4260.0,3860.0,5010.0,4310.0,3840.0,3190.0,2790.0,0.0,0.0,0.0,0.0,28820.0
Pithoragarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,200.0,,,800.0,,,,,1000.0
Pithoragarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,1200.0,,,1800.0,,,,,,3000.0
Pithoragarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,1000.0,200.0,,1000.0,800.0,,,,,3000.0
Pithoragarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,200.0,0.0,0.0,800.0,0.0,0.0,0.0,0.0,0.0,1000.0
Pithoragarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,12000.0,,,,20106.0,,,,,,,,32106.0
Pithoragarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,,,151200.0,,,,,,,,,151200.0
Pithoragarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,12000.0,,,131040.0,20106.0,,,,,,,,163146.0
Pithoragarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,20160.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20160.0
Pithoragarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,2400.0,,,200.0,,,,,2600.0
Pithoragarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,18000.0,,,1800.0,,,,,,19800.0
Pithoragarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,15600.0,2400.0,,1600.0,200.0,,,,,19800.0
Pithoragarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,2400.0,0.0,0.0,200.0,0.0,0.0,0.0,0.0,0.0,2600.0
Pithoragarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Pithoragarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Pithoragarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Pithoragarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,1000.0,900.0,900.0,900.0,,,,,3700.0
Pithoragarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,1000.0,,,,,,,,,1000.0
Pithoragarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,100.0,,,900.0,,,,,1000.0
Pithoragarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,1000.0,900.0,900.0,900.0,0.0,0.0,0.0,0.0,0.0,3700.0
Pithoragarh,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Pithoragarh,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Pithoragarh,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Pithoragarh,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,2500.0,1000.0,300.0,,,,3600.0,2400.0,,,,,9800.0
Pithoragarh,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,4000.0,,,,,,,4000.0
Pithoragarh,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.3.02,Stock Position of Gloves,4. Stock Distributed,1500.0,700.0,300.0,,,400.0,1200.0,2200.0,,,,,6300.0
Pithoragarh,16.3.02,Stock Position of Gloves,5. Total Stock,1000.0,300.0,0.0,0.0,0.0,3600.0,2400.0,200.0,0.0,0.0,0.0,0.0,7500.0
Pithoragarh,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,1900.0,700.0,700.0,,,,,,,,,,3300.0
Pithoragarh,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Pithoragarh,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,1200.0,,700.0,,,,,,,,,,1900.0
Pithoragarh,16.3.03,Stock Position of MVA Syringes,5. Total Stock,700.0,700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1400.0
Pithoragarh,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,11000.0,,,,,,,,,,,,11000.0
Pithoragarh,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Pithoragarh,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,6000.0,,,,,,,,,,,,6000.0
Pithoragarh,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
Pithoragarh,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Pithoragarh,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Pithoragarh,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Pithoragarh,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Pithoragarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Pithoragarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Pithoragarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,68000.0,46000.0,10000.0,90000.0,33000.0,3824104.0,3000.0,,,,,,4074104.0
Pithoragarh,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,100000.0,200000.0,3806104.0,,,,,,,,4106104.0
Pithoragarh,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,22000.0,36000.0,20000.0,257000.0,15000.0,3821104.0,3000.0,,,,,,4174104.0
Pithoragarh,16.3.07,Stock Position of IFA Tablets,5. Total Stock,46000.0,10000.0,90000.0,33000.0,3824104.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,4006104.0
Pithoragarh,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Pithoragarh,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Pithoragarh,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Pithoragarh,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Pithoragarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Pithoragarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Pithoragarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pithoragarh,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,100.0,100.0,,,,,,200.0
Pithoragarh,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,1000.0,,,,,,,,1000.0
Pithoragarh,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,900.0,,100.0,,,,,,1000.0
Pithoragarh,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,100.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0
Pithoragarh,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,50700.0,13500.0,14500.0,11500.0,11500.0,,,,,101700.0
Pithoragarh,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,50700.0,30000.0,4000.0,,,,,,,,84700.0
Pithoragarh,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,67200.0,3000.0,3000.0,,3000.0,,,,,76200.0
Pithoragarh,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,50700.0,13500.0,14500.0,11500.0,11500.0,8500.0,0.0,0.0,0.0,0.0,110200.0
Pithoragarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1900.0,700.0,6000.0,3400.0,2600.0,1000.0,400.0,,,,,,16000.0
Pithoragarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,6000.0,,,,,,,,,,,6000.0
Pithoragarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1200.0,700.0,2600.0,800.0,1600.0,600.0,400.0,,,,,,7900.0
Pithoragarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,700.0,6000.0,3400.0,2600.0,1000.0,400.0,0.0,0.0,0.0,0.0,0.0,0.0,14100.0
Pithoragarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,11000.0,5000.0,55000.0,43200.0,39600.0,35100.0,30600.0,29700.0,,,,,249200.0
Pithoragarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,54000.0,,,,,,,,,,,54000.0
Pithoragarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,6000.0,4000.0,11800.0,3600.0,4500.0,4500.0,900.0,8700.0,,,,,44000.0
Pithoragarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,5000.0,55000.0,43200.0,39600.0,35100.0,30600.0,29700.0,21000.0,0.0,0.0,0.0,0.0,259200.0
Pithoragarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4350.0,4350.0,8000.0,8000.0,8000.0,8000.0,8000.0,8000.0,,,,,56700.0
Pithoragarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,4000.0,,,,,,,,,,,4000.0
Pithoragarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Pithoragarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,350.0,,,,,,700.0,,,,,1050.0
Pithoragarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4350.0,8000.0,8000.0,8000.0,8000.0,8000.0,8000.0,7300.0,0.0,0.0,0.0,0.0,59650.0
Pithoragarh,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,,,,,1.0,1.0,,,,,,4.0
Pithoragarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,,,1.0
Pithoragarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,1.0,,,,2.0
Pithoragarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,1.0,1.0,1.0,,,3.0
Pithoragarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,3.0,,,1.0,,1.0,1.0,1.0,,1.0,8.0
Pithoragarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Pithoragarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,3.0,,,1.0,,1.0,1.0,1.0,,1.0,8.0
Pithoragarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,,,,,1.0,2.0,1.0,1.0,1.0,3.0,10.0
Pithoragarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Pithoragarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,,,,,2.0,2.0,1.0,1.0,1.0,3.0,11.0
Pithoragarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Pithoragarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Pithoragarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Pithoragarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Pithoragarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,1.0,,,1.0,1.0,,,,,3.0
Pithoragarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,,,2.0,1.0,,,,,4.0
Pithoragarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Pithoragarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pithoragarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Pithoragarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Pithoragarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Pithoragarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,1.0,,,,,,,,1.0
Pithoragarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Pithoragarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pithoragarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Pithoragarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,1.0,,,,,,,1.0
Pithoragarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Pithoragarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,1.0,,,,,,,1.0
Pithoragarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Pithoragarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Pithoragarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,,,,,1.0,,2.0,,1.0,5.0
Pithoragarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,,1.0,3.0,1.0,,1.0,1.0,,,,8.0
Pithoragarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,2.0,,1.0,3.0,1.0,,2.0,1.0,2.0,,1.0,13.0
Pithoragarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Pithoragarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,1.0,,,,,1.0,,,3.0
Pithoragarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,2.0,,,,,,,,2.0
Pithoragarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,1.0,3.0,,,,,1.0,,,5.0
Pithoragarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Pithoragarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,1.0,2.0,2.0,3.0,4.0,,1.0,1.0,2.0,4.0,,21.0
Pithoragarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,,1.0,2.0,1.0,,,,,,,5.0
Pithoragarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,1.0,2.0,3.0,5.0,5.0,,1.0,1.0,2.0,4.0,,26.0
Pithoragarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,3.0,1.0,,3.0,6.0,2.0,,,,,1.0,16.0
Pithoragarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,3.0,1.0,,3.0,6.0,2.0,,,,,1.0,16.0
Pithoragarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Pithoragarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Pithoragarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Pithoragarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Pithoragarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Pithoragarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,,,2.0,1.0,,1.0,,,,5.0
Pithoragarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,,,2.0,1.0,,1.0,,,,5.0
Pithoragarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,1.0,,,1.0,2.0,,,1.0,2.0,,,8.0
Pithoragarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,1.0,1.0,,,,,1.0,,4.0
Pithoragarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,1.0,,1.0,2.0,3.0,,,1.0,2.0,1.0,,12.0
Pithoragarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,3.0,,,1.0,,,,,,1.0,5.0
Pithoragarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,3.0,,,1.0,,,,,,1.0,5.0
Pithoragarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Pithoragarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Pithoragarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,,,1.0,1.0,,1.0,1.0,,,,5.0
Pithoragarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,2.0,,1.0,1.0,1.0,4.0,2.0,,11.0
Pithoragarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,,,3.0,1.0,1.0,2.0,2.0,4.0,2.0,,16.0
Pithoragarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,1.0,1.0,1.0,,1.0,,1.0,3.0,1.0,9.0
Pithoragarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,3.0,3.0,2.0,5.0,6.0,2.0,8.0,5.0,9.0,12.0,8.0,,63.0
Pithoragarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,3.0,2.0,6.0,7.0,3.0,8.0,6.0,9.0,13.0,11.0,1.0,72.0
Pithoragarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Pithoragarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,2.0,,,,3.0,2.0,3.0,1.0,1.0,,12.0
Pithoragarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,6.0,10.0,4.0,4.0,4.0,6.0,2.0,5.0,4.0,3.0,5.0,3.0,56.0
Pithoragarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,6.0,10.0,6.0,4.0,4.0,6.0,5.0,7.0,7.0,4.0,6.0,3.0,68.0
Rudraprayag,1.1,Total number of pregnant women Registered for ANC,TOTAL,416.0,456.0,407.0,403.0,440.0,344.0,310.0,289.0,347.0,355.0,407.0,382.0,4556.0
Rudraprayag,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,259.0,233.0,233.0,264.0,253.0,207.0,206.0,172.0,210.0,217.0,244.0,214.0,2712.0
Rudraprayag,1.2,Number of Pregnant women registered under JSY,TOTAL,416.0,456.0,407.0,403.0,434.0,344.0,310.0,289.0,349.0,355.0,407.0,382.0,4552.0
Rudraprayag,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,257.0,287.0,281.0,313.0,316.0,359.0,335.0,314.0,320.0,276.0,291.0,269.0,3618.0
Rudraprayag,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,366.0,396.0,350.0,360.0,392.0,304.0,280.0,240.0,284.0,308.0,357.0,326.0,3963.0
Rudraprayag,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,334.0,404.0,403.0,350.0,412.0,386.0,315.0,294.0,265.0,314.0,298.0,349.0,4124.0
Rudraprayag,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,84.0,122.0,211.0,327.0,266.0,190.0,160.0,138.0,153.0,213.0,228.0,221.0,2313.0
Rudraprayag,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,4.0,9.0,1.0,1.0,0.0,5.0,4.0,0.0,1.0,1.0,0.0,26.0
Rudraprayag,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,122.0,117.0,126.0,166.0,96.0,120.0,99.0,67.0,73.0,97.0,120.0,107.0,1310.0
Rudraprayag,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Rudraprayag,1.8,Number of pregnancy test kits used at SC level,TOTAL,337.0,384.0,309.0,306.0,281.0,248.0,215.0,166.0,208.0,226.0,256.0,231.0,3167.0
Rudraprayag,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,47.0,31.0,42.0,49.0,88.0,89.0,60.0,56.0,58.0,69.0,41.0,37.0,667.0
Rudraprayag,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,5.0,3.0,1.0,19.0,16.0,24.0,14.0,8.0,11.0,12.0,20.0,17.0,150.0
Rudraprayag,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,52.0,34.0,43.0,68.0,104.0,113.0,74.0,64.0,69.0,81.0,61.0,54.0,817.0
Rudraprayag,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,31.0,22.0,29.0,29.0,63.0,71.0,29.0,39.0,35.0,51.0,36.0,30.0,465.0
Rudraprayag,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,13.0,11.0,6.0,19.0,30.0,34.0,31.0,10.0,2.0,8.0,21.0,10.0,195.0
Rudraprayag,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,141.0,131.0,104.0,183.0,216.0,197.0,183.0,154.0,139.0,137.0,180.0,154.0,1919.0
Rudraprayag,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,141.0,131.0,104.0,183.0,216.0,197.0,183.0,154.0,149.0,137.0,180.0,154.0,1929.0
Rudraprayag,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,141.0,131.0,105.0,183.0,216.0,197.0,176.0,154.0,139.0,137.0,180.0,154.0,1913.0
Rudraprayag,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,107.0,93.0,72.0,92.0,104.0,135.0,112.0,92.0,94.0,102.0,130.0,124.0,1257.0
Rudraprayag,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Rudraprayag,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Rudraprayag,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Rudraprayag,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Rudraprayag,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Rudraprayag,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Rudraprayag,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,,,,,0.0,0.0,0.0,0.0,0.0,10.0,1.0,11.0
Rudraprayag,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rudraprayag,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,,,,,0.0,0.0,0.0,0.0,0.0,10.0,1.0,11.0
Rudraprayag,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Rudraprayag,4.1.1.a,Number of male live births,TOTAL,90.0,76.0,60.0,130.0,165.0,167.0,133.0,109.0,97.0,103.0,111.0,107.0,1348.0
Rudraprayag,4.1.1.b,Number of female live births,TOTAL,101.0,88.0,87.0,117.0,152.0,140.0,123.0,107.0,109.0,114.0,122.0,101.0,1361.0
Rudraprayag,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,191.0,164.0,147.0,247.0,317.0,307.0,256.0,216.0,206.0,217.0,233.0,208.0,2709.0
Rudraprayag,4.1.2,Number of still births,TOTAL,3.0,1.0,1.0,4.0,3.0,3.0,1.0,2.0,5.0,1.0,7.0,2.0,33.0
Rudraprayag,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,4.0,10.0
Rudraprayag,4.2.1,Number of Newborns weighed at birth,TOTAL,192.0,164.0,148.0,247.0,317.0,308.0,247.0,214.0,197.0,217.0,235.0,208.0,2694.0
Rudraprayag,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,29.0,19.0,18.0,15.0,53.0,11.0,31.0,26.0,19.0,17.0,10.0,7.0,255.0
Rudraprayag,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,192.0,164.0,148.0,247.0,317.0,302.0,243.0,214.0,197.0,217.0,235.0,208.0,2684.0
Rudraprayag,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Rudraprayag,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,,,2.0,2.0,,,,,,11.0,2.0,17.0
Rudraprayag,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rudraprayag,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,11.0,2.0,17.0
Rudraprayag,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Rudraprayag,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,,,2.0,2.0,,,0.0,0.0,0.0,11.0,2.0,17.0
Rudraprayag,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,,,,,,,0.0,0.0,0.0,10.0,2.0,12.0
Rudraprayag,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,,,2.0,2.0,,,0.0,0.0,0.0,11.0,2.0,17.0
Rudraprayag,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,161.0,143.0,115.0,133.0,182.0,187.0,160.0,123.0,125.0,143.0,188.0,131.0,1791.0
Rudraprayag,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,86.0,123.0,95.0,117.0,170.0,190.0,119.0,97.0,89.0,124.0,97.0,111.0,1418.0
Rudraprayag,6.3,PNC maternal complications attended,TOTAL,1.0,0.0,0.0,3.0,6.0,7.0,4.0,2.0,6.0,2.0,2.0,3.0,36.0
Rudraprayag,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,3.0,8.0
Rudraprayag,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0
Rudraprayag,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,4.0,10.0
Rudraprayag,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,3.0,6.0,8.0,1.0,5.0,12.0,0.0,3.0,1.0,0.0,1.0,1.0,41.0
Rudraprayag,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,66.0,87.0,117.0,60.0,88.0,70.0,61.0,62.0,13.0,35.0,17.0,20.0,696.0
Rudraprayag,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,69.0,93.0,125.0,61.0,93.0,82.0,61.0,65.0,14.0,35.0,18.0,21.0,737.0
Rudraprayag,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Rudraprayag,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Rudraprayag,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,4.0
Rudraprayag,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,226.0,226.0
Rudraprayag,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,51.0,19.0,2.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,121.0,377.0,575.0
Rudraprayag,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0,25.0
Rudraprayag,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,51.0,19.0,2.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,121.0,628.0,826.0
Rudraprayag,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,184.0,203.0,198.0,213.0,217.0,214.0,222.0,208.0,244.0,240.0,253.0,185.0,2581.0
Rudraprayag,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,6.0,12.0,0.0,25.0
Rudraprayag,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,5.0,6.0,4.0,7.0,6.0,5.0,6.0,7.0,7.0,11.0,12.0,5.0,81.0
Rudraprayag,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,11.0,6.0,4.0,12.0,15.0,15.0,,13.0,11.0,13.0,14.0,9.0,123.0
Rudraprayag,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,200.0,215.0,206.0,232.0,238.0,234.0,228.0,228.0,269.0,270.0,291.0,199.0,2810.0
Rudraprayag,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,13.0,11.0,8.0,17.0,17.0,17.0,20.0,21.0,17.0,16.0,23.0,9.0,189.0
Rudraprayag,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Rudraprayag,9.06,Number of IUCD removals,TOTAL,48.0,66.0,66.0,67.0,71.0,71.0,68.0,59.0,75.0,90.0,104.0,91.0,876.0
Rudraprayag,9.07,Number of Oral Pills cycles distributed,TOTAL,764.0,927.0,917.0,860.0,898.0,861.0,930.0,1024.0,993.0,1012.0,1023.0,1130.0,11339.0
Rudraprayag,9.08,Number of Condom pieces distributed,TOTAL,13250.0,12070.0,10995.0,12910.0,13560.0,13759.0,13949.0,14770.0,17973.0,14520.0,14300.0,13460.0,165516.0
Rudraprayag,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Rudraprayag,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,20.0,26.0,36.0,21.0,14.0,96.0,71.0,36.0,34.0,26.0,31.0,227.0,638.0
Rudraprayag,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Rudraprayag,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,255.0,228.0,220.0,267.0,316.0,423.0,369.0,331.0,356.0,365.0,272.0,330.0,3732.0
Rudraprayag,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,40.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,46.0
Rudraprayag,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,96.0,24.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,120.0
Rudraprayag,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,120.0,84.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,209.0
Rudraprayag,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,272.0,305.0,293.0,244.0,289.0,372.0,433.0,378.0,399.0,355.0,340.0,280.0,3960.0
Rudraprayag,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,178.0,306.0,302.0,304.0,247.0,302.0,379.0,446.0,392.0,385.0,343.0,345.0,3929.0
Rudraprayag,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,228.0,216.0,329.0,317.0,300.0,250.0,299.0,382.0,428.0,408.0,370.0,332.0,3859.0
Rudraprayag,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,259.0,267.0,232.0,332.0,393.0,490.0,417.0,386.0,387.0,406.0,321.0,346.0,4236.0
Rudraprayag,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,311.0,311.0,288.0,235.0,289.0,372.0,431.0,370.0,399.0,355.0,340.0,280.0,3981.0
Rudraprayag,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,271.0,333.0,304.0,295.0,247.0,302.0,381.0,446.0,395.0,385.0,343.0,345.0,4047.0
Rudraprayag,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,354.0,298.0,333.0,310.0,300.0,250.0,299.0,386.0,428.0,405.0,370.0,332.0,4065.0
Rudraprayag,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,79.0,110.0,95.0,141.0,161.0,218.0,173.0,150.0,145.0,180.0,138.0,210.0,1800.0
Rudraprayag,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,45.0,6.0,0.0,0.0,0.0,9.0,12.0,0.0,0.0,0.0,0.0,18.0,90.0
Rudraprayag,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,105.0,32.0,0.0,0.0,0.0,3.0,12.0,0.0,0.0,0.0,0.0,29.0,181.0
Rudraprayag,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,128.0,94.0,10.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,20.0,256.0
Rudraprayag,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,309.0,386.0,351.0,347.0,330.0,340.0,323.0,306.0,324.0,353.0,251.0,299.0,3919.0
Rudraprayag,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,359.0,347.0,346.0,351.0,350.0,324.0,301.0,285.0,321.0,401.0,380.0,341.0,4106.0
Rudraprayag,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,158.0,195.0,168.0,168.0,157.0,171.0,151.0,166.0,153.0,189.0,134.0,160.0,1970.0
Rudraprayag,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,148.0,191.0,168.0,170.0,170.0,171.0,166.0,140.0,141.0,167.0,110.0,139.0,1881.0
Rudraprayag,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,306.0,386.0,336.0,338.0,327.0,342.0,317.0,306.0,294.0,356.0,244.0,299.0,3851.0
Rudraprayag,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,376.0,350.0,352.0,363.0,353.0,327.0,338.0,289.0,365.0,400.0,379.0,364.0,4256.0
Rudraprayag,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,376.0,350.0,352.0,363.0,353.0,327.0,336.0,289.0,365.0,400.0,379.0,364.0,4254.0
Rudraprayag,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,96.0,98.0,97.0,95.0,88.0,93.0,74.0,96.0,0.0,0.0,0.0,737.0
Rudraprayag,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,78.0,71.0,91.0,94.0,72.0,67.0,63.0,95.0,0.0,0.0,0.0,631.0
Rudraprayag,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,174.0,169.0,188.0,189.0,160.0,160.0,137.0,191.0,0.0,0.0,0.0,1368.0
Rudraprayag,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,338.0,357.0,357.0,370.0,399.0,387.0,411.0,390.0,438.0,452.0,376.0,353.0,4628.0
Rudraprayag,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,320.0,368.0,350.0,381.0,369.0,394.0,453.0,413.0,476.0,420.0,392.0,336.0,4672.0
Rudraprayag,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,291.0,337.0,341.0,331.0,368.0,327.0,398.0,394.0,459.0,404.0,370.0,317.0,4337.0
Rudraprayag,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,1.0,,1.0,,1.0,1.0,0.0,0.0,0.0,4.0
Rudraprayag,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,5.0,,2.0,4.0,,7.0,12.0,7.0,6.0,3.0,1.0,2.0,49.0
Rudraprayag,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,645.0,647.0,622.0,636.0,645.0,654.0,709.0,708.0,718.0,663.0,676.0,674.0,7997.0
Rudraprayag,10.4.2,Number of Immunisation sessions held during the month,TOTAL,545.0,568.0,520.0,522.0,535.0,545.0,601.0,610.0,644.0,563.0,575.0,562.0,6790.0
Rudraprayag,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,501.0,530.0,493.0,502.0,515.0,520.0,588.0,539.0,612.0,553.0,532.0,537.0,6422.0
Rudraprayag,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
Rudraprayag,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,295.0,266.0,277.0,362.0,332.0,336.0,334.0,319.0,339.0,328.0,236.0,274.0,3698.0
Rudraprayag,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,168.0,143.0,148.0,525.0,474.0,457.0,419.0,367.0,452.0,506.0,447.0,379.0,4485.0
Rudraprayag,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,124.0,105.0,76.0,214.0,302.0,374.0,398.0,419.0,430.0,449.0,389.0,356.0,3636.0
Rudraprayag,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,3.0,,34.0,33.0,29.0,10.0,28.0,14.0,21.0,2.0,2.0,4.0,180.0
Rudraprayag,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
Rudraprayag,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,,1.0,,1.0,,,,,,,,-1.0
Rudraprayag,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,1.0,,,,,,1.0,,,,,-1.0
Rudraprayag,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,470.0,531.0,514.0,517.0,502.0,510.0,512.0,504.0,537.0,524.0,524.0,537.0,-1.0
Rudraprayag,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Rudraprayag,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,12.0
Rudraprayag,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3.0,3.0,2.0,2.0,2.0,2.0,2.0,3.0,2.0,2.0,2.0,2.0,-1.0
Rudraprayag,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,10.0,12.0,14.0,23.0,14.0,14.0,15.0,15.0,14.0,16.0,8.0,11.0,166.0
Rudraprayag,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Rudraprayag,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Rudraprayag,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Rudraprayag,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Rudraprayag,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Rudraprayag,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,109.0,74.0,53.0,69.0,73.0,71.0,49.0,49.0,54.0,59.0,64.0,69.0,793.0
Rudraprayag,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,97.0,223.0,253.0,148.0,167.0,161.0,116.0,86.0,90.0,86.0,118.0,275.0,1820.0
Rudraprayag,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,177.0,95.0,66.0,76.0,95.0,69.0,43.0,62.0,59.0,66.0,77.0,59.0,944.0
Rudraprayag,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,149.0,285.0,280.0,221.0,219.0,223.0,193.0,141.0,102.0,134.0,182.0,413.0,2542.0
Rudraprayag,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,286.0,169.0,119.0,145.0,168.0,140.0,92.0,111.0,113.0,125.0,141.0,128.0,1737.0
Rudraprayag,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,246.0,508.0,533.0,369.0,386.0,384.0,309.0,227.0,192.0,220.0,300.0,688.0,4362.0
Rudraprayag,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,1.0,0.0,0.0,4.0
Rudraprayag,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0
Rudraprayag,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,1.0,2.0,0.0,0.0,6.0
Rudraprayag,14.11,In-Patient Head Count at midnight,TOTAL,494.0,596.0,495.0,441.0,475.0,436.0,343.0,308.0,268.0,224.0,382.0,604.0,5066.0
Rudraprayag,14.12.1,OPD attendance (All),TOTAL,13708.0,18439.0,16405.0,15757.0,18454.0,17100.0,14941.0,13163.0,13875.0,14115.0,15971.0,14657.0,186585.0
Rudraprayag,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,21.0,26.0,19.0,17.0,14.0,8.0,19.0,14.0,14.0,18.0,15.0,19.0,204.0
Rudraprayag,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,1.0,11.0
Rudraprayag,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Rudraprayag,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,57.0,45.0,16.0,18.0,29.0,30.0,29.0,23.0,20.0,32.0,142.0,175.0,616.0
Rudraprayag,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Rudraprayag,14.14.a,Number of patients given AYUSH treatment,TOTAL,977.0,1013.0,1025.0,953.0,939.0,781.0,785.0,685.0,652.0,726.0,717.0,572.0,9825.0
Rudraprayag,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,133.0,279.0,338.0,243.0,288.0,259.0,226.0,198.0,167.0,144.0,131.0,209.0,2615.0
Rudraprayag,14.14.c,Number of Adolescents counselled,TOTAL,77.0,85.0,110.0,104.0,80.0,73.0,73.0,65.0,7.0,50.0,46.0,35.0,805.0
Rudraprayag,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Rudraprayag,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,568.0,672.0,854.0,905.0,844.0,652.0,542.0,374.0,524.0,517.0,578.0,553.0,7583.0
Rudraprayag,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,5.0,5.0,3.0,5.0,5.0,2.0,3.0,3.0,1.0,6.0,7.0,112.0,157.0
Rudraprayag,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,59.0,111.0,60.0,95.0,60.0,60.0,56.0,50.0,49.0,72.0,42.0,46.0,760.0
Rudraprayag,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1.0,1.0,1.0,1.0,8.0
Rudraprayag,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,85.0,191.0,71.0,103.0,97.0,108.0,82.0,64.0,87.0,72.0,57.0,48.0,1065.0
Rudraprayag,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,3.0,0.0,3.0,0.0,10.0
Rudraprayag,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,204.0,343.0,131.0,284.0,230.0,173.0,155.0,129.0,183.0,170.0,213.0,191.0,2406.0
Rudraprayag,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,348.0,645.0,262.0,482.0,387.0,341.0,293.0,243.0,319.0,314.0,312.0,285.0,4231.0
Rudraprayag,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,0.0,0.0,1.0,0.0,3.0,1.0,0.0,4.0,1.0,4.0,1.0,18.0
Rudraprayag,15.2,Number of Widal tests conducted,Number tested,76.0,73.0,143.0,214.0,192.0,293.0,191.0,48.0,64.0,38.0,73.0,75.0,1480.0
Rudraprayag,15.3.a,Number of VDRL tests conducted on males,Number tested,0.0,53.0,2.0,0.0,0.0,,0.0,0.0,0.0,0.0,1.0,0.0,56.0
Rudraprayag,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,1.0,2.0,0.0,0.0,2.0,,0.0,0.0,0.0,0.0,0.0,1.0,6.0
Rudraprayag,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,193.0,221.0,273.0,272.0,219.0,153.0,125.0,106.0,141.0,173.0,205.0,178.0,2259.0
Rudraprayag,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,194.0,276.0,275.0,272.0,221.0,153.0,125.0,106.0,141.0,173.0,206.0,179.0,2321.0
Rudraprayag,15.4.1,Number of blood smears examined for Malaria,TOTAL,232.0,284.0,185.0,292.0,295.0,358.0,283.0,205.0,239.0,331.0,224.0,247.0,3175.0
Rudraprayag,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,2.0,1.0,1.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Rudraprayag,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0,0.0,1.0,0.0,0.0,5.0
Rudraprayag,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2400.0,1150.0,,,1250.0,1610.0,3220.0,2900.0,2600.0,1100.0,2510.0,1310.0,20050.0
Rudraprayag,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2400.0,2000.0,,,2000.0,2000.0,1500.0,1000.0,,2000.0,1000.0,1000.0,14900.0
Rudraprayag,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1250.0,1800.0,,,1640.0,390.0,1320.0,1300.0,1500.0,510.0,2200.0,380.0,12290.0
Rudraprayag,16.1.1,Stock position of DPT vaccines,5. Total Stock,3550.0,1350.0,0.0,0.0,1610.0,3220.0,3400.0,2600.0,1100.0,2590.0,1310.0,1930.0,22660.0
Rudraprayag,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,2110.0,1610.0,,,1000.0,1430.0,2570.0,3420.0,3420.0,1820.0,2160.0,1510.0,21050.0
Rudraprayag,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2110.0,2000.0,,,2000.0,2000.0,2000.0,1000.0,,2000.0,120.0,1200.0,14430.0
Rudraprayag,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,500.0,1410.0,,,1660.0,860.0,850.0,1000.0,1600.0,1660.0,1850.0,380.0,11770.0
Rudraprayag,16.1.1A,Stock Position of Pentavalent,5. Total Stock,3720.0,2200.0,0.0,0.0,1340.0,2570.0,3720.0,3420.0,1820.0,2160.0,430.0,2330.0,23710.0
Rudraprayag,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,5400.0,3400.0,,,1400.0,2860.0,3940.0,2280.0,4680.0,1880.0,3020.0,0.0,28860.0
Rudraprayag,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5400.0,6000.0,,,2000.0,4000.0,2000.0,4000.0,,50300.0,30000.0,2500.0,106200.0
Rudraprayag,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2000.0,3920.0,,,2540.0,2920.0,3660.0,1600.0,2800.0,47160.0,33020.0,1700.0,101320.0
Rudraprayag,16.1.2,Stock position of OPV vaccines,5. Total Stock,8800.0,5480.0,0.0,0.0,860.0,3940.0,2280.0,4680.0,1880.0,5020.0,0.0,800.0,33740.0
Rudraprayag,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2560.0,3310.0,,,1800.0,1620.0,3790.0,3820.0,3820.0,13200.0,1520.0,2220.0,37660.0
Rudraprayag,16.1.3,Stock position of TT vaccines,2. Stocks Received,4560.0,3000.0,,,2000.0,3000.0,1000.0,1000.0,,2000.0,3000.0,1000.0,20560.0
Rudraprayag,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1250.0,2200.0,,,1980.0,830.0,,1000.0,2500.0,1800.0,2300.0,510.0,14370.0
Rudraprayag,16.1.3,Stock position of TT vaccines,5. Total Stock,5870.0,4110.0,0.0,0.0,1820.0,3790.0,4790.0,3820.0,1320.0,13400.0,2220.0,2710.0,43850.0
Rudraprayag,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rudraprayag,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Rudraprayag,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rudraprayag,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2940.0,1940.0,,,1430.0,2050.0,1850.0,2350.0,2850.0,2250.0,1860.0,2170.0,21690.0
Rudraprayag,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2940.0,1000.0,,,1000.0,,1500.0,1000.0,,1000.0,1000.0,,9440.0
Rudraprayag,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1000.0,270.0,,,380.0,200.0,1670.0,500.0,600.0,1390.0,690.0,220.0,6920.0
Rudraprayag,16.1.5,Stock position of BCG vaccines,5. Total Stock,4880.0,2670.0,0.0,0.0,2050.0,1850.0,1680.0,2850.0,2250.0,1860.0,2170.0,1950.0,24210.0
Rudraprayag,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1450.0,1200.0,,,280.0,375.0,1630.0,2345.0,2645.0,1645.0,1740.0,1530.0,14840.0
Rudraprayag,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1950.0,1000.0,,,1000.0,2000.0,1500.0,1250.0,,1000.0,1000.0,500.0,11200.0
Rudraprayag,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,750.0,1235.0,,,905.0,745.0,785.0,950.0,1000.0,905.0,1210.0,235.0,8720.0
Rudraprayag,16.1.6,Stock position of Measles vaccines,5. Total Stock,2650.0,965.0,0.0,0.0,375.0,1630.0,2345.0,2645.0,1645.0,1740.0,1530.0,1795.0,17320.0
Rudraprayag,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rudraprayag,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Rudraprayag,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rudraprayag,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2230.0,1630.0,,,1450.0,1410.0,1370.0,1000.0,1000.0,900.0,830.0,800.0,12620.0
Rudraprayag,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2230.0,1200.0,,,,,,,,,,,3430.0
Rudraprayag,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,600.0,540.0,,,40.0,40.0,370.0,,100.0,70.0,30.0,50.0,1840.0
Rudraprayag,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3860.0,2290.0,0.0,0.0,1410.0,1370.0,1000.0,1000.0,900.0,830.0,800.0,750.0,14210.0
Rudraprayag,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,350.0,950.0,850.0,850.0,600.0,1100.0,500.0,1100.0,600.0,600.0,400.0,300.0,8200.0
Rudraprayag,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,1200.0,,,,1200.0,,600.0,,,,,600.0,3600.0
Rudraprayag,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,100.0,,250.0,700.0,600.0,,500.0,,200.0,100.0,,3050.0
Rudraprayag,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,950.0,850.0,850.0,600.0,1100.0,500.0,1100.0,600.0,600.0,400.0,300.0,900.0,8750.0
Rudraprayag,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,25200.0,20160.0,9360.0,,,,30240.0,5040.0,35280.0,15120.0,9720.0,150120.0
Rudraprayag,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,50400.0,,,,25200.0,,30240.0,,30240.0,,,13140.0,149220.0
Rudraprayag,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,25200.0,5040.0,10800.0,9360.0,25200.0,,,25200.0,,20160.0,5400.0,360.0,126720.0
Rudraprayag,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,25200.0,20160.0,9360.0,0.0,0.0,0.0,30240.0,5040.0,35280.0,15120.0,9720.0,22500.0,172620.0
Rudraprayag,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,2000.0,2000.0,1000.0,,1100.0,1100.0,2900.0,1100.0,4100.0,3500.0,2900.0,21700.0
Rudraprayag,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,5000.0,,,,3000.0,,1800.0,,3000.0,,,1800.0,14600.0
Rudraprayag,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,3000.0,,1000.0,1000.0,1900.0,,,1800.0,,600.0,600.0,,9900.0
Rudraprayag,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2000.0,2000.0,1000.0,0.0,1100.0,1100.0,2900.0,1100.0,4100.0,3500.0,2900.0,4700.0,26400.0
Rudraprayag,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,100.0,50.0,50.0,50.0,100.0,100.0,100.0,550.0
Rudraprayag,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,600.0,,,,50.0,,,,650.0
Rudraprayag,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,500.0,50.0,,,,,100.0,,650.0
Rudraprayag,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,100.0,50.0,50.0,50.0,100.0,100.0,0.0,100.0,550.0
Rudraprayag,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1050.0,600.0,600.0,600.0,1650.0,2050.0,2050.0,2050.0,2050.0,1750.0,1750.0,1500.0,17700.0
Rudraprayag,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,500.0,,,1050.0,400.0,,,,,,,,1950.0
Rudraprayag,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,950.0,,,,,,,,300.0,,250.0,250.0,1750.0
Rudraprayag,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,600.0,600.0,600.0,1650.0,2050.0,2050.0,2050.0,2050.0,1750.0,1750.0,1500.0,1250.0,17900.0
Rudraprayag,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,400.0,300.0,600.0,500.0,1210.0,810.0,610.0,940.0,740.0,540.0,450.0,300.0,7400.0
Rudraprayag,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,500.0,,800.0,,,1000.0,,,,,,2300.0
Rudraprayag,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,100.0,200.0,100.0,90.0,400.0,200.0,660.0,200.0,200.0,90.0,150.0,50.0,2440.0
Rudraprayag,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,300.0,600.0,500.0,1210.0,810.0,610.0,950.0,740.0,540.0,450.0,300.0,250.0,7260.0
Rudraprayag,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,2023.0,1823.0,2223.0,1923.0,2813.0,2613.0,2413.0,3913.0,3613.0,3113.0,1937.0,1637.0,30044.0
Rudraprayag,16.3.02,Stock Position of Gloves,2. Stocks Received,,1000.0,,1000.0,,,1500.0,,,,,,3500.0
Rudraprayag,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.3.02,Stock Position of Gloves,4. Stock Distributed,200.0,600.0,300.0,110.0,200.0,200.0,,300.0,500.0,1176.0,300.0,300.0,4186.0
Rudraprayag,16.3.02,Stock Position of Gloves,5. Total Stock,1823.0,2223.0,1923.0,2813.0,2613.0,2413.0,3913.0,3613.0,3113.0,1937.0,1637.0,1337.0,29358.0
Rudraprayag,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,4.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,18.0
Rudraprayag,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,4.0,,,,,,,,21.0,25.0
Rudraprayag,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,2.0,,,,,,,,2.0
Rudraprayag,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,4.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,23.0,41.0
Rudraprayag,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,400.0,150.0,,,550.0
Rudraprayag,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,500.0,,,,,500.0
Rudraprayag,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,100.0,250.0,150.0,,,500.0
Rudraprayag,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,400.0,150.0,0.0,0.0,0.0,550.0
Rudraprayag,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Rudraprayag,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Rudraprayag,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Rudraprayag,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,25.0,45.0,45.0,45.0,40.0,35.0,25.0,25.0,25.0,10.0,40.0,25.0,385.0
Rudraprayag,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,40.0,,,,,,,,,30.0,,,70.0
Rudraprayag,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,20.0,,,5.0,5.0,10.0,,,15.0,,15.0,,70.0
Rudraprayag,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,45.0,45.0,45.0,40.0,35.0,25.0,25.0,25.0,10.0,40.0,25.0,25.0,385.0
Rudraprayag,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,30000.0,140000.0,96800.0,71400.0,59400.0,61000.0,946000.0,561288.0,108332.0,68332.0,64332.0,2206884.0
Rudraprayag,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,38000.0,140000.0,,,,20000.0,2234388.0,,,,,,2432388.0
Rudraprayag,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,30000.0,,,,,,,,,,,30000.0
Rudraprayag,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,8000.0,,43200.0,25400.0,12000.0,21600.0,1349388.0,384712.0,452956.0,40000.0,4000.0,38500.0,2379756.0
Rudraprayag,16.3.07,Stock Position of IFA Tablets,5. Total Stock,30000.0,140000.0,96800.0,71400.0,59400.0,57800.0,946000.0,561288.0,108332.0,68332.0,64332.0,25832.0,2229516.0
Rudraprayag,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Rudraprayag,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Rudraprayag,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Rudraprayag,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rudraprayag,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,1940.0,2940.0,1940.0,1740.0,160.0,,1100.0,775.0,675.0,175.0,830.0,530.0,12805.0
Rudraprayag,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,1300.0,,,,,1300.0,,,,1000.0,,,3600.0
Rudraprayag,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,300.0,1000.0,200.0,1580.0,160.0,200.0,325.0,100.0,500.0,345.0,300.0,100.0,5110.0
Rudraprayag,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,2940.0,1940.0,1740.0,160.0,0.0,1100.0,775.0,675.0,175.0,830.0,530.0,430.0,11295.0
Rudraprayag,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,36000.0,,,,,,,,,36000.0
Rudraprayag,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,36000.0,,,,,,,,,,36000.0
Rudraprayag,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,36000.0,,,,,,,,,36000.0
Rudraprayag,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,36000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,36000.0
Rudraprayag,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,10937.0,10437.0,5437.0,19437.0,18437.0,9437.0,9237.0,7811.0,7611.0,7411.0,10881.0,10381.0,127454.0
Rudraprayag,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,16000.0,18000.0,,,,,,3780.0,,,37780.0
Rudraprayag,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,500.0,5000.0,2000.0,19000.0,9000.0,200.0,1426.0,200.0,200.0,310.0,500.0,200.0,38536.0
Rudraprayag,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,10437.0,5437.0,19437.0,18437.0,9437.0,9237.0,7811.0,7611.0,7411.0,10881.0,10381.0,10181.0,126698.0
Rudraprayag,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,400.0,200.0,,1000.0,900.0,1900.0,1300.0,800.0,800.0,2200.0,2200.0,1600.0,13300.0
Rudraprayag,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,2000.0,,2000.0,,2000.0,,2000.0,,,2000.0,10000.0
Rudraprayag,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,200.0,200.0,1000.0,100.0,1000.0,600.0,2500.0,,600.0,,600.0,100.0,6900.0
Rudraprayag,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,200.0,0.0,1000.0,900.0,1900.0,1300.0,800.0,800.0,2200.0,2200.0,1600.0,3500.0,16400.0
Rudraprayag,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,6800.0,2800.0,12600.0,7100.0,19900.0,17900.0,14900.0,13700.0,24500.0,19400.0,17900.0,157500.0
Rudraprayag,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,17600.0,,10800.0,,18000.0,,7200.0,,10800.0,,,7200.0,71600.0
Rudraprayag,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,10800.0,4000.0,1000.0,5500.0,5200.0,2000.0,10200.0,1800.0,,5100.0,2000.0,800.0,48400.0
Rudraprayag,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,6800.0,2800.0,12600.0,7100.0,19900.0,17900.0,14900.0,13100.0,24500.0,19400.0,17400.0,24300.0,180700.0
Rudraprayag,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,2400.0,400.0,2600.0,2800.0,3790.0,3290.0,3790.0,3790.0,3790.0,3790.0,3290.0,33730.0
Rudraprayag,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,,2400.0,1200.0,2000.0,,2000.0,,,,,,10000.0
Rudraprayag,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Rudraprayag,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,2000.0,,1000.0,1010.0,500.0,1500.0,,,,500.0,600.0,7110.0
Rudraprayag,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2400.0,400.0,2800.0,2800.0,3790.0,3290.0,3790.0,3790.0,3790.0,3790.0,3290.0,2690.0,36620.0
Rudraprayag,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Rudraprayag,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Rudraprayag,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rudraprayag,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Rudraprayag,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Rudraprayag,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rudraprayag,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Rudraprayag,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Rudraprayag,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rudraprayag,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Rudraprayag,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,1.0,,,,1.0,,,,,2.0
Rudraprayag,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rudraprayag,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,1.0,,,,1.0,,,,,2.0
Rudraprayag,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rudraprayag,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rudraprayag,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Rudraprayag,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rudraprayag,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rudraprayag,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Rudraprayag,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rudraprayag,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rudraprayag,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Rudraprayag,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rudraprayag,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rudraprayag,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Rudraprayag,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Rudraprayag,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Rudraprayag,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Rudraprayag,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Rudraprayag,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Rudraprayag,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,1.0,,,,,,1.0
Rudraprayag,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Rudraprayag,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,1.0,2.0,,,,,,2.0,,,5.0
Rudraprayag,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,1.0,2.0,,,,,,2.0,,,5.0
Rudraprayag,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Rudraprayag,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Rudraprayag,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,1.0,2.0,1.0,,,1.0,,,1.0,,,6.0
Rudraprayag,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,1.0,2.0,1.0,,,1.0,,1.0,1.0,,,7.0
Tehri Garhwal,1.1,Total number of pregnant women Registered for ANC,TOTAL,1039.0,1032.0,1021.0,1079.0,1181.0,1063.0,878.0,668.0,722.0,779.0,969.0,949.0,11380.0
Tehri Garhwal,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,485.0,446.0,466.0,535.0,533.0,519.0,429.0,340.0,384.0,397.0,513.0,451.0,5498.0
Tehri Garhwal,1.2,Number of Pregnant women registered under JSY,TOTAL,1039.0,1032.0,1021.0,1079.0,1181.0,1063.0,878.0,668.0,722.0,779.0,969.0,949.0,11380.0
Tehri Garhwal,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,677.0,653.0,762.0,780.0,746.0,779.0,653.0,761.0,655.0,597.0,513.0,601.0,8177.0
Tehri Garhwal,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1003.0,964.0,942.0,969.0,1032.0,942.0,798.0,607.0,652.0,692.0,884.0,842.0,10327.0
Tehri Garhwal,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,911.0,975.0,935.0,975.0,1006.0,988.0,922.0,886.0,676.0,689.0,779.0,959.0,10701.0
Tehri Garhwal,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,642.0,553.0,684.0,561.0,532.0,421.0,225.0,183.0,183.0,224.0,191.0,208.0,4607.0
Tehri Garhwal,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,7.0,4.0,16.0,8.0,14.0,27.0,7.0,6.0,1.0,9.0,11.0,21.0,131.0
Tehri Garhwal,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0
Tehri Garhwal,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,357.0,400.0,506.0,603.0,724.0,542.0,484.0,362.0,332.0,567.0,452.0,389.0,5718.0
Tehri Garhwal,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1.0,2.0,4.0,16.0,2.0,1.0,1.0,4.0,2.0,2.0,6.0,0.0,41.0
Tehri Garhwal,1.8,Number of pregnancy test kits used at SC level,TOTAL,383.0,376.0,355.0,527.0,522.0,514.0,410.0,326.0,343.0,262.0,334.0,303.0,4655.0
Tehri Garhwal,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,22.0,25.0,16.0,21.0,29.0,29.0,18.0,14.0,20.0,9.0,27.0,13.0,243.0
Tehri Garhwal,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,106.0,128.0,122.0,224.0,223.0,248.0,182.0,165.0,152.0,201.0,175.0,158.0,2084.0
Tehri Garhwal,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,128.0,153.0,138.0,245.0,252.0,277.0,200.0,179.0,172.0,210.0,202.0,171.0,2327.0
Tehri Garhwal,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,65.0,282.0,80.0,114.0,121.0,134.0,83.0,80.0,81.0,96.0,101.0,71.0,1308.0
Tehri Garhwal,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,9.0,8.0,26.0,22.0,26.0,16.0,10.0,32.0,24.0,18.0,14.0,109.0,314.0
Tehri Garhwal,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,247.0,249.0,288.0,390.0,390.0,361.0,339.0,301.0,306.0,396.0,315.0,268.0,3850.0
Tehri Garhwal,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,246.0,248.0,285.0,383.0,377.0,360.0,336.0,299.0,305.0,396.0,315.0,268.0,3818.0
Tehri Garhwal,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,247.0,246.0,288.0,378.0,390.0,365.0,333.0,299.0,329.0,396.0,315.0,278.0,3864.0
Tehri Garhwal,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,230.0,248.0,312.0,436.0,479.0,333.0,256.0,269.0,289.0,517.0,411.0,382.0,4162.0
Tehri Garhwal,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,10.0,13.0,18.0,21.0,12.0,16.0,8.0,15.0,15.0,7.0,23.0,,158.0
Tehri Garhwal,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Tehri Garhwal,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Tehri Garhwal,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,6.0,8.0,11.0,12.0,8.0,8.0,6.0,8.0,8.0,6.0,9.0,,90.0
Tehri Garhwal,4.1.1.a,Number of male live births,TOTAL,202.0,219.0,231.0,348.0,350.0,337.0,275.0,253.0,254.0,316.0,270.0,225.0,3280.0
Tehri Garhwal,4.1.1.b,Number of female live births,TOTAL,176.0,189.0,204.0,304.0,305.0,315.0,267.0,234.0,234.0,293.0,265.0,215.0,3001.0
Tehri Garhwal,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,378.0,408.0,435.0,652.0,655.0,652.0,542.0,487.0,488.0,609.0,535.0,440.0,6281.0
Tehri Garhwal,4.1.2,Number of still births,TOTAL,9.0,10.0,12.0,7.0,6.0,8.0,7.0,11.0,6.0,4.0,10.0,2.0,92.0
Tehri Garhwal,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,44.0,11.0,30.0,55.0,35.0,34.0,31.0,19.0,35.0,28.0,36.0,21.0,379.0
Tehri Garhwal,4.2.1,Number of Newborns weighed at birth,TOTAL,331.0,342.0,364.0,495.0,538.0,465.0,429.0,391.0,424.0,525.0,463.0,372.0,5139.0
Tehri Garhwal,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,19.0,47.0,28.0,52.0,44.0,68.0,41.0,22.0,31.0,25.0,27.0,28.0,432.0
Tehri Garhwal,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,321.0,344.0,379.0,513.0,557.0,509.0,488.0,412.0,448.0,556.0,491.0,414.0,5432.0
Tehri Garhwal,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,8.0,1.0,8.0,0.0,0.0,5.0,0.0,0.0,2.0,0.0,0.0,0.0,24.0
Tehri Garhwal,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,1.0,0.0,0.0,1.0,3.0,0.0,26.0,0.0,0.0,0.0,0.0,4.0,35.0
Tehri Garhwal,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Tehri Garhwal,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,9.0,1.0,8.0,1.0,3.0,5.0,27.0,0.0,2.0,0.0,0.0,4.0,60.0
Tehri Garhwal,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1.0,0.0,2.0,0.0,2.0,2.0,26.0,3.0,11.0,8.0,0.0,0.0,55.0
Tehri Garhwal,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,0.0,0.0,0.0,1.0,0.0,0.0,24.0,17.0,2.0,0.0,0.0,45.0
Tehri Garhwal,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,9.0,1.0,10.0,150.0,10.0,7.0,26.0,0.0,19.0,0.0,0.0,0.0,232.0
Tehri Garhwal,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,218.0,268.0,254.0,291.0,301.0,249.0,271.0,278.0,301.0,317.0,269.0,184.0,3201.0
Tehri Garhwal,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,234.0,226.0,225.0,297.0,306.0,332.0,259.0,268.0,395.0,344.0,254.0,194.0,3334.0
Tehri Garhwal,6.3,PNC maternal complications attended,TOTAL,1.0,1.0,8.0,0.0,0.0,0.0,0.0,0.0,39.0,0.0,0.0,0.0,49.0
Tehri Garhwal,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,26.0,24.0,25.0,29.0,26.0,15.0,10.0,13.0,27.0,10.0,19.0,12.0,236.0
Tehri Garhwal,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,26.0,24.0,25.0,29.0,26.0,15.0,10.0,13.0,27.0,10.0,19.0,12.0,236.0
Tehri Garhwal,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,5.0,4.0,3.0,5.0,3.0,3.0,6.0,4.0,0.0,25.0,5.0,9.0,72.0
Tehri Garhwal,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,37.0,69.0,58.0,37.0,55.0,49.0,41.0,52.0,29.0,35.0,37.0,51.0,550.0
Tehri Garhwal,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,42.0,73.0,61.0,42.0,58.0,52.0,47.0,56.0,29.0,60.0,42.0,60.0,622.0
Tehri Garhwal,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Tehri Garhwal,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Tehri Garhwal,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,3.0
Tehri Garhwal,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,5.0,0.0,3.0,45.0,0.0,1.0,14.0,159.0,246.0,209.0,44.0,163.0,889.0
Tehri Garhwal,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,2.0,6.0,6.0,1.0,1.0,4.0,65.0,61.0,118.0,63.0,3.0,330.0
Tehri Garhwal,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,4.0,2.0,3.0,2.0,0.0,1.0,2.0,7.0,11.0,0.0,33.0
Tehri Garhwal,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,6.0,2.0,13.0,53.0,4.0,4.0,18.0,225.0,309.0,334.0,118.0,166.0,1252.0
Tehri Garhwal,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,9.0,6.0,5.0,12.0,4.0,6.0,8.0,4.0,11.0,7.0,13.0,0.0,85.0
Tehri Garhwal,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,3.0
Tehri Garhwal,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,9.0,6.0,5.0,13.0,4.0,6.0,8.0,4.0,11.0,7.0,15.0,0.0,88.0
Tehri Garhwal,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Tehri Garhwal,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Tehri Garhwal,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,170.0,167.0,152.0,204.0,192.0,129.0,102.0,111.0,168.0,145.0,138.0,215.0,1893.0
Tehri Garhwal,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,31.0,21.0,20.0,50.0,19.0,29.0,15.0,20.0,23.0,33.0,31.0,32.0,324.0
Tehri Garhwal,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,14.0,5.0,5.0,24.0,6.0,2.0,5.0,1.0,4.0,2.0,1.0,0.0,69.0
Tehri Garhwal,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,10.0,5.0,7.0,13.0,13.0,7.0,4.0,6.0,8.0,4.0,6.0,14.0,97.0
Tehri Garhwal,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,225.0,198.0,184.0,291.0,230.0,167.0,126.0,138.0,203.0,184.0,176.0,261.0,2383.0
Tehri Garhwal,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,26.0,22.0,36.0,61.0,50.0,36.0,31.0,37.0,39.0,46.0,50.0,46.0,480.0
Tehri Garhwal,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.06,Number of IUCD removals,TOTAL,49.0,73.0,67.0,83.0,94.0,376.0,52.0,43.0,68.0,69.0,66.0,72.0,1112.0
Tehri Garhwal,9.07,Number of Oral Pills cycles distributed,TOTAL,1169.0,1954.0,2015.0,2952.0,2155.0,2181.0,1658.0,1682.0,1154.0,1469.0,2406.0,2901.0,23696.0
Tehri Garhwal,9.08,Number of Condom pieces distributed,TOTAL,17072.0,22399.0,22324.0,34882.0,31190.0,25824.0,23332.0,14456.0,18570.0,20646.0,42167.0,38712.0,311574.0
Tehri Garhwal,9.09,Number of Centchroman (weekly) pills given,TOTAL,5.0,0.0,5.0,10.0,10.0,40.0,11.0,2.0,0.0,5.0,1.0,50.0,139.0
Tehri Garhwal,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,193.0,178.0,198.0,206.0,192.0,128.0,106.0,81.0,42.0,55.0,119.0,107.0,1605.0
Tehri Garhwal,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,3.0
Tehri Garhwal,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Tehri Garhwal,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,4.0,4.0,2.0,2.0,6.0,5.0,5.0,10.0,9.0,7.0,9.0,-1.0
Tehri Garhwal,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,519.0,635.0,646.0,651.0,801.0,1055.0,974.0,962.0,810.0,719.0,810.0,784.0,9366.0
Tehri Garhwal,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3.0,0.0,0.0,0.0,0.0,5.0,6.0,12.0,1.0,1.0,0.0,0.0,28.0
Tehri Garhwal,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,12.0,4.0,4.0,0.0,0.0,7.0,1.0,8.0,9.0,1.0,1.0,0.0,47.0
Tehri Garhwal,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,65.0,12.0,8.0,1.0,0.0,7.0,2.0,2.0,7.0,11.0,0.0,1.0,116.0
Tehri Garhwal,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,836.0,836.0,720.0,711.0,748.0,968.0,1091.0,1110.0,984.0,823.0,759.0,926.0,10512.0
Tehri Garhwal,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,889.0,891.0,854.0,817.0,678.0,771.0,994.0,1141.0,1157.0,1015.0,773.0,921.0,10901.0
Tehri Garhwal,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,810.0,860.0,881.0,879.0,782.0,686.0,799.0,1028.0,1189.0,1145.0,974.0,851.0,10884.0
Tehri Garhwal,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,235.0,284.0,321.0,449.0,448.0,416.0,401.0,351.0,325.0,415.0,391.0,314.0,4350.0
Tehri Garhwal,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,841.0,830.0,719.0,709.0,682.0,971.0,1089.0,1122.0,985.0,824.0,754.0,925.0,10451.0
Tehri Garhwal,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,903.0,884.0,858.0,798.0,644.0,770.0,989.0,1148.0,1166.0,1016.0,772.0,920.0,10868.0
Tehri Garhwal,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,870.0,868.0,887.0,863.0,728.0,686.0,797.0,1031.0,1198.0,1156.0,965.0,872.0,10921.0
Tehri Garhwal,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,180.0,217.0,266.0,364.0,357.0,318.0,317.0,287.0,276.0,328.0,299.0,265.0,3474.0
Tehri Garhwal,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,9.0,18.0,0.0,0.0,0.0,0.0,3.0,6.0,0.0,0.0,0.0,0.0,36.0
Tehri Garhwal,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,18.0,18.0,4.0,0.0,0.0,0.0,0.0,3.0,1.0,0.0,0.0,0.0,44.0
Tehri Garhwal,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,66.0,35.0,8.0,1.0,2.0,7.0,1.0,2.0,0.0,1.0,0.0,0.0,123.0
Tehri Garhwal,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,831.0,908.0,1001.0,967.0,917.0,953.0,1088.0,1013.0,814.0,682.0,723.0,1154.0,11051.0
Tehri Garhwal,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,792.0,767.0,870.0,837.0,781.0,637.0,969.0,814.0,771.0,712.0,759.0,889.0,9598.0
Tehri Garhwal,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,451.0,488.0,532.0,522.0,506.0,485.0,571.0,527.0,423.0,345.0,382.0,601.0,5833.0
Tehri Garhwal,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,380.0,421.0,476.0,452.0,438.0,463.0,521.0,486.0,386.0,337.0,344.0,554.0,5258.0
Tehri Garhwal,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,831.0,909.0,1008.0,974.0,944.0,948.0,1092.0,1013.0,809.0,682.0,726.0,1155.0,11091.0
Tehri Garhwal,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,871.0,798.0,873.0,929.0,777.0,682.0,1040.0,818.0,798.0,727.0,765.0,891.0,9969.0
Tehri Garhwal,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,872.0,798.0,873.0,929.0,740.0,700.0,1039.0,821.0,798.0,727.0,765.0,891.0,9953.0
Tehri Garhwal,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,445.0,431.0,441.0,457.0,421.0,354.0,544.0,449.0,426.0,404.0,418.0,461.0,5251.0
Tehri Garhwal,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,425.0,368.0,416.0,440.0,398.0,302.0,463.0,363.0,348.0,328.0,332.0,413.0,4596.0
Tehri Garhwal,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,870.0,799.0,857.0,897.0,819.0,656.0,1007.0,812.0,774.0,732.0,750.0,874.0,9847.0
Tehri Garhwal,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,666.0,629.0,753.0,733.0,673.0,824.0,847.0,562.0,516.0,605.0,580.0,638.0,8026.0
Tehri Garhwal,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,587.0,605.0,727.0,724.0,653.0,754.0,823.0,495.0,497.0,517.0,569.0,565.0,7516.0
Tehri Garhwal,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,490.0,547.0,572.0,590.0,568.0,565.0,605.0,425.0,428.0,452.0,496.0,512.0,6250.0
Tehri Garhwal,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,0.0,0.0,0.0,5.0,5.0,5.0,10.0,0.0,0.0,5.0,11.0,45.0
Tehri Garhwal,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,236.0,245.0,367.0,349.0,366.0,409.0,430.0,436.0,261.0,252.0,289.0,329.0,3969.0
Tehri Garhwal,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,983.0,970.0,1005.0,1032.0,1047.0,1046.0,1757.0,1539.0,1787.0,1380.0,1293.0,1405.0,15244.0
Tehri Garhwal,10.4.2,Number of Immunisation sessions held during the month,TOTAL,941.0,917.0,959.0,971.0,988.0,973.0,1676.0,1497.0,1754.0,1348.0,1235.0,1345.0,14604.0
Tehri Garhwal,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,850.0,850.0,864.0,894.0,906.0,894.0,1556.0,1376.0,1648.0,1167.0,1127.0,1206.0,13338.0
Tehri Garhwal,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,485.0,486.0,531.0,442.0,320.0,101.0,54.0,27.0,8.0,221.0,768.0,838.0,4281.0
Tehri Garhwal,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,242.0,219.0,229.0,312.0,237.0,57.0,35.0,19.0,3.0,108.0,320.0,455.0,2236.0
Tehri Garhwal,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,96.0,81.0,54.0,148.0,72.0,3.0,2.0,3.0,0.0,17.0,130.0,175.0,781.0
Tehri Garhwal,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,0.0,1.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,12.0
Tehri Garhwal,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,31.0,55.0,113.0,70.0,64.0,26.0,29.0,18.0,14.0,16.0,12.0,64.0,512.0
Tehri Garhwal,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Tehri Garhwal,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,2.0,4.0,34.0,2.0,2.0,16.0,15.0,7.0,25.0,4.0,0.0,0.0,111.0
Tehri Garhwal,13.1,Number of Patients operated for cataract,TOTAL,2.0,32.0,15.0,9.0,25.0,8.0,4.0,14.0,82.0,105.0,67.0,64.0,427.0
Tehri Garhwal,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,2.0,32.0,15.0,11.0,27.0,8.0,4.0,14.0,81.0,148.0,67.0,64.0,473.0
Tehri Garhwal,13.3,Number of School children detected with Refractive errors,TOTAL,3.0,5.0,1.0,19.0,36.0,33.0,11.0,7.0,23.0,73.0,23.0,9.0,243.0
Tehri Garhwal,13.4,Number of children provided free glasses,TOTAL,0.0,11.0,9.0,4.0,14.0,29.0,58.0,21.0,7.0,55.0,7.0,30.0,245.0
Tehri Garhwal,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,,1.0,,,1.0,1.0,1.0,1.0,2.0,1.0,1.0,-1.0
Tehri Garhwal,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,5.0,5.0,5.0,5.0,4.0,4.0,5.0,10.0,7.0,8.0,8.0,-1.0
Tehri Garhwal,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,580.0,585.0,604.0,635.0,655.0,668.0,762.0,815.0,561.0,639.0,609.0,666.0,-1.0
Tehri Garhwal,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,3.0,3.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,1.0,,-1.0
Tehri Garhwal,14.05,Number of RKS meetings held during the month,TOTAL,8.0,8.0,11.0,8.0,8.0,8.0,8.0,8.0,3.0,3.0,3.0,4.0,80.0
Tehri Garhwal,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,11.0,11.0,8.0,7.0,8.0,8.0,9.0,12.0,11.0,13.0,11.0,-1.0
Tehri Garhwal,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,11.0,11.0,9.0,7.0,6.0,19.0,11.0,59.0,14.0,9.0,7.0,9.0,172.0
Tehri Garhwal,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,-1.0
Tehri Garhwal,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,4.0,4.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Tehri Garhwal,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,61.0,92.0,132.0,117.0,84.0,82.0,49.0,25.0,33.0,28.0,48.0,52.0,803.0
Tehri Garhwal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,199.0,435.0,454.0,485.0,520.0,432.0,388.0,215.0,299.0,224.0,202.0,267.0,4120.0
Tehri Garhwal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,48.0,52.0,92.0,208.0,99.0,249.0,71.0,227.0,43.0,27.0,47.0,274.0,1437.0
Tehri Garhwal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,544.0,1058.0,1076.0,971.0,952.0,802.0,670.0,299.0,558.0,435.0,441.0,338.0,8144.0
Tehri Garhwal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,109.0,144.0,224.0,325.0,183.0,331.0,120.0,252.0,76.0,55.0,95.0,326.0,2240.0
Tehri Garhwal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,743.0,1493.0,1530.0,1456.0,1472.0,1234.0,1058.0,514.0,857.0,659.0,643.0,605.0,12264.0
Tehri Garhwal,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,1.0,1.0,1.0,1.0,5.0,0.0,1.0,0.0,0.0,0.0,1.0,11.0
Tehri Garhwal,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,0.0,1.0,2.0,2.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,8.0
Tehri Garhwal,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,1.0,1.0,2.0,3.0,3.0,5.0,0.0,1.0,1.0,1.0,0.0,1.0,19.0
Tehri Garhwal,14.11,In-Patient Head Count at midnight,TOTAL,309.0,260.0,201.0,241.0,232.0,309.0,167.0,268.0,126.0,280.0,239.0,288.0,2920.0
Tehri Garhwal,14.12.1,OPD attendance (All),TOTAL,23799.0,32806.0,34554.0,36792.0,35809.0,40037.0,32493.0,26727.0,30751.0,28916.0,29886.0,27855.0,380425.0
Tehri Garhwal,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1.0,4.0,4.0,4.0,4.0,5.0,3.0,2.0,2.0,0.0,1.0,1.0,31.0
Tehri Garhwal,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Tehri Garhwal,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1.0,26.0,15.0,9.0,4.0,3.0,7.0,5.0,4.0,3.0,2.0,5.0,84.0
Tehri Garhwal,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,14.14.a,Number of patients given AYUSH treatment,TOTAL,4635.0,5434.0,5210.0,5850.0,5318.0,5264.0,4350.0,4110.0,3785.0,4033.0,3473.0,2967.0,54429.0
Tehri Garhwal,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,70.0,89.0,216.0,66.0,81.0,68.0,53.0,53.0,45.0,90.0,142.0,114.0,1087.0
Tehri Garhwal,14.14.c,Number of Adolescents counselled,TOTAL,30.0,118.0,571.0,254.0,412.0,259.0,249.0,427.0,811.0,404.0,585.0,431.0,4551.0
Tehri Garhwal,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1887.0,2414.0,2602.0,2746.0,2958.0,2503.0,2474.0,1891.0,2189.0,1570.0,1773.0,1951.0,26958.0
Tehri Garhwal,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,21.0,23.0,42.0,33.0,29.0,21.0,12.0,12.0,23.0,16.0,21.0,18.0,271.0
Tehri Garhwal,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,44.0,44.0,62.0,57.0,79.0,39.0,37.0,64.0,38.0,75.0,43.0,49.0,631.0
Tehri Garhwal,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,5.0
Tehri Garhwal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,120.0,99.0,134.0,88.0,100.0,114.0,34.0,99.0,96.0,99.0,55.0,44.0,1082.0
Tehri Garhwal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0
Tehri Garhwal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,334.0,313.0,426.0,444.0,336.0,315.0,230.0,209.0,320.0,136.0,244.0,227.0,3534.0
Tehri Garhwal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Tehri Garhwal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,498.0,456.0,622.0,589.0,515.0,468.0,301.0,372.0,454.0,310.0,342.0,320.0,5247.0
Tehri Garhwal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,0.0,3.0,0.0,0.0,1.0,0.0,1.0,0.0,2.0,0.0,0.0,8.0
Tehri Garhwal,15.2,Number of Widal tests conducted,Number tested,341.0,561.0,563.0,449.0,609.0,801.0,562.0,325.0,281.0,200.0,245.0,326.0,5263.0
Tehri Garhwal,15.3.a,Number of VDRL tests conducted on males,Number tested,9.0,51.0,11.0,4.0,8.0,143.0,144.0,14.0,29.0,12.0,9.0,10.0,444.0
Tehri Garhwal,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,25.0,21.0,126.0,18.0,41.0,69.0,21.0,77.0,61.0,33.0,32.0,39.0,563.0
Tehri Garhwal,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,312.0,359.0,385.0,523.0,473.0,249.0,342.0,202.0,452.0,269.0,377.0,439.0,4382.0
Tehri Garhwal,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,346.0,431.0,522.0,545.0,522.0,461.0,507.0,293.0,542.0,314.0,418.0,488.0,5389.0
Tehri Garhwal,15.4.1,Number of blood smears examined for Malaria,TOTAL,787.0,900.0,971.0,951.0,957.0,1280.0,790.0,515.0,537.0,441.0,464.0,445.0,9038.0
Tehri Garhwal,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,1.0,2.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,5.0
Tehri Garhwal,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Tehri Garhwal,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3480.0,4180.0,1580.0,2930.0,2540.0,4420.0,2110.0,2370.0,3390.0,1410.0,4260.0,2110.0,34780.0
Tehri Garhwal,16.1.1,Stock position of DPT vaccines,2. Stocks Received,3000.0,,4000.0,2000.0,4000.0,,3000.0,3000.0,,5000.0,,4000.0,28000.0
Tehri Garhwal,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2300.0,2600.0,2650.0,2390.0,2120.0,2310.0,2740.0,1980.0,1980.0,2150.0,2150.0,2800.0,28170.0
Tehri Garhwal,16.1.1,Stock position of DPT vaccines,5. Total Stock,4180.0,1580.0,2930.0,2540.0,4420.0,2110.0,2370.0,3390.0,1410.0,4260.0,2110.0,3310.0,34610.0
Tehri Garhwal,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,2140.0,6000.0,2500.0,330.0,3000.0,430.0,4480.0,1090.0,590.0,500.0,680.0,1070.0,22810.0
Tehri Garhwal,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,7000.0,,,6500.0,0.0,6000.0,,2000.0,3000.0,2800.0,3900.0,4800.0,36000.0
Tehri Garhwal,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3140.0,3500.0,2170.0,3830.0,2570.0,1950.0,3390.0,2500.0,3090.0,2440.0,3510.0,2770.0,34860.0
Tehri Garhwal,16.1.1A,Stock Position of Pentavalent,5. Total Stock,6000.0,2500.0,330.0,3000.0,430.0,4480.0,1090.0,590.0,500.0,860.0,1070.0,3100.0,23950.0
Tehri Garhwal,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,7020.0,7200.0,1960.0,,8700.0,10000.0,4520.0,5860.0,5960.0,4200.0,2380.0,880.0,58680.0
Tehri Garhwal,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5000.0,,3000.0,10000.0,6000.0,,8000.0,6000.0,5000.0,4000.0,,0.0,47000.0
Tehri Garhwal,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Tehri Garhwal,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4820.0,5240.0,4960.0,1300.0,4700.0,5480.0,6660.0,5900.0,6760.0,5820.0,1500.0,0.0,53140.0
Tehri Garhwal,16.1.2,Stock position of OPV vaccines,5. Total Stock,7200.0,1960.0,0.0,8700.0,10000.0,4520.0,5860.0,5960.0,4200.0,2380.0,880.0,880.0,52540.0
Tehri Garhwal,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,960.0,9070.0,5640.0,4260.0,5610.0,8670.0,4740.0,6040.0,9290.0,7090.0,5390.0,2490.0,69250.0
Tehri Garhwal,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,,2500.0,5000.0,7000.0,,6000.0,6000.0,,1000.0,,5000.0,42500.0
Tehri Garhwal,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1890.0,3430.0,3880.0,3650.0,3940.0,3930.0,4700.0,2750.0,2200.0,2700.0,2900.0,3740.0,39710.0
Tehri Garhwal,16.1.3,Stock position of TT vaccines,5. Total Stock,9070.0,5640.0,4260.0,5610.0,8670.0,4740.0,6040.0,9290.0,7090.0,5390.0,2490.0,3750.0,72040.0
Tehri Garhwal,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tehri Garhwal,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Tehri Garhwal,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tehri Garhwal,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1500.0,1550.0,190.0,2330.0,2770.0,3200.0,2020.0,1670.0,1800.0,1040.0,3840.0,1340.0,23250.0
Tehri Garhwal,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1500.0,,3500.0,1500.0,1500.0,,2000.0,2500.0,2000.0,5500.0,,4000.0,24000.0
Tehri Garhwal,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1450.0,1360.0,1360.0,1060.0,1070.0,1180.0,2350.0,2370.0,2760.0,2700.0,2500.0,2410.0,22570.0
Tehri Garhwal,16.1.5,Stock position of BCG vaccines,5. Total Stock,1550.0,190.0,2330.0,2770.0,3200.0,2020.0,1670.0,1800.0,1040.0,3840.0,1340.0,2930.0,24680.0
Tehri Garhwal,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4150.0,3540.0,1280.0,3830.0,3120.0,5950.0,3610.0,3790.0,5445.0,2745.0,6345.0,3795.0,47600.0
Tehri Garhwal,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1500.0,,5000.0,1500.0,5000.0,,3500.0,5000.0,,7000.0,,7000.0,35500.0
Tehri Garhwal,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2110.0,2260.0,2450.0,2210.0,2170.0,2340.0,3320.0,3345.0,2700.0,3400.0,2550.0,2575.0,31430.0
Tehri Garhwal,16.1.6,Stock position of Measles vaccines,5. Total Stock,3540.0,1280.0,3830.0,3120.0,5950.0,3610.0,3790.0,5445.0,2745.0,6345.0,3795.0,8220.0,51670.0
Tehri Garhwal,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tehri Garhwal,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Tehri Garhwal,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tehri Garhwal,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3160.0,3160.0,2820.0,2800.0,2750.0,2650.0,2650.0,2650.0,2530.0,2230.0,2230.0,2130.0,31760.0
Tehri Garhwal,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,0.0,,,,,,,,0.0
Tehri Garhwal,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,340.0,20.0,50.0,100.0,,,120.0,300.0,,100.0,1100.0,2130.0
Tehri Garhwal,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3160.0,2820.0,2800.0,2750.0,2650.0,2650.0,2650.0,2530.0,2230.0,2230.0,2130.0,1030.0,29630.0
Tehri Garhwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,6025.0,7861.0,6658.0,6658.0,6788.0,6358.0,6358.0,6358.0,6358.0,5858.0,4858.0,4358.0,74496.0
Tehri Garhwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,4800.0,0.0,,4800.0,,,,,,,,0.0,9600.0
Tehri Garhwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,0.0,,,,,,,,,,0.0,0.0
Tehri Garhwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,2964.0,1203.0,,4670.0,430.0,,,,500.0,1000.0,500.0,0.0,11267.0
Tehri Garhwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,7861.0,6658.0,6658.0,6788.0,6358.0,6358.0,6358.0,6358.0,5858.0,4858.0,4358.0,4358.0,72829.0
Tehri Garhwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,74447.0,50447.0,38447.0,97288.0,47767.0,47767.0,47767.0,47767.0,43727.0,48767.0,18527.0,562718.0
Tehri Garhwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,140447.0,,,110880.0,,,,,,100800.0,,,352127.0
Tehri Garhwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,66000.0,24000.0,12000.0,52039.0,49521.0,,,,4040.0,95760.0,30240.0,,333600.0
Tehri Garhwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,74447.0,50447.0,38447.0,97288.0,47767.0,47767.0,47767.0,47767.0,43727.0,48767.0,18527.0,18527.0,581245.0
Tehri Garhwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,3671.0,1671.0,671.0,3471.0,1500.0,1500.0,500.0,500.0,500.0,7200.0,3000.0,24184.0
Tehri Garhwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,9671.0,,,12000.0,,,3300.0,,,15000.0,,0.0,39971.0
Tehri Garhwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,0.0,0.0
Tehri Garhwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,6000.0,2000.0,1000.0,9200.0,1971.0,,4300.0,,,8300.0,4200.0,0.0,36971.0
Tehri Garhwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,3671.0,1671.0,671.0,3471.0,1500.0,1500.0,500.0,500.0,500.0,7200.0,3000.0,3000.0,27184.0
Tehri Garhwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,500.0,500.0,500.0,200.0,200.0,200.0,200.0,200.0,500.0,2500.0,2000.0,7500.0
Tehri Garhwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,800.0,,,,,,,,300.0,5000.0,,0.0,6100.0
Tehri Garhwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,300.0,0.0,,300.0,,,,,,3000.0,500.0,0.0,4100.0
Tehri Garhwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,500.0,500.0,500.0,200.0,200.0,200.0,200.0,200.0,500.0,2500.0,2000.0,2000.0,9500.0
Tehri Garhwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3174.0,2474.0,2474.0,2474.0,2474.0,2474.0,2474.0,1974.0,1974.0,1774.0,1700.0,1700.0,27140.0
Tehri Garhwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,2000.0,,0.0,2000.0
Tehri Garhwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,700.0,0.0,,,,,500.0,,200.0,2074.0,0.0,0.0,3474.0
Tehri Garhwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,2474.0,2474.0,2474.0,2474.0,2474.0,2474.0,1974.0,1974.0,1774.0,1700.0,1700.0,1700.0,25666.0
Tehri Garhwal,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,700.0,700.0,250.0,250.0,250.0,250.0,250.0,250.0,250.0,0.0,,,3150.0
Tehri Garhwal,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Tehri Garhwal,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,450.0,,,,,,250.0,250.0,,,,950.0
Tehri Garhwal,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,700.0,250.0,250.0,250.0,250.0,250.0,250.0,0.0,0.0,0.0,0.0,0.0,2200.0
Tehri Garhwal,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,25.0,775.0,775.0,297.0,297.0,297.0,297.0,297.0,97.0,47.0,0.0,,3204.0
Tehri Garhwal,16.3.02,Stock Position of Gloves,2. Stocks Received,750.0,,,,,,,,,,,,750.0
Tehri Garhwal,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.3.02,Stock Position of Gloves,4. Stock Distributed,,0.0,478.0,,,,,200.0,50.0,47.0,0.0,,775.0
Tehri Garhwal,16.3.02,Stock Position of Gloves,5. Total Stock,775.0,775.0,297.0,297.0,297.0,297.0,297.0,97.0,47.0,0.0,0.0,0.0,3179.0
Tehri Garhwal,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,48.0
Tehri Garhwal,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,0.0,0.0
Tehri Garhwal,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,0.0,0.0
Tehri Garhwal,16.3.03,Stock Position of MVA Syringes,5. Total Stock,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,48.0
Tehri Garhwal,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Tehri Garhwal,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Tehri Garhwal,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Tehri Garhwal,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Tehri Garhwal,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Tehri Garhwal,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Tehri Garhwal,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Tehri Garhwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Tehri Garhwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Tehri Garhwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,130000.0,80000.0,15000.0,9000.0,9000.0,4000.0,4000.0,4000.0,4000.0,0.0,,,259000.0
Tehri Garhwal,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Tehri Garhwal,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,50000.0,65000.0,6000.0,,5000.0,,,,4000.0,,,,130000.0
Tehri Garhwal,16.3.07,Stock Position of IFA Tablets,5. Total Stock,80000.0,15000.0,9000.0,9000.0,4000.0,4000.0,4000.0,4000.0,0.0,0.0,0.0,0.0,129000.0
Tehri Garhwal,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,0.0,,,,,,,,,,0.0
Tehri Garhwal,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Tehri Garhwal,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Tehri Garhwal,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Tehri Garhwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Tehri Garhwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Tehri Garhwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tehri Garhwal,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,40.0,40.0,20.0,20.0,20.0,20.0,20.0,2500.0,2500.0,1388.0,606.0,606.0,7780.0
Tehri Garhwal,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,2500.0,,,,,,2500.0
Tehri Garhwal,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,20.0,,,,,20.0,1112.0,1112.0,782.0,,,3046.0
Tehri Garhwal,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,40.0,20.0,20.0,20.0,20.0,20.0,2500.0,1388.0,1388.0,606.0,606.0,606.0,7234.0
Tehri Garhwal,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,5375.0,5375.0,8600.0,8600.0,8600.0,5575.0,5575.0,47700.0
Tehri Garhwal,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,10925.0,,3225.0,,,,,0.0,14150.0
Tehri Garhwal,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,5550.0,,,,,3025.0,,0.0,8575.0
Tehri Garhwal,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,5375.0,5375.0,8600.0,8600.0,8600.0,5575.0,5575.0,5575.0,53275.0
Tehri Garhwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,200.0,0.0,1400.0,800.0,2000.0,800.0,200.0,0.0,1400.0,300.0,5600.0,3600.0,16300.0
Tehri Garhwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,2000.0,,2000.0,,,,2000.0,,6000.0,,0.0,12000.0
Tehri Garhwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,200.0,600.0,600.0,800.0,1200.0,600.0,200.0,600.0,1100.0,700.0,2000.0,400.0,9000.0
Tehri Garhwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,1400.0,800.0,2000.0,800.0,200.0,0.0,1400.0,300.0,5600.0,3600.0,3200.0,19300.0
Tehri Garhwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,1500.0,300.0,14400.0,12000.0,23700.0,14700.0,15600.0,7200.0,11400.0,8400.0,43700.0,33500.0,186400.0
Tehri Garhwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,18000.0,,18000.0,,7200.0,,7200.0,,43200.0,,,93600.0
Tehri Garhwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,1200.0,3900.0,2400.0,6300.0,9000.0,6300.0,8400.0,3000.0,3000.0,7900.0,10200.0,1800.0,63400.0
Tehri Garhwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,300.0,14400.0,12000.0,23700.0,14700.0,15600.0,7200.0,11400.0,8400.0,43700.0,33500.0,31700.0,216600.0
Tehri Garhwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,600.0,400.0,2600.0,2400.0,4000.0,2400.0,2400.0,1500.0,1000.0,1000.0,4300.0,3300.0,25900.0
Tehri Garhwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,2400.0,,2000.0,1200.0,,,,,4000.0,,,9600.0
Tehri Garhwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Tehri Garhwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,200.0,200.0,200.0,400.0,2800.0,,900.0,500.0,,700.0,1000.0,100.0,7000.0
Tehri Garhwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,400.0,2600.0,2400.0,4000.0,2400.0,2400.0,1500.0,1000.0,1000.0,4300.0,3300.0,3200.0,28500.0
Tehri Garhwal,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Tehri Garhwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Tehri Garhwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tehri Garhwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Tehri Garhwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Tehri Garhwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tehri Garhwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Tehri Garhwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Tehri Garhwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tehri Garhwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Tehri Garhwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,1.0,1.0,,,,,,1.0,,1.0,5.0
Tehri Garhwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tehri Garhwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,1.0,1.0,,,,,,1.0,,1.0,5.0
Tehri Garhwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tehri Garhwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tehri Garhwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Tehri Garhwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tehri Garhwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tehri Garhwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Tehri Garhwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tehri Garhwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Tehri Garhwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,1.0,,,1.0
Tehri Garhwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tehri Garhwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tehri Garhwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Tehri Garhwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,,,1.0,,,,,,,,2.0
Tehri Garhwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Tehri Garhwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,,,1.0,,,,,,,,2.0
Tehri Garhwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Tehri Garhwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,,,,,,1.0
Tehri Garhwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Tehri Garhwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,1.0,,,,1.0
Tehri Garhwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,2.0,,,,,2.0
Tehri Garhwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,1.0,2.0,1.0,2.0,1.0,2.0,,1.0,2.0,12.0
Tehri Garhwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,1.0,2.0,1.0,2.0,3.0,2.0,,1.0,2.0,14.0
Tehri Garhwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Tehri Garhwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Tehri Garhwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,3.0,,,,,,3.0
Tehri Garhwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,,,,3.0,,,,,,4.0
Tehri Garhwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Tehri Garhwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,2.0,,,,1.0,,,,3.0
Tehri Garhwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,1.0,,,1.0,,2.0,3.0,3.0,10.0
Tehri Garhwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,3.0,,,1.0,1.0,2.0,3.0,3.0,13.0
Tehri Garhwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Tehri Garhwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,1.0,,,,,,,,1.0
Tehri Garhwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Tehri Garhwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,1.0,,1.0
Tehri Garhwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,1.0,1.0,1.0,1.0,,1.0,,,5.0
Tehri Garhwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,,,,,,,,1.0,,,2.0
Tehri Garhwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,1.0,,,1.0,1.0,1.0,1.0,,2.0,,,7.0
Tehri Garhwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Tehri Garhwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,1.0,,,,,,,,,1.0
Tehri Garhwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Tehri Garhwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Tehri Garhwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Tehri Garhwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,1.0,1.0,1.0,,3.0
Tehri Garhwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,1.0,,,1.0,,2.0,1.0,,5.0
Tehri Garhwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,1.0,,1.0,1.0,1.0,3.0,2.0,,9.0
Tehri Garhwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,3.0,,2.0,1.0,1.0,,7.0
Tehri Garhwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,1.0,1.0,3.0,,1.0,1.0,5.0,1.0,1.0,5.0,3.0,22.0
Tehri Garhwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,1.0,1.0,3.0,,1.0,4.0,5.0,3.0,2.0,6.0,3.0,29.0
Tehri Garhwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Tehri Garhwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,3.0,,1.0,,,2.0,1.0,,7.0
Tehri Garhwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,1.0,1.0,,3.0,4.0,2.0,3.0,7.0,3.0,6.0,7.0,37.0
Tehri Garhwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,1.0,1.0,,6.0,4.0,3.0,3.0,7.0,5.0,7.0,7.0,44.0
Udham Singh Nagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,3783.0,3760.0,3135.0,4424.0,3625.0,4003.0,3275.0,2935.0,3194.0,3425.0,3471.0,3726.0,42756.0
Udham Singh Nagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2454.0,2396.0,2022.0,3123.0,2483.0,2565.0,2071.0,1678.0,2126.0,2343.0,2318.0,2453.0,28032.0
Udham Singh Nagar,1.2,Number of Pregnant women registered under JSY,TOTAL,3783.0,3760.0,3135.0,4424.0,3625.0,4002.0,3275.0,2935.0,3194.0,3426.0,3471.0,3726.0,42756.0
Udham Singh Nagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2214.0,2328.0,2273.0,2673.0,2544.0,2454.0,2284.0,2193.0,2267.0,2508.0,2288.0,2613.0,28639.0
Udham Singh Nagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3271.0,3290.0,2727.0,3830.0,3169.0,3414.0,2765.0,2218.0,2716.0,2852.0,2920.0,3214.0,36386.0
Udham Singh Nagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3174.0,3422.0,3189.0,3568.0,3525.0,3436.0,3420.0,2874.0,2964.0,3072.0,3076.0,3449.0,39169.0
Udham Singh Nagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,490.0,1031.0,846.0,1092.0,751.0,833.0,412.0,655.0,515.0,531.0,589.0,983.0,8728.0
Udham Singh Nagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,37.0,24.0,36.0,148.0,142.0,36.0,27.0,34.0,29.0,34.0,41.0,43.0,631.0
Udham Singh Nagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,1.0,1.0,2.0,3.0,3.0,3.0,3.0,2.0,2.0,4.0,3.0,29.0
Udham Singh Nagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,948.0,1661.0,977.0,645.0,1343.0,1339.0,1111.0,1132.0,1382.0,1305.0,1300.0,1072.0,14215.0
Udham Singh Nagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,51.0,19.0,21.0,27.0,23.0,37.0,31.0,43.0,43.0,35.0,18.0,8.0,356.0
Udham Singh Nagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,482.0,501.0,527.0,1126.0,811.0,792.0,1186.0,706.0,744.0,706.0,1228.0,1926.0,10735.0
Udham Singh Nagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,8.0,11.0,25.0,24.0,56.0,44.0,65.0,33.0,54.0,52.0,47.0,66.0,485.0
Udham Singh Nagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,224.0,294.0,307.0,331.0,332.0,346.0,344.0,323.0,285.0,298.0,255.0,286.0,3625.0
Udham Singh Nagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,232.0,305.0,332.0,355.0,388.0,390.0,409.0,356.0,339.0,350.0,302.0,352.0,4110.0
Udham Singh Nagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,196.0,280.0,307.0,339.0,373.0,374.0,372.0,337.0,320.0,337.0,282.0,315.0,3832.0
Udham Singh Nagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,14.0,22.0,29.0,12.0,34.0,7.0,8.0,12.0,5.0,10.0,4.0,1.0,158.0
Udham Singh Nagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1009.0,990.0,1208.0,1473.0,1690.0,1617.0,1501.0,1279.0,1408.0,1409.0,1204.0,1099.0,15887.0
Udham Singh Nagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,726.0,715.0,849.0,1114.0,1277.0,1149.0,1111.0,952.0,776.0,986.0,967.0,830.0,11452.0
Udham Singh Nagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1005.0,981.0,1097.0,1473.0,1689.0,1400.0,1721.0,1264.0,1320.0,1395.0,1237.0,1099.0,15681.0
Udham Singh Nagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,720.0,699.0,842.0,1012.0,1157.0,976.0,1462.0,882.0,955.0,902.0,966.0,951.0,11524.0
Udham Singh Nagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,487.0,494.0,569.0,657.0,710.0,711.0,777.0,734.0,862.0,767.0,,,6768.0
Udham Singh Nagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udham Singh Nagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udham Singh Nagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udham Singh Nagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,2.0,0.0,2.0,0.0,3.0,3.0,8.0,7.0,5.0,6.0,5.0,10.0,51.0
Udham Singh Nagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,31.0,23.0,33.0,63.0,70.0,35.0,45.0,27.0,59.0,30.0,46.0,4.0,466.0
Udham Singh Nagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,33.0,23.0,35.0,63.0,73.0,38.0,53.0,34.0,64.0,36.0,51.0,14.0,517.0
Udham Singh Nagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0.0,7.0,5.0,4.0,2.0,4.0,0.0,32.0,4.0,3.0,,,61.0
Udham Singh Nagar,4.1.1.a,Number of male live births,TOTAL,910.0,943.0,1134.0,1309.0,1465.0,1460.0,1414.0,1242.0,1285.0,1349.0,813.0,742.0,14066.0
Udham Singh Nagar,4.1.1.b,Number of female live births,TOTAL,806.0,835.0,952.0,1162.0,1308.0,1290.0,1258.0,1119.0,1303.0,1147.0,709.0,676.0,12565.0
Udham Singh Nagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1716.0,1778.0,2086.0,2471.0,2773.0,2750.0,2672.0,2361.0,2588.0,2496.0,1522.0,1418.0,26631.0
Udham Singh Nagar,4.1.2,Number of still births,TOTAL,17.0,15.0,26.0,18.0,18.0,36.0,19.0,12.0,27.0,26.0,31.0,16.0,261.0
Udham Singh Nagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,79.0,68.0,88.0,117.0,76.0,69.0,83.0,43.0,66.0,62.0,80.0,63.0,894.0
Udham Singh Nagar,4.2.1,Number of Newborns weighed at birth,TOTAL,1702.0,1769.0,2065.0,2467.0,2765.0,2728.0,2634.0,2350.0,2579.0,1800.0,1511.0,1405.0,25775.0
Udham Singh Nagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,56.0,63.0,42.0,59.0,85.0,65.0,54.0,61.0,59.0,60.0,46.0,42.0,692.0
Udham Singh Nagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1668.0,1741.0,2011.0,2387.0,2665.0,2626.0,2560.0,2292.0,2505.0,2433.0,1462.0,1396.0,25746.0
Udham Singh Nagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Udham Singh Nagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,2.0,0.0,1.0,0.0,8.0,11.0,8.0,4.0,1.0,8.0,7.0,5.0,55.0
Udham Singh Nagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,94.0,48.0,99.0,99.0,95.0,67.0,92.0,62.0,92.0,78.0,72.0,73.0,971.0
Udham Singh Nagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,96.0,48.0,100.0,103.0,103.0,78.0,100.0,66.0,93.0,86.0,79.0,78.0,1030.0
Udham Singh Nagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udham Singh Nagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,92.0,36.0,90.0,87.0,101.0,69.0,82.0,52.0,82.0,61.0,80.0,78.0,910.0
Udham Singh Nagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,17.0,18.0,13.0,21.0,13.0,18.0,15.0,15.0,18.0,19.0,12.0,2.0,181.0
Udham Singh Nagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,92.0,36.0,90.0,87.0,93.0,58.0,82.0,52.0,82.0,61.0,76.0,78.0,887.0
Udham Singh Nagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,44.0,37.0,40.0,50.0,47.0,46.0,56.0,38.0,36.0,26.0,13.0,10.0,443.0
Udham Singh Nagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1070.0,1186.0,1411.0,1807.0,1868.0,1950.0,1850.0,1582.0,1657.0,1716.0,1507.0,1420.0,19024.0
Udham Singh Nagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,918.0,1045.0,1392.0,1561.0,1607.0,1671.0,1753.0,1526.0,1565.0,1709.0,1375.0,1318.0,17440.0
Udham Singh Nagar,6.3,PNC maternal complications attended,TOTAL,33.0,20.0,31.0,32.0,26.0,24.0,23.0,47.0,19.0,26.0,21.0,15.0,317.0
Udham Singh Nagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,29.0,23.0,29.0,55.0,34.0,24.0,18.0,25.0,44.0,30.0,42.0,27.0,380.0
Udham Singh Nagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,8.0,9.0,8.0,10.0,5.0,14.0,5.0,5.0,6.0,6.0,5.0,5.0,86.0
Udham Singh Nagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,37.0,32.0,37.0,65.0,39.0,38.0,23.0,30.0,50.0,36.0,47.0,32.0,466.0
Udham Singh Nagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,145.0,107.0,115.0,51.0,94.0,25.0,39.0,56.0,67.0,82.0,93.0,124.0,998.0
Udham Singh Nagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,251.0,178.0,152.0,130.0,144.0,157.0,129.0,145.0,167.0,224.0,197.0,207.0,2081.0
Udham Singh Nagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,396.0,285.0,267.0,181.0,238.0,182.0,168.0,201.0,234.0,306.0,290.0,331.0,3079.0
Udham Singh Nagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
Udham Singh Nagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,2.0,6.0,6.0,20.0,12.0,7.0,3.0,11.0,9.0,8.0,1.0,20.0,105.0
Udham Singh Nagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,5.0,3.0,5.0,32.0,7.0,8.0,7.0,1.0,1.0,1.0,4.0,1.0,75.0
Udham Singh Nagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,7.0,9.0,11.0,53.0,19.0,15.0,10.0,12.0,10.0,9.0,5.0,22.0,182.0
Udham Singh Nagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udham Singh Nagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,5.0,0.0,43.0,24.0,22.0,0.0,0.0,20.0,8.0,17.0,106.0,245.0
Udham Singh Nagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,7.0,16.0,0.0,122.0,44.0,44.0,0.0,12.0,103.0,79.0,41.0,78.0,546.0
Udham Singh Nagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,7.0,21.0,0.0,165.0,68.0,66.0,0.0,12.0,123.0,87.0,58.0,184.0,791.0
Udham Singh Nagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udham Singh Nagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,29.0,8.0,0.0,44.0,20.0,55.0,14.0,0.0,90.0,71.0,33.0,40.0,404.0
Udham Singh Nagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,37.0,82.0,18.0,84.0,19.0,48.0,38.0,36.0,68.0,67.0,84.0,72.0,653.0
Udham Singh Nagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,40.0,13.0,9.0,92.0,11.0,31.0,15.0,31.0,78.0,64.0,18.0,43.0,445.0
Udham Singh Nagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,106.0,103.0,27.0,220.0,50.0,134.0,67.0,67.0,236.0,202.0,135.0,155.0,1502.0
Udham Singh Nagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udham Singh Nagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,7.0
Udham Singh Nagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,9.0,1.0,8.0,14.0,10.0,7.0,6.0,3.0,12.0,4.0,0.0,0.0,74.0
Udham Singh Nagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,9.0,1.0,8.0,14.0,10.0,7.0,6.0,3.0,19.0,4.0,0.0,0.0,81.0
Udham Singh Nagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udham Singh Nagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,934.0,1138.0,1127.0,2268.0,1508.0,1337.0,1102.0,1039.0,1200.0,1316.0,1371.0,1401.0,15741.0
Udham Singh Nagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,18.0,29.0,54.0,16.0,18.0,36.0,15.0,26.0,17.0,19.0,20.0,268.0
Udham Singh Nagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,53.0,91.0,68.0,71.0,66.0,47.0,37.0,41.0,35.0,55.0,44.0,41.0,649.0
Udham Singh Nagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,318.0,303.0,246.0,421.0,322.0,298.0,284.0,203.0,347.0,205.0,190.0,190.0,3327.0
Udham Singh Nagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1305.0,1550.0,1470.0,2814.0,1912.0,1700.0,1459.0,1298.0,1608.0,1593.0,1624.0,1652.0,19985.0
Udham Singh Nagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,195.0,241.0,244.0,292.0,262.0,192.0,163.0,144.0,219.0,209.0,184.0,167.0,2512.0
Udham Singh Nagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udham Singh Nagar,9.06,Number of IUCD removals,TOTAL,365.0,406.0,370.0,519.0,468.0,443.0,421.0,394.0,425.0,420.0,468.0,538.0,5237.0
Udham Singh Nagar,9.07,Number of Oral Pills cycles distributed,TOTAL,5734.0,2765.0,5559.0,10288.0,7778.0,6189.0,7627.0,4313.0,7603.0,8182.0,7535.0,9497.0,83070.0
Udham Singh Nagar,9.08,Number of Condom pieces distributed,TOTAL,49931.0,17216.0,12551.0,135740.0,99858.0,76017.0,82202.0,55861.0,83039.0,73310.0,60874.0,63958.0,810557.0
Udham Singh Nagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0,0.0,4.0
Udham Singh Nagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,280.0,243.0,114.0,1859.0,157.0,101.0,78.0,119.0,343.0,586.0,2899.0,2482.0,9261.0
Udham Singh Nagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Udham Singh Nagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,9.0,5.0,6.0,5.0,6.0,5.0,5.0,7.0,6.0,10.0,9.0,-1.0
Udham Singh Nagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2583.0,2763.0,2344.0,3326.0,3491.0,3439.0,3433.0,3048.0,3421.0,3169.0,2946.0,2892.0,36855.0
Udham Singh Nagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,7.0,0.0,0.0,6.0,2.0,33.0,37.0,61.0,21.0,10.0,3.0,4.0,184.0
Udham Singh Nagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,92.0,111.0,64.0,80.0,49.0,63.0,195.0,97.0,79.0,78.0,27.0,16.0,951.0
Udham Singh Nagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,357.0,232.0,90.0,112.0,82.0,102.0,199.0,91.0,76.0,93.0,49.0,27.0,1510.0
Udham Singh Nagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2996.0,2612.0,2235.0,2731.0,2634.0,3187.0,3474.0,3146.0,3346.0,3084.0,2861.0,2973.0,35279.0
Udham Singh Nagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3091.0,2688.0,2400.0,2601.0,2533.0,2764.0,3005.0,3094.0,3387.0,3194.0,2951.0,2902.0,34610.0
Udham Singh Nagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2736.0,2748.0,2376.0,2807.0,2929.0,2776.0,2665.0,2763.0,3331.0,3319.0,2950.0,2850.0,34250.0
Udham Singh Nagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1115.0,1159.0,1313.0,1652.0,1811.0,1870.0,1655.0,1518.0,1741.0,1673.0,1480.0,1257.0,18244.0
Udham Singh Nagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3001.0,2612.0,2233.0,2737.0,2638.0,3220.0,3511.0,3208.0,3361.0,3090.0,2860.0,2979.0,35450.0
Udham Singh Nagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3184.0,2799.0,2461.0,2675.0,2578.0,2827.0,3201.0,3201.0,3476.0,3270.0,2974.0,2916.0,35562.0
Udham Singh Nagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3093.0,2979.0,2463.0,2931.0,3010.0,2878.0,2863.0,2853.0,3411.0,3404.0,2997.0,2878.0,35760.0
Udham Singh Nagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,742.0,927.0,1059.0,1059.0,1220.0,1316.0,1153.0,1036.0,1162.0,1128.0,970.0,803.0,12575.0
Udham Singh Nagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,6.0,0.0,0.0,5.0,3.0,33.0,7.0,35.0,21.0,22.0,2.0,0.0,134.0
Udham Singh Nagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,92.0,108.0,64.0,81.0,49.0,45.0,40.0,41.0,59.0,61.0,8.0,9.0,657.0
Udham Singh Nagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,357.0,229.0,88.0,106.0,79.0,78.0,62.0,42.0,63.0,49.0,21.0,6.0,1180.0
Udham Singh Nagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2969.0,2936.0,2721.0,3333.0,3103.0,3284.0,3335.0,3049.0,3044.0,2685.0,2465.0,2625.0,35549.0
Udham Singh Nagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2544.0,2531.0,2368.0,3225.0,2652.0,2873.0,3802.0,2933.0,3110.0,2803.0,2733.0,2557.0,34131.0
Udham Singh Nagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3003.0,2914.0,2740.0,3284.0,2973.0,2964.0,745.0,3842.0,3222.0,2474.0,2691.0,2647.0,33499.0
Udham Singh Nagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1567.0,1506.0,1414.0,1752.0,1634.0,1718.0,1743.0,1587.0,1564.0,1439.0,1279.0,1373.0,18576.0
Udham Singh Nagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1401.0,1425.0,1302.0,1545.0,1467.0,1526.0,1566.0,1454.0,1470.0,1239.0,1169.0,1236.0,16800.0
Udham Singh Nagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2968.0,2931.0,2716.0,3297.0,3101.0,3244.0,3309.0,3041.0,3034.0,2678.0,2448.0,2609.0,35376.0
Udham Singh Nagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2418.0,2492.0,2464.0,3310.0,2688.0,3272.0,3884.0,2904.0,3040.0,2771.0,2756.0,2552.0,34551.0
Udham Singh Nagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2428.0,2489.0,2374.0,3299.0,2685.0,3272.0,3882.0,2904.0,3040.0,2773.0,2756.0,2433.0,34335.0
Udham Singh Nagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1152.0,1220.0,1095.0,1532.0,1205.0,1672.0,1873.0,1348.0,1590.0,1289.0,1351.0,1282.0,16609.0
Udham Singh Nagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1061.0,1099.0,1044.0,1413.0,1122.0,1595.0,1785.0,1258.0,1423.0,1149.0,1238.0,1177.0,15364.0
Udham Singh Nagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2213.0,2319.0,2139.0,2945.0,2327.0,3267.0,3658.0,2606.0,3013.0,2438.0,2589.0,2459.0,31973.0
Udham Singh Nagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1131.0,1090.0,1230.0,1604.0,1683.0,2471.0,2255.0,1614.0,1449.0,1708.0,1483.0,1309.0,19027.0
Udham Singh Nagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,998.0,1256.0,1238.0,1557.0,1389.0,2263.0,1631.0,1283.0,1182.0,1427.0,1082.0,1288.0,16594.0
Udham Singh Nagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,851.0,1120.0,1215.0,1208.0,1326.0,1468.0,1356.0,1061.0,999.0,1256.0,981.0,1091.0,13932.0
Udham Singh Nagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,4.0,0.0,15.0,19.0,12.0,13.0,10.0,6.0,4.0,7.0,6.0,96.0
Udham Singh Nagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1341.0,1411.0,1353.0,1469.0,1495.0,1536.0,1583.0,1543.0,1749.0,1735.0,1701.0,1763.0,18679.0
Udham Singh Nagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1190.0,1330.0,1184.0,1415.0,1441.0,1460.0,1525.0,1408.0,1647.0,1603.0,1549.0,1660.0,17412.0
Udham Singh Nagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1182.0,1280.0,1171.0,1373.0,1428.0,1428.0,1511.0,1381.0,1639.0,1587.0,1534.0,1647.0,17161.0
Udham Singh Nagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2475.0,2527.0,2378.0,3257.0,2693.0,2785.0,698.0,3559.0,3423.0,2603.0,3006.0,2676.0,32080.0
Udham Singh Nagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,139.0,1635.0,3572.0,2469.0,1315.0,280.0,204.0,157.0,0.0,418.0,4442.0,4151.0,18782.0
Udham Singh Nagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,104.0,908.0,1058.0,1367.0,421.0,149.0,213.0,28.0,0.0,269.0,5037.0,6521.0,16075.0
Udham Singh Nagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,21.0,75.0,22.0,112.0,43.0,54.0,21.0,0.0,0.0,143.0,2143.0,4276.0,6910.0
Udham Singh Nagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,51.0,48.0,33.0,36.0,32.0,56.0,29.0,12.0,27.0,24.0,60.0,173.0,581.0
Udham Singh Nagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,1125.0,0.0,0.0,0.0,81.0,0.0,1209.0
Udham Singh Nagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,11.0,9.0,14.0,12.0,5.0,9.0,14.0,18.0,13.0,16.0,18.0,12.0,151.0
Udham Singh Nagar,13.1,Number of Patients operated for cataract,TOTAL,0.0,12.0,108.0,37.0,452.0,39.0,43.0,449.0,36.0,2904.0,100.0,127.0,4307.0
Udham Singh Nagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,12.0,104.0,37.0,452.0,39.0,43.0,389.0,29.0,2891.0,81.0,127.0,4204.0
Udham Singh Nagar,13.3,Number of School children detected with Refractive errors,TOTAL,174.0,23.0,50.0,71.0,146.0,117.0,127.0,206.0,196.0,278.0,75.0,29.0,1492.0
Udham Singh Nagar,13.4,Number of children provided free glasses,TOTAL,7.0,7.0,15.0,24.0,20.0,46.0,45.0,25.0,150.0,53.0,168.0,51.0,611.0
Udham Singh Nagar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,6.0,6.0,5.0,5.0,5.0,6.0,5.0,5.0,5.0,5.0,-1.0
Udham Singh Nagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,11.0,9.0,11.0,6.0,5.0,7.0,6.0,7.0,6.0,10.0,9.0,-1.0
Udham Singh Nagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,606.0,735.0,657.0,781.0,861.0,724.0,751.0,653.0,702.0,647.0,614.0,620.0,-1.0
Udham Singh Nagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,7.0,6.0,7.0,6.0,6.0,6.0,6.0,6.0,6.0,7.0,7.0,-1.0
Udham Singh Nagar,14.05,Number of RKS meetings held during the month,TOTAL,1.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,18.0
Udham Singh Nagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,7.0,9.0,6.0,8.0,5.0,3.0,5.0,6.0,5.0,6.0,9.0,8.0,-1.0
Udham Singh Nagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,2.0,4.0,8.0,4.0,6.0,2.0,3.0,5.0,9.0,9.0,8.0,7.0,67.0
Udham Singh Nagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,4.0,4.0,4.0,3.0,3.0,3.0,4.0,3.0,4.0,3.0,4.0,-1.0
Udham Singh Nagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,0.0,2.0,2.0,2.0,0.0,2.0,2.0,2.0,2.0,-1.0
Udham Singh Nagar,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,391.0,434.0,632.0,494.0,524.0,495.0,439.0,399.0,400.0,437.0,375.0,309.0,5329.0
Udham Singh Nagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,623.0,671.0,657.0,681.0,651.0,603.0,621.0,558.0,497.0,444.0,497.0,631.0,7134.0
Udham Singh Nagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,323.0,604.0,1064.0,430.0,455.0,447.0,437.0,327.0,375.0,404.0,572.0,239.0,5677.0
Udham Singh Nagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1930.0,1861.0,1849.0,2552.0,2190.0,2437.0,2050.0,1803.0,2006.0,1973.0,1715.0,1716.0,24082.0
Udham Singh Nagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,714.0,1038.0,1696.0,924.0,979.0,942.0,876.0,726.0,775.0,841.0,947.0,548.0,11006.0
Udham Singh Nagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2553.0,2532.0,2506.0,3233.0,2841.0,3040.0,2671.0,2361.0,2503.0,2417.0,2212.0,2347.0,31216.0
Udham Singh Nagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,5.0,4.0,3.0,1.0,6.0,4.0,3.0,0.0,7.0,8.0,49.0,93.0
Udham Singh Nagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,3.0,1.0,3.0,0.0,3.0,1.0,2.0,5.0,3.0,1.0,0.0,23.0
Udham Singh Nagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,4.0,8.0,5.0,6.0,1.0,9.0,5.0,5.0,5.0,10.0,9.0,49.0,116.0
Udham Singh Nagar,14.11,In-Patient Head Count at midnight,TOTAL,1643.0,1571.0,1559.0,1957.0,1991.0,1979.0,1821.0,1489.0,1303.0,1510.0,1469.0,1726.0,20018.0
Udham Singh Nagar,14.12.1,OPD attendance (All),TOTAL,81494.0,86229.0,84564.0,84496.0,96103.0,110211.0,92833.0,85213.0,91239.0,83884.0,88204.0,175031.0,1159501.0
Udham Singh Nagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,183.0,147.0,69.0,82.0,114.0,69.0,73.0,73.0,94.0,72.0,98.0,48.0,1122.0
Udham Singh Nagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,20.0,1.0,5.0,3.0,9.0,2.0,3.0,4.0,3.0,4.0,9.0,6.0,69.0
Udham Singh Nagar,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,37.0,49.0,59.0,42.0,100.0,58.0,42.0,90.0,63.0,102.0,106.0,69.0,817.0
Udham Singh Nagar,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,4633.0,5406.0,4392.0,4011.0,6351.0,6466.0,7296.0,4538.0,6027.0,6787.0,6911.0,6403.0,69221.0
Udham Singh Nagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1603.0,1585.0,1729.0,2051.0,2271.0,2060.0,1910.0,1764.0,1792.0,2249.0,2286.0,1996.0,23296.0
Udham Singh Nagar,14.14.c,Number of Adolescents counselled,TOTAL,121.0,197.0,1672.0,299.0,618.0,184.0,335.0,168.0,718.0,491.0,494.0,577.0,5874.0
Udham Singh Nagar,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4162.0,4742.0,3977.0,5075.0,4275.0,5263.0,4674.0,3427.0,4528.0,4092.0,4318.0,4119.0,52652.0
Udham Singh Nagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,82.0,104.0,93.0,95.0,101.0,105.0,89.0,88.0,84.0,85.0,53.0,104.0,1083.0
Udham Singh Nagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,805.0,656.0,594.0,744.0,518.0,447.0,420.0,385.0,556.0,557.0,270.0,533.0,6485.0
Udham Singh Nagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,6.0,7.0,2.0,3.0,2.0,3.0,3.0,2.0,6.0,5.0,1.0,5.0,45.0
Udham Singh Nagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,568.0,552.0,429.0,639.0,314.0,311.0,412.0,390.0,631.0,842.0,327.0,525.0,5940.0
Udham Singh Nagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,0.0,2.0,1.0,2.0,0.0,2.0,1.0,1.0,1.0,4.0,15.0
Udham Singh Nagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1993.0,2158.0,1734.0,2082.0,1629.0,1591.0,1470.0,1287.0,1756.0,1388.0,1420.0,1687.0,20195.0
Udham Singh Nagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,1.0,1.0,1.0,0.0,3.0,1.0,1.0,2.0,0.0,0.0,2.0,14.0
Udham Singh Nagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3366.0,3366.0,2757.0,3465.0,2461.0,2349.0,2302.0,2062.0,2943.0,2787.0,2017.0,2745.0,32620.0
Udham Singh Nagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8.0,9.0,3.0,6.0,3.0,8.0,4.0,5.0,9.0,6.0,2.0,11.0,74.0
Udham Singh Nagar,15.2,Number of Widal tests conducted,Number tested,665.0,743.0,545.0,524.0,518.0,1278.0,1150.0,463.0,267.0,309.0,479.0,562.0,7503.0
Udham Singh Nagar,15.3.a,Number of VDRL tests conducted on males,Number tested,109.0,64.0,26.0,49.0,20.0,14.0,30.0,54.0,42.0,69.0,62.0,65.0,604.0
Udham Singh Nagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,135.0,68.0,90.0,71.0,47.0,129.0,102.0,99.0,111.0,142.0,119.0,79.0,1192.0
Udham Singh Nagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,968.0,688.0,736.0,853.0,477.0,1005.0,771.0,753.0,1434.0,1206.0,1262.0,935.0,11088.0
Udham Singh Nagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1212.0,820.0,852.0,973.0,544.0,1148.0,903.0,906.0,1587.0,1417.0,1443.0,1079.0,12884.0
Udham Singh Nagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,1081.0,1116.0,1015.0,779.0,1025.0,2105.0,1815.0,1308.0,727.0,695.0,865.0,938.0,13469.0
Udham Singh Nagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,10.0,11.0,8.0,4.0,10.0,24.0,14.0,2.0,4.0,4.0,1.0,4.0,96.0
Udham Singh Nagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2000.0,0.0,1000.0,7000.0,10500.0,5500.0,5500.0,500.0,4000.0,11500.0,6000.0,6500.0,60000.0
Udham Singh Nagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2500.0,6000.0,11000.0,11000.0,0.0,4000.0,5500.0,10000.0,14000.0,10000.0,6000.0,0.0,80000.0
Udham Singh Nagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4500.0,5000.0,5000.0,7500.0,5000.0,4000.0,10500.0,6500.0,6500.0,15500.0,5500.0,4500.0,80000.0
Udham Singh Nagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,1000.0,7000.0,10500.0,5500.0,5500.0,500.0,4000.0,11500.0,6000.0,6500.0,2000.0,60000.0
Udham Singh Nagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,15750.0,6000.0,5000.0,1300.0,7500.0,1500.0,1000.0,2000.0,2000.0,12000.0,6000.0,12200.0,72250.0
Udham Singh Nagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,8500.0,1500.0,18000.0,2000.0,4500.0,14000.0,6000.0,22000.0,10000.0,14000.0,0.0,100500.0
Udham Singh Nagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,9750.0,9500.0,5200.0,11800.0,8000.0,5000.0,13000.0,6000.0,12000.0,16000.0,7800.0,7800.0,111850.0
Udham Singh Nagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,6000.0,5000.0,1300.0,7500.0,1500.0,1000.0,2000.0,2000.0,12000.0,6000.0,12200.0,4400.0,60900.0
Udham Singh Nagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3000.0,7500.0,12000.0,7500.0,12500.0,2500.0,4500.0,3000.0,8500.0,8500.0,11500.0,7000.0,88000.0
Udham Singh Nagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,17000.0,10000.0,22000.0,4000.0,15000.0,21000.0,20000.0,20000.0,20000.0,0.0,0.0,169000.0
Udham Singh Nagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,15500.0,12500.0,14500.0,17000.0,14000.0,13000.0,22500.0,14500.0,20000.0,17000.0,4500.0,3000.0,168000.0
Udham Singh Nagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,7500.0,12000.0,7500.0,12500.0,2500.0,4500.0,3000.0,8500.0,8500.0,11500.0,7000.0,4000.0,89000.0
Udham Singh Nagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,8000.0,4000.0,7500.0,9000.0,10000.0,2000.0,6000.0,11000.0,11000.0,14000.0,4000.0,3000.0,89500.0
Udham Singh Nagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,5000.0,10500.0,10500.0,14000.0,1500.0,15000.0,15000.0,6000.0,14000.0,10000.0,5000.0,10000.0,116500.0
Udham Singh Nagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,9000.0,7000.0,9000.0,13000.0,9500.0,11000.0,10000.0,6000.0,11000.0,20000.0,6000.0,7000.0,118500.0
Udham Singh Nagar,16.1.3,Stock position of TT vaccines,5. Total Stock,4000.0,7500.0,9000.0,10000.0,2000.0,6000.0,11000.0,11000.0,14000.0,4000.0,3000.0,6000.0,87500.0
Udham Singh Nagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4500.0,4000.0,4000.0,5000.0,6000.0,6000.0,4000.0,5500.0,8000.0,7000.0,6500.0,500.0,61000.0
Udham Singh Nagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,6000.0,5000.0,5000.0,8000.0,5000.0,3000.0,10000.0,6000.0,11000.0,6000.0,0.0,5000.0,70000.0
Udham Singh Nagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6500.0,5000.0,4000.0,7000.0,5000.0,5000.0,8500.0,3500.0,12000.0,6500.0,6000.0,5000.0,74000.0
Udham Singh Nagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,4000.0,4000.0,5000.0,6000.0,6000.0,4000.0,5500.0,8000.0,7000.0,6500.0,500.0,500.0,57000.0
Udham Singh Nagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,6250.0,1500.0,5000.0,4250.0,6000.0,2650.0,6250.0,3250.0,4750.0,5000.0,6500.0,750.0,52150.0
Udham Singh Nagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2500.0,9000.0,5000.0,11500.0,3000.0,10000.0,7000.0,8000.0,12000.0,10000.0,0.0,7000.0,85000.0
Udham Singh Nagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7250.0,5500.0,5750.0,9750.0,6350.0,6400.0,10000.0,6500.0,11750.0,8500.0,5750.0,7000.0,90500.0
Udham Singh Nagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,1500.0,5000.0,4250.0,6000.0,2650.0,6250.0,3250.0,4750.0,5000.0,6500.0,750.0,750.0,46650.0
Udham Singh Nagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,16000.0,10000.0,5000.0,19000.0,9000.0,1400.0,0.0,0.0,9000.0,0.0,13500.0,3000.0,85900.0
Udham Singh Nagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,20000.0,0.0,0.0,0.0,0.0,20000.0,0.0,20000.0,0.0,0.0,60000.0
Udham Singh Nagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,6000.0,5000.0,6000.0,10000.0,7600.0,1400.0,0.0,11000.0,9000.0,6500.0,10500.0,3000.0,76000.0
Udham Singh Nagar,16.1.7,Stock position of JE vaccines,5. Total Stock,10000.0,5000.0,19000.0,9000.0,1400.0,0.0,0.0,9000.0,0.0,13500.0,3000.0,0.0,69900.0
Udham Singh Nagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,10800.0,8100.0,7200.0,6000.0,5400.0,5100.0,4500.0,600.0,4500.0,3000.0,3300.0,2700.0,61200.0
Udham Singh Nagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,6000.0,0.0,3000.0,0.0,0.0,9000.0
Udham Singh Nagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2700.0,900.0,1200.0,600.0,300.0,600.0,3900.0,2100.0,1500.0,2700.0,600.0,1500.0,18600.0
Udham Singh Nagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,8100.0,7200.0,6000.0,5400.0,5100.0,4500.0,600.0,4500.0,3000.0,3300.0,2700.0,1200.0,51600.0
Udham Singh Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,18800.0,15300.0,15300.0,15300.0,23714.0,22514.0,20114.0,30314.0,27914.0,23114.0,20114.0,12914.0,245412.0
Udham Singh Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,18914.0,0.0,0.0,12000.0,0.0,0.0,0.0,0.0,0.0,30914.0
Udham Singh Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,3500.0,0.0,0.0,10500.0,1200.0,2400.0,1800.0,2400.0,4800.0,3000.0,7200.0,0.0,36800.0
Udham Singh Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,15300.0,15300.0,15300.0,23714.0,22514.0,20114.0,30314.0,27914.0,23114.0,20114.0,12914.0,12914.0,239526.0
Udham Singh Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,30240.0,0.0,0.0,0.0,206880.0,131040.0,45360.0,228720.0,142320.0,30000.0,76560.0,25200.0,916320.0
Udham Singh Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,428400.0,0.0,0.0,250800.0,0.0,0.0,100800.0,0.0,0.0,780000.0
Udham Singh Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,30240.0,0.0,0.0,221520.0,75840.0,85680.0,67440.0,86400.0,112320.0,54240.0,51360.0,5040.0,790080.0
Udham Singh Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,206880.0,131040.0,45360.0,228720.0,142320.0,30000.0,76560.0,25200.0,20160.0,906240.0
Udham Singh Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,12600.0,6000.0,3000.0,1800.0,18000.0,10800.0,4800.0,31000.0,24400.0,11800.0,40600.0,25600.0,190400.0
Udham Singh Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,30000.0,0.0,0.0,32000.0,0.0,0.0,38000.0,0.0,0.0,100000.0
Udham Singh Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,6600.0,3000.0,1200.0,13800.0,7200.0,6000.0,5800.0,6600.0,12600.0,9200.0,15000.0,3800.0,90800.0
Udham Singh Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,6000.0,3000.0,1800.0,18000.0,10800.0,4800.0,31000.0,24400.0,11800.0,40600.0,25600.0,21800.0,199600.0
Udham Singh Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3600.0,3000.0,3000.0,3000.0,0.0,0.0,0.0,19000.0,17000.0,13000.0,14000.0,7000.0,82600.0
Udham Singh Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,0.0,0.0,20000.0,0.0,0.0,40000.0
Udham Singh Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,600.0,0.0,0.0,3000.0,0.0,0.0,1000.0,2000.0,4000.0,19000.0,7000.0,0.0,36600.0
Udham Singh Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,3000.0,3000.0,3000.0,0.0,0.0,0.0,19000.0,17000.0,13000.0,14000.0,7000.0,7000.0,86000.0
Udham Singh Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1000.0,1000.0,1000.0,1000.0,2950.0,2950.0,2950.0,3150.0,3150.0,2650.0,2650.0,2000.0,26450.0
Udham Singh Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1950.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,3950.0
Udham Singh Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,1800.0,0.0,500.0,0.0,650.0,0.0,2950.0
Udham Singh Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1000.0,1000.0,1000.0,2950.0,2950.0,2950.0,3150.0,3150.0,2650.0,2650.0,2000.0,2000.0,27450.0
Udham Singh Nagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Udham Singh Nagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6732.0,0.0,6732.0
Udham Singh Nagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8820.0,0.0,450.0,9270.0
Udham Singh Nagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2088.0,6732.0,0.0,8820.0
Udham Singh Nagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6732.0,0.0,450.0,7182.0
Udham Singh Nagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,98040.0,95840.0,94560.0,109040.0,397480.0
Udham Singh Nagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,99280.0,0.0,0.0,16200.0,0.0,115480.0
Udham Singh Nagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1240.0,2200.0,1280.0,1720.0,2160.0,8600.0
Udham Singh Nagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,98040.0,95840.0,94560.0,109040.0,106880.0,504360.0
Udham Singh Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,5200.0,1000.0,0.0,1400.0,4200.0,600.0,6400.0,200.0,4200.0,4200.0,11400.0,17000.0,55800.0
Udham Singh Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,2000.0,6000.0,0.0,8000.0,0.0,8000.0,4000.0,15000.0,12000.0,0.0,55000.0
Udham Singh Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,4200.0,1000.0,600.0,3200.0,3600.0,2200.0,6200.0,4000.0,4000.0,7800.0,6400.0,13000.0,56200.0
Udham Singh Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1000.0,0.0,1400.0,4200.0,600.0,6400.0,200.0,4200.0,4200.0,11400.0,17000.0,4000.0,54600.0
Udham Singh Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,36000.0,2500.0,14400.0,43200.0,43200.0,63200.0,77600.0,14400.0,57600.0,57600.0,127800.0,163800.0,701300.0
Udham Singh Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,36000.0,46800.0,54000.0,56000.0,43200.0,0.0,72000.0,36000.0,120600.0,72000.0,0.0,536600.0
Udham Singh Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,33500.0,24100.0,18000.0,54000.0,36000.0,28800.0,63200.0,28800.0,36000.0,50400.0,36000.0,32400.0,441200.0
Udham Singh Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,2500.0,14400.0,43200.0,43200.0,63200.0,77600.0,14400.0,57600.0,57600.0,127800.0,163800.0,131400.0,796700.0
Udham Singh Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,6200.0,3600.0,400.0,3300.0,8200.0,8500.0,8400.0,3800.0,12000.0,12000.0,24800.0,28300.0,119500.0
Udham Singh Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,4000.0,6000.0,2000.0,2000.0,0.0,10000.0,2000.0,19800.0,8000.0,0.0,53800.0
Udham Singh Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udham Singh Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2600.0,3200.0,1100.0,1100.0,1700.0,2100.0,4600.0,1800.0,2000.0,7000.0,4500.0,4000.0,35700.0
Udham Singh Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3600.0,400.0,3300.0,8200.0,8500.0,8400.0,3800.0,12000.0,12000.0,24800.0,28300.0,24300.0,137600.0
Udham Singh Nagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Udham Singh Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Udham Singh Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Udham Singh Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Udham Singh Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Udham Singh Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Udham Singh Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Udham Singh Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Udham Singh Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Udham Singh Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Udham Singh Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Udham Singh Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Udham Singh Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Udham Singh Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Udham Singh Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Udham Singh Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Udham Singh Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Udham Singh Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Udham Singh Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Udham Singh Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,1.0,,1.0,1.0,,,,,,3.0
Udham Singh Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,1.0,1.0,,1.0,1.0,,1.0,2.0,,,7.0
Udham Singh Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,1.0,2.0,,2.0,2.0,,1.0,2.0,,,10.0
Udham Singh Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Udham Singh Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,1.0,,,,1.0
Udham Singh Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Udham Singh Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Uttarkashi,1.1,Total number of pregnant women Registered for ANC,TOTAL,559.0,527.0,460.0,535.0,539.0,474.0,513.0,388.0,450.0,460.0,575.0,593.0,6073.0
Uttarkashi,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,214.0,178.0,193.0,214.0,220.0,213.0,206.0,185.0,205.0,198.0,376.0,327.0,2729.0
Uttarkashi,1.2,Number of Pregnant women registered under JSY,TOTAL,559.0,527.0,460.0,535.0,539.0,474.0,513.0,388.0,450.0,460.0,575.0,593.0,6073.0
Uttarkashi,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,284.0,313.0,357.0,381.0,359.0,390.0,328.0,349.0,341.0,249.0,325.0,348.0,4024.0
Uttarkashi,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,559.0,526.0,460.0,534.0,536.0,473.0,511.0,388.0,450.0,458.0,575.0,589.0,6059.0
Uttarkashi,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,477.0,495.0,485.0,459.0,460.0,490.0,456.0,450.0,372.0,405.0,475.0,549.0,5573.0
Uttarkashi,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,0.0,52.0,88.0,285.0,387.0,381.0,301.0,209.0,221.0,137.0,150.0,117.0,2328.0
Uttarkashi,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,24.0,20.0,10.0,7.0,4.0,6.0,19.0,11.0,9.0,13.0,10.0,8.0,141.0
Uttarkashi,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,1.0,1.0,1.0,2.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,7.0
Uttarkashi,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,877.0,1005.0,959.0,872.0,935.0,876.0,721.0,863.0,1041.0,1009.0,965.0,1011.0,11134.0
Uttarkashi,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,10.0,24.0,7.0,15.0,17.0,11.0,9.0,23.0,34.0,19.0,8.0,16.0,193.0
Uttarkashi,1.8,Number of pregnancy test kits used at SC level,TOTAL,64.0,33.0,232.0,236.0,215.0,205.0,197.0,168.0,142.0,182.0,278.0,267.0,2219.0
Uttarkashi,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,3.0,1.0,7.0,4.0,6.0,7.0,4.0,4.0,0.0,7.0,4.0,3.0,50.0
Uttarkashi,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,66.0,72.0,73.0,111.0,83.0,85.0,74.0,86.0,79.0,66.0,76.0,65.0,936.0
Uttarkashi,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,69.0,73.0,80.0,115.0,89.0,92.0,78.0,90.0,79.0,73.0,80.0,68.0,986.0
Uttarkashi,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,59.0,70.0,82.0,94.0,68.0,78.0,54.0,78.0,68.0,64.0,69.0,42.0,826.0
Uttarkashi,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,42.0,19.0,19.0,42.0,54.0,43.0,35.0,21.0,31.0,30.0,28.0,50.0,414.0
Uttarkashi,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,242.0,259.0,267.0,306.0,297.0,294.0,361.0,331.0,278.0,297.0,268.0,300.0,3500.0
Uttarkashi,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,133.0,140.0,147.0,127.0,137.0,130.0,192.0,219.0,134.0,171.0,157.0,167.0,1854.0
Uttarkashi,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,241.0,257.0,265.0,304.0,293.0,292.0,357.0,329.0,277.0,291.0,263.0,297.0,3466.0
Uttarkashi,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,65.0,69.0,86.0,281.0,83.0,150.0,101.0,163.0,112.0,435.0,150.0,417.0,2112.0
Uttarkashi,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Uttarkashi,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Uttarkashi,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Uttarkashi,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Uttarkashi,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,1.0,1.0,3.0,0.0,0.0,0.0,4.0,3.0,8.0,8.0,3.0,5.0,36.0
Uttarkashi,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttarkashi,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,1.0,1.0,3.0,0.0,0.0,0.0,4.0,3.0,8.0,8.0,3.0,5.0,36.0
Uttarkashi,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Uttarkashi,4.1.1.a,Number of male live births,TOTAL,146.0,173.0,161.0,217.0,206.0,194.0,236.0,230.0,178.0,184.0,192.0,192.0,2309.0
Uttarkashi,4.1.1.b,Number of female live births,TOTAL,153.0,152.0,180.0,199.0,168.0,180.0,200.0,179.0,173.0,180.0,152.0,169.0,2085.0
Uttarkashi,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,299.0,325.0,341.0,416.0,374.0,374.0,436.0,409.0,351.0,364.0,344.0,361.0,4394.0
Uttarkashi,4.1.2,Number of still births,TOTAL,11.0,9.0,6.0,7.0,13.0,12.0,6.0,14.0,6.0,6.0,5.0,8.0,103.0
Uttarkashi,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,18.0,18.0,25.0,13.0,17.0,17.0,15.0,16.0,21.0,26.0,42.0,27.0,255.0
Uttarkashi,4.2.1,Number of Newborns weighed at birth,TOTAL,297.0,316.0,340.0,413.0,372.0,368.0,425.0,402.0,338.0,360.0,339.0,358.0,4328.0
Uttarkashi,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,6.0,14.0,19.0,22.0,29.0,30.0,29.0,38.0,18.0,25.0,21.0,31.0,282.0
Uttarkashi,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,282.0,316.0,337.0,411.0,360.0,368.0,422.0,392.0,337.0,352.0,339.0,350.0,4266.0
Uttarkashi,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Uttarkashi,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,22.0,20.0,15.0,16.0,44.0,20.0,46.0,40.0,20.0,26.0,31.0,26.0,326.0
Uttarkashi,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttarkashi,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,22.0,20.0,16.0,16.0,44.0,20.0,46.0,40.0,20.0,26.0,31.0,26.0,327.0
Uttarkashi,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Uttarkashi,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,11.0,12.0,6.0,15.0,20.0,12.0,30.0,35.0,10.0,7.0,6.0,6.0,170.0
Uttarkashi,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,1.0,1.0,1.0,2.0,1.0,1.0,0.0,0.0,0.0,8.0,9.0,24.0
Uttarkashi,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,11.0,8.0,3.0,5.0,10.0,8.0,10.0,5.0,10.0,9.0,6.0,12.0,97.0
Uttarkashi,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,1.0,8.0,11.0,14.0,12.0,12.0,5.0,23.0,7.0,19.0,12.0,4.0,128.0
Uttarkashi,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,146.0,248.0,249.0,333.0,282.0,262.0,377.0,325.0,285.0,316.0,279.0,299.0,3401.0
Uttarkashi,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,139.0,166.0,154.0,188.0,196.0,221.0,194.0,173.0,155.0,166.0,153.0,145.0,2050.0
Uttarkashi,6.3,PNC maternal complications attended,TOTAL,0.0,6.0,2.0,10.0,10.0,5.0,0.0,0.0,0.0,0.0,2.0,3.0,38.0
Uttarkashi,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,12.0,10.0,8.0,7.0,5.0,2.0,2.0,3.0,9.0,20.0,29.0,16.0,123.0
Uttarkashi,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,12.0,10.0,8.0,7.0,5.0,2.0,2.0,3.0,9.0,20.0,29.0,16.0,123.0
Uttarkashi,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,53.0,52.0,68.0,71.0,74.0,72.0,51.0,68.0,50.0,51.0,67.0,87.0,764.0
Uttarkashi,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,177.0,204.0,256.0,259.0,264.0,279.0,260.0,221.0,205.0,194.0,242.0,230.0,2791.0
Uttarkashi,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,230.0,256.0,324.0,330.0,338.0,351.0,311.0,289.0,255.0,245.0,309.0,317.0,3555.0
Uttarkashi,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,4.0,16.0,11.0,3.0,1.0,36.0
Uttarkashi,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,4.0,2.0,5.0,5.0,0.0,18.0
Uttarkashi,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,1.0,2.0,0.0,0.0,1.0,1.0,6.0
Uttarkashi,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttarkashi,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,1.0,1.0,1.0,2.0,10.0,18.0,16.0,9.0,2.0,60.0
Uttarkashi,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Uttarkashi,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,0.0,52.0,239.0,120.0,53.0,5.0,473.0
Uttarkashi,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,7.0,0.0,2.0,6.0,98.0,225.0,100.0,19.0,0.0,457.0
Uttarkashi,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,2.0,0.0,0.0,1.0,3.0,3.0,3.0,7.0,24.0,31.0,22.0,13.0,109.0
Uttarkashi,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttarkashi,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,2.0,0.0,0.0,12.0,3.0,5.0,9.0,157.0,488.0,251.0,94.0,18.0,1039.0
Uttarkashi,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Uttarkashi,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttarkashi,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Uttarkashi,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttarkashi,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Uttarkashi,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,61.0,89.0,98.0,234.0,98.0,148.0,111.0,89.0,114.0,136.0,186.0,168.0,1532.0
Uttarkashi,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,1.0,3.0,4.0,3.0,1.0,0.0,7.0,3.0,8.0,8.0,4.0,42.0
Uttarkashi,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,14.0,5.0,15.0,16.0,8.0,9.0,15.0,8.0,10.0,6.0,20.0,19.0,145.0
Uttarkashi,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,26.0,28.0,30.0,38.0,36.0,22.0,22.0,31.0,31.0,24.0,25.0,33.0,346.0
Uttarkashi,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttarkashi,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,101.0,123.0,146.0,292.0,145.0,180.0,148.0,135.0,158.0,174.0,239.0,224.0,2065.0
Uttarkashi,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,35.0,34.0,37.0,64.0,42.0,35.0,35.0,39.0,43.0,30.0,40.0,44.0,478.0
Uttarkashi,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Uttarkashi,9.06,Number of IUCD removals,TOTAL,18.0,23.0,10.0,38.0,33.0,35.0,34.0,34.0,43.0,42.0,57.0,56.0,423.0
Uttarkashi,9.07,Number of Oral Pills cycles distributed,TOTAL,975.0,1203.0,1251.0,2119.0,1469.0,1443.0,1438.0,1371.0,1271.0,1040.0,1318.0,1293.0,16191.0
Uttarkashi,9.08,Number of Condom pieces distributed,TOTAL,13536.0,17380.0,16809.0,27959.0,16903.0,16786.0,17351.0,15245.0,14911.0,13571.0,15588.0,14853.0,200892.0
Uttarkashi,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,47.0,31.0,71.0,306.0,72.0,1.0,2.0,0.0,0.0,0.0,24.0,29.0,583.0
Uttarkashi,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,9.12,Number of Institutions having NSV trained doctors,TOTAL,,1.0,1.0,1.0,,3.0,1.0,,1.0,2.0,,,-1.0
Uttarkashi,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,376.0,419.0,317.0,424.0,489.0,448.0,719.0,490.0,428.0,466.0,434.0,461.0,5471.0
Uttarkashi,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,26.0,23.0,15.0,2.0,2.0,1.0,70.0
Uttarkashi,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,7.0,12.0,5.0,3.0,0.0,0.0,5.0,24.0,14.0,18.0,3.0,5.0,96.0
Uttarkashi,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,48.0,19.0,9.0,4.0,3.0,0.0,9.0,7.0,27.0,11.0,5.0,8.0,150.0
Uttarkashi,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,419.0,482.0,395.0,394.0,453.0,416.0,636.0,499.0,549.0,473.0,465.0,479.0,5660.0
Uttarkashi,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,468.0,442.0,483.0,441.0,384.0,440.0,448.0,657.0,512.0,540.0,470.0,484.0,5769.0
Uttarkashi,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,418.0,453.0,429.0,486.0,415.0,390.0,426.0,467.0,618.0,476.0,533.0,466.0,5577.0
Uttarkashi,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,233.0,243.0,266.0,302.0,287.0,279.0,322.0,399.0,202.0,267.0,258.0,262.0,3320.0
Uttarkashi,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,415.0,482.0,395.0,394.0,451.0,415.0,645.0,489.0,560.0,474.0,468.0,481.0,5669.0
Uttarkashi,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,473.0,454.0,488.0,442.0,384.0,439.0,452.0,692.0,525.0,559.0,471.0,486.0,5865.0
Uttarkashi,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,463.0,474.0,438.0,490.0,418.0,387.0,435.0,444.0,641.0,487.0,534.0,474.0,5685.0
Uttarkashi,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,211.0,225.0,245.0,276.0,252.0,262.0,304.0,302.0,181.0,253.0,240.0,253.0,3004.0
Uttarkashi,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,3.0
Uttarkashi,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7.0,12.0,5.0,3.0,0.0,0.0,4.0,5.0,3.0,5.0,0.0,0.0,44.0
Uttarkashi,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,48.0,19.0,9.0,4.0,3.0,0.0,8.0,7.0,3.0,2.0,0.0,1.0,104.0
Uttarkashi,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,392.0,478.0,476.0,534.0,468.0,439.0,590.0,452.0,444.0,412.0,428.0,420.0,5533.0
Uttarkashi,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,426.0,441.0,403.0,410.0,418.0,386.0,677.0,460.0,445.0,424.0,434.0,465.0,5389.0
Uttarkashi,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,199.0,243.0,253.0,281.0,258.0,234.0,314.0,252.0,225.0,199.0,232.0,209.0,2899.0
Uttarkashi,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,193.0,235.0,223.0,255.0,210.0,205.0,276.0,200.0,219.0,213.0,196.0,209.0,2634.0
Uttarkashi,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,392.0,478.0,476.0,536.0,468.0,439.0,590.0,452.0,444.0,412.0,428.0,418.0,5533.0
Uttarkashi,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,433.0,442.0,401.0,408.0,408.0,384.0,679.0,460.0,445.0,423.0,434.0,465.0,5382.0
Uttarkashi,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,433.0,442.0,401.0,407.0,408.0,384.0,679.0,460.0,445.0,423.0,435.0,465.0,5382.0
Uttarkashi,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,27.0,26.0,14.0,25.0,17.0,15.0,29.0,17.0,17.0,14.0,14.0,27.0,242.0
Uttarkashi,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,16.0,18.0,18.0,17.0,17.0,12.0,19.0,14.0,10.0,17.0,6.0,24.0,188.0
Uttarkashi,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,43.0,44.0,32.0,42.0,34.0,27.0,48.0,31.0,27.0,31.0,20.0,51.0,430.0
Uttarkashi,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,327.0,358.0,394.0,386.0,357.0,360.0,429.0,325.0,311.0,320.0,323.0,354.0,4244.0
Uttarkashi,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,303.0,375.0,365.0,313.0,360.0,366.0,372.0,259.0,310.0,276.0,301.0,318.0,3918.0
Uttarkashi,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,294.0,338.0,326.0,306.0,300.0,337.0,307.0,244.0,258.0,242.0,281.0,444.0,3677.0
Uttarkashi,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,2.0,1.0,8.0,62.0,26.0,2.0,2.0,2.0,30.0,2.0,138.0
Uttarkashi,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Uttarkashi,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,7.0,7.0,14.0,41.0,51.0,45.0,95.0,114.0,136.0,88.0,67.0,113.0,778.0
Uttarkashi,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,342.0,368.0,362.0,381.0,362.0,334.0,467.0,415.0,464.0,480.0,457.0,424.0,4856.0
Uttarkashi,10.4.2,Number of Immunisation sessions held during the month,TOTAL,327.0,346.0,332.0,339.0,340.0,320.0,442.0,390.0,448.0,474.0,450.0,417.0,4625.0
Uttarkashi,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,289.0,317.0,316.0,322.0,314.0,277.0,366.0,353.0,410.0,434.0,417.0,393.0,4208.0
Uttarkashi,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,2.0,6.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Uttarkashi,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,260.0,288.0,441.0,456.0,2317.0,222.0,208.0,140.0,161.0,174.0,181.0,206.0,5054.0
Uttarkashi,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,43.0,47.0,50.0,46.0,30.0,21.0,31.0,27.0,40.0,25.0,41.0,10.0,411.0
Uttarkashi,13.1,Number of Patients operated for cataract,TOTAL,32.0,10.0,28.0,14.0,19.0,24.0,21.0,36.0,22.0,100.0,88.0,31.0,425.0
Uttarkashi,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,32.0,10.0,28.0,14.0,18.0,24.0,21.0,35.0,22.0,100.0,88.0,31.0,423.0
Uttarkashi,13.3,Number of School children detected with Refractive errors,TOTAL,6.0,3.0,0.0,10.0,48.0,14.0,26.0,14.0,28.0,3.0,12.0,1.0,165.0
Uttarkashi,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,11.0,8.0,48.0,1.0,43.0,0.0,14.0,33.0,0.0,158.0
Uttarkashi,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,3.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Uttarkashi,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,2.0,2.0,,,,,,-1.0
Uttarkashi,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,178.0,192.0,196.0,213.0,209.0,209.0,152.0,147.0,153.0,187.0,216.0,214.0,-1.0
Uttarkashi,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,3.0,-1.0
Uttarkashi,14.05,Number of RKS meetings held during the month,TOTAL,1.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,1.0,0.0,2.0,1.0,9.0
Uttarkashi,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,6.0,4.0,6.0,5.0,6.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Uttarkashi,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,15.0,14.0,36.0,17.0,20.0,26.0,9.0,9.0,3.0,11.0,9.0,13.0,182.0
Uttarkashi,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,3.0,2.0,2.0,2.0,2.0,3.0,2.0,3.0,2.0,3.0,-1.0
Uttarkashi,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Uttarkashi,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Uttarkashi,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Uttarkashi,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Uttarkashi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,296.0,333.0,210.0,273.0,204.0,201.0,215.0,167.0,170.0,152.0,185.0,226.0,2632.0
Uttarkashi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,199.0,449.0,703.0,587.0,434.0,460.0,418.0,291.0,275.0,342.0,305.0,359.0,4822.0
Uttarkashi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,491.0,406.0,165.0,173.0,145.0,174.0,147.0,114.0,159.0,152.0,165.0,234.0,2525.0
Uttarkashi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,378.0,598.0,881.0,1133.0,1079.0,855.0,881.0,568.0,1088.0,704.0,650.0,731.0,9546.0
Uttarkashi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,787.0,739.0,375.0,446.0,349.0,375.0,362.0,281.0,329.0,304.0,350.0,460.0,5157.0
Uttarkashi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,577.0,1047.0,1584.0,1720.0,1513.0,1315.0,1299.0,859.0,1363.0,1046.0,955.0,1090.0,14368.0
Uttarkashi,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,4.0,10.0,10.0,6.0,1.0,6.0,6.0,7.0,8.0,4.0,5.0,72.0
Uttarkashi,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,3.0,2.0,4.0,5.0,7.0,4.0,0.0,1.0,8.0,3.0,4.0,45.0
Uttarkashi,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,9.0,7.0,12.0,14.0,11.0,8.0,10.0,6.0,8.0,16.0,7.0,9.0,117.0
Uttarkashi,14.11,In-Patient Head Count at midnight,TOTAL,2800.0,900.0,2472.0,2571.0,2025.0,2102.0,1858.0,2222.0,2246.0,2897.0,2120.0,396.0,24609.0
Uttarkashi,14.12.1,OPD attendance (All),TOTAL,22474.0,26518.0,26990.0,26627.0,26460.0,29539.0,24416.0,21770.0,24516.0,23613.0,26202.0,24002.0,303127.0
Uttarkashi,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,32.0,48.0,73.0,89.0,67.0,53.0,67.0,101.0,77.0,127.0,100.0,101.0,935.0
Uttarkashi,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,8.0,8.0,12.0,12.0,12.0,10.0,9.0,16.0,10.0,12.0,12.0,9.0,130.0
Uttarkashi,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Uttarkashi,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,119.0,85.0,86.0,46.0,90.0,58.0,83.0,74.0,158.0,117.0,47.0,22.0,985.0
Uttarkashi,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Uttarkashi,14.14.a,Number of patients given AYUSH treatment,TOTAL,3004.0,2780.0,2734.0,4012.0,4040.0,3605.0,2876.0,2461.0,2259.0,2302.0,2377.0,2572.0,35022.0
Uttarkashi,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,662.0,696.0,781.0,440.0,797.0,757.0,603.0,793.0,1107.0,552.0,532.0,677.0,8397.0
Uttarkashi,14.14.c,Number of Adolescents counselled,TOTAL,44.0,45.0,57.0,27.0,23.0,12.0,14.0,15.0,11.0,35.0,12.0,10.0,305.0
Uttarkashi,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Uttarkashi,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1574.0,1884.0,1803.0,1899.0,2003.0,2173.0,1813.0,1621.0,1902.0,1419.0,1542.0,1664.0,21297.0
Uttarkashi,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,21.0,39.0,21.0,36.0,38.0,25.0,30.0,42.0,32.0,30.0,29.0,36.0,379.0
Uttarkashi,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,102.0,136.0,91.0,103.0,117.0,79.0,106.0,78.0,86.0,52.0,99.0,97.0,1146.0
Uttarkashi,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,3.0
Uttarkashi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,99.0,63.0,105.0,122.0,132.0,109.0,112.0,122.0,172.0,146.0,115.0,143.0,1440.0
Uttarkashi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,3.0
Uttarkashi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,358.0,343.0,358.0,369.0,414.0,434.0,297.0,269.0,288.0,297.0,283.0,318.0,4028.0
Uttarkashi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Uttarkashi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,559.0,542.0,554.0,594.0,663.0,622.0,515.0,469.0,546.0,495.0,497.0,558.0,6614.0
Uttarkashi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0,7.0
Uttarkashi,15.2,Number of Widal tests conducted,Number tested,183.0,205.0,300.0,231.0,242.0,477.0,299.0,100.0,130.0,71.0,88.0,172.0,2498.0
Uttarkashi,15.3.a,Number of VDRL tests conducted on males,Number tested,12.0,19.0,12.0,15.0,15.0,21.0,18.0,31.0,20.0,31.0,19.0,60.0,273.0
Uttarkashi,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,41.0,53.0,34.0,61.0,61.0,42.0,67.0,49.0,66.0,60.0,31.0,110.0,675.0
Uttarkashi,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,166.0,142.0,205.0,159.0,245.0,213.0,157.0,189.0,197.0,85.0,65.0,44.0,1867.0
Uttarkashi,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,219.0,214.0,251.0,235.0,321.0,276.0,242.0,269.0,283.0,176.0,115.0,214.0,2815.0
Uttarkashi,15.4.1,Number of blood smears examined for Malaria,TOTAL,192.0,272.0,299.0,345.0,386.0,416.0,430.0,214.0,223.0,208.0,202.0,202.0,3389.0
Uttarkashi,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Uttarkashi,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1850.0,1150.0,750.0,3050.0,2350.0,1200.0,2300.0,2860.0,1260.0,1860.0,900.0,1900.0,21430.0
Uttarkashi,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,3500.0,0.0,0.0,2000.0,2000.0,0.0,1500.0,0.0,1500.0,1000.0,11500.0
Uttarkashi,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,700.0,400.0,1200.0,700.0,1150.0,900.0,1440.0,1600.0,900.0,960.0,500.0,1200.0,11650.0
Uttarkashi,16.1.1,Stock position of DPT vaccines,5. Total Stock,1150.0,750.0,3050.0,2350.0,1200.0,2300.0,2860.0,1260.0,1860.0,900.0,1900.0,1700.0,21280.0
Uttarkashi,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,6000.0,3800.0,2200.0,700.0,3000.0,1700.0,4500.0,3150.0,1650.0,4250.0,2350.0,3700.0,37000.0
Uttarkashi,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,4000.0,0.0,4000.0,1000.0,0.0,4000.0,0.0,2700.0,0.0,15700.0
Uttarkashi,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2200.0,1600.0,1500.0,1700.0,1300.0,1200.0,2350.0,1500.0,1400.0,1900.0,1350.0,1000.0,19000.0
Uttarkashi,16.1.1A,Stock Position of Pentavalent,5. Total Stock,3800.0,2200.0,700.0,3000.0,1700.0,4500.0,3150.0,1650.0,4250.0,2350.0,3700.0,2700.0,33700.0
Uttarkashi,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,6000.0,4700.0,2800.0,1500.0,4200.0,2700.0,1480.0,7480.0,3780.0,60680.0,540.0,2040.0,97900.0
Uttarkashi,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,2000.0,7000.0,0.0,3000.0,10000.0,0.0,60000.0,0.0,62000.0,0.0,144000.0
Uttarkashi,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1300.0,1900.0,3300.0,4300.0,1500.0,4220.0,4000.0,3700.0,3100.0,60140.0,60500.0,0.0,147960.0
Uttarkashi,16.1.2,Stock position of OPV vaccines,5. Total Stock,4700.0,2800.0,1500.0,4200.0,2700.0,1480.0,7480.0,3780.0,60680.0,540.0,2040.0,2040.0,93940.0
Uttarkashi,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2880.0,1480.0,230.0,5030.0,3530.0,2770.0,6070.0,6870.0,5370.0,6070.0,4070.0,4770.0,49140.0
Uttarkashi,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,8000.0,2000.0,0.0,6000.0,3000.0,0.0,3000.0,0.0,2000.0,2000.0,26000.0
Uttarkashi,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1400.0,1250.0,3200.0,3500.0,760.0,2700.0,2200.0,1500.0,2300.0,2000.0,1300.0,1300.0,23410.0
Uttarkashi,16.1.3,Stock position of TT vaccines,5. Total Stock,1480.0,230.0,5030.0,3530.0,2770.0,6070.0,6870.0,5370.0,6070.0,4070.0,4770.0,5470.0,51730.0
Uttarkashi,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4230.0,3530.0,2330.0,4780.0,3980.0,2880.0,3580.0,5830.0,3780.0,2180.0,1480.0,3480.0,42060.0
Uttarkashi,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,3000.0,0.0,0.0,2000.0,6000.0,0.0,0.0,0.0,3000.0,0.0,14000.0
Uttarkashi,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,700.0,1200.0,550.0,800.0,1100.0,1300.0,3750.0,2050.0,1600.0,700.0,1000.0,1300.0,16050.0
Uttarkashi,16.1.5,Stock position of BCG vaccines,5. Total Stock,3530.0,2330.0,4780.0,3980.0,2880.0,3580.0,5830.0,3780.0,2180.0,1480.0,3480.0,2180.0,40010.0
Uttarkashi,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4050.0,3050.0,1350.0,3350.0,1600.0,1250.0,3750.0,6000.0,4250.0,2625.0,1000.0,2000.0,34275.0
Uttarkashi,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,3500.0,0.0,0.0,4000.0,4500.0,0.0,0.0,0.0,2000.0,2000.0,16000.0
Uttarkashi,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1000.0,1700.0,1500.0,1750.0,350.0,1500.0,2250.0,1750.0,1625.0,1625.0,1000.0,1500.0,17550.0
Uttarkashi,16.1.6,Stock position of Measles vaccines,5. Total Stock,3050.0,1350.0,3350.0,1600.0,1250.0,3750.0,6000.0,4250.0,2625.0,1000.0,2000.0,2500.0,32725.0
Uttarkashi,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,490.0,190.0,90.0,790.0,490.0,190.0,1190.0,1690.0,1640.0,1240.0,1140.0,900.0,10040.0
Uttarkashi,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,900.0,0.0,0.0,1200.0,900.0,0.0,0.0,0.0,0.0,0.0,3000.0
Uttarkashi,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,300.0,100.0,200.0,300.0,300.0,200.0,400.0,50.0,400.0,100.0,240.0,40.0,2630.0
Uttarkashi,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,190.0,90.0,790.0,490.0,190.0,1190.0,1690.0,1640.0,1240.0,1140.0,900.0,860.0,10410.0
Uttarkashi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,50.0,1276.0,1276.0,1176.0,1126.0,1126.0,1126.0,1076.0,1076.0,1076.0,1076.0,1076.0,12536.0
Uttarkashi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,4876.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4876.0
Uttarkashi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,3650.0,0.0,100.0,50.0,0.0,0.0,50.0,0.0,0.0,0.0,0.0,0.0,3850.0
Uttarkashi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1276.0,1276.0,1176.0,1126.0,1126.0,1126.0,1076.0,1076.0,1076.0,1076.0,1076.0,1076.0,13562.0
Uttarkashi,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,33600.0,33600.0,30660.0,20580.0,20580.0,20580.0,9600.0,4560.0,440.0,20600.0,20600.0,215400.0
Uttarkashi,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,151200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5040.0,25200.0,,0.0,181440.0
Uttarkashi,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Uttarkashi,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,117600.0,0.0,2940.0,10080.0,0.0,0.0,10980.0,5040.0,9160.0,5040.0,,12500.0,173340.0
Uttarkashi,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,33600.0,33600.0,30660.0,20580.0,20580.0,20580.0,9600.0,4560.0,440.0,20600.0,20600.0,8100.0,223500.0
Uttarkashi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,2900.0,2900.0,1900.0,1300.0,1300.0,1300.0,400.0,0.0,700.0,9500.0,9500.0,31700.0
Uttarkashi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,15000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,10800.0,,0.0,26800.0
Uttarkashi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Uttarkashi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,12100.0,0.0,1000.0,600.0,0.0,0.0,900.0,400.0,300.0,2000.0,,3300.0,20600.0
Uttarkashi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2900.0,2900.0,1900.0,1300.0,1300.0,1300.0,400.0,0.0,700.0,9500.0,9500.0,6200.0,37900.0
Uttarkashi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,360.0,310.0,310.0,210.0,50.0,50.0,50.0,0.0,0.0,680.0,580.0,580.0,3180.0
Uttarkashi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,,0.0,1000.0
Uttarkashi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Uttarkashi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,50.0,0.0,100.0,160.0,0.0,0.0,50.0,0.0,320.0,100.0,,0.0,780.0
Uttarkashi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,310.0,310.0,210.0,50.0,50.0,50.0,0.0,0.0,680.0,580.0,580.0,580.0,3400.0
Uttarkashi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,900.0,300.0,300.0,200.0,12100.0
Uttarkashi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,400.0,600.0,0.0,100.0,0.0,1100.0
Uttarkashi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,1300.0,900.0,300.0,300.0,200.0,200.0,11000.0
Uttarkashi,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,950.0,590.0,400.0,300.0,100.0,100.0,0.0,300.0,200.0,100.0,50.0,10.0,3100.0
Uttarkashi,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,500.0,0.0,0.0,0.0,0.0,0.0,500.0
Uttarkashi,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,360.0,190.0,100.0,200.0,0.0,100.0,200.0,100.0,100.0,50.0,40.0,0.0,1440.0
Uttarkashi,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,590.0,400.0,300.0,100.0,100.0,0.0,300.0,200.0,100.0,50.0,10.0,10.0,2160.0
Uttarkashi,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,1025.0,540.0,280.0,125.0,2135.0,1700.0,3075.0,2680.0,2455.0,1835.0,2015.0,1925.0,19790.0
Uttarkashi,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,2400.0,0.0,1825.0,0.0,0.0,0.0,500.0,0.0,0.0,4725.0
Uttarkashi,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.02,Stock Position of Gloves,4. Stock Distributed,485.0,260.0,155.0,390.0,435.0,450.0,395.0,225.0,620.0,320.0,90.0,170.0,3995.0
Uttarkashi,16.3.02,Stock Position of Gloves,5. Total Stock,540.0,280.0,125.0,2135.0,1700.0,3075.0,2680.0,2455.0,1835.0,2015.0,1925.0,1755.0,20520.0
Uttarkashi,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,200.0,200.0,100.0,50.0,20.0,18600.0,17000.0,13700.0,11800.0,10200.0,8000.0,6000.0,85870.0
Uttarkashi,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0
Uttarkashi,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,100.0,50.0,30.0,1420.0,1600.0,3300.0,1900.0,1600.0,2200.0,2000.0,1500.0,15700.0
Uttarkashi,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,200.0,100.0,50.0,20.0,18600.0,17000.0,13700.0,11800.0,10200.0,8000.0,6000.0,4500.0,90170.0
Uttarkashi,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,22.0,35.0,31.0,29.0,28.0,18.0,23.0,15.0,12.0,5.0,2.0,2.0,222.0
Uttarkashi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,20.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0
Uttarkashi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,7.0,4.0,2.0,1.0,10.0,5.0,8.0,3.0,7.0,3.0,0.0,0.0,50.0
Uttarkashi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,35.0,31.0,29.0,28.0,18.0,23.0,15.0,12.0,5.0,2.0,2.0,2.0,202.0
Uttarkashi,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,1070.0,275.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1345.0
Uttarkashi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,795.0,275.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1070.0
Uttarkashi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,275.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,275.0
Uttarkashi,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,18000.0,12750.0,9350.0,5820.0,10425.0,8500.0,7450.0,6400.0,6310.0,6085.0,16285.0,13800.0,121175.0
Uttarkashi,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,37200.0,0.0,0.0,0.0,0.0,0.0,11340.0,0.0,0.0,48540.0
Uttarkashi,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,5250.0,3400.0,3530.0,32595.0,1925.0,1050.0,1050.0,90.0,225.0,1140.0,2485.0,2500.0,55240.0
Uttarkashi,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,12750.0,9350.0,5820.0,10425.0,8500.0,7450.0,6400.0,6310.0,6085.0,16285.0,13800.0,11300.0,114475.0
Uttarkashi,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,6600.0,3600.0,2200.0,1800.0,4600.0,3800.0,2200.0,2000.0,2000.0,800.0,800.0,2400.0,32800.0
Uttarkashi,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0,8000.0
Uttarkashi,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3000.0,1400.0,400.0,1200.0,800.0,1600.0,200.0,0.0,1200.0,0.0,400.0,400.0,10600.0
Uttarkashi,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3600.0,2200.0,1800.0,4600.0,3800.0,2200.0,2000.0,2000.0,800.0,800.0,2400.0,4000.0,30200.0
Uttarkashi,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,18000.0,8100.0,5700.0,7800.0,10800.0,8100.0,13200.0,16200.0,10800.0,13800.0,11700.0,6900.0,131100.0
Uttarkashi,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,10800.0,7200.0,0.0,14400.0,7200.0,0.0,7200.0,0.0,0.0,7200.0,54000.0
Uttarkashi,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,9900.0,2400.0,8700.0,4200.0,2700.0,9300.0,4200.0,5400.0,4200.0,2100.0,4800.0,1500.0,59400.0
Uttarkashi,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,8100.0,5700.0,7800.0,10800.0,8100.0,13200.0,16200.0,10800.0,13800.0,11700.0,6900.0,12600.0,125700.0
Uttarkashi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2600.0,1600.0,1200.0,2400.0,2200.0,2000.0,3700.0,3700.0,2800.0,1800.0,1800.0,1600.0,27400.0
Uttarkashi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,2000.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0
Uttarkashi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttarkashi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1000.0,400.0,800.0,200.0,200.0,300.0,0.0,900.0,1000.0,0.0,200.0,0.0,5000.0
Uttarkashi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1600.0,1200.0,2400.0,2200.0,2000.0,3700.0,3700.0,2800.0,1800.0,1800.0,1600.0,1600.0,26400.0
Uttarkashi,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Uttarkashi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Uttarkashi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Uttarkashi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Uttarkashi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Uttarkashi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Uttarkashi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Uttarkashi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,1.0,,,,,,,,,1.0
Uttarkashi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Uttarkashi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,1.0,,,,,,,,,1.0
Uttarkashi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,2.0,,1.0,,,,,,3.0
Uttarkashi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Uttarkashi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,2.0,,1.0,,,,,,3.0
Uttarkashi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Uttarkashi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Uttarkashi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,,,,,,,1.0
Uttarkashi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,1.0,,,,,,,,,1.0
Uttarkashi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Uttarkashi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,,,,,,,,1.0
Uttarkashi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,1.0,,1.0,,,,1.0,1.0,,4.0
Uttarkashi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Uttarkashi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,,1.0,,,,1.0,1.0,,4.0
Uttarkashi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Uttarkashi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Uttarkashi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Uttarkashi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Uttarkashi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Uttarkashi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Uttarkashi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Uttarkashi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,,,,,,,,1.0,2.0,,4.0
Uttarkashi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,,,,,,,,1.0,2.0,,4.0
Uttarkashi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,1.0,,1.0,,,2.0
Uttarkashi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,5.0,3.0,,1.0,1.0,,2.0,1.0,5.0,4.0,3.0,6.0,31.0
Uttarkashi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,5.0,3.0,,1.0,1.0,,2.0,2.0,5.0,5.0,3.0,6.0,33.0
Uttarkashi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Uttarkashi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Uttarkashi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,1.0,,,,,,1.0
Uttarkashi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Uttarkashi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,1.0,2.0,,1.0,1.0,,,,,,5.0
Uttarkashi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,4.0,1.0,1.0,,1.0,,,,1.0,1.0,,,9.0
Uttarkashi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,1.0,2.0,2.0,1.0,1.0,1.0,,1.0,1.0,,,14.0
Uttarkashi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Uttarkashi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,1.0,,,,,1.0,,2.0
Uttarkashi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,1.0,,,,1.0,1.0,,3.0
Uttarkashi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Uttarkashi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Uttarkashi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Uttarkashi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Uttarkashi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Uttarkashi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Uttarkashi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Uttarkashi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,,,1.0,1.0,,,,,1.0,2.0,1.0,7.0
Uttarkashi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Uttarkashi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,,,1.0,1.0,,,,,1.0,3.0,1.0,9.0
Uttarkashi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,2.0,,1.0,,,,,1.0,,,4.0
Uttarkashi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,2.0,,1.0,,,,,1.0,,,4.0
Uttarkashi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Uttarkashi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Uttarkashi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,1.0,,,,,,,1.0
Uttarkashi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,,1.0,,,,,,,,,2.0
Uttarkashi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,3.0,3.0
Uttarkashi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,,1.0,,,,,,,,3.0,5.0
Uttarkashi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Uttarkashi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,,1.0,1.0,2.0,2.0,,,,,,7.0
Uttarkashi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,2.0,3.0,3.0,4.0,,4.0,,,5.0,2.0,3.0,28.0
Uttarkashi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,2.0,3.0,4.0,5.0,2.0,6.0,,,5.0,2.0,3.0,35.0
Uttarkashi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,3.0,,,,,1.0,1.0,1.0,,,,6.0
Uttarkashi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,5.0,7.0,4.0,6.0,10.0,2.0,1.0,2.0,4.0,6.0,4.0,3.0,54.0
Uttarkashi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,19.0,6.0,27.0,8.0,17.0,19.0,5.0,21.0,20.0,27.0,9.0,6.0,184.0
Uttarkashi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,24.0,16.0,31.0,14.0,27.0,21.0,7.0,24.0,25.0,33.0,13.0,9.0,244.0
